<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Pharmaceutics</journal-id><journal-id journal-id-type="iso-abbrev">Pharmaceutics</journal-id><journal-id journal-id-type="pmc-domain-id">2103</journal-id><journal-id journal-id-type="pmc-domain">pharmamdpi</journal-id><journal-id journal-id-type="publisher-id">pharmaceutics</journal-id><journal-title-group><journal-title>Pharmaceutics</journal-title></journal-title-group><issn pub-type="epub">1999-4923</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11054966</article-id><article-id pub-id-type="pmcid-ver">PMC11054966.1</article-id><article-id pub-id-type="pmcaid">11054966</article-id><article-id pub-id-type="pmcaiid">11054966</article-id><article-id pub-id-type="pmid">38675115</article-id><article-id pub-id-type="doi">10.3390/pharmaceutics16040454</article-id><article-id pub-id-type="publisher-id">pharmaceutics-16-00454</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Overview of Ethnobotanical&#8211;Pharmacological Studies Carried Out on Medicinal Plants from the Serra da Estrela Natural Park: Focus on Their Antidiabetic Potential</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Lahlou</surname><given-names initials="RA">Radhia Aitfella</given-names></name><xref rid="af1-pharmaceutics-16-00454" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0446-9020</contrib-id><name name-style="western"><surname>Carvalho</surname><given-names initials="F">Filomena</given-names></name><xref rid="af1-pharmaceutics-16-00454" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pereira</surname><given-names initials="MJ">Maria Jo&#227;o</given-names></name><xref rid="af2-pharmaceutics-16-00454" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1657-344X</contrib-id><name name-style="western"><surname>Lopes</surname><given-names initials="J">Jo&#227;o</given-names></name><xref rid="af3-pharmaceutics-16-00454" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5264-3516</contrib-id><name name-style="western"><surname>Silva</surname><given-names initials="LR">Lu&#237;s R.</given-names></name><xref rid="af1-pharmaceutics-16-00454" ref-type="aff">1</xref><xref rid="af4-pharmaceutics-16-00454" ref-type="aff">4</xref><xref rid="af5-pharmaceutics-16-00454" ref-type="aff">5</xref><xref rid="c1-pharmaceutics-16-00454" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Woerdenbag</surname><given-names initials="HJ">Herman J.</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-pharmaceutics-16-00454"><label>1</label>SPRINT Sport Physical Activity and Health Research &amp; Innovation Center, Instituto Polit&#233;cnico da Guarda, 6300-559 Guarda, Portugal; <email>radhialahlou@ipg.pt</email> (R.A.L.); <email>filomenacarvalho@ipg.pt</email> (F.C.)</aff><aff id="af2-pharmaceutics-16-00454"><label>2</label>CERENA/DER, Instituto Superior T&#233;cnico, Universidade de Lisboa, Av. Rovisco Pais, 1049-001 Lisbon, Portugal; <email>maria.pereira@tecnico.ulisboa.pt</email></aff><aff id="af3-pharmaceutics-16-00454"><label>3</label>iMed.ULisboa, Research Institute for Medicines, Faculdade de Farm&#225;cia, University of Lisboa, 1649-003 Lisboa, Portugal; <email>jlopes@ff.ulisboa.pt</email></aff><aff id="af4-pharmaceutics-16-00454"><label>4</label>CICS-UBI&#8212;Health Sciences Research Center, University of Beira Interior, 6201-506 Covilh&#227;, Portugal</aff><aff id="af5-pharmaceutics-16-00454"><label>5</label>CERES, Department of Chemical Engineering, University of Coimbra, 3030-790 Coimbra, Portugal</aff><author-notes><corresp id="c1-pharmaceutics-16-00454"><label>*</label>Correspondence: <email>luissilva@ipg.pt</email></corresp></author-notes><pub-date pub-type="epub"><day>25</day><month>3</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>4</month><year>2024</year></pub-date><volume>16</volume><issue>4</issue><issue-id pub-id-type="pmc-issue-id">461198</issue-id><elocation-id>454</elocation-id><history><date date-type="received"><day>27</day><month>2</month><year>2024</year></date><date date-type="rev-recd"><day>19</day><month>3</month><year>2024</year></date><date date-type="accepted"><day>21</day><month>3</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>25</day><month>03</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>28</day><month>04</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-12-18 13:25:50.540"><day>18</day><month>12</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; 2024 by the authors.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="pharmaceutics-16-00454.pdf"/><abstract><p>The Serra da Estrela Natural Park (NPSE) in Portugal stands out as a well-preserved region abundant in medicinal plants, particularly known for their pharmaceutical applications in diabetes prevention and treatment. This comprehensive review explores these plants&#8217; botanical diversity, traditional uses, pharmacological applications, and chemical composition. The NPSE boast a rich diversity with 138 medicinal plants across 55 families identified as traditionally and pharmacologically used against diabetes globally. Notably, the <italic toggle="yes">Asteraceae</italic> and <italic toggle="yes">Lamiaceae</italic> families are prevalent in antidiabetic applications. In vitro studies have revealed their significant inhibition of carbohydrate-metabolizing enzymes, and certain plant co-products regulate genes involved in carbohydrate metabolism and insulin secretion. In vivo trials have demonstrated antidiabetic effects, including glycaemia regulation, insulin secretion, antioxidant activity, and lipid profile modulation. Medicinal plants in NPSE exhibit various activities beyond antidiabetic, such as antioxidant, anti-inflammatory, antibacterial, anti-cancer, and more. Chemical analyses have identified over fifty compounds like phenolic acids, flavonoids, terpenoids, and polysaccharides responsible for their efficacy against diabetes. These findings underscore the potential of NPSE medicinal plants as antidiabetic candidates, urging further research to develop effective plant-based antidiabetic drugs, beverages, and supplements.</p></abstract><kwd-group><kwd>Natural Park of Serra da Estrela</kwd><kwd>botanical diversity</kwd><kwd>medicinal plants</kwd><kwd>diabetes prevention</kwd><kwd>pharmacological applications</kwd><kwd>chemical composition</kwd></kwd-group><funding-group><award-group><funding-source>Programa Operacional Regional do Centro</funding-source><award-id>CEN-TRO-04-3559-FSE-000162</award-id></award-group><award-group><funding-source>National Funds</funding-source><award-id>CICS-UBI (UIDP/00709/2020)</award-id></award-group><award-group><funding-source>Funda&#231;&#227;o La Caixa and Funda&#231;&#227;o para a Ci&#234;ncia e Tecnologia (FCT)</funding-source></award-group><funding-statement>This work was funded by the Programa Operacional Regional do Centro (CEN-TRO-04-3559-FSE-000162) within the European Social Fund (ESF), CICS-UBI (UIDP/00709/2020) financed by National Funds from Funda&#231;&#227;o para a Ci&#234;ncia e a Tecnologia (FCT), Community Funds (UIDB/00709/2020), by Funda&#231;&#227;o La Caixa and Funda&#231;&#227;o para a Ci&#234;ncia e Tecnologia (FCT) under the Programa Promove Project PD21-00023 (PharmaStar).</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-pharmaceutics-16-00454"><title>1. Introduction</title><p>Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease associated with multiple dysfunctions in the endocrine system [<xref rid="B1-pharmaceutics-16-00454" ref-type="bibr">1</xref>], affecting the metabolism of carbohydrates, lipids, and proteins [<xref rid="B2-pharmaceutics-16-00454" ref-type="bibr">2</xref>]. This disorder is related to a defect in insulin secretion and/or a progressive alteration in its function in the body [<xref rid="B3-pharmaceutics-16-00454" ref-type="bibr">3</xref>,<xref rid="B4-pharmaceutics-16-00454" ref-type="bibr">4</xref>]. The onset of hyperglycemia and insulin resistance leads to the accumulation of free fatty acids, lipid peroxidation, the disruption of cellular antioxidant defences, and inflammatory reactions [<xref rid="B5-pharmaceutics-16-00454" ref-type="bibr">5</xref>,<xref rid="B6-pharmaceutics-16-00454" ref-type="bibr">6</xref>,<xref rid="B7-pharmaceutics-16-00454" ref-type="bibr">7</xref>,<xref rid="B8-pharmaceutics-16-00454" ref-type="bibr">8</xref>]. Although some of the underlying mechanisms are uncertain, all these factors contribute to the disturbance of the integrity of physiological barriers [<xref rid="B9-pharmaceutics-16-00454" ref-type="bibr">9</xref>], mainly by altering the vascular integrity of tissues, and may contribute to the clinically recognised complications of diabetes (hypertension, diabetic peripheral neuropathy, chronic kidney disease, retinopathy, cardiovascular disease, and others) [<xref rid="B10-pharmaceutics-16-00454" ref-type="bibr">10</xref>,<xref rid="B11-pharmaceutics-16-00454" ref-type="bibr">11</xref>,<xref rid="B12-pharmaceutics-16-00454" ref-type="bibr">12</xref>,<xref rid="B13-pharmaceutics-16-00454" ref-type="bibr">13</xref>,<xref rid="B14-pharmaceutics-16-00454" ref-type="bibr">14</xref>,<xref rid="B15-pharmaceutics-16-00454" ref-type="bibr">15</xref>]. T2DM is often associated with fatty liver, sleep apnea syndrome, depression, cognitive decline, and dementia [<xref rid="B16-pharmaceutics-16-00454" ref-type="bibr">16</xref>].</p><p>According to current diabetes statistics, more than 90% of cases worldwide are T2DM; the older generation is the most affected of the 500 million people suffering from the disease [<xref rid="B17-pharmaceutics-16-00454" ref-type="bibr">17</xref>]. About 422 million people worldwide have T2DM, most living in low&#8211;middle-income countries, and 1.5 million deaths are directly attributed to diabetes yearly [<xref rid="B18-pharmaceutics-16-00454" ref-type="bibr">18</xref>]. In Portugal, the incidence of T2DM is much higher than in other types of diabetes [<xref rid="B19-pharmaceutics-16-00454" ref-type="bibr">19</xref>,<xref rid="B20-pharmaceutics-16-00454" ref-type="bibr">20</xref>]. Epidemiological studies show that Portugal (9.1%) is among the countries with the highest rates in Europe, alongside Turkey (14.5%), Spain (10.3%), Andorra (9.7%), and Serbia (9.1%) [<xref rid="B17-pharmaceutics-16-00454" ref-type="bibr">17</xref>]. It is estimated that T2DM affects 13.6% of the Portuguese population aged between 20 and 79; an equivalent rate of 5.9% of people are unaware that they have the disease [<xref rid="B21-pharmaceutics-16-00454" ref-type="bibr">21</xref>]. The data for 2021 already show an increase in the number of new cases identified [<xref rid="B19-pharmaceutics-16-00454" ref-type="bibr">19</xref>]. Around 857,272 people with T2DM have been registered with the Portuguese National Health Service, including 74,396 new diagnoses [<xref rid="B19-pharmaceutics-16-00454" ref-type="bibr">19</xref>]. Approximately 200 new patients are diagnosed with diabetes daily in Portugal [<xref rid="B19-pharmaceutics-16-00454" ref-type="bibr">19</xref>]. </p><p>T2DM can occur for a variety of reasons. Hyperglycaemia, obesity, hypertriglyceridaemia, poor eating habits, lack of exercise, ageing, family history, alcohol consumption, smoking, stress, anxiety, and depression are the main risk factors for the onset of the disease in adults [<xref rid="B22-pharmaceutics-16-00454" ref-type="bibr">22</xref>,<xref rid="B23-pharmaceutics-16-00454" ref-type="bibr">23</xref>,<xref rid="B24-pharmaceutics-16-00454" ref-type="bibr">24</xref>,<xref rid="B25-pharmaceutics-16-00454" ref-type="bibr">25</xref>,<xref rid="B26-pharmaceutics-16-00454" ref-type="bibr">26</xref>]. Statistics show it is present in young people due to poor diet and lifestyle [<xref rid="B17-pharmaceutics-16-00454" ref-type="bibr">17</xref>,<xref rid="B27-pharmaceutics-16-00454" ref-type="bibr">27</xref>,<xref rid="B28-pharmaceutics-16-00454" ref-type="bibr">28</xref>]. Multiple studies have shown that people from different ethnic backgrounds may have specific phenotypes that increase susceptibility to hypertension, insulin resistance, and dyslipidaemia [<xref rid="B29-pharmaceutics-16-00454" ref-type="bibr">29</xref>]. People of Latin American, East, Southeast and South Asian, sub-Saharan African, Middle Eastern, and North African origin living in Europe are 1.3 to 3.7 times more likely to have T2DM than white European populations [<xref rid="B30-pharmaceutics-16-00454" ref-type="bibr">30</xref>]. In the United States, 14.7% of American Indians and Alaska Natives have been diagnosed with diabetes, compared with 7.5% of non-Hispanic white Americans [<xref rid="B31-pharmaceutics-16-00454" ref-type="bibr">31</xref>]. Regarding the gender factor, both men and women are affected, but worldwide, an estimated 17.7 million more men than women have T2DM [<xref rid="B17-pharmaceutics-16-00454" ref-type="bibr">17</xref>,<xref rid="B32-pharmaceutics-16-00454" ref-type="bibr">32</xref>,<xref rid="B33-pharmaceutics-16-00454" ref-type="bibr">33</xref>]. Insulin sensitivity and response capacity are significantly higher in women than men [<xref rid="B34-pharmaceutics-16-00454" ref-type="bibr">34</xref>]. Genetic polymorphisms between the two sexes, differences in the mechanism of action of sex hormones, visceral and hepatic adiposity, hypoadiponectinemia, adiponectin, insulin-sensitive hormones, resting energy expenditure, and lipid metabolism may contribute to higher insulin sensitivity in men than in women [<xref rid="B35-pharmaceutics-16-00454" ref-type="bibr">35</xref>,<xref rid="B36-pharmaceutics-16-00454" ref-type="bibr">36</xref>,<xref rid="B37-pharmaceutics-16-00454" ref-type="bibr">37</xref>,<xref rid="B38-pharmaceutics-16-00454" ref-type="bibr">38</xref>,<xref rid="B39-pharmaceutics-16-00454" ref-type="bibr">39</xref>].</p><p>The accumulation of excessive body fat (obesity) triggers a broad spectrum of metabolic issues and diseases, comprising insulin resistance, atherogenic dyslipidaemia [high plasma triglyceride and low HDL (high-density lipoprotein) cholesterol content], non-alcoholic fatty liver disease (NAFLD), -cell dysfunction, pre-diabetes, and T2DM [<xref rid="B40-pharmaceutics-16-00454" ref-type="bibr">40</xref>,<xref rid="B41-pharmaceutics-16-00454" ref-type="bibr">41</xref>]. Obesity strongly influences T2DM in adults, children, and adolescents [<xref rid="B42-pharmaceutics-16-00454" ref-type="bibr">42</xref>,<xref rid="B43-pharmaceutics-16-00454" ref-type="bibr">43</xref>]. It is a serious concern associated with poorer mental outcomes, reduced quality of life, and the leading cause of death worldwide [<xref rid="B44-pharmaceutics-16-00454" ref-type="bibr">44</xref>]. Obesity increases the risk of developing T2DM by at least a factor of six [<xref rid="B17-pharmaceutics-16-00454" ref-type="bibr">17</xref>,<xref rid="B45-pharmaceutics-16-00454" ref-type="bibr">45</xref>]. The prevalence of obesity in adults (age &#8805; 20 years) was 38.8% between 2013 and 2016 [<xref rid="B46-pharmaceutics-16-00454" ref-type="bibr">46</xref>]. If the obesity trends continue, projections are that one in three adults will have type 2 by 2050 [<xref rid="B47-pharmaceutics-16-00454" ref-type="bibr">47</xref>,<xref rid="B48-pharmaceutics-16-00454" ref-type="bibr">48</xref>]. The prevalence of T2DM is also positively correlated with the duration of obesity and body mass index (BMI) in childhood [<xref rid="B43-pharmaceutics-16-00454" ref-type="bibr">43</xref>,<xref rid="B49-pharmaceutics-16-00454" ref-type="bibr">49</xref>,<xref rid="B50-pharmaceutics-16-00454" ref-type="bibr">50</xref>]. The proportion of T2DM is higher in people who were obese in childhood and of normal weight in adulthood than in people of normal weight in childhood [<xref rid="B43-pharmaceutics-16-00454" ref-type="bibr">43</xref>,<xref rid="B51-pharmaceutics-16-00454" ref-type="bibr">51</xref>]. Obesity and type T2DM represent the greatest threat to the development of atherosclerosis and CAD (coronary artery disease) [<xref rid="B52-pharmaceutics-16-00454" ref-type="bibr">52</xref>]. These two health conditions are oxidative damage, inflammation, and insulin resistance [<xref rid="B5-pharmaceutics-16-00454" ref-type="bibr">5</xref>]. Indeed, under diabetic or hyperglycaemic conditions, excess reactive oxygen species (ROS) are released in various tissues and may play a role in developing many complications [<xref rid="B53-pharmaceutics-16-00454" ref-type="bibr">53</xref>]. This state can persist even when hyperglycaemia is controlled. A disequilibrium occurs with the antioxidant defence systems. This modification scenario is known as oxidative stress [<xref rid="B54-pharmaceutics-16-00454" ref-type="bibr">54</xref>]. It mainly causes endothelial dysfunction, leading to vascular lesions, the abnormal production of plasma lipids, the activation of platelets and increased coagulation, and the activation of inflammatory processes [<xref rid="B54-pharmaceutics-16-00454" ref-type="bibr">54</xref>,<xref rid="B55-pharmaceutics-16-00454" ref-type="bibr">55</xref>]. This damage can be prevented when adequate glycaemic control is established early but is not easily reversed if poor control is maintained over a prolonged period [<xref rid="B56-pharmaceutics-16-00454" ref-type="bibr">56</xref>]. Oxidative stress causes potential damage to lipids, DNA, and proteins and is responsible for altering intracellular signalling pathways, leading to insulin resistance [<xref rid="B57-pharmaceutics-16-00454" ref-type="bibr">57</xref>]. The hyperglycemic environment and free fatty acids lead to the appearance of metabolic stress because of an increase in ROS and a change in the mitochondrial electron transport chain [<xref rid="B58-pharmaceutics-16-00454" ref-type="bibr">58</xref>,<xref rid="B59-pharmaceutics-16-00454" ref-type="bibr">59</xref>,<xref rid="B60-pharmaceutics-16-00454" ref-type="bibr">60</xref>]. ROS are considered key signalling molecules that play an important role in the progression of inflammatory disorders, contributing to the development of insulin resistance and the predicted long-term complications of T2DM [<xref rid="B57-pharmaceutics-16-00454" ref-type="bibr">57</xref>,<xref rid="B61-pharmaceutics-16-00454" ref-type="bibr">61</xref>]. The activation of the immune system and increased circulating acute-phase inflammatory markers can significantly and directly impact insulin resistance or blood glucose levels [<xref rid="B62-pharmaceutics-16-00454" ref-type="bibr">62</xref>].</p><p>Postprandial hyperglycaemia in people with T2DM can be managed by several approaches, including lifestyle modification, i.e., regular physical activity and a healthy diet [<xref rid="B63-pharmaceutics-16-00454" ref-type="bibr">63</xref>]. The administration of pharmacological drugs accompanies these measures. Some of these can delay carbohydrate absorption by reducing the digestion of polysaccharides and their bioavailability (e.g., &#945;-glucosidase inhibitors) [<xref rid="B64-pharmaceutics-16-00454" ref-type="bibr">64</xref>,<xref rid="B65-pharmaceutics-16-00454" ref-type="bibr">65</xref>]. Others are mainly used to increase the availability of endogenous insulin. These include sulphonylureas, such as Glibenclamide, and glinides, insulin analogues that act on the sulphonylurea receptor in the pancreas to promote insulin secretion. Glucagon-like peptide-1 (GLP-1) agonists and dipeptidyl peptidase-IV (DPP-IV) inhibitors can also increase endogenous insulin by acting on ileal cells in the small intestine. Other drugs used to improve insulin sensitivity include thiazolidinediones, peroxisome proliferator-activated receptor gamma (PPAR<italic toggle="yes">&#947;</italic>) agonists, and metformin, a biguanide [<xref rid="B66-pharmaceutics-16-00454" ref-type="bibr">66</xref>,<xref rid="B67-pharmaceutics-16-00454" ref-type="bibr">67</xref>]. All these drug treatments are prescribed either as monotherapy or with other hypoglycaemic agents [<xref rid="B68-pharmaceutics-16-00454" ref-type="bibr">68</xref>]. The administration of exogenous insulin remains the primary treatment for some patients with T2DM who are unable to control their blood glucose with oral hypoglycaemic agents [<xref rid="B68-pharmaceutics-16-00454" ref-type="bibr">68</xref>,<xref rid="B69-pharmaceutics-16-00454" ref-type="bibr">69</xref>]. If all types of oral hypoglycaemic agents and insulin are administered correctly, and with a healthy lifestyle, people with T2DM can manage and reduce the side effects of the disease. However, certain iterations linked to the risk of hypoglycaemia or co-morbidities have been observed [<xref rid="B70-pharmaceutics-16-00454" ref-type="bibr">70</xref>]. These occur following a progressive decline in <italic toggle="yes">&#946;</italic>-cell function and a reduction in therapeutic efficacy due to inappropriate or ineffective dosing regimens, altered drug metabolism, lack of target specificity, and solubility and permeability problems [<xref rid="B68-pharmaceutics-16-00454" ref-type="bibr">68</xref>]. In treated patients, weight gain, weakness, fatigue, lactic acidosis, nausea or diarrhoea, abdominal discomfort, and a metallic taste have been observed [<xref rid="B71-pharmaceutics-16-00454" ref-type="bibr">71</xref>,<xref rid="B72-pharmaceutics-16-00454" ref-type="bibr">72</xref>]. </p><p>In this context, medicinal plants have a well-established record of circumventing the problems mentioned about the conventional use of drugs [<xref rid="B73-pharmaceutics-16-00454" ref-type="bibr">73</xref>]. Medicinal compounds derived from plants could provide new, straightforward approaches to preventing and treating T2DM and its complications [<xref rid="B74-pharmaceutics-16-00454" ref-type="bibr">74</xref>,<xref rid="B75-pharmaceutics-16-00454" ref-type="bibr">75</xref>,<xref rid="B76-pharmaceutics-16-00454" ref-type="bibr">76</xref>]. Traditional knowledge and practices have enabled the development of most modern medicines [<xref rid="B73-pharmaceutics-16-00454" ref-type="bibr">73</xref>,<xref rid="B77-pharmaceutics-16-00454" ref-type="bibr">77</xref>]. Many natural resources have been used to develop almost 25% of the major pharmaceutical compounds and their derivatives currently on the market [<xref rid="B78-pharmaceutics-16-00454" ref-type="bibr">78</xref>,<xref rid="B79-pharmaceutics-16-00454" ref-type="bibr">79</xref>]. These plant resources have great potential as alternative hypoglycaemic medicines because of their safety, efficacy, affordability, and availability. They constitute an almost unlimited source of bioactive compounds, and their use as antidiabetic agents has been exploited in various ways [<xref rid="B74-pharmaceutics-16-00454" ref-type="bibr">74</xref>,<xref rid="B75-pharmaceutics-16-00454" ref-type="bibr">75</xref>]. Secondary metabolites, such as flavonoids, phenolic acids, alkaloids, tannins, terpenoids, saponins, triterpenoids, steroidal glycosides, etc., have shown innumerable promising results against T2DM [<xref rid="B80-pharmaceutics-16-00454" ref-type="bibr">80</xref>,<xref rid="B81-pharmaceutics-16-00454" ref-type="bibr">81</xref>,<xref rid="B82-pharmaceutics-16-00454" ref-type="bibr">82</xref>,<xref rid="B83-pharmaceutics-16-00454" ref-type="bibr">83</xref>]. They are effective in different stages of diabetes. They can control insulin resistance, impact glucose absorption, and regulate multiple glucose and lipid metabolism stages and the inhibition and/or activation of the expression of genes involved in glucose homeostasis [<xref rid="B81-pharmaceutics-16-00454" ref-type="bibr">81</xref>]. These natural antidiabetic agents can act alone or with conventional treatments to strengthen the body&#8217;s ability to cope with the disease [<xref rid="B84-pharmaceutics-16-00454" ref-type="bibr">84</xref>]. However, some of these compounds have not yet been studied in depth. As some of the antidiabetic actions of many medicinal plants are still unexplored, researchers are focusing more and more on finding new treatments that work quickly and at lower costs [<xref rid="B85-pharmaceutics-16-00454" ref-type="bibr">85</xref>]. </p><p>The information needed to assess the efficacy of potentially important medicinal plants and to prove their antidiabetic value must be effective and well-validated [<xref rid="B74-pharmaceutics-16-00454" ref-type="bibr">74</xref>,<xref rid="B86-pharmaceutics-16-00454" ref-type="bibr">86</xref>]. One method of sourcing information on medicinal plants is ethnopharmacological studies [<xref rid="B87-pharmaceutics-16-00454" ref-type="bibr">87</xref>]. They provide rich information from the local community and contribute to discovering and developing natural medicines [<xref rid="B86-pharmaceutics-16-00454" ref-type="bibr">86</xref>]. An analysis of the medicinal literature concerning the NPSE (the Serra da Estrela Natural Park) shows that documentation on local medicinal plants is weak and almost non-existent, hence the importance of an in-depth study [<xref rid="B88-pharmaceutics-16-00454" ref-type="bibr">88</xref>,<xref rid="B89-pharmaceutics-16-00454" ref-type="bibr">89</xref>,<xref rid="B90-pharmaceutics-16-00454" ref-type="bibr">90</xref>,<xref rid="B91-pharmaceutics-16-00454" ref-type="bibr">91</xref>,<xref rid="B92-pharmaceutics-16-00454" ref-type="bibr">92</xref>,<xref rid="B93-pharmaceutics-16-00454" ref-type="bibr">93</xref>,<xref rid="B94-pharmaceutics-16-00454" ref-type="bibr">94</xref>,<xref rid="B95-pharmaceutics-16-00454" ref-type="bibr">95</xref>,<xref rid="B96-pharmaceutics-16-00454" ref-type="bibr">96</xref>,<xref rid="B97-pharmaceutics-16-00454" ref-type="bibr">97</xref>,<xref rid="B98-pharmaceutics-16-00454" ref-type="bibr">98</xref>]. Therefore, to obtain a complete perspective on the potential use of medicinal plants from the NPSE as alternative solutions for combating diabetes, the most relevant studies concerning the botanical diversity, the known traditional uses of local plants, the validation of their antidiabetic activities (in vitro and in vivo studies), the underlying mechanisms of action, their pharmacological activities, the plant-derived chemical compounds that may be responsible for these activities, and the challenges and prospects for the antidiabetic activity of medicinal plants from the NPSE have been critically analysed in this review. </p></sec><sec id="sec2-pharmaceutics-16-00454"><title>2. Materials and Methods</title><sec id="sec2dot1-pharmaceutics-16-00454"><title>2.1. Geographical and Climate Features of the Serra da Estrela Natural Park</title><p>Continental Portugal has several mountain ranges. The highest is in the centre-east, the &#8220;Serra da Estrela&#8221; (40&#176;20&#8242; N, 7&#176;35&#8242; W) (<xref rid="pharmaceutics-16-00454-f001" ref-type="fig">Figure 1</xref>) [<xref rid="B99-pharmaceutics-16-00454" ref-type="bibr">99</xref>]. Its massif forms the western part of the Cordillera Central, with its highest point called &#8220;La Torre&#8221; at an altitude of 1993 m [<xref rid="B88-pharmaceutics-16-00454" ref-type="bibr">88</xref>,<xref rid="B89-pharmaceutics-16-00454" ref-type="bibr">89</xref>,<xref rid="B90-pharmaceutics-16-00454" ref-type="bibr">90</xref>,<xref rid="B91-pharmaceutics-16-00454" ref-type="bibr">91</xref>]. Part of the Iberian Peninsula is traversed by this mountain range, over 500 km long, stretching from almost the Atlantic coast to just north of Madrid [<xref rid="B88-pharmaceutics-16-00454" ref-type="bibr">88</xref>,<xref rid="B89-pharmaceutics-16-00454" ref-type="bibr">89</xref>,<xref rid="B90-pharmaceutics-16-00454" ref-type="bibr">90</xref>,<xref rid="B91-pharmaceutics-16-00454" ref-type="bibr">91</xref>]. Most of these mountains lie within the boundaries of the NPSE, created in 1976 [<xref rid="B100-pharmaceutics-16-00454" ref-type="bibr">100</xref>,<xref rid="B101-pharmaceutics-16-00454" ref-type="bibr">101</xref>,<xref rid="B102-pharmaceutics-16-00454" ref-type="bibr">102</xref>] and covering around 100,000 hectares [<xref rid="B88-pharmaceutics-16-00454" ref-type="bibr">88</xref>,<xref rid="B89-pharmaceutics-16-00454" ref-type="bibr">89</xref>,<xref rid="B90-pharmaceutics-16-00454" ref-type="bibr">90</xref>,<xref rid="B91-pharmaceutics-16-00454" ref-type="bibr">91</xref>]. This area is a biological and community interest site integral to the Natura 2000 network [<xref rid="B100-pharmaceutics-16-00454" ref-type="bibr">100</xref>,<xref rid="B101-pharmaceutics-16-00454" ref-type="bibr">101</xref>]. Six municipalities (Seia, Gouveia, Celorico da Beira, Guarda, Manteigas, and Covilha) (<xref rid="pharmaceutics-16-00454-f001" ref-type="fig">Figure 1</xref>) and two districts (in the north, the district of Guarda, and the south, the community of Castelo Branco) have joined forces to draw up this project [<xref rid="B88-pharmaceutics-16-00454" ref-type="bibr">88</xref>,<xref rid="B89-pharmaceutics-16-00454" ref-type="bibr">89</xref>,<xref rid="B90-pharmaceutics-16-00454" ref-type="bibr">90</xref>,<xref rid="B91-pharmaceutics-16-00454" ref-type="bibr">91</xref>,<xref rid="B100-pharmaceutics-16-00454" ref-type="bibr">100</xref>,<xref rid="B101-pharmaceutics-16-00454" ref-type="bibr">101</xref>,<xref rid="B102-pharmaceutics-16-00454" ref-type="bibr">102</xref>]. The mountains are mainly composed of granite in the central part and schist in the periphery, dominating the Mondego and the Zezere plains (a tributary of the Tagus) [<xref rid="B88-pharmaceutics-16-00454" ref-type="bibr">88</xref>,<xref rid="B89-pharmaceutics-16-00454" ref-type="bibr">89</xref>,<xref rid="B90-pharmaceutics-16-00454" ref-type="bibr">90</xref>,<xref rid="B91-pharmaceutics-16-00454" ref-type="bibr">91</xref>]. In the north-east, the landscape is characterized by the watersheds of three major basins: the Douro (the largest river on the Iberian Peninsula), the Tagus (the longest river on the Iberian Peninsula), and the Mondego (the largest river in Portugal) [<xref rid="B88-pharmaceutics-16-00454" ref-type="bibr">88</xref>,<xref rid="B89-pharmaceutics-16-00454" ref-type="bibr">89</xref>,<xref rid="B90-pharmaceutics-16-00454" ref-type="bibr">90</xref>,<xref rid="B91-pharmaceutics-16-00454" ref-type="bibr">91</xref>].</p><p>The climate of Serra da Estrela is influenced by several factors: temperature, atmospheric pressure, wind, humidity, and precipitation, as well as geographical factors [<xref rid="B103-pharmaceutics-16-00454" ref-type="bibr">103</xref>,<xref rid="B104-pharmaceutics-16-00454" ref-type="bibr">104</xref>]. Its high altitude among the surrounding land, the general organisation of the relief, and the relative proximity of the Atlantic Ocean, some one hundred kilometres away, play a decisive role in the complex mosaic of local climates that characterise the region [<xref rid="B88-pharmaceutics-16-00454" ref-type="bibr">88</xref>,<xref rid="B89-pharmaceutics-16-00454" ref-type="bibr">89</xref>,<xref rid="B90-pharmaceutics-16-00454" ref-type="bibr">90</xref>,<xref rid="B91-pharmaceutics-16-00454" ref-type="bibr">91</xref>]. Thus, all the climate factors are controlled by the overall latitudinal position of the mountains and influenced by the north&#8211;south temperate climate and the southeast-northwest Mediterranean macroclimate [<xref rid="B99-pharmaceutics-16-00454" ref-type="bibr">99</xref>,<xref rid="B103-pharmaceutics-16-00454" ref-type="bibr">103</xref>,<xref rid="B104-pharmaceutics-16-00454" ref-type="bibr">104</xref>]. They are also controlled by the Atlantic&#8217;s longitudinal position and the Iberian Peninsula&#8217;s interior (maritime influences mainly to the west and continental influences to the east and west) [<xref rid="B88-pharmaceutics-16-00454" ref-type="bibr">88</xref>,<xref rid="B89-pharmaceutics-16-00454" ref-type="bibr">89</xref>,<xref rid="B90-pharmaceutics-16-00454" ref-type="bibr">90</xref>,<xref rid="B91-pharmaceutics-16-00454" ref-type="bibr">91</xref>]. Average annual rainfall is around 2500 mm at the summit, while the plateaux record is more than 2000 mm [<xref rid="B88-pharmaceutics-16-00454" ref-type="bibr">88</xref>,<xref rid="B89-pharmaceutics-16-00454" ref-type="bibr">89</xref>,<xref rid="B99-pharmaceutics-16-00454" ref-type="bibr">99</xref>,<xref rid="B105-pharmaceutics-16-00454" ref-type="bibr">105</xref>]. The highest number of precipitation days is observed in the western part of the mountains, while the lowest values are in the basal areas, in the north-western and south-eastern sectors, with around 1000 to 1200 mm [<xref rid="B88-pharmaceutics-16-00454" ref-type="bibr">88</xref>,<xref rid="B89-pharmaceutics-16-00454" ref-type="bibr">89</xref>,<xref rid="B90-pharmaceutics-16-00454" ref-type="bibr">90</xref>,<xref rid="B99-pharmaceutics-16-00454" ref-type="bibr">99</xref>,<xref rid="B105-pharmaceutics-16-00454" ref-type="bibr">105</xref>]. The region is characterized by hot, dry summers and wet winters, with snowfall more frequent between December and March [<xref rid="B99-pharmaceutics-16-00454" ref-type="bibr">99</xref>,<xref rid="B103-pharmaceutics-16-00454" ref-type="bibr">103</xref>,<xref rid="B104-pharmaceutics-16-00454" ref-type="bibr">104</xref>]. The most striking aspects of the relief are the glacial forms and deposits. The snowfall is heaviest in the higher mountain areas but lightest and most irregular in the lower regions [<xref rid="B88-pharmaceutics-16-00454" ref-type="bibr">88</xref>,<xref rid="B89-pharmaceutics-16-00454" ref-type="bibr">89</xref>,<xref rid="B90-pharmaceutics-16-00454" ref-type="bibr">90</xref>,<xref rid="B91-pharmaceutics-16-00454" ref-type="bibr">91</xref>].</p><fig position="anchor" id="pharmaceutics-16-00454-f001" orientation="portrait"><label>Figure 1</label><caption><p>Geolocalization of Serra da Estrela Natural Park [<xref rid="B106-pharmaceutics-16-00454" ref-type="bibr">106</xref>].</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pharmaceutics-16-00454-g001.jpg"/></fig></sec><sec id="sec2dot2-pharmaceutics-16-00454"><title>2.2. Ethnobotanical Data Collection and Selection Criteria</title><p>The information on the plant species of the Serra da Estrela region has been collected from the databases of the World Checklist of Vascular Plants [<xref rid="B107-pharmaceutics-16-00454" ref-type="bibr">107</xref>]. It is an international collaborative programme with editors, compilers, and reviewers from all over the world. The main objective of the database is to provide high-quality, expertly reviewed taxonomic data on all vascular plants based on the nomenclatural data provided by the International Plant Name Index (IPNI). </p><p>The Flora-On database is also used; it is a portal coordinated by the Portuguese Botanical Society containing photographic, geographical, morphological, and ecological information for all vascular plant species in Portugal [<xref rid="B108-pharmaceutics-16-00454" ref-type="bibr">108</xref>]. The search was supported by the INaturalist database [<xref rid="B109-pharmaceutics-16-00454" ref-type="bibr">109</xref>]. It is a joint initiative of the California Academy of Sciences and the National Geographic Society. It is also a species identification system and a tool for recording the occurrence of organisms. It can be used to record sightings, get help with identifications, collaborate with others to collect information for a common purpose, or access sighting data collected by iNaturalist users [<xref rid="B109-pharmaceutics-16-00454" ref-type="bibr">109</xref>]. All databases were screened using a combination of the keywords &#8220;Family&#8221;, &#8220;Species&#8221;, &#8220;Species Synonyms&#8221;, and &#8220;Subspecies&#8221;. This approach enabled us to find 97 different families. The total number of species is 888 (a complete list of the taxa is given in <xref rid="app1-pharmaceutics-16-00454" ref-type="app">Table S1</xref>). Based on this list of plants, a systematic literature search on their traditional and diabetic uses was conducted. Data were obtained from scientific databases, including NCBI, Scopus, Web of Science, and Google Scholar (<xref rid="pharmaceutics-16-00454-f002" ref-type="fig">Figure 2</xref>). The preliminary selection was initially performed using the search terms &#8220;Serra da Estrela&#8221; and &#8220;medicinal plants&#8221; to cover the maximum range of medicinal plants used against diabetes. As the number of studies was small, we carried out another selection, but universal, by searching by keyword for all medicinal plants from the Serra da Estrela region and their possible worldwide uses. The Boolean operator &#8220;AND&#8221; followed by the keyword &#8220;Diabetes&#8221; or &#8220;Hypoglycaemic&#8221; was used for this search to cover literature reports dealing exclusively with T2DM anywhere in the world. This search was carried out specifically for each plant on the databases, using the leading taxonomic designation of the species and other botanical synonym names, followed by the keywords mentioned. The names of each plant and combinations of the terms &#8220;Traditional&#8221;, &#8220;Ethnobotanical&#8221;, &#8220;Ethnobotany&#8221;, &#8220;Folk remedies&#8221;, and &#8220;Ethnomedicinal&#8221; were used to search the above databases (<xref rid="pharmaceutics-16-00454-f002" ref-type="fig">Figure 2</xref>). </p></sec></sec><sec sec-type="results" id="sec3-pharmaceutics-16-00454"><title>3. Results</title><sec id="sec3dot1-pharmaceutics-16-00454"><title>3.1. Botanical Diversity of NPSE and Ethnopharmacological Uses of Medicinal Plants with Antidiabetic Potential</title><p>Mountains have always been an excellent challenge for humankind, who have never ceased climbing, cultivating, and domesticating. They are open-air laboratories of knowledge, home to species and communities that have adapted to their environment in various ways. They provide fertile ground for observing and understanding the evolution of species and the distribution of organisms in similar contexts, from one mountain to another thousands of kilometres away. They are, therefore, important ecosystems because they harbour high levels of biodiversity and endemicity [<xref rid="B110-pharmaceutics-16-00454" ref-type="bibr">110</xref>]. They provide essential services such as climate regulation, freshwater supply and purification, and nutrient cycling [<xref rid="B111-pharmaceutics-16-00454" ref-type="bibr">111</xref>,<xref rid="B112-pharmaceutics-16-00454" ref-type="bibr">112</xref>,<xref rid="B113-pharmaceutics-16-00454" ref-type="bibr">113</xref>,<xref rid="B114-pharmaceutics-16-00454" ref-type="bibr">114</xref>,<xref rid="B115-pharmaceutics-16-00454" ref-type="bibr">115</xref>]. </p><p>The inaccessible NPSE vegetation is the best preserved in the region [<xref rid="B88-pharmaceutics-16-00454" ref-type="bibr">88</xref>,<xref rid="B89-pharmaceutics-16-00454" ref-type="bibr">89</xref>]. The isolation of the summits and the extreme conditions that prevail there have encouraged the appearance of new species and facilitated species isolation, speciation, extinction, and migration [<xref rid="B114-pharmaceutics-16-00454" ref-type="bibr">114</xref>]. According to Jansen et al. [<xref rid="B88-pharmaceutics-16-00454" ref-type="bibr">88</xref>], the flora of this mountainous region shows significant contrasts as you go up in altitude. The vegetation is divided into several levels, the boundaries of which vary according to exposure. Within this tiering, the transitions in vegetation are distinguishable, and each level corresponds to a well-defined ecosystem. In addition, the isolation of the summits and the extreme prevailing conditions have encouraged the appearance of new species. Many species are endemic to these areas, making the NPSE one of the wealthiest regions in Portugal for certain groups of plants [<xref rid="B88-pharmaceutics-16-00454" ref-type="bibr">88</xref>,<xref rid="B89-pharmaceutics-16-00454" ref-type="bibr">89</xref>].</p><p>The climatic heterogeneity contributing to the region&#8217;s high biodiversity has attracted botanists&#8217; interest [<xref rid="B99-pharmaceutics-16-00454" ref-type="bibr">99</xref>]. Floristic expeditions from the 18th century to the present day have enabled a rigorous characterisation of the ecosystems&#8217; flora, which is essential for their in-depth knowledge and conservation [<xref rid="B93-pharmaceutics-16-00454" ref-type="bibr">93</xref>]. According to the three bioclimatic levels (Meso-Mediterranean, Supra-Mediterranean, Oromediterranean) defined in the Serra da Estrela region, three vegetation ranges (basal, intermediate, and upper) have been characterized. The three combined levels have identified approximately 900 vascular species and subspecies [<xref rid="B88-pharmaceutics-16-00454" ref-type="bibr">88</xref>]. Endemic Iberian species belonging to the Mediterranean and Atlantic flora are particularly well represented and distributed in an area more or less delimited by the altitude of the massif and the climatic, edaphic, and sun exposure conditions [<xref rid="B88-pharmaceutics-16-00454" ref-type="bibr">88</xref>,<xref rid="B89-pharmaceutics-16-00454" ref-type="bibr">89</xref>,<xref rid="B91-pharmaceutics-16-00454" ref-type="bibr">91</xref>,<xref rid="B102-pharmaceutics-16-00454" ref-type="bibr">102</xref>]. Some relict plant populations from northern and central Europe have also invaded the area [<xref rid="B88-pharmaceutics-16-00454" ref-type="bibr">88</xref>].</p><p>The botanical census of NPSE diversity enabled us to identify 97 families, 112 genera, and 888 vascular species (after eliminating synonyms) (<xref rid="app1-pharmaceutics-16-00454" ref-type="app">Table S1</xref>). The number of native species on the Iberian Peninsula is 133, while there are only 9 endemic species in Portugal. By contrast, the number of introduced species is 36 [<xref rid="B107-pharmaceutics-16-00454" ref-type="bibr">107</xref>,<xref rid="B108-pharmaceutics-16-00454" ref-type="bibr">108</xref>,<xref rid="B116-pharmaceutics-16-00454" ref-type="bibr">116</xref>].</p><p>The <italic toggle="yes">Asteraceae</italic> is the family with the most species/subspecies (sp) in the region (108 sp). It is followed by <italic toggle="yes">Poaceae</italic> (81 sp), <italic toggle="yes">Fabaceae</italic> (74 sp), <italic toggle="yes">Caryophyllaceae</italic> (60 sp), <italic toggle="yes">Brassicaceae</italic> (33 sp), <italic toggle="yes">Apiaceae</italic> (29 sp), <italic toggle="yes">Lamiaceae</italic> (29 sp), <italic toggle="yes">Rosaceae</italic> (28 sp), <italic toggle="yes">Plantaginaceae</italic> (27 sp), <italic toggle="yes">Polygalaceae</italic> (22 sp), <italic toggle="yes">Ranunculaceae</italic> (21 sp), <italic toggle="yes">Cyperaceae</italic> (19 sp), <italic toggle="yes">Juncaceae</italic> (18 sp), <italic toggle="yes">Rubiaceae</italic> (17 sp), <italic toggle="yes">Cistaceae</italic> (16 sp), <italic toggle="yes">Amaryllidaceae</italic> (15 sp), and <italic toggle="yes">Crassulaceae</italic> (14 sp). </p><p>Several plants found in the NPSE have been used to treat diabetes. Despite the relatively large number of studies worldwide reporting their biological potential, NPSE species have been little investigated, and species with antidiabetic potential will be the subject of particular attention in the following section. Of the 888 species listed, only 138 plants (15.54%) from different geographical regions have been selected based on traditional uses and studies into their antidiabetic potential (<xref rid="app1-pharmaceutics-16-00454" ref-type="app">Table S2</xref>). The families with the highest number of species are <italic toggle="yes">Asteraceae</italic> (21 sp), <italic toggle="yes">Lamiaceae</italic> (12 sp), <italic toggle="yes">Fabaceae</italic> (9 sp), <italic toggle="yes">Rosaceae</italic> (8 sp), <italic toggle="yes">Caryophyllaceae</italic> (6 sp), and <italic toggle="yes">Polygalaceae</italic> (5 sp) (<xref rid="pharmaceutics-16-00454-f003" ref-type="fig">Figure 3</xref>). The <italic toggle="yes">Apiaceae</italic>, <italic toggle="yes">Asparagaceae</italic>, and <italic toggle="yes">Ericaceae</italic> contain four species/subspecies, and <italic toggle="yes">Boraginaceae</italic>, <italic toggle="yes">Geraniaceae</italic>, <italic toggle="yes">Hypericaceae</italic>, and <italic toggle="yes">Fagaceae</italic> comprise three (<xref rid="pharmaceutics-16-00454-f003" ref-type="fig">Figure 3</xref>). However, the families <italic toggle="yes">Brassicaceae</italic>, <italic toggle="yes">Cistaceae</italic>, <italic toggle="yes">Amaryllidaceae</italic>, <italic toggle="yes">Scrophulariaceae</italic>, <italic toggle="yes">Papaveraceae</italic>, <italic toggle="yes">Pteridaceae</italic>, <italic toggle="yes">Caprifoliaceae</italic>, <italic toggle="yes">Gentianaceae</italic>, <italic toggle="yes">Urticaceae</italic>, <italic toggle="yes">Malvaceae</italic>, <italic toggle="yes">Cupressaceae</italic>, <italic toggle="yes">Cytinaceae</italic>, and <italic toggle="yes">Pinaceae</italic> present only two species with antidiabetic potential. As for the rest, 30 families have only one species, and 42 families have never been traditionally used or studied for their effects on diabetes (<xref rid="app1-pharmaceutics-16-00454" ref-type="app">Table S2</xref>). </p><p>The antidiabetic plants belong to fifty-five families (6.20% of the total families of NPSE) and have been reported in the literature for various traditional uses (<xref rid="app1-pharmaceutics-16-00454" ref-type="app">Supplementary Table S3</xref>). The number of species for which evidence of traditional use against diabetes had been found was 83 (<xref rid="app1-pharmaceutics-16-00454" ref-type="app">Supplementary Tables S3 and S4</xref>). The parts used and the preparation method vary from one plant to another. In most cases, the plant parts were used singularly and sometimes as a combination of two or more parts. However, there are 55 other species whose traditional use has not been revealed. They have, however, been studied for their antidiabetic efficacy (<xref rid="app1-pharmaceutics-16-00454" ref-type="app">Supplementary Table S4</xref>).</p><sec id="sec3dot1dot1-pharmaceutics-16-00454"><title>3.1.1. <italic toggle="yes">Asteraceae</italic></title><p>The <italic toggle="yes">Asteraceae</italic> family has the most significant number of plants with antidiabetic potential. Twenty-one species were selected, or 19.44% of all <italic toggle="yes">Asteraceae</italic> species and 2.17% of all species identified in the NPSE (<xref rid="app1-pharmaceutics-16-00454" ref-type="app">Tables S1 and S2</xref>). The <italic toggle="yes">Asteraceae</italic> family includes many flowering plants in nearly 1600 genera, comprising more than 23,000 species [<xref rid="B117-pharmaceutics-16-00454" ref-type="bibr">117</xref>,<xref rid="B118-pharmaceutics-16-00454" ref-type="bibr">118</xref>]. The <italic toggle="yes">Asteraceae</italic> are herbs, shrubs, trees, or lianas, with laticifers or resin ducts in some taxa [<xref rid="B119-pharmaceutics-16-00454" ref-type="bibr">119</xref>,<xref rid="B120-pharmaceutics-16-00454" ref-type="bibr">120</xref>]. Leaves are simple or compound, spiral or opposite [rarely whorled], and exstipulate. The most distinctive feature of the Asteraceae is their inflorescence structure: the highly compressed inflorescence branch system called a capitulum or flower head, in which all the flowers are attached to a receptacle surrounded by involucral bracts [<xref rid="B119-pharmaceutics-16-00454" ref-type="bibr">119</xref>,<xref rid="B120-pharmaceutics-16-00454" ref-type="bibr">120</xref>]. The <italic toggle="yes">capitulum</italic> forms a <italic toggle="yes">pseudanthium</italic>, a structure resembling a single large flower. The anthers, which include a tube, and the lower position of the ovary are other features that help to diagnose the family [<xref rid="B121-pharmaceutics-16-00454" ref-type="bibr">121</xref>]. Modifying the outer floral whorl into pappus bristles, which help disperse the seeds, is also widespread in the family. The fruit is an achene (or &#8220;cypsela&#8221;, an achene derived from an inferior ovary), typically multiple fruits of achenes, with an elongated beak forming between the fruit and the pappus in some taxa. The seeds are exalbuminate [<xref rid="B119-pharmaceutics-16-00454" ref-type="bibr">119</xref>,<xref rid="B120-pharmaceutics-16-00454" ref-type="bibr">120</xref>]. </p><p>Members of the <italic toggle="yes">Asteraceae</italic> family are distributed worldwide; some of these species are highly aromatic and have already been reported to have medicinal and therapeutic applications. For centuries, they have been used worldwide as traditional medicine against various human ailments, including T2DM, kidney, heart, lung, liver, and skin toothache inflammation, pain, constipation, toothache, throat pain, snake bite, headache, gastrointestinal disorders, diarrhoea, dysentery, tuberculosis, hepatitis, asthma, menopausal and menstrual disorders, stomach ulcers, sores, scabies, filariasis, elephantiasis, night-blindness, impotence, hair fall, jaundice, nose bleeding, allergies, viral infections, cough, bronchitis, different types of cancers, wounds and cuts, and malaria [<xref rid="B122-pharmaceutics-16-00454" ref-type="bibr">122</xref>,<xref rid="B123-pharmaceutics-16-00454" ref-type="bibr">123</xref>,<xref rid="B124-pharmaceutics-16-00454" ref-type="bibr">124</xref>,<xref rid="B125-pharmaceutics-16-00454" ref-type="bibr">125</xref>,<xref rid="B126-pharmaceutics-16-00454" ref-type="bibr">126</xref>,<xref rid="B127-pharmaceutics-16-00454" ref-type="bibr">127</xref>,<xref rid="B128-pharmaceutics-16-00454" ref-type="bibr">128</xref>].</p><p>In the NPSE, only 19 of the 55 genera listed have been studied for their antidiabetic potential (<xref rid="app1-pharmaceutics-16-00454" ref-type="app">Tables S1 and S2</xref>). Various biological activities have been reported for these <italic toggle="yes">Asteraceae</italic> species worldwide [<xref rid="B118-pharmaceutics-16-00454" ref-type="bibr">118</xref>,<xref rid="B123-pharmaceutics-16-00454" ref-type="bibr">123</xref>,<xref rid="B125-pharmaceutics-16-00454" ref-type="bibr">125</xref>,<xref rid="B126-pharmaceutics-16-00454" ref-type="bibr">126</xref>,<xref rid="B127-pharmaceutics-16-00454" ref-type="bibr">127</xref>,<xref rid="B128-pharmaceutics-16-00454" ref-type="bibr">128</xref>,<xref rid="B129-pharmaceutics-16-00454" ref-type="bibr">129</xref>,<xref rid="B130-pharmaceutics-16-00454" ref-type="bibr">130</xref>]. The species <italic toggle="yes">Arctium minus</italic> (Hill) Bernh, <italic toggle="yes">Achillea millefolium</italic>, <italic toggle="yes">Anthemis canescens</italic> (syn. <italic toggle="yes">Matricaria aurea</italic>), <italic toggle="yes">Arnica montana</italic> subsp. Atlantica, <italic toggle="yes">Bellis perennis</italic>, <italic toggle="yes">Bidens frondosa</italic>, <italic toggle="yes">Calendula arvensis</italic>, <italic toggle="yes">Chamaemelum nobile</italic> (syn. <italic toggle="yes">Matricaria chamomilla</italic> or <italic toggle="yes">Matricaria recutita</italic>), <italic toggle="yes">Cichorium intybus</italic>, <italic toggle="yes">Dittrichia viscosa</italic> subsp. Viscosa (Syn. <italic toggle="yes">Inula viscosa</italic>), <italic toggle="yes">Galinsoga parviflora</italic> (Syn. <italic toggle="yes">Galinsoga quadriradiata</italic>), <italic toggle="yes">Helichrysum stoechas</italic> subsp. <italic toggle="yes">Stoechas</italic>, and <italic toggle="yes">Hypochaeris radicata</italic> have been used extensively in traditional medicine to treat diabetes [<xref rid="B131-pharmaceutics-16-00454" ref-type="bibr">131</xref>,<xref rid="B132-pharmaceutics-16-00454" ref-type="bibr">132</xref>,<xref rid="B133-pharmaceutics-16-00454" ref-type="bibr">133</xref>,<xref rid="B134-pharmaceutics-16-00454" ref-type="bibr">134</xref>,<xref rid="B135-pharmaceutics-16-00454" ref-type="bibr">135</xref>,<xref rid="B136-pharmaceutics-16-00454" ref-type="bibr">136</xref>,<xref rid="B137-pharmaceutics-16-00454" ref-type="bibr">137</xref>,<xref rid="B138-pharmaceutics-16-00454" ref-type="bibr">138</xref>,<xref rid="B139-pharmaceutics-16-00454" ref-type="bibr">139</xref>,<xref rid="B140-pharmaceutics-16-00454" ref-type="bibr">140</xref>,<xref rid="B141-pharmaceutics-16-00454" ref-type="bibr">141</xref>,<xref rid="B142-pharmaceutics-16-00454" ref-type="bibr">142</xref>,<xref rid="B143-pharmaceutics-16-00454" ref-type="bibr">143</xref>]. Different parts include flowers, leaves, seeds, stems, and roots. However, no evidence exists of using other species, <italic toggle="yes">Anthemis canescens</italic>, <italic toggle="yes">Bellis perennis</italic>, <italic toggle="yes">Bidens frondose</italic>, <italic toggle="yes">Helichrysum stoechas</italic> subsp. <italic toggle="yes">Stoechas</italic>, <italic toggle="yes">Lactuca serriola</italic>, <italic toggle="yes">Onopordum acanthium</italic> subsp. <italic toggle="yes">Acanthium</italic>, <italic toggle="yes">Senecio vulgaris</italic>, <italic toggle="yes">Tanacetum parthenium</italic>, and <italic toggle="yes">Tanacetum vulgare</italic> (<xref rid="app1-pharmaceutics-16-00454" ref-type="app">Supplementary Tables S3 and S4</xref>).</p></sec><sec id="sec3dot1dot2-pharmaceutics-16-00454"><title>3.1.2. <italic toggle="yes">Lamiaceae</italic></title><p>The <italic toggle="yes">Lamiaceae</italic> or <italic toggle="yes">Labiatae</italic> are a family of flowering plants with a cosmopolitan distribution, comprising around 236 genera and an estimated 6900 to 7200 species [<xref rid="B144-pharmaceutics-16-00454" ref-type="bibr">144</xref>]. In continental Portugal, it is represented by 29 genera with 95 different species [<xref rid="B108-pharmaceutics-16-00454" ref-type="bibr">108</xref>]. They are herbs or shrubs, often aromatic with ethereal oils, with generally four-sided stems, opposite (or verticillate) leaves, a verticillate or thyrse inflorescence (solitary and axillary flowers in some cases), and zygomorphic (rarely actinomorphic) flowers, usually bilabiate, with a superior ovary, often deeply four-lobed (by the formation of &#8220;false septa&#8221;) with a gynobasic style, the fruit being a schizocarp of usually four nuts or a berry or a drupe [<xref rid="B119-pharmaceutics-16-00454" ref-type="bibr">119</xref>]. Since antiquity, the family has contained many culinary or flavouring herbs widely used as spices, teas, or traditional medicines. Several of its members are also used as sources of essential oils (EO) [<xref rid="B145-pharmaceutics-16-00454" ref-type="bibr">145</xref>]. They have been reported as a rich source of antidiabetic plants [<xref rid="B146-pharmaceutics-16-00454" ref-type="bibr">146</xref>]. </p><p>Based on database analysis, twelve species were selected with antidiabetic potential, representing 37.93% of all <italic toggle="yes">Lamiaceae</italic> species and 1.13% of all species identified in the NPSE (<xref rid="app1-pharmaceutics-16-00454" ref-type="app">Tables S1 and S2</xref>). Among these species are those traditionally used to treat diabetes, including <italic toggle="yes">Clinopodium nepeta</italic> subsp.<italic toggle="yes"> Spruneri</italic> (Syn. <italic toggle="yes">Calamintha officinalis</italic> Moench), <italic toggle="yes">Lavandula stoechas</italic>, <italic toggle="yes">Mentha aquatica</italic>, <italic toggle="yes">Mentha pulegium</italic>, <italic toggle="yes">Mentha suaveolens</italic>, <italic toggle="yes">Origanum vulgare</italic>, <italic toggle="yes">Prunella vulgaris</italic>, and <italic toggle="yes">Salvia verbenaca</italic> [<xref rid="B147-pharmaceutics-16-00454" ref-type="bibr">147</xref>,<xref rid="B148-pharmaceutics-16-00454" ref-type="bibr">148</xref>,<xref rid="B149-pharmaceutics-16-00454" ref-type="bibr">149</xref>,<xref rid="B150-pharmaceutics-16-00454" ref-type="bibr">150</xref>,<xref rid="B151-pharmaceutics-16-00454" ref-type="bibr">151</xref>,<xref rid="B152-pharmaceutics-16-00454" ref-type="bibr">152</xref>,<xref rid="B153-pharmaceutics-16-00454" ref-type="bibr">153</xref>,<xref rid="B154-pharmaceutics-16-00454" ref-type="bibr">154</xref>,<xref rid="B155-pharmaceutics-16-00454" ref-type="bibr">155</xref>,<xref rid="B156-pharmaceutics-16-00454" ref-type="bibr">156</xref>,<xref rid="B157-pharmaceutics-16-00454" ref-type="bibr">157</xref>,<xref rid="B158-pharmaceutics-16-00454" ref-type="bibr">158</xref>,<xref rid="B159-pharmaceutics-16-00454" ref-type="bibr">159</xref>]. To our knowledge, there is no record of <italic toggle="yes">Lavandula pedunculata</italic> subsp. <italic toggle="yes">Pedunculata</italic>, <italic toggle="yes">Melissa officinalis</italic>, <italic toggle="yes">Origanum vulgare</italic> subsp.<italic toggle="yes"> Virens</italic>, and <italic toggle="yes">Thymus mastichina</italic> being used to treat diabetes in folk medicine (<xref rid="app1-pharmaceutics-16-00454" ref-type="app">Supplementary Tables S3 and S4</xref>).</p></sec><sec id="sec3dot1dot3-pharmaceutics-16-00454"><title>3.1.3. <italic toggle="yes">Fabaceae</italic></title><p>The <italic toggle="yes">Fabaceae</italic> (or <italic toggle="yes">Leguminosae</italic>) are one of the world&#8217;s twelve flowering plants after the <italic toggle="yes">Orchidaceae</italic> and <italic toggle="yes">Asteraceae</italic>, with no fewer than 19,400 species grouped into 740 genera [<xref rid="B160-pharmaceutics-16-00454" ref-type="bibr">160</xref>]. Thanks to its ability to form root nodules with nitrogen-fixing bacteria [<xref rid="B161-pharmaceutics-16-00454" ref-type="bibr">161</xref>], this family covers the entire globe in various habitats, with representatives in almost every biome, from deserts to tropical forests [<xref rid="B160-pharmaceutics-16-00454" ref-type="bibr">160</xref>]. They grow as shrubs, trees, and even aquatic plants, have a diverse floral morphology, and are adapted to various ecological and climatic conditions. Most species in this family are of significant economic value [<xref rid="B162-pharmaceutics-16-00454" ref-type="bibr">162</xref>]. Thanks to their nitrogen-fixing behaviour, these plants can produce large quantities of protein, a nutritional source for animal and human consumption [<xref rid="B163-pharmaceutics-16-00454" ref-type="bibr">163</xref>,<xref rid="B164-pharmaceutics-16-00454" ref-type="bibr">164</xref>]. They are also considered a good source of fibre, carbohydrates, minerals, and vitamins. The <italic toggle="yes">Fabaceae</italic> members are superior to other dietary supplements due to their low-fat content compared with most cereals [<xref rid="B163-pharmaceutics-16-00454" ref-type="bibr">163</xref>]&#8212;the resistant starch and fibre act as prebiotics for probiotics or beneficial bacteria [<xref rid="B164-pharmaceutics-16-00454" ref-type="bibr">164</xref>]. Micronutrients are also essential for reducing anaemia risk [<xref rid="B164-pharmaceutics-16-00454" ref-type="bibr">164</xref>]. The consumption of most <italic toggle="yes">Fabaceae</italic> species helps moderate blood sugar levels after meals and improves insulin sensitivity. It also positively impacts sight reduction by inducing satiety [<xref rid="B165-pharmaceutics-16-00454" ref-type="bibr">165</xref>].</p><p>In the Serra da Estrela region, nine species had antidiabetic benefits out of 79 species of <italic toggle="yes">Fabaceae</italic> (12.16%) listed in the area (<xref rid="app1-pharmaceutics-16-00454" ref-type="app">Tables S1 and S2</xref>), representing 0.93% of all the species found in the NPSE. These species comprise <italic toggle="yes">Acacia dealbata</italic>, <italic toggle="yes">Lupinus angustifolius</italic>, <italic toggle="yes">Lupinus luteus</italic>, <italic toggle="yes">Pisum sativum</italic>, <italic toggle="yes">Pterospartum tridentatum</italic>, <italic toggle="yes">Retama sphaerocarpa</italic>, <italic toggle="yes">Robinia pseudoacacia</italic>, <italic toggle="yes">Trifolium pratense</italic> subsp. <italic toggle="yes">Pratense</italic>, and <italic toggle="yes">Trifolium repens.</italic> Only the four species (<italic toggle="yes">Pisum sativum</italic>, <italic toggle="yes">Pterospartum tridentatum</italic>, <italic toggle="yes">Retama sphaerocarpa</italic>, and <italic toggle="yes">Trifolium pratense</italic> subsp. <italic toggle="yes">Pratense</italic>) have been registered as being used in traditional medicine in ancient times (<xref rid="app1-pharmaceutics-16-00454" ref-type="app">Supplementary Table S3</xref>). All parts of these plants (leaves, stems, roots, and flowers) are traditionally used to combat various ailments. Pollen, bark, gum, seeds, fruit, and even cladodes are also used. As far as diabetes is concerned, only the species <italic toggle="yes">Pisum sativum</italic>, <italic toggle="yes">Pterospartum tridentatum</italic>, <italic toggle="yes">Retama sphaerocarpa</italic>, and <italic toggle="yes">Trifolium pratense</italic> are recorded as being traditionally used to treat it (<xref rid="app1-pharmaceutics-16-00454" ref-type="app">Supplementary Tables S3 and S4</xref>).</p></sec><sec id="sec3dot1dot4-pharmaceutics-16-00454"><title>3.1.4. <italic toggle="yes">Rosaceae</italic></title><p>The <italic toggle="yes">Rosaceae</italic> family include species of herbs, shrubs, or trees. They are sometimes rhizomatous, climbing, or thorny and are cosmopolitan or sub-cosmopolitan [<xref rid="B119-pharmaceutics-16-00454" ref-type="bibr">119</xref>,<xref rid="B166-pharmaceutics-16-00454" ref-type="bibr">166</xref>]. They are very diverse, particularly in the northern hemisphere, and are very important from an economic point of view, as they are the source of many cultivated fruits. These species are economically and ecologically beneficial, providing habitat anchorage [<xref rid="B167-pharmaceutics-16-00454" ref-type="bibr">167</xref>] and timber [<xref rid="B168-pharmaceutics-16-00454" ref-type="bibr">168</xref>]. Herbaceous species of the <italic toggle="yes">Rosaceae</italic> grow in temperate forests as understorey plants, in salt or freshwater marshes, in arctic tundra, in old fields, and along roadsides [<xref rid="B119-pharmaceutics-16-00454" ref-type="bibr">119</xref>,<xref rid="B166-pharmaceutics-16-00454" ref-type="bibr">166</xref>]. Woody species are pioneer species that play an essential role in the early stages of forest succession. <italic toggle="yes">Rosaceae</italic> can also be a minor component of mature mixed deciduous forests [<xref rid="B119-pharmaceutics-16-00454" ref-type="bibr">119</xref>,<xref rid="B166-pharmaceutics-16-00454" ref-type="bibr">166</xref>]. Their leaves are spiral (rarely opposite), simple or compound, undivided or divided, generally stipulate (lost in some taxa), and the stipules often adnate at the base of the petiole. The inflorescence is variable. The flowers are bisexual (generally), actinomorphic, perigynous, or epi perigynous; the receptacle is sometimes enlarged or sunken [<xref rid="B119-pharmaceutics-16-00454" ref-type="bibr">119</xref>,<xref rid="B166-pharmaceutics-16-00454" ref-type="bibr">166</xref>]. The fruit is a drupe, pome, hip, follicetum, achenecetum, or capsule. The seeds typically have no endosperm [<xref rid="B119-pharmaceutics-16-00454" ref-type="bibr">119</xref>,<xref rid="B166-pharmaceutics-16-00454" ref-type="bibr">166</xref>]. Eight species of <italic toggle="yes">Rosaceae</italic> have been identified in the Serra da Estrela region (<xref rid="app1-pharmaceutics-16-00454" ref-type="app">Tables S1 and S2</xref>), including <italic toggle="yes">Agrimonia eupatoria</italic>, <italic toggle="yes">Crataegus monogyna</italic>, <italic toggle="yes">Geum urbanum</italic>, <italic toggle="yes">Potentilla erecta</italic>, <italic toggle="yes">Prunus avium</italic>, <italic toggle="yes">Prunus lusitanica</italic> subsp. <italic toggle="yes">lusitanica</italic>, <italic toggle="yes">Rosa canina</italic>, and <italic toggle="yes">Sorbus aucuparia</italic>. These species have traditionally been used to treat diabetes, except for <italic toggle="yes">Prunus lusitanica</italic> subsp. <italic toggle="yes">Lusitanica</italic>.</p></sec><sec id="sec3dot1dot5-pharmaceutics-16-00454"><title>3.1.5. <italic toggle="yes">Caryophyllaceae</italic></title><p>The <italic toggle="yes">Caryophyllaceae</italic> family, commonly known as the rose or carnation family, comprises 104 genera and over 2000 species. They are annual or perennial herbs or small erect or prostrate shrubs; some species are more prominent or small trees. The species are distributed over almost the entire globe, with the centres of biodiversity being in Europe and Asia&#8217;s moderate to warm regions [<xref rid="B119-pharmaceutics-16-00454" ref-type="bibr">119</xref>,<xref rid="B169-pharmaceutics-16-00454" ref-type="bibr">169</xref>,<xref rid="B170-pharmaceutics-16-00454" ref-type="bibr">170</xref>]. They are also concentrated in the Mediterranean region, with various habitats and growth forms [<xref rid="B169-pharmaceutics-16-00454" ref-type="bibr">169</xref>]. The <italic toggle="yes">Caryophyllaceae</italic> are distinguished by their often-swollen nodes; simple, opposite leaves; an inflorescence of solitary flowers or dichasial cymes; actinomorphic, biseriate flowers, usually pentamerous with distinct, clawed petals; an upper ovary with free or basal distal placentation; and a capsular fruit in which only anthocyanin pigments are present [<xref rid="B119-pharmaceutics-16-00454" ref-type="bibr">119</xref>,<xref rid="B169-pharmaceutics-16-00454" ref-type="bibr">169</xref>]. An unusual feature of this family is the stable, long-lasting foam that appears when plant parts are placed in water and shaken [<xref rid="B170-pharmaceutics-16-00454" ref-type="bibr">170</xref>]. This behaviour is due to saponins, which can be as high as 20% (dry weight) in some species. The most significant quantity of saponins is generally found in the roots or seeds and can vary depending on the growing period, the part of the plant, and the season [<xref rid="B170-pharmaceutics-16-00454" ref-type="bibr">170</xref>]. </p><p><italic toggle="yes">Corrigiola litoralis</italic>, <italic toggle="yes">Corrigiola telephiifolia</italic>, <italic toggle="yes">Paronychia argentea</italic>, <italic toggle="yes">Saponaria officinalis</italic>, and <italic toggle="yes">Stellaria media</italic> are all plants belonging to the <italic toggle="yes">Caryophyllaceae</italic> family found in the NPSE that have traditionally been used to treat diabetes (except <italic toggle="yes">Spergularia rubra</italic>). The leaves and roots are the most widely used parts of the plants identified (<xref rid="app1-pharmaceutics-16-00454" ref-type="app">Supplementary Tables S3 and S4</xref>).</p></sec><sec id="sec3dot1dot6-pharmaceutics-16-00454"><title>3.1.6. <italic toggle="yes">Polygalaceae</italic></title><p>The word <italic toggle="yes">Polygalaceae</italic>, or Milkwort family, comes from a Greek name meaning &#8220;much milk&#8221;, as certain species eaten by cows are thought to increase milk production [<xref rid="B119-pharmaceutics-16-00454" ref-type="bibr">119</xref>]. This family is almost cosmopolitan (absent only from New Zealand, many islands in the South Pacific, Antarctica, and the Arctic), with many genera having a wide distribution [<xref rid="B171-pharmaceutics-16-00454" ref-type="bibr">171</xref>]. The family has many habits, from rainforest trees to small achlorophyllous grasses, including annual and perennial herbs, lianas, and shrubs of various sizes [<xref rid="B119-pharmaceutics-16-00454" ref-type="bibr">119</xref>,<xref rid="B171-pharmaceutics-16-00454" ref-type="bibr">171</xref>]. The family comprises 22 genera and between 800 and 1000 species [<xref rid="B171-pharmaceutics-16-00454" ref-type="bibr">171</xref>], characterized by simple, spiral-shaped leaves that are generally exstipulate (modified by a pair of glands or spines in some cases). Their inflorescence is a spike, raceme, or panicle. The flowers are bisexual, zygomorphic [rarely almost actinomorphic], hypogynous to perigynous, and subtended by a pair of bracteoles. The fruit is a loculicidal capsule, nut, samara, or drupe. The seeds are arillate (with a wattle) and endospermic (proteinaceous) [<xref rid="B119-pharmaceutics-16-00454" ref-type="bibr">119</xref>].</p><p>The species in the <italic toggle="yes">Polygalaceae</italic> family with antidiabetic potential identified in the NPSE are <italic toggle="yes">Polygonum aviculare</italic>, <italic toggle="yes">Polygonum hydropiper</italic>, <italic toggle="yes">Rumex acetosa</italic> subsp. <italic toggle="yes">acetosa, Rumex crispus</italic>, and <italic toggle="yes">Rumex obtusifolius</italic> (<xref rid="app1-pharmaceutics-16-00454" ref-type="app">Supplementary Table S3</xref>)<italic toggle="yes">. Polygonum hydropiper</italic> and <italic toggle="yes">Rumex obtusifolius</italic> have never traditionally been used to treat diabetes, but scientific evidence shows they are effective against the disease (<xref rid="app1-pharmaceutics-16-00454" ref-type="app">Supplementary Table S4</xref>). </p></sec><sec id="sec3dot1dot7-pharmaceutics-16-00454"><title>3.1.7. Other families</title><p>The families <italic toggle="yes">Apiaceae</italic> (<italic toggle="yes">Daucus carota</italic>, <italic toggle="yes">Eryngium campestre</italic>, <italic toggle="yes">Foeniculum vulgare</italic>, <italic toggle="yes">Heracleum sphondylium</italic>), <italic toggle="yes">Asparagaceae</italic> (<italic toggle="yes">Muscari comosum</italic>, <italic toggle="yes">Polygonatum odoratum</italic>, <italic toggle="yes">Ruscus aculeatusi</italic>, <italic toggle="yes">Urginea maritima</italic>), and <italic toggle="yes">Ericaceae</italic> (<italic toggle="yes">Arbutus unedo</italic>, <italic toggle="yes">Erica scoparia</italic> subsp. <italic toggle="yes">Scoparia</italic>, <italic toggle="yes">Vaccinium myrtillus</italic>, <italic toggle="yes">Vaccinium uliginosum</italic>) include four species whose antidiabetic potential has been studied (<xref rid="app1-pharmaceutics-16-00454" ref-type="app">Supplementary Tables S3 and S4</xref>). However, only three species have been identified for the families of <italic toggle="yes">Boraginaceae</italic>, <italic toggle="yes">Geraniaceae</italic>, <italic toggle="yes">Hypericaceae</italic>, and <italic toggle="yes">Fagaceae</italic>. The species are <italic toggle="yes">Anchusa undulata</italic>, <italic toggle="yes">Echium plantagineum</italic>, <italic toggle="yes">Lithodora prostrata</italic>, <italic toggle="yes">Geranium purpureum</italic>, <italic toggle="yes">Geranium pyrenaicum</italic> subsp. <italic toggle="yes">Lusitanicum, Geranium robertianum</italic>, <italic toggle="yes">Castanea sativa</italic>, <italic toggle="yes">Quercus pyrenaica</italic>, and <italic toggle="yes">Quercus suber</italic> (<xref rid="app1-pharmaceutics-16-00454" ref-type="app">Supplementary Table S3</xref>).</p><p>The families <italic toggle="yes">Amaryllidaceae</italic>, <italic toggle="yes">Brassicaceae</italic>, <italic toggle="yes">Caprifoliaceae</italic>, <italic toggle="yes">Cistaceae</italic>, <italic toggle="yes">Cupressaceae</italic>, <italic toggle="yes">Cytinaceae, Gentianaceae, Malvaceae, Papaveraceae, Pinaceae, Scrophulariacea,</italic> and <italic toggle="yes">Urticaceae</italic>, each of which is represented by just two species with antidiabetic potential, include <italic toggle="yes">Allium victorialis, Narcissus pseudonarcissus, Capsella bursa-pastoris, Raphanus raphanistrum subsp. raphanistrum, Lonicera periclymenum, Sambucus nigra, Cistus ladanifer, Cistus salviifolius, Juniperus communis, Juniperus communis</italic> subsp. <italic toggle="yes">alpina, Cytinus hypocistis, Cytinus hypocistis</italic> subsp. <italic toggle="yes">hypocistis</italic>, <italic toggle="yes">Centaurium erythraea</italic>, <italic toggle="yes">Gentiana lutea</italic> subsp. <italic toggle="yes">lutea</italic>, <italic toggle="yes">Malva neglecta</italic>, <italic toggle="yes">Malva sylvestris</italic>, <italic toggle="yes">Chelidonium majus</italic>, <italic toggle="yes">Papaver dubium</italic>, <italic toggle="yes">Pinus pinaster</italic>, <italic toggle="yes">Pinus sylvestris</italic>, <italic toggle="yes">Verbascum sinuatum</italic>, <italic toggle="yes">Verbascum thapsus</italic>, <italic toggle="yes">Urtica dioica</italic>, and <italic toggle="yes">Urtica membranacea</italic> (<xref rid="app1-pharmaceutics-16-00454" ref-type="app">Supplementary Table S3</xref>).</p><p>A single species has been identified in the following families <italic toggle="yes">Amaranthaceae</italic> (<italic toggle="yes">Chenopodium ambrosioides</italic>), <italic toggle="yes">Betulaceae</italic> (<italic toggle="yes">Corylus avellana</italic>), <italic toggle="yes">Buxaceae</italic> (<italic toggle="yes">Buxus sempervirens</italic>), <italic toggle="yes">Campanulaceae</italic> (<italic toggle="yes">Jasione montana</italic> var. <italic toggle="yes">gracilis</italic>), <italic toggle="yes">Cannabaceae</italic> (<italic toggle="yes">Humulus lupulus</italic>), <italic toggle="yes">Convolvulaceae</italic> (<italic toggle="yes">Convolvulus arvensis</italic>), <italic toggle="yes">Cucurbitaceae</italic> (<italic toggle="yes">Bryonia dioica</italic>), <italic toggle="yes">Dioscoreaceae</italic> (<italic toggle="yes">Tamus communis</italic>), <italic toggle="yes">Dryopteridaceae</italic> (<italic toggle="yes">Dryopteris dilatata</italic>), <italic toggle="yes">Juncaceae</italic> (<italic toggle="yes">Juncus acutus</italic>), <italic toggle="yes">Lauraceae</italic> (<italic toggle="yes">Laurus nobilis</italic>), <italic toggle="yes">Lycopodiaceae</italic> (<italic toggle="yes">Lycopodium clavatum), Lythraceae</italic> (<italic toggle="yes">Lythrum salicaria</italic>), <italic toggle="yes">Moraceae</italic> (<italic toggle="yes">Ficus carica</italic>), <italic toggle="yes">Myrtaceae</italic> (<italic toggle="yes">Eucalyptus globulus</italic>), <italic toggle="yes">Oleaceae</italic> (<italic toggle="yes">Olea europaea</italic> var. <italic toggle="yes">europaea</italic>), <italic toggle="yes">Oxalidaceae</italic> (<italic toggle="yes">Oxalis pes-caprae</italic>), Phytolaccaceae (<italic toggle="yes">Phytolacca americana</italic>), <italic toggle="yes">Poaceae</italic> (<italic toggle="yes">Avena sativa</italic>), <italic toggle="yes">Portulacaceae</italic> (<italic toggle="yes">Portulaca oleracea</italic>), <italic toggle="yes">Pteridaceae</italic> (<italic toggle="yes">Adiantum capillus-veneris</italic> L.), <italic toggle="yes">Primulaceae</italic> (<italic toggle="yes">Anagallis arvensis</italic>), <italic toggle="yes">Rubiaceae</italic> (<italic toggle="yes">Galium aparine</italic>), <italic toggle="yes">Simaroubaceae</italic> (<italic toggle="yes">Ailanthus altissima</italic>), <italic toggle="yes">Solanaceae</italic> (<italic toggle="yes">Solanum nigrum</italic>), <italic toggle="yes">Taxaceae</italic> (<italic toggle="yes">Taxus baccata</italic>), <italic toggle="yes">Thymelaeaceae</italic> (<italic toggle="yes">Daphne gnidium</italic>), <italic toggle="yes">Ulmaceae</italic> (<italic toggle="yes">Ulmus glabra</italic>), <italic toggle="yes">Verbenaceae</italic> (<italic toggle="yes">Verbena officinalis</italic>), and <italic toggle="yes">Vitaceae</italic> (<italic toggle="yes">Vitis vinifera</italic> subsp. <italic toggle="yes">sylvestris</italic>) (<xref rid="app1-pharmaceutics-16-00454" ref-type="app">Supplementary Tables S3 and S4</xref>). Finally, no species have been traditionally used or studied for its antidiabetic potential in the rest of the families listed (42) in the NPSE (<xref rid="app1-pharmaceutics-16-00454" ref-type="app">Table S2</xref>).</p></sec></sec><sec id="sec3dot2-pharmaceutics-16-00454"><title>3.2. Medicinal Plants with Antidiabetic Potential in NPSE</title><sec id="sec3dot2dot1-pharmaceutics-16-00454"><title>3.2.1. <italic toggle="yes">Asteraceae</italic> Family</title><list list-type="bullet"><list-item><p><italic toggle="yes">Arctium minus</italic> (Hill) Bernh.</p></list-item></list><p><italic toggle="yes">Arctium</italic> species are known for their pharmacological effects and chemical diversity [<xref rid="B172-pharmaceutics-16-00454" ref-type="bibr">172</xref>]. These plants, also known as &#8220;burdock&#8221;, are biennial herbs found in waste ground, streams, and roadsides, more rarely in woods and forests, in temperate regions of Europe and Asia, and sporadically in subtropical and tropical regions [<xref rid="B172-pharmaceutics-16-00454" ref-type="bibr">172</xref>]. Several Arctium plants have also been reported in folk medicines for T2DM. Among its most investigated members is the species <italic toggle="yes">Arctium minus</italic> (Hill) Bernh (<xref rid="pharmaceutics-16-00454-t001" ref-type="table">Table 1</xref>). Its extracts exert antihyperglycaemic properties through various mechanisms. According to &#304;lg&#252;n et al. [<xref rid="B173-pharmaceutics-16-00454" ref-type="bibr">173</xref>], only the leaf extracts (excluding leaf ethyl acetate extract) showed <italic toggle="yes">&#945;</italic>-amylase inhibition activity at a 1 mg/mL concentration (<xref rid="pharmaceutics-16-00454-t002" ref-type="table">Table 2</xref>). In the <italic toggle="yes">&#945;</italic>- glucosidase inhibition assay, the dichloromethane extract of the <italic toggle="yes">A. minus</italic> leaf had the highest enzyme inhibition activity, with 87.12% inhibition, compared with the other extracts and with acarbose at a concentration of 1 mg/mL [<xref rid="B173-pharmaceutics-16-00454" ref-type="bibr">173</xref>]. The hypoglycaemic activity of the crude aqueous extract of the leaves and roots of <italic toggle="yes">A. minus</italic> was also tested in alloxan (ALO)-induced diabetic rats [<xref rid="B174-pharmaceutics-16-00454" ref-type="bibr">174</xref>].</p><p>In this study, the aqueous extract of the leaves caused a 6.2% reduction in blood sugar levels in the rats. The same result was observed with the positive control Glibenclamide. These results are still better than those of the aqueous root extract (5.8%). In any case, these results prove the hypoglycaemic activity of this species [<xref rid="B174-pharmaceutics-16-00454" ref-type="bibr">174</xref>]. Arctium roots contain inulin, the common name for all linear fructans (insulin-like fructans, ITF), a type of indigestible carbohydrate that is more or less polymerised [<xref rid="B175-pharmaceutics-16-00454" ref-type="bibr">175</xref>]. It comprises fructose units (2 to 60 units) and a terminal glucose unit. Because of its complex structure, inulin resists breakdown by the digestive enzymes of the small intestine, which are specific to <italic toggle="yes">&#945;</italic>-glycosidic bonds; the compound is therefore classified as a &#8220;non-digestible&#8221; oligosaccharide [<xref rid="B175-pharmaceutics-16-00454" ref-type="bibr">175</xref>]. When inulin remains in the upper gastrointestinal tract, it is fermented by the microbial flora of the colon (or large intestine) to produce short-chain fatty acids (SCFAs), which serve as a source of energy for the resident bacteria while exerting numerous other effects on the health of the host [<xref rid="B175-pharmaceutics-16-00454" ref-type="bibr">175</xref>]. Inulin promotes the growth (i.e., an increase in the number) of specific health-promoting intestinal micro-organisms, thereby positively modifying the intestinal ecosystem, in addition to inulin&#8211;host interaction or immunomodulatory effects [<xref rid="B176-pharmaceutics-16-00454" ref-type="bibr">176</xref>,<xref rid="B177-pharmaceutics-16-00454" ref-type="bibr">177</xref>]. In this way, dietary inulin-induced changes to the microbiota could improve type 2 diabetes mellitus [<xref rid="B175-pharmaceutics-16-00454" ref-type="bibr">175</xref>,<xref rid="B178-pharmaceutics-16-00454" ref-type="bibr">178</xref>,<xref rid="B179-pharmaceutics-16-00454" ref-type="bibr">179</xref>,<xref rid="B180-pharmaceutics-16-00454" ref-type="bibr">180</xref>]. The intestinal symbiosis supported by supplementation with inulin, among other dietary fibres, provides preventive and/or therapeutic options for many metabolic disorders, including obesity, type 2 diabetes mellitus, cardiometabolic diseases, kidney disease, and hyperuricaemia [<xref rid="B175-pharmaceutics-16-00454" ref-type="bibr">175</xref>]. </p><p>As a result, <italic toggle="yes">A. minus</italic> roots used by diabetic patients can slow the digestion of carbohydrates, reduce absorption, and control glucose intolerance [<xref rid="B181-pharmaceutics-16-00454" ref-type="bibr">181</xref>]. However, controversial results have been obtained by Fereira et al. [<xref rid="B182-pharmaceutics-16-00454" ref-type="bibr">182</xref>]. In their study, the plant did not control hyperglycaemia in a Goto-Kakizaki (GK) rat model. The plant extract was prepared from a plant sample from a Portuguese herbalist. However, analysis of the plant extract revealed the presence of heavy metals, nickel (Ni) and cadmium (Cd), which could inhibit insulin release and have toxic effects on rats [<xref rid="B182-pharmaceutics-16-00454" ref-type="bibr">182</xref>]. According to the authors (<xref rid="pharmaceutics-16-00454-t002" ref-type="table">Table 2</xref>), all medicinal plants may contain them, as they can bioaccumulate several heavy metals. These results could be attributed to the different animal models of diabetes, the conditions of experimentation, and the different chemotypes investigated [<xref rid="B174-pharmaceutics-16-00454" ref-type="bibr">174</xref>,<xref rid="B182-pharmaceutics-16-00454" ref-type="bibr">182</xref>]. Several studies have demonstrated the richness of this plant in bioactive compounds. <italic toggle="yes">Arctium minus</italic> is rich in polysaccharide compounds, flavonoids, phenolic acids, and the lignan Arctiin. These chemical compounds are associated with the diverse biological activities observed by the plant [<xref rid="B183-pharmaceutics-16-00454" ref-type="bibr">183</xref>,<xref rid="B184-pharmaceutics-16-00454" ref-type="bibr">184</xref>,<xref rid="B185-pharmaceutics-16-00454" ref-type="bibr">185</xref>], which are helpful to diabetic patients in reducing oxidative stress and the common low-grade inflammation related to the disease [<xref rid="B186-pharmaceutics-16-00454" ref-type="bibr">186</xref>,<xref rid="B187-pharmaceutics-16-00454" ref-type="bibr">187</xref>].</p><table-wrap position="anchor" id="pharmaceutics-16-00454-t001" orientation="portrait"><object-id pub-id-type="pii">pharmaceutics-16-00454-t001_Table 1</object-id><label>Table 1</label><caption><p>NPSE medicinal plants reported constituents to pharmacological use.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Pharmacological Uses</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Chemical Constituents</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr><tr><th colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Asteraceae</italic>
</th></tr></thead><tbody><tr><td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1"><italic toggle="yes">Arctium minus</italic> (Hill) Bernh</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antimicrobial, antioxidant, anti-inflammatory, antinociceptive, acetylcholinesterase inhibitory activities, anti-cancer.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenolic acids: Rosmarinic acid, quinic acid, caffeic acid, chlorogenic acid, cynarin, hydroxy cinnamoyl quinic acid.<break/>Flavonoids: Rutin, isoquercetin, luteolin kaempferol-3-<italic toggle="yes">O</italic>-rhamnoglucoside, quercimeritrin, astragalin, arabinose, rhamnose, mannose, cellulose, inulin.<break/>Polysaccharides: Pectic substance, rhamnogalacturonan, hemicellulose (arabinan, arabinogalactan, galactan, xylan, xyloglucan, galacturonic acid, glucose, galactose.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B118-pharmaceutics-16-00454" ref-type="bibr">118</xref>,<xref rid="B173-pharmaceutics-16-00454" ref-type="bibr">173</xref>,<xref rid="B183-pharmaceutics-16-00454" ref-type="bibr">183</xref>,<xref rid="B184-pharmaceutics-16-00454" ref-type="bibr">184</xref>,<xref rid="B185-pharmaceutics-16-00454" ref-type="bibr">185</xref>,<xref rid="B188-pharmaceutics-16-00454" ref-type="bibr">188</xref>,<xref rid="B189-pharmaceutics-16-00454" ref-type="bibr">189</xref>]</td></tr><tr><td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Achillea millefolium</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anxiolytic, antimicrobial, antioxidant, vasoprotective, vasorelaxant, anti-appetite (orexigenic), anti-tumor, anti-ulcerogenic, hypotensive, analgesic, modulation of mitochondria respiration, anti-inflammatory, anti-neuroinflammatory, anti-proliferative, antiplatelet, skin-rejuvenating, antinociceptive, hepatoprotective, antiplasmodial, anthelmintic, antispasmodic, anti-cancer, antispermatogenic, for haemorrhoids and dysmenorrhea.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenolic acids: <italic toggle="yes">Cis</italic> and <italic toggle="yes">trans</italic>-3,5-<italic toggle="yes">O</italic>-dicaffeoylquinic acids, chlorogenic acid, <italic toggle="yes">p</italic>-coumaric acid, neochlorogenic acid, ferulic acid, stachydrine.<break/>Flavonoids: Resveratrol, morin, myricetin, naringin, naringenin, apigenin, quercetin, luteolin <italic toggle="yes">O</italic>-acetylhexoside, apigenin <italic toggle="yes">O</italic>-acetylhexoside, centaureidin, casticin, artemetin, luteolin 7-glucoside, luteolin 4&#8242;-<italic toggle="yes">O</italic>-glucosid, apigenin 7-glucoside, apigenin 4&#8242;-<italic toggle="yes">O</italic>-<italic toggle="yes">&#945;</italic>-glucopyranoside, 5-Hydroxy-3,6,7,4&#8242;-tetramethoxyflavone, kaempferol, isorhamnetin glycosides, rutin, cynaroside, cosmosiin, vicenin-2.<break/>Sesquiterpenoids: paulitin, isopaulitin, psilostachyin C, desacetylmatricarin, sintenin, achillicin, 8a-(Angeloyloxy), artabsin 1,4-endoperoxide, 8a-(Tigloyloxy)artabsin 1,4-endoperoxide, 7b-Hydroxy-a-longipin-2-en-1-one, a-Longipin-2-en-1-one (longipinanes), Millefoliumins F and G, leucodin, 8<italic toggle="yes">&#945;</italic>-angeloxy-leucodin, achillin, 8<italic toggle="yes">&#945;</italic>-angeloxy-achillin, desacetylmatricarin.<break/>Organic acids and phenols: oxalic, quinic, citric acids, fatty acids (with linoleic and palmitic acids), tocopherols (<italic toggle="yes">&#947;</italic>-tocopherol), ascorbic acid, carboxylic acid, salicylic acid, thymol, carvacrol, pyrocatechol, adenine, mandelic acid, methyl esters of caprylic-linolenic-undecylenic acid.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B172-pharmaceutics-16-00454" ref-type="bibr">172</xref>,<xref rid="B190-pharmaceutics-16-00454" ref-type="bibr">190</xref>,<xref rid="B191-pharmaceutics-16-00454" ref-type="bibr">191</xref>,<xref rid="B192-pharmaceutics-16-00454" ref-type="bibr">192</xref>,<xref rid="B193-pharmaceutics-16-00454" ref-type="bibr">193</xref>,<xref rid="B194-pharmaceutics-16-00454" ref-type="bibr">194</xref>,<xref rid="B195-pharmaceutics-16-00454" ref-type="bibr">195</xref>,<xref rid="B196-pharmaceutics-16-00454" ref-type="bibr">196</xref>,<xref rid="B197-pharmaceutics-16-00454" ref-type="bibr">197</xref>,<xref rid="B198-pharmaceutics-16-00454" ref-type="bibr">198</xref>,<xref rid="B199-pharmaceutics-16-00454" ref-type="bibr">199</xref>,<xref rid="B200-pharmaceutics-16-00454" ref-type="bibr">200</xref>,<xref rid="B201-pharmaceutics-16-00454" ref-type="bibr">201</xref>,<xref rid="B202-pharmaceutics-16-00454" ref-type="bibr">202</xref>,<xref rid="B203-pharmaceutics-16-00454" ref-type="bibr">203</xref>,<xref rid="B204-pharmaceutics-16-00454" ref-type="bibr">204</xref>,<xref rid="B205-pharmaceutics-16-00454" ref-type="bibr">205</xref>,<xref rid="B206-pharmaceutics-16-00454" ref-type="bibr">206</xref>,<xref rid="B207-pharmaceutics-16-00454" ref-type="bibr">207</xref>,<xref rid="B208-pharmaceutics-16-00454" ref-type="bibr">208</xref>,<xref rid="B209-pharmaceutics-16-00454" ref-type="bibr">209</xref>,<xref rid="B210-pharmaceutics-16-00454" ref-type="bibr">210</xref>,<xref rid="B211-pharmaceutics-16-00454" ref-type="bibr">211</xref>,<xref rid="B212-pharmaceutics-16-00454" ref-type="bibr">212</xref>,<xref rid="B213-pharmaceutics-16-00454" ref-type="bibr">213</xref>,<xref rid="B214-pharmaceutics-16-00454" ref-type="bibr">214</xref>,<xref rid="B215-pharmaceutics-16-00454" ref-type="bibr">215</xref>,<xref rid="B216-pharmaceutics-16-00454" ref-type="bibr">216</xref>]</td></tr><tr><td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1"><italic toggle="yes">Anthemis canescens</italic> (syn. <italic toggle="yes">Matricaria aurea</italic>)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antioxidant, anti-inflammatory, anti-ulcer, analgesic, antibacterial, anti-cancer.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenolic acids: <italic toggle="yes">p</italic>-coumaric acid, ferulic acid, shikimic acid, protocatechuic acid, <italic toggle="yes">p</italic>-aminobenzoic acid, digalloyl-shikimic acid, epicatechin, <italic toggle="yes">p</italic>-hydroxybenzoic acid, rosmarinic acid, 7,8-dihydroxycoumarin, chlorogenic acid, 1-<italic toggle="yes">O</italic>-<italic toggle="yes">b</italic>-<sc>d</sc>-glucopyranosyl sinapate, 5-methoxysalicylic acid.<break/>Flavonoids: Apigenin, apigenin-7-<italic toggle="yes">O</italic>-rhamnoglucoside (Rhoifolin), apigenin 8-C-glucoside, apigenin-7-<italic toggle="yes">O</italic>-glucoside, 4&#8242;-Methoxyapigenin (Acacetin), luteolin, luteolin-6-C-glucoside, quercetin, quercetin-3-D-xyloside, quercetin-7-<italic toggle="yes">O</italic>-rhamnoside, quercetin-3-arabinoside, quercitrin, kaempferol-3-glucuronide, kaempferol-3-<italic toggle="yes">O</italic>-alpha-L-rhamnoside, kaempferol-3-<italic toggle="yes">O</italic>-alpha-L-arabinoside, Kaempferide, eriodictyol-7-<italic toggle="yes">O</italic>-glucoside, baicalin, isovitexin 7-<italic toggle="yes">O</italic>-glucoside (saponarin), syringetin-3-<italic toggle="yes">O</italic>-galactoside, rhamnetin, isorhamnetin, isorhamnetin-3-<italic toggle="yes">O</italic>-rutinoside, isorhamnetin-3-<italic toggle="yes">O</italic>-glucoside, myricitrin, daidzein-8-C-glucoside, cyanidin-3-glucoside, myricetin, diosmetin 7-<italic toggle="yes">O</italic>-rutinoside, hesperetin-7-<italic toggle="yes">O</italic>-neohesperidoside, maritimetin-6-<italic toggle="yes">O</italic>-glucoside, acacetin-7-<italic toggle="yes">O</italic>-neohesperidoside, acacetin-7-<italic toggle="yes">O</italic>-rutinoside, naringenin, esculetin, formononetin, resveratrol, eriodictyol.<break/>Others: Anthocyanins (delphinidin-3-rutinoside), terpenes alkaloids (gibberellin A4), chalcones (Okanin-4&#8242;-<italic toggle="yes">O</italic>-glucoside), coumarins (Scopoletin, 4-methylumbelliferone).</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B217-pharmaceutics-16-00454" ref-type="bibr">217</xref>,<xref rid="B218-pharmaceutics-16-00454" ref-type="bibr">218</xref>,<xref rid="B219-pharmaceutics-16-00454" ref-type="bibr">219</xref>,<xref rid="B220-pharmaceutics-16-00454" ref-type="bibr">220</xref>,<xref rid="B221-pharmaceutics-16-00454" ref-type="bibr">221</xref>,<xref rid="B222-pharmaceutics-16-00454" ref-type="bibr">222</xref>]</td></tr><tr><td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Arnica montana</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antiphlogistic, inotropic, antibiotic, anti-inflammatory, immunomodulatory, antiplatelet, uterotonic, anti-rheumatic, anti-osteoarthritic, antimicrobial, improve circulation, increase respiration, ureotonic, antioxidant, hepatoprotective, insecticidal, hypopigmentation, antihair loss, anticough, antihaemorrhagic and analgesic in febrile conditions.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenolic acids: Chlorogenic acid, 3,5-dicaffeoylquinic acid, 4,5-dicaffeoylquinic acid<break/>Flavonoids: Kaempferol 3-<italic toggle="yes">O</italic>-glucoside, 6-methoxy-kaempferol 3-<italic toggle="yes">O</italic>-glucoside, hispidulin, quercetin 3-<italic toggle="yes">O</italic>-glucoside, quercetin 3-<italic toggle="yes">O</italic>-glucuronic acid, patuletin 3-<italic toggle="yes">O</italic>-glucoside, luteolin, apigenin.<break/>Sesquiterpene lactones: Helenalin,11a,13-dihydohelenalin. <break/>Others: Carotenoids, diterpenes, arnidiol, 2-pyrrolidineacetic acid, pyrrolizidine alkaloids (tussilagine and isotussilagine), polyacetylenes, coumarins (umbelliferone and scopoletin), lignans, dicaffeoyl quinic derivatives (1,3-3,5 and 4,5 dicaffeoyl quinic acids), umbelliferone, scopoletin, oligosaccharides, sesquiterpene lactones (2,3-dihydroaromaticin, chamissonoid, mexicanin 1).</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B223-pharmaceutics-16-00454" ref-type="bibr">223</xref>,<xref rid="B224-pharmaceutics-16-00454" ref-type="bibr">224</xref>,<xref rid="B225-pharmaceutics-16-00454" ref-type="bibr">225</xref>]</td></tr><tr><td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Bellis perennis</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wound healing, anxiolytic, anti-tumor, antibacterial, anti-fungal, anti-hyperlipidemic, antioxidant, postpartum anti-hemorrhagic, pancreatic lipase inhibitor, and cytotoxic activities.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenolic acids: Chlorogenic acid, neochlorogenic acid, rosmarinic acid, caffeoylquinic acids.<break/>Flavonoids: Isorhamnetin 3-<italic toggle="yes">O-&#946;</italic>-d-galactopyranoside, isorhamnetin 3-<italic toggle="yes">O</italic>-<italic toggle="yes">&#946;-</italic>d-(6 &#8243;-acetyl)-galactopyranoside and kaempferol 3-<italic toggle="yes">O</italic>-<italic toggle="yes">&#946;</italic>-d-glucopyranoside.<break/>Triterpene saponins: Perennisosides I-VII, bellidioside A, asterbatanoside D, bernardioside A/F/B2, bellissaponin BS6/BA1/BA2,<break/>Anthocyanins: Cyanidin 3-<italic toggle="yes">O</italic>-(4&#8243;-<italic toggle="yes">O</italic>-(malonyl)-2&#8243;<italic toggle="yes">O</italic>-(<italic toggle="yes">&#946;</italic> d-glucuronyl)-<italic toggle="yes">&#946;</italic>-d-glucopyranoside), cyanidin 3-<italic toggle="yes">O</italic>-(2&#8243;-<italic toggle="yes">O</italic>-(<italic toggle="yes">&#946;</italic>-d-glucuronyl)-<italic toggle="yes">&#946;</italic>-d-glucopyranoside), cyanidin 3-<italic toggle="yes">O</italic>-(6&#8243;-<italic toggle="yes">O</italic>-(malonyl)-2&#8243;-O-(<italic toggle="yes">&#946;</italic>-d-glucuronyl)-<italic toggle="yes">&#946;</italic>-d-glucopyranoside).</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B226-pharmaceutics-16-00454" ref-type="bibr">226</xref>,<xref rid="B227-pharmaceutics-16-00454" ref-type="bibr">227</xref>,<xref rid="B228-pharmaceutics-16-00454" ref-type="bibr">228</xref>,<xref rid="B229-pharmaceutics-16-00454" ref-type="bibr">229</xref>,<xref rid="B230-pharmaceutics-16-00454" ref-type="bibr">230</xref>,<xref rid="B231-pharmaceutics-16-00454" ref-type="bibr">231</xref>,<xref rid="B232-pharmaceutics-16-00454" ref-type="bibr">232</xref>,<xref rid="B233-pharmaceutics-16-00454" ref-type="bibr">233</xref>,<xref rid="B234-pharmaceutics-16-00454" ref-type="bibr">234</xref>,<xref rid="B235-pharmaceutics-16-00454" ref-type="bibr">235</xref>,<xref rid="B236-pharmaceutics-16-00454" ref-type="bibr">236</xref>,<xref rid="B237-pharmaceutics-16-00454" ref-type="bibr">237</xref>]</td></tr><tr><td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Bidens frondose</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibacterial, antioxidant, antidiarrheal, anti-malarial, anti-inflammatory, allelopathic.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenolic acids and their ethers: Caffeic acid, 4,5-di-<italic toggle="yes">O</italic> caffeoylquinic acid 1-methyl ether, isoferuloyl ethyl ester, protocatechuic acid.<break/>Flavonoids: Okanin-4&#8242;-<italic toggle="yes">O</italic>-(6&#8243;-<italic toggle="yes">O</italic>-acetyl-2&#8221;-<italic toggle="yes">O</italic>-caffeoyl-6&#8243;-<italic toggle="yes">O</italic>-glucopyranoside), okanin-4&#8242;-<italic toggle="yes">O</italic>-(2&#8221;-<italic toggle="yes">O</italic>-caffeoyl-6&#8243;-<italic toggle="yes">O</italic>-<italic toggle="yes">p</italic>-coumaroyl-<italic toggle="yes">&#946;</italic>-D-glucopyranoside), 4-<italic toggle="yes">O</italic>-methylokanin-4&#8242;-<italic toggle="yes">O</italic>-(6&#8243;-<italic toggle="yes">O</italic>-<italic toggle="yes">p</italic>-coumaroyl-&#946;-D-glucopyranoside), 4-<italic toggle="yes">O</italic>-methylokanin-4&#8242;-<italic toggle="yes">O</italic>-(6&#8243;-<italic toggle="yes">O</italic>-acetyl-<italic toggle="yes">&#946;</italic>-D-glucopyranoside), 4-<italic toggle="yes">O</italic>-methylokanin-4&#8242;-<italic toggle="yes">O</italic>-(6&#8243;-<italic toggle="yes">O</italic>-acetyl-2&#8221;-<italic toggle="yes">O</italic>-caffeoyl-<italic toggle="yes">&#946;</italic>-D-glucopyranoside), okanin-4&#8242;-<italic toggle="yes">O</italic>-(6&#8243;-<italic toggle="yes">O</italic>-<italic toggle="yes">p</italic>-coumaroyl <italic toggle="yes">&#946;</italic>-D-glucopyranoside), okanin-4&#8242;-<italic toggle="yes">O</italic>-(6&#8243;-<italic toggle="yes">O</italic>-acetyl-<italic toggle="yes">&#946;</italic>-D-glucopyranoside), (Z)-6&#8243;-<italic toggle="yes">O</italic>-<italic toggle="yes">p</italic>-coumaroyl-maritimein, (Z)-6&#8243;-<italic toggle="yes">O</italic>-acetylmaritimein, apigenin, luteolin, luteolin-7-<italic toggle="yes">O</italic>- <italic toggle="yes">&#946;</italic>-D-glucopyranoside, luteolin-7-<italic toggle="yes">O</italic>-(<italic toggle="yes">&#946;</italic>-dglucopyranosyl)-2-glucopyranoside, kaempferol-3-<italic toggle="yes">O</italic>-<italic toggle="yes">&#946;</italic>-D-glucopyranoside, quercetin-3-<italic toggle="yes">O</italic>-<italic toggle="yes">&#946;</italic>-D-glucopyranoside, 8,3&#8242;,4&#8242;-trihydroxyflavone-7-<italic toggle="yes">O</italic>-(6&#8242;&#8242;-<italic toggle="yes">O</italic>-<italic toggle="yes">p</italic>-coumaroyl)-<italic toggle="yes">&#946;</italic>-D-glucopyranoside, 6-hydroxyluteolin-7-<italic toggle="yes">O</italic>-glucoside, 3&#8242;&#8242;-(3-hydroxy-3-methylglutaroyl)-ester of 6-hydroxyluteolin-7-<italic toggle="yes">O</italic>-<italic toggle="yes">&#946;</italic>-D-glucopyranoside, 8,3&#8242;,4&#8242;-trihydroxyflavone-7-<italic toggle="yes">O</italic>-<italic toggle="yes">&#946;</italic>-D-glucopyranoside, 3&#8242;-hydroxyscutellarein-7-<italic toggle="yes">O</italic>-(6&#8242;&#8242;-<italic toggle="yes">O</italic>protocatechuoyl)-<italic toggle="yes">&#946;</italic>-glucopyranoside, (&#8722;)-4&#8242;-methoxy-7-<italic toggle="yes">O&#946;</italic>-dglucopyranosyl-8,3&#8242;-dihydroxyflavanone, (&#8722;)-4&#8242;-methoxy-7-<italic toggle="yes">O</italic>-(6&#8242;&#8242;-acetyl)-<italic toggle="yes">&#946;</italic>dglucopyranosyl-8,3&#8242;-dihydroxyflavanone, hesperetin-7-<italic toggle="yes">O</italic>-<italic toggle="yes">&#946;</italic>-D-glucopyranoside.<break/>Others: 2&#8242;-butoxyethylconiferin, butylconiferin, 2-methoxy-4-(2&#8242;-hydroxyethyl)-phenol-1-<italic toggle="yes">O</italic>-<italic toggle="yes">&#946;</italic>-D-glucopyranoside, (1&#8242;R,2&#8242;R)-guaiacyl glycerol 3&#8242;-<italic toggle="yes">O</italic>-<italic toggle="yes">&#946;</italic>-dglucopyranoside, threo-5-hydroxy3,7-dimethoxyphenylpropane-8,9-diol, 3-(4-hydroxy-3-methoxyphenyl)-3-methoxypropane1,2-diol, 3-(4-Hydroxy-3-methoxyphenyl)propane-1,2-diol, guaiacylglycerol, wilfordiol B, caffeoylcalleryanin, 1-<italic toggle="yes">O</italic>-(E)-caffeoyl-<italic toggle="yes">&#946;</italic>-dgentiobiose, dihydrophaseic acid, 1,3,5-trimethoxybenzene, vanillin, galacturonic acid, galactose, glucose, arabinose, xylose, rhamnose.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B238-pharmaceutics-16-00454" ref-type="bibr">238</xref>,<xref rid="B239-pharmaceutics-16-00454" ref-type="bibr">239</xref>,<xref rid="B240-pharmaceutics-16-00454" ref-type="bibr">240</xref>,<xref rid="B241-pharmaceutics-16-00454" ref-type="bibr">241</xref>,<xref rid="B242-pharmaceutics-16-00454" ref-type="bibr">242</xref>]</td></tr><tr><td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Calendula arvensis</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibacterial, anti-fungal, antiparasitic, anti-inflammatory, antioxidant, wound healing, antimutagenic, immunomodulatory, and anti-cancer.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenolic acids: Isomeric form hydroxy ferulic acid hexoside, 5-<italic toggle="yes">O</italic>-caffeoylquinic acid, 4-<italic toggle="yes">O</italic>-caffeoylquinic acid, caffeic acid, sinapic acid, sinapic acid hexoside, hexoside derivative, caffeoylshikimic acid, 3,4-<italic toggle="yes">O</italic>-dicaffeoylquinic acid, 5-<italic toggle="yes">O</italic>-feruloyl quinic acid, protocatechuic acid pentoside, quinic acid with an aldonic residue.<break/>Flavonoids: Quercetin hydrate, quercetin dihexoside, quercetin-3-<italic toggle="yes">O</italic>-rutinoside, quercetin-3-<italic toggle="yes">O</italic>-neohesperidoside, quercetin-3-omalonylhexoside, quercetin acetyl hexoside, quercetin hexoside I, quercetin 3-<italic toggle="yes">O</italic>-<italic toggle="yes">&#946;</italic>-D-glucopyranoside, quercetin 3-<italic toggle="yes">O</italic>-<italic toggle="yes">&#946;</italic>-D-galactopyranoside, apigenin-8-C-pentose-6-chexose or apigenin-8-chexose-6-C-pentose, apigenin-<italic toggle="yes">O</italic>-hexosylpentosyl, isorhamnetin-3-<italic toggle="yes">O</italic>-hexoside.<break/>Saponins: 3-<italic toggle="yes">O</italic>-(<italic toggle="yes">&#946;</italic>-D-galactopyranosyl-(1&#10230;3)-<italic toggle="yes">&#946;</italic>-D-glucopyranosyl) oleanolic acid-28-<italic toggle="yes">O</italic>- <italic toggle="yes">&#946;</italic>-D-glucopyranoside, 3<italic toggle="yes">&#946;</italic>-<italic toggle="yes">O</italic>-(<italic toggle="yes">&#946;</italic>-D-galactopyranosyl-(1&#10230;3)-<italic toggle="yes">&#946;</italic>-D-glucopyranosyl) oleanolic acid, 3<italic toggle="yes">&#946;</italic>-<italic toggle="yes">O</italic>-(<italic toggle="yes">&#946;</italic>-D-galactopyranosyl-(1&#10230;3)-<italic toggle="yes">&#946;</italic>-D-glucopyranosyluronic acid) oleanolic acid-28-<italic toggle="yes">O</italic>- <italic toggle="yes">&#946;</italic>-D-glucopyranoside, 3<italic toggle="yes">&#946;</italic>-<italic toggle="yes">O</italic>-(<italic toggle="yes">&#946;</italic>-D-galactopyranosyl-(1&#10230;3)-<italic toggle="yes">&#946;</italic>-D-glucopyranosyluronic acid) oleanolic acid, 4-<italic toggle="yes">O</italic>-(<italic toggle="yes">&#946;</italic>-D-fucopyranosyl)-4-alloaromadendrole, arvensoside A, arvensoside B, derivatives of arvensoside B, calenduloside D, calenduloside C, 4-<italic toggle="yes">O</italic>-(<italic toggle="yes">&#946;</italic>-D-fucopyranosyl)-4-alloaromadendrole, 4-<italic toggle="yes">O</italic>-(<italic toggle="yes">&#946;</italic> -D-fucopyranosyl)-4-alloaromadendrol-2&#8243;-methylpropanoyl esters, 4-<italic toggle="yes">O</italic>-(<italic toggle="yes">&#946;</italic> -D-fucopyranosyl)-4-alloaromadendrol -2&#8243;-methyl-2&#8243;-butenoyl esters, <break/>Sesquiterpeneglycosides: 3<italic toggle="yes">&#945;</italic>,7<italic toggle="yes">&#946;</italic>-dihydroxy-5<italic toggle="yes">&#946;</italic>,6<italic toggle="yes">&#946;</italic>-epoxyeudesm-4(15)-ene-11-(<italic toggle="yes">O</italic>-<italic toggle="yes">&#946;</italic>-D-fucopyranoside-2&#8242;,4&#8242; -diangelate-3&#8242;-acetate), 7&#946;-Hydroxy-3<italic toggle="yes">&#946;</italic>-acetoxy-5<italic toggle="yes">&#946;</italic>,6<italic toggle="yes">&#946;</italic>-epoxyeudesm-5(15)-ene-11-(<italic toggle="yes">O</italic>-<italic toggle="yes">&#946;</italic>-D-ficopyranoside-2&#8242;,4&#8242;-diangelate-3&#8242;-acetate), 3&#945;,7<italic toggle="yes">&#946;</italic>-Dihydroxy-5<italic toggle="yes">&#946;</italic>,6<italic toggle="yes">&#946;</italic>-epoxyeudesm-4(15)-ene-11-(<italic toggle="yes">O</italic>-<italic toggle="yes">&#946;</italic>-D-fucopyranoside-2&#8242;,4&#8242;-diangelate-3&#8242;-isobutyrate), 3<italic toggle="yes">&#945;</italic>,7<italic toggle="yes">&#946;</italic>-dihydroxy -5<italic toggle="yes">&#946;</italic>, 6<italic toggle="yes">&#946;</italic>-epoxyeudesm-4(15)-ene-11-(<italic toggle="yes">O</italic>-<italic toggle="yes">&#946;</italic>-D-fucopyranoside-2&#8242;, 4&#8242;-diangelate-3&#8242;-methylbutyrate), and 3<italic toggle="yes">&#945;</italic>,7<italic toggle="yes">&#946;</italic>-dihydroxy-15-acetoxyeudesm-4(5)-ene-11-(<italic toggle="yes">O</italic>-<italic toggle="yes">&#946;</italic>-D-fucopyranoside-2&#8242;,4&#8242;-diangelate-3&#8242;-acetate).<break/>Carboxylic acids/Fatty acids: Stearic acid, oleic acid, linoleic acid, linolenic acid, palmitic acid, palmitoleic acid, <italic toggle="yes">&#945;</italic>-linolenic acid, quinic acid, citric acid, and tetracosanoic acid.<break/>Polysaccharides: L-threonic acid, D-(&#8722;)-tagatofuranose, D-(&#8722;)-fructofuranose, D-(&#8722;)-fructopyranose, D-(&#8722;)-psicopyranose, D-(+)-mannopyranose, D-(+)-galactopyranose, <italic toggle="yes">&#946;</italic>-D-glucopyranose, D-gluconic acid, galactaric acid, sucrose, cellobiose.<break/>Others: Ethyl butyrate, 2-methyl-3-furanthiol, methional, 1-octen-3-one, ethyl hexanoate, 2-6-Dimethyl-3 ethyl pyrazine, (E)-2-nonenal, (E,E)-2,4-octadienal, 5-methyl-2-furanaldehyde, citronellol, phenethylacetate, <italic toggle="yes">&#945;</italic>-terpineol, lactone-like, and <italic toggle="yes">&#948;-</italic>decalactone, Neophytadiene, phytol, <italic toggle="yes">&#945;</italic>-bisabolol, 8,14-cedranoxide, stigmasterol, stigmast-5-ene, amyrin, lup-20(29)-en-28-al, 3-oxo-ursan-28-oic acid, myo-inositol, 1H-benzocyclohepten-9-ol, 1-hexacosanol, untriacontane, 4-aminobutanoic acid, isomer of platynecine derivative, ligstroside hexoside, calendasaponin A, calenduloside G isomer, <italic toggle="yes">&#946;</italic>-sitosterol.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B243-pharmaceutics-16-00454" ref-type="bibr">243</xref>]</td></tr><tr><td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1"><italic toggle="yes">Chamaemelum nobile</italic> (syn. <italic toggle="yes">Anthemis nobilis</italic> L. or <italic toggle="yes">Chamomilla nobilis</italic>)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory, antioxidant, antinociceptive, antimutagenic, sedative, anxiolytic, antispasmodic, anxiety, depression, sleep quality and insomnia, postoperative gastrointestinal dysfunction, diarrhoea, colic, nausea, vomiting, acute, diuretic, chronic pain, antibacterial, anti-fungal, insecticidal, hypotensive, antiplatelet aggregation, antioxidant, effect in asthma and polycystic ovary, nervous endocrine, cytotoxic, bronchodilator, antispasmodic, carminative, anti-emetic, antispasmodic, cytostatic, anti-oedema sedative properties</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenolic acids: The glucose esters caffeic acid, ferulic acid, anthenobilic acid, trans-caffeic acid-glucose ester, trans- and cis- forms of the caffeic acid, 3-<italic toggle="yes">O</italic>-caffeoylquinic acid, 5-<italic toggle="yes">O</italic>-caffeoylquinic acid-hexoside, 3,4-<italic toggle="yes">O</italic>-dicaffeoylquinic acid, protocatechuic acid, caffeoyl-hexoside-methylglutarate, 5-<italic toggle="yes">O</italic>-caffeoylquinic acid, <italic toggle="yes">p</italic>-coumaroyl-hexoside-methylglutarate 1,3,5-<italic toggle="yes">O</italic>-Tricaffeoylquinic acid.<break/>Flavonoids: Apigenin, apigenin 6-C-glucose-8-C-glucose, apigenin <italic toggle="yes">O</italic>-glucuronide, apigenin <italic toggle="yes">O</italic>-glucuronylhexoside, luteolin, luteolin <italic toggle="yes">O</italic>-hexoside, luteolin <italic toggle="yes">O</italic>-rutinoside, luteolin <italic toggle="yes">O</italic>-acetylhexoside, luteolin-7-glucoside, luteolin <italic toggle="yes">O</italic>-pentosylhexoside, luteolin <italic toggle="yes">O</italic>-glucuronide, luteolin <italic toggle="yes">O</italic>-rhamnosylhexoside, quercetin, quercetin 3-<italic toggle="yes">O</italic>-glucuronide, quercetin 7-<italic toggle="yes">O</italic>-malonylhexoside, quercetin <italic toggle="yes">O</italic>-acetylhexoside, isorhamnetin <italic toggle="yes">O</italic>-acetylhexoside, myricetin 3-<italic toggle="yes">O</italic>-glucoside, rutin, anthemoside (apigenin2,3-dihydorycinnamoyl acid 7-<italic toggle="yes">O</italic>-<italic toggle="yes">&#946;</italic>-D-glucose), cosmosioside (apigenin 7-<italic toggle="yes">O</italic>-<italic toggle="yes">&#946;</italic>-D-glucose), apiin (apigenin 7-<italic toggle="yes">O</italic>-&#946;-D-apiosylglucoside), chamaemeloside [apigenin 7-<italic toggle="yes">O</italic>-<italic toggle="yes">&#946;</italic>-D-glucose-6&#8243;-(3&#8242;&#8243;-hydroxy-3&#8242;&#8243;-methyl-glutarate)], luteolin 7-<italic toggle="yes">O</italic>-<italic toggle="yes">&#946;</italic>-D-glucose, quercetin 3-<italic toggle="yes">O</italic>-<italic toggle="yes">&#945;</italic>-L-rhamnoside, kaempferol, kaempferol <italic toggle="yes">O</italic>-pentosylhexoside, catechins.<break/>Terpenoids and steroids: <italic toggle="yes">&#945;</italic>-bisabolol, chamazulene, anthesterols, <italic toggle="yes">&#946;</italic>-amyrin, taraxasterol, pseudotaraxasterol, <italic toggle="yes">&#946;</italic>-sitosterol.<break/>Coumarins: Herniarin, umbelliferone, scopoletin-7-glucoside. <break/>Others: Angelic and tiglic acid esters, anthemic acid, choline, phenolic, phytosterols, inositol, oxalic acid, quinic acid, malic acid, citric acid, fumaric acids, octulosonic acid, betahydroperoxyisonobilin, hydroxyisonobiline, germacranolide-type sesquiterpene lactones (nobilin, 3-epinobilin, 1,10-epoxynobilin, 3-dehydronobilin), amyl and isobutyl alcohols, 1<italic toggle="yes">&#946;</italic>-Hydroperoxyisonobilin, alkyl hydroperoxides, <italic toggle="yes">Cis</italic>- and <italic toggle="yes">trans</italic>-spiroether derivatives, <italic toggle="yes">cis-</italic> and <italic toggle="yes">trans</italic>-dehydromatricariaester and tiophenesetrs, polyacetylenes.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B244-pharmaceutics-16-00454" ref-type="bibr">244</xref>,<xref rid="B245-pharmaceutics-16-00454" ref-type="bibr">245</xref>,<xref rid="B246-pharmaceutics-16-00454" ref-type="bibr">246</xref>]</td></tr><tr><td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Cichorium intybus</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The hepatoprotective, anti-inflammatory, antioxidant, sedative, immunomodulatory effect, cardiovascular, hypolipidemic, gastro-protective, anti-tumor, anti-leukaemic, cytotoxic, antimicrobial, allergenic, antibiotic, anti-cancer, anti hyperuricemia, antiprotozoal, anthelmintic, anti-malarial, sedative.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenolic acids: Chlorogenic acid, chicoric acid, <italic toggle="yes">p</italic>-coumaric acids, protocatechuic acid, p-hydroxybenzoic, iso vanillic, gallic acid, 4-amino-benzoic, <italic toggle="yes">p</italic>-OH-benzoic, caffeine, ferulic acid, isoferulic acid, vanillic acid, benzoic acid, ellagic acid, alpha-cumaric, 3,4,5-methoxy-cinnamic, salycilic acid, cinnamic acid, 3-<italic toggle="yes">O</italic>-<italic toggle="yes">p</italic>-coumaroyl quinic acid.<break/>Flavonoids: Quercetin, quercetin glucuronide, luteolin glucuronide, catechin, catechol, epicatechin, cyanidin-3-<italic toggle="yes">O</italic>-(6&#8243;-malonyl-<italic toggle="yes">&#946;</italic>-glucopyranoside), delphinidin 3,5-di-<italic toggle="yes">O</italic>-(6-<italic toggle="yes">O</italic>-malonyl-<italic toggle="yes">&#946;</italic>-d-glucoside), delphinidin 3-<italic toggle="yes">O</italic>-(6-<italic toggle="yes">O</italic>-malonyl-<italic toggle="yes">&#946;</italic>-d-glucoside)-5-<italic toggle="yes">O</italic>-<italic toggle="yes">&#946;-</italic>d-glucoside, delphinidin 3-<italic toggle="yes">O</italic>-<italic toggle="yes">&#946;</italic>-d-glucoside-5-<italic toggle="yes">O</italic>-(6-<italic toggle="yes">O</italic>-malonyl<italic toggle="yes">-&#946;</italic>-d-glucoside), delphinidin 3,5-di-<italic toggle="yes">O</italic>-<italic toggle="yes">&#946;</italic>-d-glucoside.<break/>Fatty acids and derivatives: Lauric acid methyl ester, myristic acid methyl ester, palmitoleic methyl ester, palmitic acid methyl ester, methyl dihydromalvalate, 9,12- linoleic methyl ester, stearic acid methyl ester, methyl linolelaidate, linolenic acid methyl ester, 11-eicosenoic acid methyl ester, eicosanoic acid methyl ester, <italic toggle="yes">n-</italic>hexadecanyl hexadecanoate, <italic toggle="yes">n-</italic>pentadecanyl octadec-9-enoate, <italic toggle="yes">n</italic>-hexadecanyl octadec-9-enoate, <italic toggle="yes">n</italic>-hexadecanyl octadecenoate, <italic toggle="yes">n</italic>-octadecanyl octadecenoate, <italic toggle="yes">&#945;</italic>-linolenic acid, oleic acid, linoleic acid, palmitic acid.<break/>Sesquiterpene lactones: Lactucin, 8-deoxylactucin, 11(S),13-dihydro-8-deoxylactucin, lactucopicrin, 11(S),13- dihydrolactucopicrin, jacquinelin, crepidiaside B, lactuside A, 11(S), 13-dihydrolactucin, lactucin, 8-deoxylactucin, 11(S), 13-dihydro-8-deoxylactucin, 11(S),13-dihydrolactucopicrin, lactucopicrin<break/>Others: Inulin, coumarin, epigallocatechin gallate.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B247-pharmaceutics-16-00454" ref-type="bibr">247</xref>,<xref rid="B248-pharmaceutics-16-00454" ref-type="bibr">248</xref>]</td></tr><tr><td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1"><italic toggle="yes">Dittrichia viscosa</italic> subsp. <italic toggle="yes">Viscosa</italic> (Syn. <italic toggle="yes">Inula viscosa</italic>)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antiphlogistic, antiviral, anti-fungal, antibacterial, antiseptic, anti-inflammatory, allelopathic potential, fungicidal, nematicidal, anti-ulcerogenic, antihelmintic, anti-cancer, neuroprotective effects</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenolic acids and derivatives: Caffeic acid, di-o-caffeoylquinic acid, rosmarinic acid, protocatechuic acid hexoside, caffeoyl hexose, <italic toggle="yes">p</italic>-coumaroyl hexose, 1-O-caffeoylquinic acid, 3-O-caffeoylquinic acid, 4-O-caffeoylquinic acid, di-O-Caffeoylquinic acid, caffeic acid phenethyl ester, (<italic toggle="yes">Epi</italic>)-rosmanol methyl ether, rosmanol, epirosmanol, dicaffeoylshikimic acid, N-caffeoyl-tryptophan, dihydroxybenzoic acid.<break/>Flavonoids: Dihydroquercetin, 3-<italic toggle="yes">O</italic>-methylquercetin, quercetin-<italic toggle="yes">O</italic>-(caffeoyl)-hexoside, quercetin dihexoside, quercetin-3-<italic toggle="yes">O</italic>-(6&#8243;-acetyl) hexoside, quercetin rhamnoside, cirsiliol, 3-<italic toggle="yes">O</italic>-acetylpadmatin, padmatin, nepetin, spinacetin, diosmetin, rhamnetin, hesperetin, hispidulin, catechin, medioresinol, <italic toggle="yes">&#947;</italic>-mangostin, banaxanthone E, <italic toggle="yes">epi</italic>- granilin, naringenin, isorhamnetin, diosmetin, cirsimaritin derivative, genkwanin, rutin, kaempferol-<italic toggle="yes">O</italic>-deoxyhexoside, kaempferol-3-<italic toggle="yes">O</italic>-(6&#8243;-acetyl) hexoside, kaempferol-3-<italic toggle="yes">O</italic>-(caffeoyl)-hexoside, aromadendrin, naringenin-7-<italic toggle="yes">O</italic>-hexoside, isorhamnetin glycoside, isorhamnetin-<italic toggle="yes">O</italic>-pentosylhexoside, kaempferol-<italic toggle="yes">O</italic>-(<italic toggle="yes">p</italic>-coumaroyl)-hexoside, kaempferol-<italic toggle="yes">O</italic>-(feruloyl)-hexoside, 3,7-dihydroxycoumarin, nepetin, spinacetin, dihydroxycoumarin, padmatin isomer 1/2, cinchonain.<break/>Sesquiterpenes: <italic toggle="yes">&#945;</italic>- and <italic toggle="yes">&#947;</italic>- costic acid isomers, ilicic acid, hydroxyalantolactone, tomentosine/inulviscolide, alantolactone, inulanolide,<break/>Others: Galloylquinic acid, (<italic toggle="yes">Epi</italic>)-gallocatechin-3-gallate, paxanthone, proanthocyanidin dimer, prodelphinidin B3, malic acid I and II, caffeoyl-malic acid, shikimoyl blechnic acid.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B249-pharmaceutics-16-00454" ref-type="bibr">249</xref>,<xref rid="B250-pharmaceutics-16-00454" ref-type="bibr">250</xref>,<xref rid="B251-pharmaceutics-16-00454" ref-type="bibr">251</xref>,<xref rid="B252-pharmaceutics-16-00454" ref-type="bibr">252</xref>,<xref rid="B253-pharmaceutics-16-00454" ref-type="bibr">253</xref>,<xref rid="B254-pharmaceutics-16-00454" ref-type="bibr">254</xref>,<xref rid="B255-pharmaceutics-16-00454" ref-type="bibr">255</xref>,<xref rid="B256-pharmaceutics-16-00454" ref-type="bibr">256</xref>,<xref rid="B257-pharmaceutics-16-00454" ref-type="bibr">257</xref>,<xref rid="B258-pharmaceutics-16-00454" ref-type="bibr">258</xref>,<xref rid="B259-pharmaceutics-16-00454" ref-type="bibr">259</xref>]</td></tr><tr><td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Galinsoga parviflora</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibacterial, antioxidant, anti-arthritic, antiplatelet, anti-inflammatory, anti-fungal.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kaempferol, gallic acid, 2,4,5-tricaffeolylglucaric acid, 2,3,4,5-tetracaffeolylglucaric acid, 2,3,4-tricaffeolylaltraric acid, 3,4,5-tricaffeolylaltraric acid, beta-sitosterol-3-<italic toggle="yes">O</italic>-beta-glucoside, quercetine, beta-sitosterol, 3,5,7,3&#8242;,4&#8242;pentahydroxyflavanone, 4-hydroxybenzoic acid.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B260-pharmaceutics-16-00454" ref-type="bibr">260</xref>]</td></tr><tr><td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Helichrysum stoechas</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibacterial, anti-proliferative, neuroprotective, anti-inflammatory, antioxidant treatment for urolithiasis.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neo-chlorogenic acid, chlorogenic acid and crypto-chlorogenic acid, isomeric dicaffeoyl quinic acids, isomeric naringenin glucosides, quercetin, isoquercitrin, kaempferol, apigenin glucosides, tetrahydroxychalcone-glucoside, Helipyrone A/B/C, Italipyrone, 20-prenylitalipyrone, Bitalin A (R)-form, 6-methyleuparin, helipyrone, 5,7-dihydroxy-3,6,8-trimethoxyflavone, quercetagetin-7-<italic toggle="yes">O</italic>-glucopyranoside, santinol B.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B261-pharmaceutics-16-00454" ref-type="bibr">261</xref>,<xref rid="B262-pharmaceutics-16-00454" ref-type="bibr">262</xref>,<xref rid="B263-pharmaceutics-16-00454" ref-type="bibr">263</xref>,<xref rid="B264-pharmaceutics-16-00454" ref-type="bibr">264</xref>]</td></tr><tr><td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Hypochaeris radicata</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Treatment of jaundice, rheumatism, and antibacterial, anti-fungal properties with antioxidant and anti-inflammatory, antihemolytic.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chicoric acid, hypochoeroside C, hypochoeroside D, 5-<italic toggle="yes">O</italic>-caffeoylshikimic acid, 4-(3,4-dihydroxybenzyl)-2-(3,4-dihydroxyphenyl)tetrahydrofuran-3-carboxy-<italic toggle="yes">O</italic>-<italic toggle="yes">&#946;</italic>-D-glucopyranoside, 4-(3,4-dihydroxybenzyl)-2-(3,4-dihydroxyphenyl)tetrahydrofuran-3-carboxy-<italic toggle="yes">O</italic>-&#946;-D-glucopyranosyl-2&#8242;-<italic toggle="yes">O</italic>-methacrylate, (7S,8R,8&#8242;R)-7-(3,4-dihydroxyphenyl)-3&#8242;,4&#8242;-dihydroxy-7,8,7&#8242;,8&#8242;-tetrahydronaphtho [8,8&#8242;-c]furan-1(3H)-one, (7S,8R,8&#8242;R)-7-(3,4-dihydroxyphenyl)-3&#8242;,4&#8242;-dihydroxy-8&#8242;-(hydroxymethyl)-7,8,7&#8242;,8&#8242;-tetrahydronaphthalen-8-carboxylic acid, confertin, scopoletin.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B265-pharmaceutics-16-00454" ref-type="bibr">265</xref>,<xref rid="B266-pharmaceutics-16-00454" ref-type="bibr">266</xref>,<xref rid="B267-pharmaceutics-16-00454" ref-type="bibr">267</xref>,<xref rid="B268-pharmaceutics-16-00454" ref-type="bibr">268</xref>]</td></tr><tr><td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Lactuca serriola</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hepatoprotective, antioxidant, antivenom, allelopathic, sedative, anticonvulsant, antiepileptic, anti-inflammatory, anti-carcinogenic activities</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chlorogenic acid, caffeic acid, quercetin, lactutin, 8-deoxylactucin, jacquilenin, 11-<italic toggle="yes">&#946;</italic>-13-dihydrolactucin, deacetoxymatricarin (=leucodin, leucomisin), loliolide, guaiane ester, the melampolide glucoside, luteolin-7-<italic toggle="yes">O</italic>-<italic toggle="yes">&#946;</italic>-D glucoside, protocatechuic acid, 4-hydroxybenzoic acid, lactuside A, kaempferol, lactucone, lactucic acids, lactucopicrin, sesquiterpene esters, vitamins, oxalic acid, <italic toggle="yes">&#946;</italic>-carotene, iron, lupeol, lupeol acetate, oleanans, <italic toggle="yes">&#945;</italic>-amyrin, <italic toggle="yes">&#946;</italic>-amyrin.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B269-pharmaceutics-16-00454" ref-type="bibr">269</xref>,<xref rid="B270-pharmaceutics-16-00454" ref-type="bibr">270</xref>,<xref rid="B271-pharmaceutics-16-00454" ref-type="bibr">271</xref>,<xref rid="B272-pharmaceutics-16-00454" ref-type="bibr">272</xref>,<xref rid="B273-pharmaceutics-16-00454" ref-type="bibr">273</xref>,<xref rid="B274-pharmaceutics-16-00454" ref-type="bibr">274</xref>,<xref rid="B275-pharmaceutics-16-00454" ref-type="bibr">275</xref>,<xref rid="B276-pharmaceutics-16-00454" ref-type="bibr">276</xref>]</td></tr><tr><td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Onopordum acanthium</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antihypertensive, bactericide, cardiotonic, hemostatic agent, used against hypotonicity, anti-inflammatory, anti-malarial, anti-inflammatory, anti-tumor, cytotoxicity, antipyretic, analgesic, anti-tumor, regeneration, phytotoxic.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenolic acids and derivatives: Isochlorogenic acid, caffeic acid, <break/>Flavonoids: Apigenin, luteolin, scutellarein, nepetin, chrysoeriol, hispidulin, pectolinarigenin, scutellarein 4&#8242;-methyl ether, quercetin, apigenin-7-<italic toggle="yes">O</italic>-glucoside, apigenin-7-<italic toggle="yes">O</italic>-rutinoside, apigenin-7-<italic toggle="yes">O</italic>-<italic toggle="yes">&#946;</italic>-D-glucuronide, luteolin-7-<italic toggle="yes">O</italic>-glucoside, quercetin-3-<italic toggle="yes">O</italic>-glucoside, isorhamnetin-3-<italic toggle="yes">O</italic>-glucoside, riodictyol; cyanin, aconiside.<break/>Others: Pinoresinol, syringaresinol, medioresinol, nitidanin diisovalerianate; arctiin, aesculin; aesculetin, 4<italic toggle="yes">&#946;</italic>,15-dihydro-3-dehydrozaluzanin C, zaluzanin C, 4<italic toggle="yes">&#946;</italic>,15,11<italic toggle="yes">&#946;</italic>,13-tetrahydrozaluzanin C, onopordopicrin; arctiopicrin, Elemanolide 11(13)-dehydromelitensin <italic toggle="yes">&#946;</italic>-hydroxyisobutyrate; acanthiolide, <italic toggle="yes">&#945;</italic>-amyrin; <italic toggle="yes">&#946;</italic>-amyrin, lupeol; taraxasterol, steroids, heptadecatetraen-(2,8,10,16)-diin-(4, 6)-al-(1), tridecadien-(1,11)-tetrain-(3,5,7,9), heptadecatetraen-(1,7,9,15)-diin-(11,13), heptadecatetraen-(2,8,10,16)-diin-(4,6)-ol-(1)), linoleic acid, oleic acid, palmitic acid, stearic acid, pentadecanoic acid, hentriacontanoic acid, nonacosanoic acid, arachidic acid, margaric acid, myristic acid, behenic acid, palmitoleic acid, gadoleic acid, erucic acid, vaccenic acids, <italic toggle="yes">&#945;</italic>-tocopherol, <italic toggle="yes">&#945;</italic>-tocotrienol, <italic toggle="yes">&#946;</italic>-tocopherol, <italic toggle="yes">&#947;-</italic>tocopherol, 1-amino-2-propanol, stachydrine, choline, phytin.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B277-pharmaceutics-16-00454" ref-type="bibr">277</xref>,<xref rid="B278-pharmaceutics-16-00454" ref-type="bibr">278</xref>,<xref rid="B279-pharmaceutics-16-00454" ref-type="bibr">279</xref>,<xref rid="B280-pharmaceutics-16-00454" ref-type="bibr">280</xref>,<xref rid="B281-pharmaceutics-16-00454" ref-type="bibr">281</xref>,<xref rid="B282-pharmaceutics-16-00454" ref-type="bibr">282</xref>,<xref rid="B283-pharmaceutics-16-00454" ref-type="bibr">283</xref>,<xref rid="B284-pharmaceutics-16-00454" ref-type="bibr">284</xref>]</td></tr><tr><td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Senecio vulgaris</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antioxidant, cytotoxic, antibacterial, anti-fungal</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenolic acids and derivatives: Caffeic acid, protocatechuic acid, 3-<italic toggle="yes">O</italic>-caffeoylquinic acid (chlorogenic acid), dicaffeoylquinic acid, <italic toggle="yes">p</italic>-hydroxy benzene-acetic acid, vanillic acid, syringic acid, <italic toggle="yes">p</italic>-hydroxy benzene-acetic acid derivative, <italic toggle="yes">p</italic>-hydroxycinnamic acid.<break/>Flavonoids: Quercitin-3-glucoside (Isoquercitrin), quercetin 3-<italic toggle="yes">O</italic>-rhamnoside (quercitrin), kaempferol-3-<italic toggle="yes">O</italic>-di-deoxyhexoside.<break/>Pyrrolizidine alkaloid: Retrorsine N-oxide, spartioidine N-oxide, seneciophylline N-oxide, integerrimine N-oxide, senecionine N-oxide, usaramine, neosenkirkine, riddelline, <italic toggle="yes">neo</italic>platyphylline, retrorsine, spartioidine, platyphylline, integerrimine, senecionine.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B285-pharmaceutics-16-00454" ref-type="bibr">285</xref>,<xref rid="B286-pharmaceutics-16-00454" ref-type="bibr">286</xref>,<xref rid="B287-pharmaceutics-16-00454" ref-type="bibr">287</xref>,<xref rid="B288-pharmaceutics-16-00454" ref-type="bibr">288</xref>]</td></tr><tr><td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Solidago virgaurea</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antioxidant, anti-inflammatory, analgesic, spasmolytic, antihypertensive, diuretic effects and benefits in other urinary tract conditions, <break/>antibacterial, anti-fungal, antiparasitic, cytotoxic and anti-tumor, antimutagenic, cardioprotective, antisenescence effects.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenolic acids and derivatives: Caffeic acid, chlorogenic acid, 5-<italic toggle="yes">O</italic>-caffeoylquinic (neo chlorogenic) acid, 3,5-di-<italic toggle="yes">O</italic>-caffeoylquinic acid, 3,4-di-<italic toggle="yes">O</italic>-caffeoylquinic acid, 4,5-di-<italic toggle="yes">O</italic>-caffeoylquinic acid, 3,4,5-tri-O-caffeoylquinic acid, methyl 3,5-di-<italic toggle="yes">O</italic>-caffeoylquinate, 3-hydroxyphenyl acetic acid, 3,4-dihydroxyphenylacetic acid, 5-p-coumaroylquinic acid, homovanilic acid, <italic toggle="yes">p</italic>-coumaric acid, ferulic acid, sinapic acid, rosmarinic acid benzoic acid, 3-hydroxybenzoic acid, 4-hydroxybenzoic acid, 3,4-dihydroxybenzoic (protocatechuic) acid, salicylic acid, gentisic acid, vanillic acid, gallic acid, leiocarposide, 2-methoxybenzyl-2,6-dimethoxy benzoate. <break/>Flavonoids: Quercetin, quercetin-3-<italic toggle="yes">O</italic>-glucoside (isoquercitrin), quercetin-3-<italic toggle="yes">O</italic>-galactoside (hyperoside), quercetin-3-<italic toggle="yes">O</italic>-rhamnoside (quercitrin), quercetin-3-<italic toggle="yes">O</italic>-rutinoside (rutin), quercetin-3-O-arabinopyranoside (avicularin), kaempferol-3-<italic toggle="yes">O</italic>-glucoside (astragalin), kaempferol-3-O-rhamnoside (afzelin), kaempferol-3-<italic toggle="yes">O</italic>-rutinoside (nicotiflorin), kaempferol-3-<italic toggle="yes">O</italic>-robinobioside (biorobin), myricetin 3-rhamnoside (myricitrin), Isorhamnetin-3-<italic toggle="yes">O</italic>-rutinoside (narcissin), cyanidin-3-gentiobioside mono-C-glycosylflavones, di-C-glycosyl flavones.<break/>Others: Virgaureasaponins 1&#8211;6, solidagosaponins X-XXIX, bellisaponin BA2, erythrodiol-3-acetate, <italic toggle="yes">&#945;</italic>-tocopherol quinone, 2-phyten-1-ol.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B289-pharmaceutics-16-00454" ref-type="bibr">289</xref>]</td></tr><tr><td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Sonchus asper</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antioxidant, anti-inflammatory, antibacterial, insecticidal, hepatorenal protective, used for treating bronchitis, gastrointestinal infection, cardiac dysfunction, kidney diseases, and cancer.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenolic acids and derivatives: Caffeic acid, 3-coumaric acid, chlorogenic acid, gallic acid, luteolin, luteolin-7-o, protocatechuic acid, rosemarinic acid, quinic acid, vanillic acid.<break/>Flavonoids: Apigenin, apigenin-7-o, luteolin, pyrocatechol, quercetin, rutin.<break/>Others: 11 beta,13-dihydrourospermal A, 15-<italic toggle="yes">O</italic>-beta-D-glucopyranosyl-11 beta,13-dihydrourospermal A, 15-<italic toggle="yes">O</italic>-beta-D-glucopyranosylurospermal A, 15-<italic toggle="yes">O</italic>-[6&#8242;-(p-hydroxyphenylacetyl)]-beta-D-glucopyranosylurospermal A and 14-<italic toggle="yes">O</italic>-methylacetal-15-<italic toggle="yes">O</italic>-[6&#8242;-(<italic toggle="yes">p</italic>-hydroxyphenylacetyl)]-beta-D-glucopyranosylurospermal A, asperal, emodin, methyl-(3,8-di-hydroxy-6-methyl-9-oxo-9H-xanthene)-1-carboxylate.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B118-pharmaceutics-16-00454" ref-type="bibr">118</xref>,<xref rid="B290-pharmaceutics-16-00454" ref-type="bibr">290</xref>,<xref rid="B291-pharmaceutics-16-00454" ref-type="bibr">291</xref>,<xref rid="B292-pharmaceutics-16-00454" ref-type="bibr">292</xref>,<xref rid="B293-pharmaceutics-16-00454" ref-type="bibr">293</xref>,<xref rid="B294-pharmaceutics-16-00454" ref-type="bibr">294</xref>,<xref rid="B295-pharmaceutics-16-00454" ref-type="bibr">295</xref>,<xref rid="B296-pharmaceutics-16-00454" ref-type="bibr">296</xref>,<xref rid="B297-pharmaceutics-16-00454" ref-type="bibr">297</xref>,<xref rid="B298-pharmaceutics-16-00454" ref-type="bibr">298</xref>,<xref rid="B299-pharmaceutics-16-00454" ref-type="bibr">299</xref>,<xref rid="B300-pharmaceutics-16-00454" ref-type="bibr">300</xref>]</td></tr><tr><td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Sonchus oleraceus</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antioxidant, anti-inflammatory, anti-tumor, antibacterial, anti-fungal, antidepressant, anxiolytic, antinociceptive effects, used for treating cancer, diarrhoea, and enteritis.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenolic acids and derivatives: Chicorin, caffeic acid glycoside, 4-cafffeoylquinic acid, 5-caffeoylquinic acid, <italic toggle="yes">cis</italic>-3&#8242; caffeoylquinic acid, 5-coumaroylquinic acid, caftaric acid, chicoric acid, 3,4 dicaffeoylquinic acid, 3,5 dicaffeoylquinic acid, dicaffeoylquinic acid (isomer), <italic toggle="yes">cis</italic>-3,5 dicaffeoylquinic acid (isomer), tri-O-caffeyolyquinic acid, <italic toggle="yes">cis</italic>-3,4 dicaffeoylquinic acid, 4,5 dicaffeoylquinic acid.<break/>Flavonoids: Quercetin-glucoronide-glycosyl, quercetin-hexose-hexoside, quercetin glucoside glucoronide, luteolin-glycosyl-glucuronide, luteolin-diglucoside, isorhamnetin diglucoside, luteolin, luteolin glucuronide, luteolin glycoside, quercetin-rutinoside, isorhamnetin rutinoside, luteolin, quercetin acetylglycoside, apigenin glucuronide, apigenin rutinoside, kaempferol acetylglycoside sesquiterpenes, crepidiaside A.<break/>Others: 7S,10S-3,9-dioxo-di-nor-eudesma-4-en-11-oic acid, 6 R,7S,10S-3,9-dioxo-7-hydroxyldi-nor-eudesma-4-en-11-oic acid.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B301-pharmaceutics-16-00454" ref-type="bibr">301</xref>,<xref rid="B302-pharmaceutics-16-00454" ref-type="bibr">302</xref>,<xref rid="B303-pharmaceutics-16-00454" ref-type="bibr">303</xref>,<xref rid="B304-pharmaceutics-16-00454" ref-type="bibr">304</xref>,<xref rid="B305-pharmaceutics-16-00454" ref-type="bibr">305</xref>,<xref rid="B306-pharmaceutics-16-00454" ref-type="bibr">306</xref>]</td></tr><tr><td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Tanacetum parthenium</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antioxidant, anxiolytic, antidepressant, anti-migraine agent, anticoagulant, anti-inflammatory, neuroprotective, antiviral, anti-apoptotic, anti-cancer, antiparasitic, pain reliever.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenolic acids and derivatives: 4-o-caffeoyl-quinic acid, 3,4-dicaffeoyl-quinic acid, 3,5-dicaffeoyl-quinic acid, 4,5-dicaffeoyl-quinic acid, neochlorogenic acid, ellagic acid, chlorogenic acid.<break/>Flavonoids: Kaempferol-3-rutinoside, 6-hydroxykaempferol-3,6,4&#8242;-trimethylether (santin), 6-hydroxykaempferol-3,6-dimethylether, quercetagenin-3,6-dimethylether (axillarin), quercetagenin-3,6,3&#8242;-trimethylether (jaceidin), quercetagenin-3,6,4&#8242;-trimethylether (centaureidin), apigenin, luteolin, santin, chrysoeriol, luteolin-7-glucoronides, methylquercetin, trihydroxy-methoxyflavone, costunolide, dihydro-<italic toggle="yes">&#946;</italic>-cyclopyrethrosin, sudachitin, aceronin, tanacetol A isomer, nevadensin, parthenolide, casticin, nevadensin, tanaphillin, 3-<italic toggle="yes">&#946;</italic>-hydroxyanhydroverlotorin, seco-tanapartholide A/B, hispidulin.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B307-pharmaceutics-16-00454" ref-type="bibr">307</xref>,<xref rid="B308-pharmaceutics-16-00454" ref-type="bibr">308</xref>,<xref rid="B309-pharmaceutics-16-00454" ref-type="bibr">309</xref>,<xref rid="B310-pharmaceutics-16-00454" ref-type="bibr">310</xref>,<xref rid="B311-pharmaceutics-16-00454" ref-type="bibr">311</xref>,<xref rid="B312-pharmaceutics-16-00454" ref-type="bibr">312</xref>,<xref rid="B313-pharmaceutics-16-00454" ref-type="bibr">313</xref>,<xref rid="B314-pharmaceutics-16-00454" ref-type="bibr">314</xref>,<xref rid="B315-pharmaceutics-16-00454" ref-type="bibr">315</xref>,<xref rid="B316-pharmaceutics-16-00454" ref-type="bibr">316</xref>,<xref rid="B317-pharmaceutics-16-00454" ref-type="bibr">317</xref>]</td></tr><tr><td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Tanacetum vulgare</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antioxidant, anti-inflammatory, anti-tumor, antibacterial, antiparasitic, anthelmintic, repellent, insecticidal, antiviral, anti-fungal.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenolic acids and derivatives: Caffeoylgluconic acid, 1-caffeoylquinic acid, protocatechuic acid, <italic toggle="yes">p-</italic>hydroxyphenylacetic acid 1-<italic toggle="yes">O</italic>-hexoside, protocatechuic acid-<italic toggle="yes">O</italic>-hexoside isomer, syringic acid 4-<italic toggle="yes">O</italic>-hexoside, neochlorogenic (3-caffeoylquinic) acid, <italic toggle="yes">O</italic>-caffeoyl hexose, vanillic acid 4-<italic toggle="yes">O</italic>-hexoside, vanillic acid, caffeoylgluconic acid isomer, <italic toggle="yes">O</italic>-caffeoyl hexose is&#243;mer, 4-hydroxybenzoic acid, 4-hydroxybenzoic acid-hexoside, 3-<italic toggle="yes">p-</italic>coumaroylquinic acid, caffeoylgluconic acid isomer, <italic toggle="yes">O</italic>-caffeoyl hexose isomer, quinic acid, chlorogenic (5-caffeoylquinic) acid, <italic toggle="yes">p</italic>-coumaric acid,<break/>3-feruloylquinic acid, caffeic acid-<italic toggle="yes">O</italic>-hexoside, caffeic acid, gentisic acid, 5-<italic toggle="yes">p</italic>-coumaroylquinic acid, 3-caffeoyl-5-hydroxy-dihydrocaffeoylquinic acid, <italic toggle="yes">p-</italic>hydroxyphenylacetic acid, 5-feruloylquinic acid, 1-caffeoyl-3-hydroxy-dihydrocaffeoylquinic acid, vanillic acid-4-<italic toggle="yes">O</italic>-(6-<italic toggle="yes">O</italic>-caffeoyl)-hexoside, 3,4-dicaffeoylquinic acid, 3,5-dicaffeoylquinic acid, 3-dehydrocaffeoyl-5-caffeoylquinic acid, 4,5-dicaffeoylquinic acid, shikimic acid, 4-dehydrocaffeoyl-5-caffeoylquinic acid, salicylic acid, 3-feruloyl-4-caffeoylquinic acid, 3-<italic toggle="yes">p</italic>-coumaroyl-5-caffeoylquinic acid, caffeic acid-<italic toggle="yes">O</italic>-(salicyl)-hexoside, 3-caffeoyl-5-<italic toggle="yes">p</italic>-coumaroylquinic acid, 3-feruloyl-5-caffeoylquinic acid, 4-caffeoyl-5-<italic toggle="yes">p</italic>-coumaroylquinic acid, 4-caffeoyl-5-feruloylquinic acid, 3,4,5-tricaffeoylquinic acid.<break/>Flavonoids: Apigenin, apigenin-6,8-diC-hexoside, apigenin 7-<italic toggle="yes">O</italic>-glucoside, methoxyeriodictyol-<italic toggle="yes">O</italic>-hexuronide, apigenin-<italic toggle="yes">O</italic>-hexuronide, luteolin, luteolin-<italic toggle="yes">O</italic>-hexuronide, luteolin 7-<italic toggle="yes">O</italic>-glucoside, 6-hydroxyluteolin-<italic toggle="yes">O</italic>-hexoside, luteolin 7-<italic toggle="yes">O</italic>-gentiobioside dihexoside (gentiobioside) 6-glucopyranosyl-glucopyranoside, luteolin-7-<italic toggle="yes">O</italic>-neohesperidoside, luteolin-O-caffeoylhexoside, luteolin-<italic toggle="yes">O</italic>-acetylhexosidekaempferol 3-<italic toggle="yes">O</italic>-glucuronide, rutin, quercetin, quercetin 3-O-acetylhexoside, quercetin 7-<italic toggle="yes">O</italic>-hexuronide, kaempferol, kaempferol 3-<italic toggle="yes">O</italic>-glucoside, eriodictyol-<italic toggle="yes">O</italic>-hexuronide, patuletin-<italic toggle="yes">O</italic>-hexoside, nepetin-<italic toggle="yes">O</italic>-hexoside, isorhamnetin 3-<italic toggle="yes">O</italic>-glucoside, naringenin-<italic toggle="yes">O</italic>-hexuronide, hesperetin 7-<italic toggle="yes">O</italic>-rutinoside (hesperidin), nepetin-O-hexuronide, hispidulin-<italic toggle="yes">O</italic>-hexuronide, isorhamnetin-<italic toggle="yes">O</italic>-hexuronide, chrysoeriol-<italic toggle="yes">O</italic>-hexuronide, hesperetin-<italic toggle="yes">O</italic>-hexuronide, jaceosidin -<italic toggle="yes">O</italic>-hexuronide, patuletin (6-methoxyquercetin), nepetin (6-methoxyluteolin) 6-methoxykaempferol, naringenin, hispidulin (scutellarein-6-methyl ether), chrysoeriol, hesperetin, Isorhamnetin, jaceosidin (6-hydroxyluteolin-6,3&#8242;-dimethyl ether), quercetagetin-3,6,3&#8242;(4&#8242;)-trimethyl ether, cirsimaritin (6-hydroxyapigenin-6,7-dimethyl ether), eupatilin, casticin, acacetin.<break/>Sesquiterpene lactones and derivatives: <italic toggle="yes">&#945;</italic>/<italic toggle="yes">&#946;</italic> thujone, hydroxyarbusculin, ludovicin C, tanacetin/hydroxyraynosin/armefolin, parthenolide, camphor, caryophyllene oxide, dehydrosantamarin, caryophyllene/bisabolene, linoleamide, palmitamide, oleamide.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B315-pharmaceutics-16-00454" ref-type="bibr">315</xref>,<xref rid="B318-pharmaceutics-16-00454" ref-type="bibr">318</xref>,<xref rid="B319-pharmaceutics-16-00454" ref-type="bibr">319</xref>,<xref rid="B320-pharmaceutics-16-00454" ref-type="bibr">320</xref>,<xref rid="B321-pharmaceutics-16-00454" ref-type="bibr">321</xref>,<xref rid="B322-pharmaceutics-16-00454" ref-type="bibr">322</xref>,<xref rid="B323-pharmaceutics-16-00454" ref-type="bibr">323</xref>,<xref rid="B324-pharmaceutics-16-00454" ref-type="bibr">324</xref>,<xref rid="B325-pharmaceutics-16-00454" ref-type="bibr">325</xref>,<xref rid="B326-pharmaceutics-16-00454" ref-type="bibr">326</xref>,<xref rid="B327-pharmaceutics-16-00454" ref-type="bibr">327</xref>]</td></tr><tr><td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>
<italic toggle="yes">Lamiaceae</italic>
</bold>
</td></tr><tr><td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1"><italic toggle="yes">Calamintha nepeta</italic> subsp. <italic toggle="yes">nepeta</italic> (Syn. <italic toggle="yes">Clinopodium nepeta</italic>)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Stimulant, tonic, antiseptic, antispasmodic, antioxidant, antimicrobial, anti-inflammatory, anti-ulcer, phytotoxic.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenolic acids and derivatives: 3-<italic toggle="yes">O</italic>-Caffeoylquinic acid, 4-<italic toggle="yes">O</italic>-caffeoylquinic acid, 5-<italic toggle="yes">O</italic>-caffeoylquinic acid, rosmarinic acid, quercetin-3-<italic toggle="yes">O</italic>-rutinoside, gallic acid, protocatechuic acid, chlorogenic acid, <italic toggle="yes">p</italic>-hydroxybenzoic acid, vanillic acid, syringic acid, vanillin, <italic toggle="yes">trans-</italic>cinnamic acid, coumarin, quinic acid, 12-<italic toggle="yes">O</italic>-hexosyljasmonate, caffeic acid hexamer, caffeic acid pentamer, rosmarinic acid, 12-<italic toggle="yes">O</italic>-(6&#8242;-caffeoylhexosyl)jasmonate, acacetin 7-<italic toggle="yes">O</italic>-[hexosyl(1iv &#8594; 2&#8243;)]deoxyhexosyl(1&#8242;&#8243; &#8594; 6&#8243;) hexoside.<break/>Flavonoids: Myricetin, quercetin, luteolin, hesperidin, kaempferol, kaempferol-di-<italic toggle="yes">O</italic>-hexoside, apigenin, luteolin-8-C-(3-hydroxy-3-methyl-glutaroyl) hexosyl hexoside, 6,8-C-dihexosylapigenin, caffeic acid dimer, quercetin-3-<italic toggle="yes">O</italic>-hexoside, quercetin-3-<italic toggle="yes">O</italic>-[6&#8243;-<italic toggle="yes">O</italic>-(3-hydroxy-3-methyl-glutaroyl)]hexoside, kaempferol-3-<italic toggle="yes">O</italic>-hexoside, salvianolic acid B, acacetin, acacetin 7-<italic toggle="yes">O</italic>-[6iv-<italic toggle="yes">O</italic>-acetyl-hexosyl(1iv &#8594; 2&#8243;)]deoxyhexosyl(1&#8242;&#8243; &#8594; 6&#8243;)hexoside, acacetin 7-<italic toggle="yes">O</italic>-deoxyhexosyl(1&#8242;&#8243; &#8594; 6&#8243;)hexoside.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B328-pharmaceutics-16-00454" ref-type="bibr">328</xref>,<xref rid="B329-pharmaceutics-16-00454" ref-type="bibr">329</xref>,<xref rid="B330-pharmaceutics-16-00454" ref-type="bibr">330</xref>,<xref rid="B331-pharmaceutics-16-00454" ref-type="bibr">331</xref>,<xref rid="B332-pharmaceutics-16-00454" ref-type="bibr">332</xref>,<xref rid="B333-pharmaceutics-16-00454" ref-type="bibr">333</xref>,<xref rid="B334-pharmaceutics-16-00454" ref-type="bibr">334</xref>,<xref rid="B335-pharmaceutics-16-00454" ref-type="bibr">335</xref>,<xref rid="B336-pharmaceutics-16-00454" ref-type="bibr">336</xref>]</td></tr><tr><td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Lavandula pedunculata</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory, antioxidant, antimicrobial.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenolic acids and derivatives: Salvianolic acid B, rosmarinic acid, caffeic acid, caffeic acid hexoside, <italic toggle="yes">p</italic>-coumaroyl hexoside, rosmarinic acid, rosmarinic acid hexoside, sangerinic acid, lithospermic acid A, chlorogenic acid, 3-hydroxy-4-methoxybenzaldehyde thiosemicarbazone, ferulic acid, syringic acid, vanilic acid, <italic toggle="yes">p-</italic>hydroxybenzoic acid, protocatechuic acid, gallic acid.<break/>Flavonoids: Luteolin-<italic toggle="yes">O</italic>-hexosyl-<italic toggle="yes">O</italic>-glucuronide, eriodictyol-<italic toggle="yes">O</italic>-glucuronide, luteolin-7-<italic toggle="yes">O</italic>-glucuronide, methylluteolin-<italic toggle="yes">O</italic>-glucuronide, eriodictyol-<italic toggle="yes">O</italic>-glucuronide, herniarin, myricetin.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B337-pharmaceutics-16-00454" ref-type="bibr">337</xref>,<xref rid="B338-pharmaceutics-16-00454" ref-type="bibr">338</xref>,<xref rid="B339-pharmaceutics-16-00454" ref-type="bibr">339</xref>,<xref rid="B340-pharmaceutics-16-00454" ref-type="bibr">340</xref>]</td></tr><tr><td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Lavandula stoechas</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory, antioxidant, antispasmodic, sedative, antibacterial, anti-fungal, insecticidal, larvicidal, hepatoprotective, renoprotective, anti-leishmaniasis.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenolic acids and derivatives: Protocatechuic acid, chlorogenic acid, caffeic acid, rosmarinic acid, ferulic acid, 7-methoxy coumarin. <break/>Flavonoids: Flavone di-<italic toggle="yes">O</italic>-glycosides, flavone 7-<italic toggle="yes">O</italic>-monoglycosides, pinobanksin, quercetin, pinocembrin, luteolin, vitexin, acacetin, erythrodiol.<break/>Others: Ursolic acid, vergatic acid, oleanolic acid, <italic toggle="yes">&#945;</italic>-amyrin, <italic toggle="yes">&#945;</italic>-amyrin acetate, <italic toggle="yes">&#946;</italic>-sitosterol, lupeol, two longipinane derivatives (longipin-2-ene-7<italic toggle="yes">&#946;</italic>,9<italic toggle="yes">&#945;</italic>-diol-1-one and longipin-2-ene-7<italic toggle="yes">&#946;</italic>,9<italic toggle="yes">&#945;</italic>-diol-1-one-9-monoacetate), lavanol. </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B341-pharmaceutics-16-00454" ref-type="bibr">341</xref>,<xref rid="B342-pharmaceutics-16-00454" ref-type="bibr">342</xref>,<xref rid="B343-pharmaceutics-16-00454" ref-type="bibr">343</xref>,<xref rid="B344-pharmaceutics-16-00454" ref-type="bibr">344</xref>,<xref rid="B345-pharmaceutics-16-00454" ref-type="bibr">345</xref>,<xref rid="B346-pharmaceutics-16-00454" ref-type="bibr">346</xref>,<xref rid="B347-pharmaceutics-16-00454" ref-type="bibr">347</xref>]</td></tr><tr><td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Melissa officinalis</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-proliferative, anti-tumor, antioxidant, antiangiogenic, cardioprotective, anxiolytic<break/>antidepressant, antinociceptive, neuroprotective, GABA-T inhibitor, anti-kinetoplastidae, analgesic, hypnotic, anti-Alzheimer, antispasmodic, antiviral, anti-fungal, antibacterial, for premenstrual syndromes.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenolic acids: Caffeic acid, caftaric acid, chlorogenic acid, ferulic acid, gentisic acid<italic toggle="yes">, p-</italic>Coumaric acid, rosmarinic acid.<break/>Flavonoids: Apigenin, cynaroside, daidzein, hyperoside, isoquercetin, kaempherol, luteolin, myricetin, quercetin, quercetrol, rutin.<break/>Triterpenes: Betulinic acid, oleanolic acid, ursolic acid, 23-sulfate ester of niga-ichigoside F1, 3<italic toggle="yes">&#946;</italic>,16<italic toggle="yes">&#946;,</italic>23-trihydroxy-13,28-epoxyurs-11-ene-3-<italic toggle="yes">O</italic>-<italic toggle="yes">&#946;</italic>-D-glucopyranoside, 3,23-Disulfate ester of 2<italic toggle="yes">&#945;</italic>,3<italic toggle="yes">&#946;</italic>,19<italic toggle="yes">&#945;,</italic>23-tetrahydroxyurs-12-en-28-oicacid, 3,23-Disulfate ester of 2<italic toggle="yes">&#945;</italic>,3<italic toggle="yes">&#946;</italic>,19<italic toggle="yes">&#945;</italic>,23-tetrahydroxyurs-12-en-28-oicacid 28-<italic toggle="yes">O</italic>-<italic toggle="yes">&#946;</italic>-D-glucopyranoside, 3,23-Disulfate ester of2<italic toggle="yes">&#945;</italic>,3<italic toggle="yes">&#946;</italic>,23,29-tetrahydroxyolean-12-en-28-oicacid, 3,23-disulfate ester of 3<italic toggle="yes">&#946;</italic>-23,29-trihydroxyolean-12-en-28-oic acid, 3,23-disulfate ester of 2<italic toggle="yes">&#945;</italic>,3<italic toggle="yes">&#946;</italic>-23,29-tetrahydroxyolean-12-ene-28-oicacid, 23-sulfate ester of 2<italic toggle="yes">&#945;</italic>,3<italic toggle="yes">&#946;,</italic>19 <italic toggle="yes">&#945;</italic>,23-tetrahydroxyurs-12-en-28-oic acid, melissioside A, melissioside B, melissioside C.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B348-pharmaceutics-16-00454" ref-type="bibr">348</xref>,<xref rid="B349-pharmaceutics-16-00454" ref-type="bibr">349</xref>,<xref rid="B350-pharmaceutics-16-00454" ref-type="bibr">350</xref>,<xref rid="B351-pharmaceutics-16-00454" ref-type="bibr">351</xref>]</td></tr><tr><td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Mentha aquatica</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antioxidant, anxiolytic, anti-inflammatory, hepatoprotective, antimicrobial, anti-cancer.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenolic acids: Rosmarinic acid, caffeic acid.<break/>Flavonoids: Luteolin-7-<italic toggle="yes">O</italic>-rutinoid, Eriodictyol-<italic toggle="yes">O</italic>-rutinoside, naringenin-7-<italic toggle="yes">O</italic>-rutinoside, hesperetin-7-<italic toggle="yes">O</italic>- rutinoside, luteolin glucoside, luteolin-7-O-<italic toggle="yes">&#946;</italic>-D-diglucuronide, eriocitrin, apigenin-7-<italic toggle="yes">O</italic>-<italic toggle="yes">&#946;</italic>-D-diglucuronide, luteolin-7-<italic toggle="yes">O</italic>-glucuronide, narirutin, apigenin-7-<italic toggle="yes">O</italic>-rutinoside, apigenin-7-<italic toggle="yes">O</italic>-glucuronide, hesperidin, catechin.<break/>Others: methyl ester palmitic acid, methyl ester linolenic acid, ethyl ester linolenic acid, neophytadiene, phytol, viridiflorol, rotundifolone, 2,3-<italic toggle="yes">seco</italic>-triterpene, 3-<italic toggle="yes">O</italic>-benzoyltormentic acid, tormentic acid, 1-<italic toggle="yes">O</italic>-benzoylhyptad, ienic acid, 3-epiursolic acid, hyptadienic acid, 3-<italic toggle="yes">epi</italic>-maslinic acid, 3-<italic toggle="yes">epi</italic>-tormentic acid, ursolic acid, <italic toggle="yes">&#946;</italic>-sitosterol, oleanolic acid, pomolic acid, micromeric acid, 21<italic toggle="yes">&#945;</italic>-hydroxyursolic acid, pomolic acid, hyptadienic acid, 1-<italic toggle="yes">O</italic>-linoleoyl-2-<italic toggle="yes">O</italic>-enadecanoyl-3-<italic toggle="yes">O</italic>-palmitoleoyl-<italic toggle="yes">sn</italic>-glycerol, 1-<italic toggle="yes">O</italic>-oleoyl-2-<italic toggle="yes">O</italic>-enadecanoyl-3-<italic toggle="yes">O</italic>-palmitoleoyl-<italic toggle="yes">sn</italic>-glycerol, 1, 3-<italic toggle="yes">O</italic>-dioleoyl-2-<italic toggle="yes">O</italic>-eicosanoyl-<italic toggle="yes">sn</italic>-glycerol, 1-<italic toggle="yes">O</italic>-linoleoyl-2-<italic toggle="yes">O</italic>-palmitoleoyl-<italic toggle="yes">sn</italic>-glycerol, corosolic acid, asiatic acid, choline, acetic acid, formic acid, lactic acid, quinic acid, salicylic acid, succinic acid, fructose, glucose, sucrose, alanine, aspartic acid, glycine, isoleucine, leucine, phenylalanine, threonine, valine.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B352-pharmaceutics-16-00454" ref-type="bibr">352</xref>,<xref rid="B353-pharmaceutics-16-00454" ref-type="bibr">353</xref>,<xref rid="B354-pharmaceutics-16-00454" ref-type="bibr">354</xref>,<xref rid="B355-pharmaceutics-16-00454" ref-type="bibr">355</xref>,<xref rid="B356-pharmaceutics-16-00454" ref-type="bibr">356</xref>,<xref rid="B357-pharmaceutics-16-00454" ref-type="bibr">357</xref>,<xref rid="B358-pharmaceutics-16-00454" ref-type="bibr">358</xref>,<xref rid="B359-pharmaceutics-16-00454" ref-type="bibr">359</xref>,<xref rid="B360-pharmaceutics-16-00454" ref-type="bibr">360</xref>,<xref rid="B361-pharmaceutics-16-00454" ref-type="bibr">361</xref>,<xref rid="B362-pharmaceutics-16-00454" ref-type="bibr">362</xref>,<xref rid="B363-pharmaceutics-16-00454" ref-type="bibr">363</xref>,<xref rid="B364-pharmaceutics-16-00454" ref-type="bibr">364</xref>,<xref rid="B365-pharmaceutics-16-00454" ref-type="bibr">365</xref>,<xref rid="B366-pharmaceutics-16-00454" ref-type="bibr">366</xref>,<xref rid="B367-pharmaceutics-16-00454" ref-type="bibr">367</xref>,<xref rid="B368-pharmaceutics-16-00454" ref-type="bibr">368</xref>,<xref rid="B369-pharmaceutics-16-00454" ref-type="bibr">369</xref>,<xref rid="B370-pharmaceutics-16-00454" ref-type="bibr">370</xref>,<xref rid="B371-pharmaceutics-16-00454" ref-type="bibr">371</xref>]</td></tr><tr><td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Mentha pulegium</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Insecticidal, nematicidal, allelopathic, antioxidant, antimicrobial, antiviral, antileishmanial, anti-tumor, anti-cancer, anti-hemolytic, antihypertensive, anti-inflammatory, burn wound healing, cardioprotective, stomachic, astringent, emmenagogue, decongestant, antispasmodic, antiseptic, depurative, digestive, anti-rheumatic, anti-arthritic, hepatotoxicity.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenolic acids: Gallic acid, chlorogenic acid, caffeic acid, ellagic acid, fumaric acid, protocatechuic acid, <italic toggle="yes">p</italic>-hydroxybenzoic acid, syringic acid, cinnamic acid, vanillic acid, ferulic acids, <italic toggle="yes">p</italic>-coumaric acid, chlorogenic acid, rosmarinic acid.<break/>Flavonoids: Epicatechin, catechin, apigenin, salvigenin, salvigenin, luteolin, isorhamnetin, quercetagetin-3,6-dimethylether, kaempferol, kaempferol-3-<italic toggle="yes">O</italic>-rutinoside, hesperidin, thymonin, jaceosidin, pectolinaringenin, ladanein, sorbifolin, pedalitin, diosmin, luteolin, apigenin, naringenin, chrysin, chrysoeriol, vicenin-2, gallocatechin isomer 1.<break/>Others: Alterporriol, atropisomer, altersolanol, stemphypyrone, 6-<italic toggle="yes">O</italic>-methylalater-nin, macrosporin, salvianolic acid, Lithospermic acid, jaceidinisomer 1, Jaceosidin.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B371-pharmaceutics-16-00454" ref-type="bibr">371</xref>,<xref rid="B372-pharmaceutics-16-00454" ref-type="bibr">372</xref>,<xref rid="B373-pharmaceutics-16-00454" ref-type="bibr">373</xref>,<xref rid="B374-pharmaceutics-16-00454" ref-type="bibr">374</xref>,<xref rid="B375-pharmaceutics-16-00454" ref-type="bibr">375</xref>,<xref rid="B376-pharmaceutics-16-00454" ref-type="bibr">376</xref>,<xref rid="B377-pharmaceutics-16-00454" ref-type="bibr">377</xref>,<xref rid="B378-pharmaceutics-16-00454" ref-type="bibr">378</xref>,<xref rid="B379-pharmaceutics-16-00454" ref-type="bibr">379</xref>]</td></tr><tr><td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Mentha suaveolens</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antioxidant, antimicrobial, antimutagenic, analgesic, anti-inflammatory, insecticidal, anti-cancer, antithermal skin-aging effect.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenolic acids: Cinnamic acid, chlorogenic acid, rosmarinic acid, caffeic acid, <italic toggle="yes">p</italic>-methyl coumarate, ferulic acid, <italic toggle="yes">p</italic>-coumaric acid, gallic acid, hydroxybenzoic acid, hydroxybenzoic acid, 3-dihydroxybenzoic acid, vanillic acid, salicylic acid, salicylic acid 2-<italic toggle="yes">O</italic>-<italic toggle="yes">&#946;-</italic>glucoside, <italic toggle="yes">trans-</italic>cinnamic acid, <italic toggle="yes">p</italic>-methyl coumarate, <italic toggle="yes">p</italic>-anisic acid.<break/>Flavonoids: Hesperidin, rutin, quercetin, naringenin, luteolin, kaempferol, apigenin. </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B352-pharmaceutics-16-00454" ref-type="bibr">352</xref>,<xref rid="B376-pharmaceutics-16-00454" ref-type="bibr">376</xref>,<xref rid="B380-pharmaceutics-16-00454" ref-type="bibr">380</xref>,<xref rid="B381-pharmaceutics-16-00454" ref-type="bibr">381</xref>,<xref rid="B382-pharmaceutics-16-00454" ref-type="bibr">382</xref>,<xref rid="B383-pharmaceutics-16-00454" ref-type="bibr">383</xref>,<xref rid="B384-pharmaceutics-16-00454" ref-type="bibr">384</xref>,<xref rid="B385-pharmaceutics-16-00454" ref-type="bibr">385</xref>,<xref rid="B386-pharmaceutics-16-00454" ref-type="bibr">386</xref>,<xref rid="B387-pharmaceutics-16-00454" ref-type="bibr">387</xref>]</td></tr><tr><td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1"><italic toggle="yes">Origanum vulgare</italic> L.</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibacterial, anti-fungal, antiviral, antiparasitic, antioxidant, anti-inflammatory, anti-tumoral, beneficial activity on skin disorders, effects on melanin production and on human sperm mobility, anti-Alzheimer, energy producer, stomach booster, nervous system reliever, laxative, reducing the general weakness of the body, anti-cancer, relief of migraine pain, for external use by rubbing in place of fractures and numbness of body parts, toothache, disinfection, antidiarrhoea, anticonvulsant, expectorant, nourishing, menstrual regulator, anti-urinary tract infection, treatment of sexual dysfunction, colic, sinusitis, relaxing, cardiorespiratory booster, nervous system booster, treatment of blockages, hepatoprotective.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenolic acids: Rosmarinic acid, chlorogenic acid, cinnamic acid, caffeic acid, syringic acid, benzoic acid, vanillic acid, <italic toggle="yes">galo</italic>-coumaric acid, gallic acid, protocatechuic acid, 4-hydroxybenzoic acid, <italic toggle="yes">p-</italic>coumaric acid, ferulic acid, sinapic acid, <italic toggle="yes">trans</italic>-cinnamic acid, 2,4-dihydroxybenzoic acid, phenyllactic acid.<break/>Flavonoids: Quercetin, apigenin, kaempferol, naringenin, eriodictyol, salvianolic acid B, llithospermic acid B, amburosides A, luteolin, luteolin 7-O-glucuronide, apigenin 7-O-glucuronide, (&#8722;)-epigallocatechin, (+)-catechin, rutin.<break/>Others: Thymoquinone, thymol, carvacrol, demethylbenzolignanoid, chicoric acid, calleryanin 3,4-dihydroxybenzoate, calleryanin 3-hydroxy,4-methoxybenzoate, gastrodin 3,4-dihydroxybenzoate.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B388-pharmaceutics-16-00454" ref-type="bibr">388</xref>,<xref rid="B389-pharmaceutics-16-00454" ref-type="bibr">389</xref>,<xref rid="B390-pharmaceutics-16-00454" ref-type="bibr">390</xref>,<xref rid="B391-pharmaceutics-16-00454" ref-type="bibr">391</xref>,<xref rid="B392-pharmaceutics-16-00454" ref-type="bibr">392</xref>,<xref rid="B393-pharmaceutics-16-00454" ref-type="bibr">393</xref>,<xref rid="B394-pharmaceutics-16-00454" ref-type="bibr">394</xref>,<xref rid="B395-pharmaceutics-16-00454" ref-type="bibr">395</xref>,<xref rid="B396-pharmaceutics-16-00454" ref-type="bibr">396</xref>]</td></tr><tr><td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Prunella vulgaris</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-tumor, anti-inflammation, immunoregulation, antiviral, antioxidant, anti-osteoporosis, antidepression, hypotensive, hypolipemic, <break/>cardioprotective, anti-dementia, anti-amnesia.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenolic acids: <italic toggle="yes">p-</italic>coumaric acid, caffeic acid, rosmarinic acid.<break/>Flavonoids: Kaempferol, luteolin, delphinidin, quercetin, quercetin-3-<italic toggle="yes">O</italic>-<italic toggle="yes">&#946;</italic>-D-galactoside, homoorinet, cinaroside, quercetin-3-<italic toggle="yes">O</italic>-<italic toggle="yes">&#946;</italic>-D-glucoside, kaempferol-3-<italic toggle="yes">O</italic>-<italic toggle="yes">&#946;</italic>-D-glucoside.<break/>Steroids and derivatives: Beta-sitosterol, spinasterol, stigmasterol, vulgaxanthin-I, poriferasterol monoglucoside, morin, ducosterol, (22E20S24S)-stigmast-7,22-diene-3-e, Stigmast-7-en-3<italic toggle="yes">&#946;</italic>-ol.<break/>Triterpenes: Oleanolic acid, ursolic acid, vulgarsaponin A/B, methyl oleanolate, methyl ursolate, methyl, maslinate, pravuloside A/B, palmitic acid, ethyl palmitate, tetracosanoic acid, stearic acid, 6,9-octodecadienoic acid, 3,6,7-eicosatrienoic acid, oleic acid, peanut oleic acid, moringoic acid, lauric acid, myristic acid, linolenic acid, palmitic acid, myristic acid, linoleic acid.<break/>Coumarins: Umbelliferon, scopoletin, esculetin.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B397-pharmaceutics-16-00454" ref-type="bibr">397</xref>]</td></tr><tr><td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Salvia verbenaca</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibacterial, antioxidant, anti-cancer, antiparasitic, insecticidal, antihemolytic.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenolic acids: <italic toggle="yes">p</italic>-Hydroxybenzoic acid, <italic toggle="yes">p</italic>-coumaric acid, rosmarinic acid, vanillic acid, caffeic acid, ferulic acid, 3-<italic toggle="yes">O</italic>- and 4-<italic toggle="yes">O</italic>-caffeoylquinic acids.<break/>Flavonoids: Naringenin, cirsiliol, luteolin, apigenin, naringin, hesperidin, genkwanin.<break/>Others: Palmitic acid, stearic acid, linolenic acid, arachidic acid, oleic acid, linoleic acid, palmitoleic acid, arachidic acid, verbenacines, salvinines, 6,7-dehydroroyleanone, cryptanol, sitosterol, campesterol, 6-hydroxysalvonolone, microstegiol, stigmasterol, carnosic acids, methyl carnosate contents, carnosol.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B387-pharmaceutics-16-00454" ref-type="bibr">387</xref>,<xref rid="B398-pharmaceutics-16-00454" ref-type="bibr">398</xref>,<xref rid="B399-pharmaceutics-16-00454" ref-type="bibr">399</xref>,<xref rid="B400-pharmaceutics-16-00454" ref-type="bibr">400</xref>]</td></tr><tr><td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Thymus mastichina</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibacterial, anti-fungal, antioxidant, anti-cancer, antiviral, insecticidal, insect repellent, anti-Alzheimer, anti-inflammatory.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenolic acids: Rosmarinic acid, hydroxycinnamoylquinic acid, 3-methoxysalicylic acid, caffeic acid, chlorogenic acid, salvianolic acid B/E, salvianolic acid A/K isomer.<break/>Flavonoids: Quercetin glucoside, 6-hydroxyluteolin-7-<italic toggle="yes">O</italic>-glucopyranoside, luteolin glucoside, 6- hydroxyapigenin7-<italic toggle="yes">O</italic>glucopyranoside, apigenin-7-<italic toggle="yes">O</italic>glucoside, naringenin, luteolin, carnosol, apigenin, kaempferol, chrysoeriol-<italic toggle="yes">O</italic>-hexuronide, sakuranetin, sterubin.<break/>Others: Oleanolic acid, ursolic acid, xanthophyll lutein, <italic toggle="yes">&#946;</italic>-sitosterol.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B401-pharmaceutics-16-00454" ref-type="bibr">401</xref>]</td></tr></tbody></table></table-wrap><list list-type="bullet"><list-item><p><italic toggle="yes">Achillea millefolium</italic> L.</p></list-item></list><p>The <italic toggle="yes">Achillea</italic> genus is well known for its use in preventing diabetes (<xref rid="pharmaceutics-16-00454-t002" ref-type="table">Table 2</xref>). Most of the research has been carried out on <italic toggle="yes">Achillea millefolium</italic> L. Yarrow, a perennial plant native to the temperate regions of Europe and Asia. Humans have used it for over 3000 years [<xref rid="B213-pharmaceutics-16-00454" ref-type="bibr">213</xref>]. It is commonly known as yarrow (milef&#243;lio or erva-carpinteira) and is widespread in mountain meadows, pathways, crop fields, and home gardens [<xref rid="B127-pharmaceutics-16-00454" ref-type="bibr">127</xref>]. In the study by Rezaei et al. [<xref rid="B402-pharmaceutics-16-00454" ref-type="bibr">402</xref>], the effect of a hydroalcoholic extract of this plant at 25 mg/kg/day and 100 mg/kg/day was evaluated on streptozotocin (STZ)-induced diabetic rats. The results showed that this extract had a beneficial effect on serum glucose, lipids, and liver enzymes compared with the metformin-treated groups and controls. These effects were also more pronounced at 100 mg/kg/day than at 25 mg/kg/day [<xref rid="B402-pharmaceutics-16-00454" ref-type="bibr">402</xref>]. According to Rezaei et al. [<xref rid="B402-pharmaceutics-16-00454" ref-type="bibr">402</xref>], STZ caused a considerable increase in serum liver enzyme levels, while treatment with metformin or <italic toggle="yes">A. millefolium</italic> extract significantly attenuated these elevations. </p><p>Similar results were reported in a study by Coskun et al. [<xref rid="B403-pharmaceutics-16-00454" ref-type="bibr">403</xref>] on the protective effect of Achillea on abnormal lipid profiles. Mustafa et al. (2012) evaluated the hypoglycaemic and hypolipidemic effects of the extract of <italic toggle="yes">A. millefolium</italic> in ALO-induced diabetic rats [<xref rid="B404-pharmaceutics-16-00454" ref-type="bibr">404</xref>]. They reported that the extracts at dose levels of 250 and 500 mg/kg body weight (BW) showed a significant decrease in blood glucose level, TG (Triglycerides), VLDL (Very Low-Density Lipoprotein), cholesterol, SGOT (Serum Glutamic-Oxaloacetic Transaminase Test), SGPT (Serum Glutamic Pyruvic Transaminase test), and ALP (Alkaline Phosphatase) in diabetic rats. Nematy et al. (2017) reported that the plant had dose-dependent positive effects on appetite in rats [<xref rid="B212-pharmaceutics-16-00454" ref-type="bibr">212</xref>]. According to Rezaei et al. (2020), the flavonoids present in <italic toggle="yes">A. millefolium</italic> can block serotonin receptors and increase plasma ghrelin content [<xref rid="B402-pharmaceutics-16-00454" ref-type="bibr">402</xref>], as well as appetite [<xref rid="B212-pharmaceutics-16-00454" ref-type="bibr">212</xref>,<xref rid="B405-pharmaceutics-16-00454" ref-type="bibr">405</xref>]. Therefore, this plant has antioxidant properties and can be used to improve the complications of oxidative stress conditions such as T2DM [<xref rid="B211-pharmaceutics-16-00454" ref-type="bibr">211</xref>]. This extract could act as a hypoglycaemic factor and reduce intestinal glucose absorption thanks to its pharmacological properties (<xref rid="pharmaceutics-16-00454-t001" ref-type="table">Table 1</xref>). According to Karimi et al. (2021), treatment with <italic toggle="yes">A. millefolium</italic> could protect renal tissue against the complications of diabetes by increasing Bax (Bcl-2-associated X protein) mRNA levels. This study indicates that hydroalcoholic extracts of the plant not only improve renal function through their antioxidant activity but modulate certain biochemical factors in diabetic rats [<xref rid="B406-pharmaceutics-16-00454" ref-type="bibr">406</xref>]. </p><p>Another study by Ch&#225;vez-Silva et al. (2018) suggests that the hydroethanolic extract of <italic toggle="yes">A. millefolium</italic> probably induces its antidiabetic function via the PPAR<italic toggle="yes">&#947;</italic> (activating peroxisome proliferator-activated receptors)/GLUT4 pathway, improving sensitivity to insulin and promoting the expression of glucose metabolism genes, such as GLUT4, which allow glucose to be transported into the cell, resulting in its reduction in the blood [<xref rid="B407-pharmaceutics-16-00454" ref-type="bibr">407</xref>]. On the other hand, Zolghadri et al. (2014) reported that the ethanolic extract of <italic toggle="yes">A. millefolium</italic> significantly decreased the expression of IL-1<italic toggle="yes">&#946;</italic> and iNOS (inducible Nitric Oxyde Synthase) genes against the cytotoxic effect induced by STZ on pancreatic <italic toggle="yes">&#946;</italic> cells, and those increasing insulinemia [<xref rid="B408-pharmaceutics-16-00454" ref-type="bibr">408</xref>]. Furthermore, as a result, it was persistent throughout the experiments in the oral glucose tolerance test and the STZ diabetic model; this suggests another mode of function that participates as an extrapancreatic contribution, which could induce insulin sensitisation [<xref rid="B407-pharmaceutics-16-00454" ref-type="bibr">407</xref>]. According to Ch&#225;vez-Silva et al. (2018), these results could be related to PPAR<italic toggle="yes">&#947;</italic> activation, as there is evidence that this decreases inflammatory cytokines [IL-6, TNF-&#945; (Tumour Necrosis Factor), IL-1<italic toggle="yes">&#946;</italic>, IL-10, IL-12, and gelatinase B]. It decreases iNOs and scavenger receptor A gene expression [<xref rid="B407-pharmaceutics-16-00454" ref-type="bibr">407</xref>].</p><table-wrap position="anchor" id="pharmaceutics-16-00454-t002" orientation="portrait"><object-id pub-id-type="pii">pharmaceutics-16-00454-t002_Table 2</object-id><label>Table 2</label><caption><p>Medicinal plants in NPSE for diabetes management with scientific validation of the claimed antidiabetic effects (in vitro).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Target</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Part Used/Extraction</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Observations</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr><tr><th colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Asteraceae</italic>
</th></tr></thead><tbody><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1"><italic toggle="yes">Arctium minus</italic> (Hill) Bernh</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU/A-AMY</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 mg/mL of MeOH, CH<sub>2</sub>Cl<sub>2</sub>, EtOAc, and BuOH extracts of leaves (L), flowers (F) and roots (R).</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AGLU-LMeOHext = 3.32 &#177; 9.80, AMY-LMeOHext = 12.65 &#177; 6.40.<break/>AGLU-LCH2Cl2-ext = 87.12 &#177; 8.06, AMY-LCH2Cl2-ext = 28.84 &#177; 5.57.<break/>AGLU-LEtOAc-ext = na, AMY-LEtOAc-ext = na.<break/>AGLU- LBuOH-ext = 24.49 &#177; 15.92, AMY-LBuOH-ext = 30.50 &#177; 8.35.<break/>AGLU-LAqua-ext = 15.51 &#177; 6.96, AMY-LAqua-ext = 5.74 &#177; 5.95.<break/>AGLU-FMeOHext = na, AMY-FMeOHext = na.<break/>AGLU-FCH2Cl2-ext = 21.68 &#177; 3.12, AMY-FCH2Cl2-ext = na. <break/>AGLU-FEtOAc-ext = 40.69 &#177; 6.90, AMY-FEtOAc-ext = na.<break/>AGLU-FBuOH-ext = 6.40 &#177; 4.45, AMY- FBuOH-ext = na.<break/>AGLU-FAqua-ext = 13.32 &#177; 2.22, AMY-FAqua-ext = na.<break/>AGLU-RMeOHext = na, AMY-RMeOHext = na.<break/>AGLU-RCH2Cl2-ext = 68.01 &#177; 7.02, AMY-RCH2Cl2-ext = na.<break/>AGLU-REtOAc-ext = 36.11 &#177; 10.68, AMY-REtOAc-ext = na.<break/>AGLU- FBuOH-ext = na, AMY- FBuOH-ext = na.<break/>AGLU-RAqua-ext = 30.40 &#177; 8.50, AMY-RAqua-ext = na.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B173-pharmaceutics-16-00454" ref-type="bibr">173</xref>]</td></tr><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Achillea millefolium</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hydromethanolic extract of aerial parts.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AI 55% inhibition at 1.6 mg/mL.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B409-pharmaceutics-16-00454" ref-type="bibr">409</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Hydroethanolic extract of aerial parts.</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">The extract promoted the &#945;-glucosidases inhibition by 55% at 1 mg/mL concerning control. It increased the PPAR&#947; (five times) and GLUT4 (two-fold) relative expression than the control (<italic toggle="yes">p</italic> &lt; 0.05). Finally, it significantly increased INS secretion and [Ca2+]i compared with the control.</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B407-pharmaceutics-16-00454" ref-type="bibr">407</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">INS secretion and calcium mobilization</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PPAR&#947; and GLUT4 expression analysis.</td></tr><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Arnica montana</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-AMY</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methanolic extract fractions (dried cell biomass of seeds germinated).</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">All fractions inhibited &#945;-amylase activity (almost 12%).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B410-pharmaceutics-16-00454" ref-type="bibr">410</xref>]</td></tr><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Bellis perennis</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quantification of GLUT4 translocation.</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>A mixture of flowers and leaves (EXT4404) ethanolic extracts.</p></list-item><list-item><label>-</label><p>Ethanolic extract of flowers alone (EXT4407).</p></list-item><list-item><label>-</label><p>Ethanolic extract was prepared from flowers collected from a local area.</p></list-item></list>
</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Both extracts had a clear dose-response relationship, with EXT4404 being slightly more effective than EXT4407. However, EXT4407 had no effect at 0.25 mg/L, while EXT4404 at the same concentration only increased by about 4%. Overall, all the extracts are effective inducers of GLUT4 translocation without INS.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B411-pharmaceutics-16-00454" ref-type="bibr">411</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glucose Transport Assay</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU/A-AMY</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methanol: water (80:20%, <italic toggle="yes">v</italic>/<italic toggle="yes">v</italic>) extract of flowers.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC50A-AMY: 8.48 &#177; 0.07 mg/mL of dried flowers; IC50A-GLU: 49.62 &#177; 0.01 mg/mL of dried flowers.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B412-pharmaceutics-16-00454" ref-type="bibr">412</xref>]</td></tr><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Bidens frondose</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU/A-AMY</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ethanolic extracts (80%) of aerial parts.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC50A-GLU = 0.41 mg/mL, the extracts inhibited &#945;-glucosidase enzyme strongly (64.29&#8211;75.22% at 2 mg/mL); inactive on &#945;-amylase activity.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B413-pharmaceutics-16-00454" ref-type="bibr">413</xref>]</td></tr><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Cichorium intybus</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-AMY</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aqueous extracts of aerial parts.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC50A-AMY = 136.13 &#177; 8.09 &#181;g/mL,</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Insulinotropic investigations (IC1)</td><td rowspan="4" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Caffeic, ferulic acids, and Chicoric acid (CAE, extracted from aqueous extract).</td><td rowspan="4" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Caffeic acid mainly promotes a decrease in hepatic glycogenolysis. Ferulic acid elicits a clear increase in INS release and a reduction in hepatic glycogenolysis. CAE increases INS release and glucose uptake without affecting hepatic glycogenolysis. None of these compounds implicates hepatic glucose 6-phosphatase in contrast to chlorogenic acid, an inhibitor of glucose 6-phosphatase.</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B414-pharmaceutics-16-00454" ref-type="bibr">414</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Insulin sensitizing investigations (IC2)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hepatocyte culture and glycogenolysis test (IC3)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Evaluation of glucose 6-phosphatase activity (IC4)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glucose uptake assay.</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Caffeic acid, chlorogenic acid (CGA), and chicoric acid (CAE).</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">CRA and CGA increased glucose uptake in L6 muscular cells, an effect only observed in the presence of stimulating concentrations of INS.<break/>Both CRA and CGA stimulated INS secretion from the INS-1E cells and rat islets of Langerhans. The effect of CRA is only observed in the presence of subnormal glucose levels.</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B415-pharmaceutics-16-00454" ref-type="bibr">415</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#946;-cell culture and measurement of INS secretion.</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rat pancreatic islet experiments.</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Study of G6Pase and PEPCK expression (IC5).</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Three di-O-caffeoylquinic acids (CQA) were extracted from chicory roots methanolic extract.</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">CQA suppressed hepatic glucose production in H4IIE rat hepatoma cells by reducing the expression of G6Pase and PEPCK.<break/>Activation of PI3K and MAPK pathways as a method of controlling gene expression. Promoted increased mitochondrial respiration and cellular metabolism by inducing oxidative phosphorylation and proton leak.</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B416-pharmaceutics-16-00454" ref-type="bibr">416</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gene expression of PI3K and MAPK pathways</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cellular bioenergetics (IC6).</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Differentiation induction of embryonal carcinoma stem cells into INS-producing cells (IC7)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methanolic extracts (100%) of leaves.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The extract efficiently induced the differentiation of P19 EC cells into clusters similar to pancreatic islets with the molecular, cellular, and functional characteristics of mature &#946; cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B417-pharmaceutics-16-00454" ref-type="bibr">417</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU/A-AMY</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aqueous methanolic extracts (80% methanol, 19% H2O, 1% HCl; <italic toggle="yes">v</italic>/<italic toggle="yes">v</italic>/<italic toggle="yes">v</italic>) of the plant.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC50A-AMY: 18.3 &#177; 0.7 mg/mL; IC50A-GLU: 4.25 &#177; 0.08 mg/mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B418-pharmaceutics-16-00454" ref-type="bibr">418</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glucose uptake test.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Natural chicoric acid extract (NCRAE): Hydroethanolic extract (70:30).</p></list-item><list-item><label>-</label><p>Synthetic Chicoric and Chlorogenic Acids Mixture (SCCAM) contains the two major compounds of NCRAE, in proportion to 70% of synthetic L-chicoric acid (CRA) and 30% of synthetic chlorogenic acid (CGA).</p></list-item></list>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Adding NCRAE increased glucose uptake at 50 mg/mL, which agrees with our previous report. At the same concentration of 50 &#181;g/mL, the SCCAM solution has also increased glucose uptake with a value close to the NCRAE values.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B419-pharmaceutics-16-00454" ref-type="bibr">419</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glucose uptake test and lipid accumulation assays.</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Methanolic extract (CME) and CME/DT (detannification).</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">CME and CME/DT exhibited significant glucose uptake in 3T3-L1 adipocytes with a dose-dependent response. The glucose uptake profile in the presence of PI3K and IRTK inhibitors (Wortmannin and Genistein) substantiates the mechanism used by both extracts. CME inhibited the differentiation of 3T3-L1 preadipocytes but failed to show glucose uptake in inhibitor-treated cells. The activity exhibited by CME/DT is exactly opposite to CME. PTP1B inhibition assay, mRNA, and protein expression analysis revealed the unique behaviour of CME and CME/DT.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B420-pharmaceutics-16-00454" ref-type="bibr">420</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PTP1B Inhibition study.</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glucose uptake assay.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12, 8-guaianolide sesquiterpene lactones isolated from butan-1-ol and ethyl acetate fractions of roots extract</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The compounds significantly facilitated glucose uptake in the hyperglycemic HepG2 cell model at 50 &#956;M.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B259-pharmaceutics-16-00454" ref-type="bibr">259</xref>]</td></tr><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1"><italic toggle="yes">Dittrichia viscosa</italic> subsp. <italic toggle="yes">Viscosa</italic> (Syn. <italic toggle="yes">Inula viscosa</italic>)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU/A-AMY</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methanol: water (80:20%, <italic toggle="yes">v</italic>/<italic toggle="yes">v</italic>) extract of leaves.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC50A-AMY: 1.381 &#177; 0.085 mg/mL; IC50A-GLU: 0.118 &#177; 0.02 mg/mL.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B258-pharmaceutics-16-00454" ref-type="bibr">258</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU/A-AMY</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methanol (MeOH), ethyl acetate (EtOAc), and chloroform (CHL) extracts of leaves.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC50A-GLU-EtOAc: 29.9 &#177; 1.04 &#181;g/mL; PI-A-AMY: 22.152 &#177; 0.387%<break/>IC50A-GLU-MeOH: 22.3 &#177; 2.82 &#181;g/mL; PI-A-AMY: 27.162 &#177; 1.623%<break/>IC50A-GLU-Chlo: 39.8 &#177; 0.76 &#181;g/mL; PI-A-AMY: 17.157 &#177; 0.634%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B256-pharmaceutics-16-00454" ref-type="bibr">256</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU/A-AMY</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tomentosin is extracted and purified from dichloromethane and ethanolic extract.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC50A-GLU-26.61 &#177; 0.236 &#956;M; IC50A-AMY: 26.89 &#177; 1.54 &#956;M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B421-pharmaceutics-16-00454" ref-type="bibr">421</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glucose uptake assay (IC8).</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">7-O-Methylaromadendrin (MAD) extracted from methanolic extract of the aerial part of the plant.</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">MAD significantly stimulated INS-induced glucose uptake.<break/>MAD increased the P2a and PPARg2 gene expression.<break/>MAD stimulated the reactivation of INS-mediated phosphorylation of PI3K-(Akt/PKB) and AMPK in high glucose-induced, INS-resistant HepG2 cells.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B422-pharmaceutics-16-00454" ref-type="bibr">422</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Study of aP2 and PPARg2 gene expression.</td></tr><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Galinsoga parviflora</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU/A-AMY</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aqueous extracts of leaves.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">At 2.5 mg/mL IA% (A-GLU): 40%, A-AMY: no inhibition</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B423-pharmaceutics-16-00454" ref-type="bibr">423</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Two compounds, Galinsosides A (1) and B (2), flavanone glucosides extracted from methanolic extract of whole plant.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC50A-GLU (1): 286 &#177; 0.68 &#956;M; IC50A-GLU (2): 46.7 &#177; 0.32 &#956;M.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B424-pharmaceutics-16-00454" ref-type="bibr">424</xref>]</td></tr><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Helichrysum stoechas</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU/DPP-4</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methanol extracts of aerial parts.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC50A-GLU: 481.01 &#956;g/mL, IC50DPP-4: 81.71 &#956;g/mL.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B261-pharmaceutics-16-00454" ref-type="bibr">261</xref>]</td></tr><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Hypochaeris radicata</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU/A-AMY</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aqueous extracts of leaves.<break/>HR1: Extract fresh plant materials; HR2: Extract plant materials after blanching; HR3: Blanching water extract.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC50A-GLU-HR1: 79.4 &#177; 1.7 &#956;g/mL; IC50A-GLU-HR2: 99.1 &#177; 1.9 &#956;g/mL; IC50A-GLU-HR3: 83.4 &#177; 1.8 &#956;g/mL<break/>IC50A-AMY-HR1: 41.9 &#177; 1.4 &#956;g/mL; IC50A-AMY-HR2: 84.5 &#177; 1.8 &#956;g/mL; IC50A-AMY-HR3: 51.9 &#177; 1.5 &#956;g/mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B267-pharmaceutics-16-00454" ref-type="bibr">267</xref>]</td></tr><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Lactuca serriola</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4-hydroxybenzoic acid (1), protocatechuic acid (2), kaempferol (3), quercetin (4), lactuside A (5), luteolin-7-O-&#946;-D-glucoside (6) are extracted from methanolic extracts of the leaves.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC50A-GLU-(1): 810.31 &#177; 1.03 &#181;M; IC50A-GLU-(2): 126.65 &#177; 1.82 &#181;M; IC50A-GLU-(3): 39.72 &#177; 0.43 &#181;M; IC50A-GLU-(4): 39.82 &#177; 1.12 &#181;M; IC50A-GLU-(5): 468.98 &#177; 0.45 &#181;M; IC50A-GLU-(6): 161.29 &#177; 0.31 &#181;M.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B270-pharmaceutics-16-00454" ref-type="bibr">270</xref>]</td></tr><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Senecio vulgaris</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-AMY</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methanol extract (MeOH = 1 mg/mL), Dichloromethane extract (DCM1 = 100 and DCM2 = 50 &#956;g/mL).</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MeOH-IA%: 82.46 &#177; 0.0041%, DCM1-IA%: 90.95 &#177; 0.0001%, DCM2-IA%: 59.05 &#177; 0.0001%.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B286-pharmaceutics-16-00454" ref-type="bibr">286</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ALDO</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methanol extracts of aerial parts.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IA%: 42.00% at 1mg/mL.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B425-pharmaceutics-16-00454" ref-type="bibr">425</xref>]</td></tr><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Solidago virgaurea</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU/A-AMY</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Conc-ASE (concentrated extract obtained after accelerated solvent extraction)<break/>Conc-LE (concentrated extract obtained after laser extraction).</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Conc-ASE = IC50A-GLU: 9.3 &#177; 0.9 &#181;g/mL, IC50A-AMY-33.9 &#177; 2.4 &#181;g/mL.<break/>Conc-LE = IC50A-GLU: 8.7 &#177; 0.6 &#181;g/mL, IC50A-AMY-32.1&#177;1.9 &#181;g/mL.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B426-pharmaceutics-16-00454" ref-type="bibr">426</xref>]</td></tr><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Sonchus oleraceus</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glucose uptake assay (IC13)<break/>Analysis of p-AMPK/Akt/GSK3-&#946; expression in cells.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hydroethanolic extract (90%) of the leaves (SOL).</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The glucose uptake in HepG2 cells treated with 200 &#956;g/mL SOL was significantly increased to 145%, but the uptake was lower than that treated with insulin (320%). After treatment with SOL extracts for 24 h, the p-AMPK, Akt, and GSK3&#946; expression levels significantly increased by approximately 1.7, 1.0, and 0.8 times, respectively, compared with the control.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B427-pharmaceutics-16-00454" ref-type="bibr">427</xref>]</td></tr><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Tanacetum parthenium</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ra-ALDO/AGEs</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methanolic extract (70%) (ME)<break/>Ferulic acid (FA), Apigenin (API), Luteolin-7-O-glucoside (LUG), Luteolin (LUT), Chrysosplenol (CHR), Kaempferol (KAE), Santin (SAN) were extracted and purified from the methanolic extract.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ME: ra-ALDO-IA% (61.1 &#177; 0.5%), IC50-ra-ALDO (8.04 &#177; 0.61 &#181;g/mL), IC50-AGEs (163.71 &#177; 6.31 &#181;g/mL).<break/>FA: IC50-ra-ALDO (3.20 &#177;0.12 &#181;g/mL), IC50-AGEs (5.59 &#177; 0.26 &#181;g/mL).<break/>API: IC50-ra-ALDO (1.97 &#177; 0.10 &#181;g/mL), IC50-AGEs (NA).<break/>LUG: IC50-ra-ALDO (1.31 &#177; 0.09 &#181;g/mL), IC50-AGEs (3.43 &#177; 0.12 &#181;g/mL).<break/>LUT: IC50-ra-ALDO (1.76 &#177; 0.03 &#181;g/mL), IC50-AGEs (6.73 &#177; 0.43 &#181;g/mL).<break/>CHR: IC50-ra-ALDO (1.92 &#177; 0.08 &#181;g/mL), IC50-AGEs (NA).<break/>KAE: IC50-ra-ALDO (1.11 &#177; 0.03 &#181;g/mL), IC50-AGEs (NA).<break/>SAN: IC50-ra-ALDO (NA), IC50-AGEs (NA).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B428-pharmaceutics-16-00454" ref-type="bibr">428</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU/A-AMY</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ethanolic extract of aerial parts.<break/>Extraction by accelerated solvent extraction (ASE), microwave-assisted extraction (MAE), maceration (MAC), Soxhlet (SOX), and ultrasound&#8722;assisted extraction (UAE).</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ASE: IC50A-GLU (1.63 &#177; 0.02 mmol acarbose equivalent (ACAE)/g extracts), IC50A-AMY (0.51 &#177; 0.02 ACAE/g extract).<break/>MAE: IC50A-GLU (1.64 &#177; 0.01 mmol ACAE/g extracts), IC50A-AMY (0.53 &#177; 0.05 mmol ACAE/g extract).<break/>MAC: IC50A-GLU (1.65 &#177; 0.01 mmol ACAE/g extracts), IC50A-AMY (0.52 &#177; 0.02 mmol ACAE/g extract).<break/>SOX: IC50A-GLU (1.67 &#177; 0.01 mmol ACAE/g extracts), IC50A-AMY (0.51 &#177; 0.03 mmol ACAE/g extract).<break/>UAE: IC50A-GLU (1.64 &#177; 0.01 mmol ACAE/g extracts), IC50A-AMY (0.56 &#177; 0.01 mmol ACAE/g extract).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B429-pharmaceutics-16-00454" ref-type="bibr">429</xref>]</td></tr><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Tanacetum vulgare</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU/A-AMY</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hexan, hydroethanolic, and infusion of flowers (HEXF, HETF, INFF), stems (HEXS, HETS, INFS), and aerial parts (HEXAP, HETAP, INFAP).</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HEXF: IC50A-GLU (10.41 &#177; 0.06 mmol acarbose equivalent (ACAE)/g extracts), IC50A-AMY (0.53 &#177; 0.01 mmol ACAE/g extract).<break/>HETF: IC50A-GLU (10.77 &#177; 0.15 mmol ACAE/g extracts), IC50A-AMY (0.33 &#177; 0.01 mmol ACAE/g extract).<break/>INFF: IC50A-GLU (3.57 &#177; 0.13 mmol ACAE/g extracts), IC50A-AMY (0.07 &#177; 0.01 mmol ACAE/g extract).<break/>HEXS: IC50A-GLU (10.60 &#177; 0.06 mmol ACAE/g extracts), IC50A-AMY (0.50 &#177; 0.02 mmol ACAE/g extract).<break/>HETS: IC50A-GLU (7.54 &#177; 0.65 mmol ACAE/g extracts), IC50A-AMY (0.33 &#177; 0.02 mmol ACAE/g extract).<break/>INFS: IC50A-GLU (4.00 &#177; 0.09 mmol ACAE/g extracts), IC50A-AMY (0.10 &#177; 0.01 mmol ACAE/g extract).<break/>HEXAP: IC50A-GLU (10.56 &#177; 0.04 mmol ACAE/g extracts), IC50A-AMY (0.48 &#177; 0.03 mmol ACAE/g extract).<break/>HETAP: IC50A-GLU (8.67 &#177; 1.19 mmol ACAE/g extracts), IC50A-AMY (0.35 &#177; 0.03 mmol ACAE/g extract).<break/>INFAP: IC50A-GLU (4.26 &#177; 0.12 mmol ACAE/g extracts), IC50A-AMY (0.09 &#177; 0.01 mmol ACAE/g extract).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B322-pharmaceutics-16-00454" ref-type="bibr">322</xref>]</td></tr><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Lamiaceae</italic>
</td></tr><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1"><italic toggle="yes">Calamintha nepeta</italic> subsp. <italic toggle="yes">Nepeta</italic> (Syn. <italic toggle="yes">Clinopodium nepeta</italic>)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU/A-AMY</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methanolic extract (80%) of leaves.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">At 10 mg/mL IA% (A-GLU): 66.62 &#177; 1.61%, IA% (A-AMY): 16.45 &#177; 0.94%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B333-pharmaceutics-16-00454" ref-type="bibr">333</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-AMY</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methyl alcohol: water (7:3) extract fractionated with ethyl acetate (AcOEt), dichloromethane (DCM), and n-butanol (BuOH).</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC50A-AMY of DCM, AcOEt, and BuOH &gt;200 &#181;g/mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B332-pharmaceutics-16-00454" ref-type="bibr">332</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-AMY</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methanolic extract (ME), essential oil (EO), and aqueous extract (AQ).</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC50A-AMY-ME: 24.46 mg/mL, IC50A-AMY-EO: 31.54 mg/mL, IC50A-AMY-AQ: 115.47 mg/ml</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B335-pharmaceutics-16-00454" ref-type="bibr">335</xref>]</td></tr><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Lavandula pedunculata</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU/A-AMY</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Aqueous extract of flowering tops.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC50A-AMY: 0.44 &#177; 0.05 mg/mL, IC50A-GLU-131 &#177; 20 mg/mL.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B430-pharmaceutics-16-00454" ref-type="bibr">430</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intestinal Glucose Absorption in vitro</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The extract inhibited the intestinal glucose absorption (IC50 = 81.28 &#177; 4.01 &#181;g/mL) in a concentration-dependent manner.</td></tr><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Lavandula stoechas</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU/A-AMY</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Aqueous extract of aerial parts.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC50A-AMY: 0.485 &#177; 0.13 mg/mL, IC50A-GLU: 168 &#177; 40.10 &#956;g/mL</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B431-pharmaceutics-16-00454" ref-type="bibr">431</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intestinal Glucose Absorption assay, in situ.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The extract lowered intestinal glucose absorption in situ at 250 mg/kg.</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU/A-AMY</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EO of aerial parts.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC50A-AMY: 3.00 &#177; 0.008 mg/mL, IC50A-GLU: 2.58 &#177; 0.04 mg/mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B347-pharmaceutics-16-00454" ref-type="bibr">347</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glucose production assay (IC9)</td><td rowspan="5" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Ethyl acetate (EE) and n-butanol (BE) fractions are prepared from an aqueous extract of aerial parts.</td><td rowspan="5" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">EE and BE at low doses (25&#8211;50 &#181;g/mL) significantly decreased hepatic gluconeogenesis in the H4IIE cell line by suppressing the expression of PEPCK and G6Pase. In C2C12 myotubes, both extracts increased the INS-stimulated glucose uptake more effectively than metformin. They also effectively increased the expression of lipoprotein lipase protein levels in INS-resistant myotubes at low doses. EE increased the protein level of PPAR&#947; and stimulated the activation of AKT in INS-resistant H4IIE and C2C12 cell lines.</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B432-pharmaceutics-16-00454" ref-type="bibr">432</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glucose uptake assay (IC10)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Effects on PEPCK and G6Pase gene expression.</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Effects on AKT activation and GLUT4 expression.</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Transcriptome analyses </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ursolic acid extracted from Methanol (ME), ethanol (ET), methanol-dichloromethane (1: 1, <italic toggle="yes">v</italic>/<italic toggle="yes">v</italic>) (MDI), acetone (AC), ethyl acetate (EA), diethyl ether (DEE), and chloroform extracts (CHL).</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC50A-GLU-ME: 49.86 &#177; 0.36 mg/mL, IC50A-GLU-ET: 17.81 &#177; 0.55 mg/mL, IC50A-GLU-MDI: 29.57 &#177; 0.19 mg/mL, IC50A-GLU-AC: 24.63 &#177; 0.13 mg/mL, IC50A-GLU-EA: 40.31 &#177; 0.84 mg/mL, IC50A-GLU-DEE: 23.60 &#177; 1.04 mg/mL, IC50A-GLU-CHL: 26.21 &#177; 1.00 mg/mL.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B346-pharmaceutics-16-00454" ref-type="bibr">346</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EO of flowering leaves.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC50A-AMY: 106.73 &#177; 3.27 &#181;g/mL, IC50A-GLU: 98.54 &#177; 4.84 &#181;g/mL.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B344-pharmaceutics-16-00454" ref-type="bibr">344</xref>]</td></tr><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Melissa officinalis</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-glycation assay.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aqueous extract of leaves (AQ).<break/>Rosmarinic acid (RA), melitric acid A (MA), salviaic acid A (SA), caffeic acid (CA).</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC50-AQ: 0.24 mg/mL, IC50-RA: 0.34 mM, IC50-MA: 0.38 mM, IC50-SA: 0.16 mM, IC50-CA: 0.48 mM.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B433-pharmaceutics-16-00454" ref-type="bibr">433</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU/A-AMY</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aqueous extract of leaves</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IA%: 83.9%, A-AMY: No activity.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B434-pharmaceutics-16-00454" ref-type="bibr">434</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-AMY</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lemon balm-based extract with 50% RA </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IA%: 50%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B435-pharmaceutics-16-00454" ref-type="bibr">435</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Uptake inhibition of glucose (UIG) and fructose (UIF) (IC12)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methanolic and aqueous extract of leaves.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">UIG%: &lt;25%, UIF: No activity for both extracts.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B436-pharmaceutics-16-00454" ref-type="bibr">436</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glucose consumption (IC8)</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">EO (A, B, and C compagnies) </td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">EO-A: 63.64 &#177; 11.46%, EO-B: 59.96 &#177; 3.65%, EO-C: 65.63 &#177; 9.76%.<break/>The Western blot data suggest that the key factors of the adenosine monophosphate-activated protein kinase/acetyl-CoA carboxylase pathway can be mediated by the EOs.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B437-pharmaceutics-16-00454" ref-type="bibr">437</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gene expressions analysis of p-AMPK, AMPK, p-ACC, ACC, PPAR, CEBP&#945;, and SREBP1 proteins.</td></tr><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Mentha aquatica</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-AMY</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hydroethanolic extract (70%) of the leaves.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC50A-AMY: 229.50 &#177; 4.1 &#181;g/mL.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B438-pharmaceutics-16-00454" ref-type="bibr">438</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-AMY</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methanolic (ME) and aqueous extracts (AQ) of the leaves.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IA%-ME: 61.7 &#177; 5.5%, IA%-AQ: 14.0 &#177; 3.0%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B439-pharmaceutics-16-00454" ref-type="bibr">439</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Uptake inhibition of glucose (UIG) and fructose (UIF) (IC12)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methanolic and aqueous extract of leaves.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">UIG%: &lt;25%, UIF: No activity for both extracts.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B436-pharmaceutics-16-00454" ref-type="bibr">436</xref>]</td></tr><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Mentha pulegium</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU/A-AMY</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methanolic and aqueous extract of leaves.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC50A-GLU-ME: 20.38 &#181;g/mL, IC50A-GLU-AQ: 21.65 &#181;g/mL, IC50A-AMY-ME: 23.11&#181;g/mL, IC50A-GLU-AQ: 36.47 &#181;g/mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B372-pharmaceutics-16-00454" ref-type="bibr">372</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU/A-AMY</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ethyl acetate fraction of aerial part.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC50A-GLU: 61.85 &#177; 1.69 &#181;g/mL, IC50A-AMY: 16.37 &#177; 0.11 &#181;g/mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B440-pharmaceutics-16-00454" ref-type="bibr">440</xref>]</td></tr><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Mentha suaveolens</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU/A-AMY</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EO of the aerial part.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC50A-GLU: 141.16 &#177; 0.2 &#181;g/mL, IC50A-AMY: 94.30 &#177; 0.06 &#181;g/mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B384-pharmaceutics-16-00454" ref-type="bibr">384</xref>]</td></tr><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Origanum vulgare</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-AMY</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clonal oregano shoots ethanolic extracts (50%) (O-1, O-9, O-11Y, O-11M, O-12, O-17, OK-17, O-23, O-24, O-26, GO-19-1).</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The strongest anti-amylase activity was observed for extract O-24, which had an AI index value of 2.32 &#177; 0.28 and corresponded to 57% inhibition of enzyme activity. Eight of the eleven clonal oregano extracts tested had AI index values greater than or equal to 1.5. For these experiments, an AI index value of 1.5 corresponded to approximately 33% &#945;-amylase enzyme inhibition.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B441-pharmaceutics-16-00454" ref-type="bibr">441</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ALDO</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Caffeic acid (CA), rosmarinic acid (RO), lithospermic acid B (LTO), 12-hydroxy jasmonic acid 12-O-&#946;-glucopyranoside (HDG), p-menth-3-ene-1,2-diol 1-O-&#946;-glucopyranoside (MDG) isolated from the polar extracts of aerial parts.</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">ALDO-CA: 8 &#177; 4.6%, ALDO-RO: 95 &#177; 0.0%, ALDO-LTO: 96 &#177; 1.7, ALDO-HDG: 77 &#177; 1.4%, ALDO-MDG: 41 &#177; 0.6%.<break/>EB-CA: &#8722;7.68 kcal/mol, EB-RO: 15.71 kcal/mol, EB-LTO: &#8722;16.08 kcal/mol, EB-HDG: &#8722;14.58 kcal/mol, EB-MDG: &#8722;10.57 kcal/mol.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B442-pharmaceutics-16-00454" ref-type="bibr">442</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Docking studies of ALDO inhibitory activity (EB).</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU/A-AMY</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aqueous and ethanolic (12%) extract of plant clonal lines.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">At 1000 &#181;g/mL: A-GLU (93.7%), A-AMY (95%).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B434-pharmaceutics-16-00454" ref-type="bibr">434</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Analysis of PPAR&#947;- and &#948;-mediated transactivation, a test of adipogenic potential, INS-stimulated glucose uptake, neutral red assay.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Origanum vulgare</italic> ssp. <italic toggle="yes">vulgare</italic> (1): hexane (Hex), dichloromethane (DCM), and ethyl acetate (EtOAc) extracts of the aerial part.<break/><italic toggle="yes">Origanum vulgare</italic> ssp. <italic toggle="yes">hirtum</italic> (2): dichloromethane (DCM), methanol (MeOH) extracts of the aerial part.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(1): Hex ext = Activation of the &#947;, &#948; PPARs, adipocyte differentiation (NA), INS-stimulated GLU-uptake (+), Viability of endothelial cells (NA), Viability of macrophages (NA), <break/>DCM ext = Activation of the &#947; PPARs, adipocyte differentiation (NA), INS-stimulated GLU-uptake (+), Viability of endothelial cells (-), Viability of macrophages (66.1 &#177; 5.3%).<break/>EtOAc ext = Activation of the &#947; PPARs, adipocyte differentiation (NA), INS-stimulated GLU-uptake (+), Viability of endothelial cells (NA), Viability of macrophages (2.7 &#177; 1.4%).<break/>(2): DCM ext = Activation of the &#947; PPARs, adipocyte differentiation (NA), INS-stimulated GLU-uptake (+), Viability of endothelial cells (NA), Viability of macrophages (NA),<break/>MeOH ext = Activation of the &#947;, &#948; PPARs, adipocyte differentiation (NA), INS-stimulated GLU-uptake (+), Viability of endothelial cells (NA), Viability of macrophages (NA).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B443-pharmaceutics-16-00454" ref-type="bibr">443</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DPP-IV/PTP1B</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methanolic extracts of leaves: commercial oregano extract (E1) and greenhouse-grown oregano extract (E2).<break/>Chemical fractionation by flash chromatography system (fractions FA to FI).</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DPP-IV-IC50: (E1) = 28.4 &#177; 6.3 &#956;M GAE, (E2) = 86.2 &#177; 18.8 &#956;M GAE, FA &gt; 500 &#956;M GAE, FB = 206.3 &#177; 47.2 &#956;M GAE, FC &gt; 500 &#956;M GAE, FD = 317.4 &#177; 60.7 &#956;M GAE, FE = 20.3 &#177; 3.9 &#956;M GAE, FF = 23.3 &#177; 1.9 &#956;M GAE, FG = NA, FH = NA, FI = NA.<break/>PTP1B-IA: (E1)/(E2) = NA, FA = 7.0 &#177; 3.5%, FB = 13.3 &#177; 4.2%, FC = 1.3 &#177; 1.0%, FD = NA, FE = 32.1 &#177; 3.3%, FF = 77.4 &#177; 18.4%, FG = NA, FH = NA, FI = NA.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B444-pharmaceutics-16-00454" ref-type="bibr">444</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU/A-AMY</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(1): EO of <italic toggle="yes">O. vulgare</italic> subsp. <italic toggle="yes">Hirtum.</italic><break/>(2): EO of <italic toggle="yes">O. vulgare</italic> subsp. <italic toggle="yes">Vulgare.</italic></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC50A-AMY (1): 0.14 &#177; 0.008 mmol ACEs/g; IC50A-GLU (1): 0.88 &#177; 0.03 mmol ACEs/g.<break/>IC50A-AMY (2): 0.13 &#177; 0.004 mmol ACEs/g, IC50A-GLU (2): 6.04 &#177; 0.91 mmol ACEs/g.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B390-pharmaceutics-16-00454" ref-type="bibr">390</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU/A-AMY</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methanolic extract (80%) of leaves.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU-IA = 58.41 &#177; 1.97%, A-AMY-IA = 6.79 &#177; 0.57%.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B333-pharmaceutics-16-00454" ref-type="bibr">333</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU</td><td rowspan="4" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Aqueous acetonitrile (50%) of powder leaves.</td><td rowspan="4" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">IC50A-GLU = 0.35 &#177; 0.03 &#956;g/mL, AGEs-IC50 = 0.55 &#177; 0.07 mg/mL.<break/>Cells treated with extract leaf extract at a 100 &#956;g/mL concentration showed significantly enhanced 2-NBDG uptake compared with INS-treated cells.<break/>The extract decreased the promoter activity and the mRNA and protein expression of PEPCK and SREBP-1c. I. The extract inhibited the expression of CPY2E1 and enhanced the expression of GLUT2.</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B393-pharmaceutics-16-00454" ref-type="bibr">393</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AGEs assay</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glucose uptake assay (IC13).</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The mRNA and protein expression of PEPCK, SREBP-1c, GLUT2, CYP2E1 (IC14).</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU/A-AMY/LIPA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ethanolic extracts (80% <italic toggle="yes">v</italic>/<italic toggle="yes">v</italic>).</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC50A-AMY = 44.71 &#177; 0.86 &#181;g/mL, IC50A-GLU = 7.11 &#177; 1.37 &#181;g/mL, IC50-LIPA = 922.35 &#177; 30.99 &#181;g/mL.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B395-pharmaceutics-16-00454" ref-type="bibr">395</xref>]</td></tr><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Prunella vulgaris</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Study of Glucose Production (IC15).</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Methanolic extract of arial part (PVA).<break/>Rosmarinic and caffeic acids were extracted from solid residue PVA by organic solvent, representing about 26% and 0.3% <italic toggle="yes">w</italic>/<italic toggle="yes">w</italic> of total extract.</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">The PVA lowered glucose production from glycogen (glycogenolysis), dihydroxyacetone, and alanine (gluconeogenesis). None of the phenolic acids influenced PEPCK mRNA expression, which INS downregulated. G6Pase mRNA was decreased by INS, increased by PVA, and remained unaffected by other treatments. Both compounds significantly increased GK mRNA expression; PVA did not affect this gene expression.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B445-pharmaceutics-16-00454" ref-type="bibr">445</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The mRNA expression analysis of G6Pase, GLUK, CALM, PEPCK, and GK (IC16).</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ra-ALDO/hu-ALDO/AGEs assay</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aqueous extract (AQE) partitioned sequentially with n-hexane (HEX), methylene chloride (CH2Cl2), ethyl acetate (EtOAc), n-butanol (BuOH), and water (H2O).<break/>Compounds (C1 to C6) isolated from AQE fractionation.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ra-ALDO: AQE-IA = 36.18 &#177; 1.13%, HEX-IA = 33.94 &#177; 0.49%, CH<sub>2</sub>Cl<sub>2</sub>-IA= 32.49 &#177; 0.54%, EtOAc-IA = 87.33 &#177; 2.39% (IC50 = 2.99 &#177; 0.10 &#956;g/mL), BuOH-IA = 59.56 &#177; 2.34%, H2O-IA = NA, C1 = NA, C2 = NA, C3-IC50 = 8.35 &#177; 0.51 &#956;M, C4-IC50 = 2.77 &#177; 0.48 &#956;M, C5-IC50 = 3.20 &#177; 0.55 &#956;M, C6 = NA.<break/>hu-ALDO: C1 = NA, C2 = NA, C3 = NA, C4-IC50 = 18.62 &#177; 0.40 &#956;M, C5-IC50 = 12.58 &#177; 0.32 &#956;M, C6 = NA.<break/>AGEs assay: AQE-IA = 29.26 &#177; 0.94%, HEX-IA = 33.94 &#177; 0.41%, CH2Cl2-IA = 54.03 &#177; 1.00% (IC50 = 186.72 &#177; 2.05 &#181;g/mL), EtOAc-IA = 68.31 &#177; 1.06% (IC50 = 141.34 &#177; 1.27 &#181;g/mL), BuOH-IA = 40.47 &#177; 0.68%, H2O-IA = 30.24 &#177; 1.01%, C1-IA = 9.33 &#177; 0.27%, C2= NA, C3 = NA, C4 = 20.67 &#177; 0.37%, C5-IA = 74.81 &#177; 1.41% (IC50 = 33.16 &#177; 0.54 &#181;g/mL), C6-IA = 88.69 &#177; 0.56% (IC50 = 304.36 &#177; 3.41 &#181;g/mL).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B446-pharmaceutics-16-00454" ref-type="bibr">446</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cas-3 activity and activation of the apoptotic signaling pathway (IC16) analysis (Bax/Bcl-2, Fas/FasL, phospho-JNK, phospho-ERK, phospho-p38, NF-&#954;B binding activity, phosphorylated-I&#954;B, TNF-&#945;, IL-6). </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aqueous extract (AQE).</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AQE administration significantly prevented IL-1&#946;-increased INS-1 cell death and LDH activity and attenuated IL-1&#946;-increased cas-3 activity.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B447-pharmaceutics-16-00454" ref-type="bibr">447</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU/A-AMY</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hydroethanolic extract of inflorescence (PV) contained RA (4.5%), CA (9.8%), and pCA (11.6%).</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC50A-GLU-PV: 90.9 &#956;g/mL, IC50A-AMY-PV: 47.2 &#956;g/mL<break/>IC50A-GLU-CA: 4.7 &#956;g/mL, IC50A-AMY-CA: 5.1 &#956;g/mL<break/>IC50A-GLU-RA: 11.6 &#956;g/mL, IC50A-AMY-RA: 21.7 &#956;g/ml</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B448-pharmaceutics-16-00454" ref-type="bibr">448</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NPMDA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Active compounds tested (Kaempferol, luteolin, delphinidin, quercetin, beta-sitosterol, spinasterol, stigmasterol, vulgaxanthin-I, poriferasterol monoglucoside, stigmast-7-enol, morin)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The sterols and flavonoids play an active role by affecting the TNF signalling pathway, AGE-RAGE signalling pathway, MAPK pathway, and PI3K-Akt pathway-related targets such as IL-6 and INS.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B158-pharmaceutics-16-00454" ref-type="bibr">158</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hydroethanolic extract (75%) (HE) partitioned sequentially with Petroleum ether (PE), Ethyl acetate (EtOAc), n-butanol (BuOH), and water (H2O) fractions.<break/>Compounds Caffeic acid (C1), Isoquercitrin (C2), and Rosmarinic acid (C3) isolated from AQE fractionation.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HE-IC50 = 130.46 &#177; 4.33 &#181;g/mL, PE-IC50 = 194.61 &#177; 4.69 &#181;g/mL, EtOAc-IC50 = 69.13 &#177; 2.86 &#181;g/mL, BuOH-IC50 = 124.97 &#177; 2.56 &#181;g/mL, H2O-IC50 = 191.88 &#177; 3.34 &#181;g/mL, C1-IC50 = 3.91 &#177; 0.07 &#181;g/mL, C2-IC50 = 85.52 &#177; 2.94 &#181;g/mL, C3-IC50 = 0.65 &#177; 0.04 &#181;g/mL. </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B449-pharmaceutics-16-00454" ref-type="bibr">449</xref>]</td></tr><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Salvia verbenaca</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU/A-AMY</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methanolic extract (85%) (ME) and decoction (DE) of the aerial part.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC50A-GLU-ME: 50.5 &#177; 1.40 &#181;g/mL, IC50A-AMY-ME = 101.30 &#177; 0.08 &#181;g/mL.<break/>IC50A-GLU-DE: 313.7 &#177; 1.36 &#181;g/mL, IC50A-AMY-DE = NA.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B399-pharmaceutics-16-00454" ref-type="bibr">399</xref>]</td></tr><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Thymus mastichina</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-GLU/A-AMY</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC50A-GLU = 100 &#177; 0.0 &#181;g/mL, IC50A-AMY = 4600 &#177; 0.0 &#181;g/mL.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B450-pharmaceutics-16-00454" ref-type="bibr">450</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>ACC: Acetyl-CoA carboxylase, ADIP: Adiponectin AGEs: Advanced glycation end products inhibition assay, AI: Amylase inhibition, Akt: Protein kinase B, ALDO: Aldose reductase, AMPK: Adenosine 5-monophosphate-activated protein kinase, aP2: Adipocyte-specific fatty acid binding protein; A-AMY: Alpha amylase, A-GLU: Alpha glucosidase, Bax: Bcl-2&#8211;associated X protein, Bcl-2: Marker linked to germinal center B cells, CALM: Calmodulin, cas-3: Caspase, CEBP&#945;: Transcription factor CCAAT/enhancer binding protein alpha, DPP-IV: dipeptidyl peptidase IV, EB: Energy binding (kcal/mol), ERK: Extracellular Signal-Regulated Kinases, GAPDH: Glyceraldehyde-3-phosphate dehydrogenase, GLUT4: Glucose transporter type 4, GLUK: Glucokinase, G6Pase: Glucose-6-phosphatase, hIR: Human insulin receptor, Hu-ALDO: Human recombinant aldose reductase, IL-1&#946;: Beta 1 Interleukin, INS-1 cell: Rat Insulinoma Cell Line, I&#954;B: IkappaB kinase, JNK: c-Jun N-terminal cinase, LEP: Leptin, LPL: Lipoprotein lipase, NA: Not active, NF-&#954;B: Nuclear factor-kappa B, NPMDA: Network pharmacology and Molecular Docking Analyses. The potential action targets were (IL-6 and INS), and the signalling pathways were (the AGE-RAGE signalling pathway, TNF signalling pathway, MAPK signalling pathway, PI3K-AKT signalling pathway), PEPCK: Phosphoenolpyruvate carboxykinase, PI3K: Phosphatidylinositol 3-kinase, PKB: Protein kinase B, PPAR: Activating peroxisome proliferator-activated receptors, PPARg2: Peroxisome proliferator-activated receptor g2, PTP1B: Protein tyrosine phosphatase 1B, P38: Mitogen-activated protein kinases, ra-ALDO: Rat lens aldose reductase, SREBP1: Sterol Regulatory Element-binding Protein, TNF-&#945;: Tumor necrosis factor. In vitro Cellular models studied. IC1: Rat insulinoma-derived INS-1 &#946;-cells, IC2: L6 myocyte cells, IC3: Hepatocytes were isolated from rats fed ad lib., IC4: Microsomal fractions of hepatic cells, IC5: H4IIE cells (Rat hepatoma cell line), IC6: Changes in mitochondrial respiration and glycolysis, IC7: The P19 cell line (embryonic carcinoma cell line), IC8: 3T3-L1 (Murine preadipocyte cell line), IC9: HepG2 (Human hepatocellular liver carcinoma) and differentiated 3T3-L1. IC10: Palmitate-induced INS resistance model in H4IIE cells, IC11: Palmitate-induced INS resistance model in C2C12 cells (immortalized mouse myoblast cell line), IC12: Human colorectal adenocarcinoma Caco2 (Cancer coli-2) cells, IC13: HepG2 cells, IC14: HepG2 and E47 cells (Cellosaurus Hep G2-E47), IC15: Rat hepatocytes, IC16: Fao Cells differentiated derivatives of the clonal cell line H4IIEC3, which was derived from the Reuber H35 rat hepatoma, IC17: INS-1 cells (INS-1 832/13 Rat Insulinoma Cell Line), IC18: The pRB-deficient mouse embryonic fibroblasts (ME3), adipocyte differentiation 3T3-L1 cells, Hepa 1-6 cells (CRL1830), mouse hepatoma from BW7756 tumours in C57L mice, Murine monocyte/macrophage cell line RAW264.7, the human hybrid cell line EAhy926.</p></fn></table-wrap-foot></table-wrap><list list-type="bullet"><list-item><p><italic toggle="yes">Anthemis canescens</italic> var. <italic toggle="yes">aurea</italic></p></list-item></list><p>The native range of <italic toggle="yes">Anthemis canescens</italic> var.<italic toggle="yes"> aurea</italic> (syn. <italic toggle="yes">Matricaria aurea</italic>), also known as corn chamomile, is from the Mediterranean to the northwest of India and the Arabian Peninsula. It is annual and grows primarily in the subtropical biome [<xref rid="B116-pharmaceutics-16-00454" ref-type="bibr">116</xref>]. Several scientific studies have examined these effects, notably Ismail et al. [<xref rid="B217-pharmaceutics-16-00454" ref-type="bibr">217</xref>]. A T2DM rat model was used, along with identification of chemical components by LC-MS/MS (liquid chromatography coupled to tandem mass spectrometry), and enzyme activity assays, gene expression analyses by q-RTPCR, network pharmacology analyses, and molecular docking simulations were also carried out in an attempt to elucidate the molecular mechanism(s) of this plant&#8217;s antidiabetic effects [<xref rid="B217-pharmaceutics-16-00454" ref-type="bibr">217</xref>]. The results showed that only the polar hydroethanol extract of <italic toggle="yes">M. aurea</italic> exhibited remarkable antidiabetic activity. In addition, it improved dyslipidaemia, insulin resistance status, ALT (alanine transaminase), and AST (aspartate aminotransferase) levels [<xref rid="B217-pharmaceutics-16-00454" ref-type="bibr">217</xref>]. </p><p>LC-MS/MS analysis of the hydroethanol extract identified 62 compounds, including the popular flavonoids of chamomile, apigenin and luteolin, other flavonoids and their glycosides, coumarin derivatives, and phenolic acids (<xref rid="pharmaceutics-16-00454-t001" ref-type="table">Table 1</xref>). According to the authors [<xref rid="B217-pharmaceutics-16-00454" ref-type="bibr">217</xref>], the 46 compounds selected were linked to 364 candidate T2DM targets. Network analysis enabled them to identify 123 pivotal proteins, including insulin signalling and metabolic proteins: IRS1 (insulin receptor substrate 1), IRS2 (insulin receptor substrate 2), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), AKT1 (AKT serine/threonine kinase 1), AKT2 (AKT serine/threonine kinase 2), MAPK1 (mitogen-activated protein kinase 1), MAPK3 (mitogen-activated protein kinase 3), and PCK1 (phosphoenolpyruvate carboxykinase 1), inflammatory proteins TNF and IL1B (interleukin-1Beta), antioxidant enzymes: CAT (catalase), SOD (superoxide dismutase), and others [<xref rid="B217-pharmaceutics-16-00454" ref-type="bibr">217</xref>]. Subsequent filtering enabled them to identify 40 crucial principal targets (major hubs) of <italic toggle="yes">M. aurea</italic> in treating T2DM. Functional enrichment analyses of the candidate targets revealed that the plant targets were mainly involved in the inflammatory, energy-sensing/endocrine/metabolic, and oxidative stress modules. According to Ismail et al. (2022), the hydroethanol extract of <italic toggle="yes">M. aurea</italic> is capable of significantly increasing PIK3R1 and decreasing IL1B, PCK1 (phosphoenolpyruvate carboxykinase 1), and MIR29A (microRNA 29a human gene) according to q-RTPCR gene expression analysis [<xref rid="B217-pharmaceutics-16-00454" ref-type="bibr">217</xref>]. Based on experimental and computational analyses, this study revealed that <italic toggle="yes">M. aurea</italic> exerted antidiabetic action via simultaneous modulation of multiple targets and pathways, including inflammatory, energy-sensing/endocrine/metabolic, and oxidative stress pathways [<xref rid="B217-pharmaceutics-16-00454" ref-type="bibr">217</xref>].</p><list list-type="bullet"><list-item><p><italic toggle="yes">Bellis perennis</italic> L. and <italic toggle="yes">Bidens frondose</italic></p></list-item></list><p>The <italic toggle="yes">Bellis</italic> genus comprises around twenty species of small annual or perennial herbs found mainly in the Mediterranean region. <italic toggle="yes">Bellis perennis</italic> L. (common daisy) is widely distributed in continental Portugal and used in folk medicine (<xref rid="app1-pharmaceutics-16-00454" ref-type="app">Supplementary Table S3</xref>). Many of its pharmaceutical functions derive from the antioxidant characteristics of its contents and its quantity of phenolic compounds. All parts of this plant have been studied, and several chemical compounds have been characterized. In a study by Haselgr&#252;bler et al. (2018), the effect of its ethanolic extracts (50%) revealed significant efficacy in inducing GLUT4 translocation in the in vitro cell system applied using a screening assay based on fluorescence microscopy [<xref rid="B411-pharmaceutics-16-00454" ref-type="bibr">411</xref>]. The extracts also reduced blood glucose levels in chicken embryos (in vivo), confirming the plant activity in a living organism. </p><p>According to the results of high-performance liquid chromatography (HPLC), the numerous polyphenolic compounds identified and quantified, including apigenin glycosides, quercitrin, and chlorogenic acid (<xref rid="pharmaceutics-16-00454-t001" ref-type="table">Table 1</xref>), potentially contribute to stimulating the transfer of GLUT4 from the cytosolic zone to the plasma membrane, leading to decreased blood glucose levels [<xref rid="B411-pharmaceutics-16-00454" ref-type="bibr">411</xref>]. Moreover, it was shown in the study by Nowicka and Wojdy&#322;o (2019) that the methanolic extract (50%) has a high content of triterpenoids, carotenoids, and flavonols, with the ability to inhibit <italic toggle="yes">&#945;</italic>-amylase and <italic toggle="yes">&#945;</italic>-glucosidase (<xref rid="pharmaceutics-16-00454-t001" ref-type="table">Table 1</xref>). The species <italic toggle="yes">Bidens frondosa</italic> also displayed promising results in diabetes [<xref rid="B412-pharmaceutics-16-00454" ref-type="bibr">412</xref>]. The acute hypoglycaemic activity of its ethanolic extract (80%) was studied in normoglycaemic, glucose-loaded, and STZ-induced diabetic rats [<xref rid="B413-pharmaceutics-16-00454" ref-type="bibr">413</xref>]. The subacute antidiabetic effect was studied in an 8-day experiment. The extract showed a promising and significant hypoglycaemic impact in all the in vivo models tested [<xref rid="B413-pharmaceutics-16-00454" ref-type="bibr">413</xref>]. The acute antidiabetic effect was 42% at 500 mg/kg. The <italic toggle="yes">&#945;</italic>-glucosidase and <italic toggle="yes">&#945;</italic>-amylase inhibitory activity of the extract was also determined and showed strong inhibition of the <italic toggle="yes">&#945;</italic>-glucosidase enzyme (75.22% at 2 mg/mL) [<xref rid="B413-pharmaceutics-16-00454" ref-type="bibr">413</xref>] (<xref rid="pharmaceutics-16-00454-t002" ref-type="table">Table 2</xref>). </p><list list-type="bullet"><list-item><p>
<italic toggle="yes">Chamaemelum nobile</italic>
</p></list-item></list><p>Roman chamomile, as <italic toggle="yes">Chamaemelum nobile</italic> (syn. <italic toggle="yes">Anthemis nobilis</italic> L. or <italic toggle="yes">Chamomilla nobilis</italic>), is an ornamental plant known as a medicinal plant since the Middle Ages [<xref rid="B245-pharmaceutics-16-00454" ref-type="bibr">245</xref>]. It is native to Southwest Europe (France, Spain, and Portugal) but is present all over Europe, North Africa, and Southwest Asia [<xref rid="B245-pharmaceutics-16-00454" ref-type="bibr">245</xref>]. The plant is cultivated mainly in England, Belgium, France, Germany, Hungary, Poland, Bulgaria, Egypt, and Argentina. Pharmacological studies have revealed a wide range of biological properties and a broad phytochemical diversity (<xref rid="pharmaceutics-16-00454-t001" ref-type="table">Table 1</xref>). </p><p>Among these studies, Eddouks et al. (2005) carried out a single study on the plant against diabetes. A single dose and daily oral administration (20 mg/kg BW) for 15 days tested the aqueous extract of the aerial part of Roman chamomille on blood glucose concentrations and basal insulin levels in normal and STZ-induced diabetic rats [<xref rid="B451-pharmaceutics-16-00454" ref-type="bibr">451</xref>]. Single oral administration of the aqueous extract reduced blood glucose levels from 6.0 &#177; 0.3 mmol/L to 4.9 &#177; 0.09 mmol/L (<italic toggle="yes">p</italic> &lt; 0.05) 6 h after administration in normal rats and from 21.1 &#177; 1.3 mmol/L to 14.5 &#177; 0.9 mmol/L (<italic toggle="yes">p</italic> &lt; 0.001) in streptozotocin-induced diabetic rats [<xref rid="B451-pharmaceutics-16-00454" ref-type="bibr">451</xref>]. In addition, blood glucose levels decreased from 6.1 &#177; 0.06 mmol/L to 4.6 &#177; 0.17 mmol/L and from 21.1 &#177; 1.31 mmol/L to 13.7 &#177; 0.90 mmol/L in normal and STZ diabetic rats, respectively, after 15 days of treatment [<xref rid="B451-pharmaceutics-16-00454" ref-type="bibr">451</xref>]. Basal plasma insulin concentrations remained unchanged after treatment in normal and STZ diabetic rats. </p><p>According to the authors, the mechanism of this pharmacological activity may be independent of insulin secretion [<xref rid="B451-pharmaceutics-16-00454" ref-type="bibr">451</xref>]. It can exert hypoglycaemic activity in the gastrointestinal tract by slowing digestion and reducing the carbohydrate absorption rate [<xref rid="B451-pharmaceutics-16-00454" ref-type="bibr">451</xref>]. Another study conducted on the compound chamaemeloside, an apigenin glycoside containing a hydroxymethylglutaric acid (HMG) fraction extracted from this plant [<xref rid="B452-pharmaceutics-16-00454" ref-type="bibr">452</xref>], showed that it did not affect glucose uptake in cultured L6 muscle cells but reduced plasma glucose levels in SwissWebster mice by 19.2% and 31.9% at doses of 125 and 250 mg/kg, respectively. Chamaemeloside only exerted its effect after 4 h of i.p. (intraperitoneal) administration [<xref rid="B452-pharmaceutics-16-00454" ref-type="bibr">452</xref>]. The effect on interpretandial blood glucose levels in normal rats and oral glucose tolerance was also studied. The results showed that interprandial blood glucose levels were unaffected, but that chamaemeloside significantly improved glucose tolerance 4 h after administration [<xref rid="B452-pharmaceutics-16-00454" ref-type="bibr">452</xref>]. </p><p>According to Witherup et al. (1995), chamaemeloside may influence glucose homeostasis via multiple mechanisms, including the release of HMG acid from chamaemeloside and its modulation of insulin secretion [<xref rid="B452-pharmaceutics-16-00454" ref-type="bibr">452</xref>,<xref rid="B453-pharmaceutics-16-00454" ref-type="bibr">453</xref>]. A clinical study was also conducted on the hypoglycemic effect of Roman chamomile [<xref rid="B454-pharmaceutics-16-00454" ref-type="bibr">454</xref>]. Twenty-six pre-diabetic volunteers (twenty-one men and five women; mean age: 50.5 &#177; 8.5 years) were selected for an 8-week study of supplementation with mixed plant extracts combining a hot water extract of <italic toggle="yes">Anthemis nobilis</italic> (synonym of Roman chamomile), <italic toggle="yes">Crataegus oxyacantha</italic> (hawthorn berry), <italic toggle="yes">Houttuynia cordata</italic> (dokudami), and <italic toggle="yes">Vitis vinifera</italic> at a dose of 1200 mg [<xref rid="B454-pharmaceutics-16-00454" ref-type="bibr">454</xref>]. The results showed that the mixture reduced abnormal glucose levels and the risk of developing diabetes. The underlying mechanism of action can be attributed to stimulating peripheral energy utilisation, particularly in muscle and adipose tissue [<xref rid="B454-pharmaceutics-16-00454" ref-type="bibr">454</xref>].</p><list list-type="bullet"><list-item><p><italic toggle="yes">Cichorium intybus</italic> L.</p></list-item></list><p>Plants in the <italic toggle="yes">Cichorium</italic> genus are particularly valuable for their exceptional therapeutic and medicinal properties (<xref rid="pharmaceutics-16-00454-t001" ref-type="table">Table 1</xref>). It includes plants from the dandelion tribe in the sunflower family, with ten to twelve species, four to six of which are wild species. They are herbaceous perennials, typically Mediterranean, native to Europe, western Asia, and North America. Among its species is <italic toggle="yes">Cichorium intybus</italic> L. (<italic toggle="yes">Asteraceae</italic>), commonly known as chicory, widely cultivated in many countries worldwide for its many traditional uses and as an edible food. Indeed, it has been included in Chinese Pharmacopoeia for its many beneficial effects on various ailments, from wounds to diabetes (<xref rid="app1-pharmaceutics-16-00454" ref-type="app">Supplementary Table S3</xref>).</p><p>In a study by Pushparaj et al. (2007), the hypoglycaemic and hypolipidaemic properties of an ethanolic extract of <italic toggle="yes">C. intybus</italic> were tested on Sprague&#8211;Dawley rats treated with STZ (<xref rid="pharmaceutics-16-00454-t003" ref-type="table">Table 3</xref>). The oral glucose tolerance test (OGTT) (a dose of 125 mg plant extract/kg BW) showed a potent hypoglycaemic effect. In addition, the daily administration of the extract (125 mg/kg) for 14 days to diabetic rats reduced serum glucose by 20%, triglycerides by 91% and total cholesterol by 16% [<xref rid="B455-pharmaceutics-16-00454" ref-type="bibr">455</xref>]. However, there was no change in serum insulin levels, ruling out the possibility that the extract induces insulin secretion by pancreatic <italic toggle="yes">&#946;</italic>-cells. </p><p>This effect on pancreatic <italic toggle="yes">&#946;</italic>-cells was also demonstrated in a study by Ghamarian et al. (2012). Aqueous chicory seed extract prevented BW loss and reduced fasting blood glucose levels in a four-week trial in rats (<xref rid="pharmaceutics-16-00454-t003" ref-type="table">Table 3</xref>). Chicory appears to have both short-term (around 2 h) and long-term (28 days) effects on T2DM and is a natural food supplement for slowing the progression of diabetes [<xref rid="B456-pharmaceutics-16-00454" ref-type="bibr">456</xref>]. The ethanolic extract of chicory seeds containing 9.6% caffeoylquinic acids improved blood sugar levels, reduced the atherogenic index, and increased blood antioxidant status during a 28-day treatment on Wistar rats (WR) [<xref rid="B457-pharmaceutics-16-00454" ref-type="bibr">457</xref>]. </p><p>In another study by Petrovi&#263; et al. (2024), a polyherbal mixture composed of <italic toggle="yes">Centaurium erythraea</italic> aerial parts, <italic toggle="yes">Cichorium intybus</italic> roots, and <italic toggle="yes">Potentilla erecta</italic> rhizomes was tested to determine its potential toxicity in vivo and its effect on diabetic complications [<xref rid="B458-pharmaceutics-16-00454" ref-type="bibr">458</xref>]. The results showed that treatment with the decoction had no toxic effect. Its antidiabetic activity was high in vitro and in vivo studies (<xref rid="pharmaceutics-16-00454-t002" ref-type="table">Table 2</xref> and <xref rid="pharmaceutics-16-00454-t003" ref-type="table">Table 3</xref>). Fourteen days of treatment with the decoction (15 g/kg) completely normalized the blood glucose levels of diabetic animals, whereas treatment with insulin and glimepiride only slightly lowered glycaemic values [<xref rid="B458-pharmaceutics-16-00454" ref-type="bibr">458</xref>]. In addition, the lipid status of the treated animals and the levels of AST, ALT, ALP, creatinine, urea, and MDA (malondialdehyde) were completely normalized [<xref rid="B458-pharmaceutics-16-00454" ref-type="bibr">458</xref>]. In addition, the polyherbal mixture completely restored histopathological changes in the liver, the kidneys, and the four <italic toggle="yes">Cornu ammonis</italic> regions of the hippocampus. According to the authors, the ameliorative effect of the treatment was essentially due to bioactive compounds [<xref rid="B458-pharmaceutics-16-00454" ref-type="bibr">458</xref>]. They are known for their hepatoprotective activities and ability to lower serum transaminases, ALP, and MDA [<xref rid="B459-pharmaceutics-16-00454" ref-type="bibr">459</xref>,<xref rid="B460-pharmaceutics-16-00454" ref-type="bibr">460</xref>], with even greater success than glimepiride [<xref rid="B461-pharmaceutics-16-00454" ref-type="bibr">461</xref>,<xref rid="B462-pharmaceutics-16-00454" ref-type="bibr">462</xref>]. </p><p>On the other hand, treatment with the polyherbal mixture increased hepatic glycogen deposition via <italic toggle="yes">&#946;</italic>-cell regeneration by the various compounds present in the preparation [<xref rid="B458-pharmaceutics-16-00454" ref-type="bibr">458</xref>]. Indeed, hydroxybenzoic acid, one of the bioactive compounds in the tested polyherbal mixture, can regenerate <italic toggle="yes">&#946;</italic>-cells and normal serum insulin and hepatic glycogen levels [<xref rid="B463-pharmaceutics-16-00454" ref-type="bibr">463</xref>]. In addition, the hepatoprotective activity observed can also be explained by the high antioxidant activity of the mixture [<xref rid="B458-pharmaceutics-16-00454" ref-type="bibr">458</xref>], which boosts antioxidant defense enzymes via the expression of Nrf2/cytochrome P450 2E1 (CYP2E1), reduces inflammation via the inactivation of MAPK/NF-&#954;B (Nuclear factor-kappa B) signalling pathways, and reduces apoptosis via the regulation of B-cell lymphoma 2 (Bcl-2)/protein kinase B (AKT)/CAT expression [<xref rid="B464-pharmaceutics-16-00454" ref-type="bibr">464</xref>]. </p><p>Furthermore, caffeic acid in the herbal mixture decreases the level of MDA in the kidney and visibly reduces renal epithelial damage in the diabetic animal model [<xref rid="B458-pharmaceutics-16-00454" ref-type="bibr">458</xref>]. At the same time, rutin administration regulates renal function and reduces the degree of renal tissue damage in induced nephropathy by downregulating TGF<italic toggle="yes">&#946;</italic>-1 (transforming growth factor beta 1) and fibronectin expression [<xref rid="B460-pharmaceutics-16-00454" ref-type="bibr">460</xref>,<xref rid="B465-pharmaceutics-16-00454" ref-type="bibr">465</xref>]. Epicatechin also reduces lipid peroxidation in kidneys due to benzo rings and aromatic compounds that can bind hydroxyl radicals in tissues [<xref rid="B466-pharmaceutics-16-00454" ref-type="bibr">466</xref>]. Hyperoside, in treating diabetic nephropathy, regulates blood urea and creatinine levels. It reduces renal tissue damage by suppressing the expression of fibronectin, collagen IV, and tissue inhibitors of metalloproteinase 1 (TIMP-1) while promoting the expression of matrix metalloproteinases 9 and 2 (MMP-9 and MMP-2) [<xref rid="B467-pharmaceutics-16-00454" ref-type="bibr">467</xref>]. It also prevents further podocyte apoptosis in the glomerulus following diabetes, allowing the regeneration of damaged tissue via the miR-499-5p/APC (anaphase-promoting complex) axis [<xref rid="B468-pharmaceutics-16-00454" ref-type="bibr">468</xref>]. In addition, isoquercetin possesses nephroprotective capacity through its hypoglycaemic, hypolipidaemic [<xref rid="B469-pharmaceutics-16-00454" ref-type="bibr">469</xref>,<xref rid="B470-pharmaceutics-16-00454" ref-type="bibr">470</xref>], and hepatoprotective activities, similar to sulphonylureas [<xref rid="B470-pharmaceutics-16-00454" ref-type="bibr">470</xref>]. In addition, caffeic acid regulates lipid status and blood glucose. It attenuates oxidative damage in blood cells, liver cells, and kidney tissue [<xref rid="B460-pharmaceutics-16-00454" ref-type="bibr">460</xref>] by upregulating nuclear erythroid-related factor 2 (NRF2) and downregulating NF-&#954;B [<xref rid="B471-pharmaceutics-16-00454" ref-type="bibr">471</xref>]. Caffeoylquinic or chlorogenic acids (CQAs), abundant intermediates of lignin biosynthesis in chicory, have also been reported to improve human glucose metabolism (<xref rid="pharmaceutics-16-00454-t003" ref-type="table">Table 3</xref>). </p><p>According to the study by Palatini Jackson et al. (2017), the three di-O-caffeoylquinic acids extracted from chicory suppressed hepatic glucose production in H4IIE rat hepatoma cells by reducing the expression of glucose-6-phosphatase (G6Pase) and phosphoenolpyruvate carboxykinase (PEPCK), two key enzymes that regulate hepatic gluconeogenesis [<xref rid="B416-pharmaceutics-16-00454" ref-type="bibr">416</xref>]. Direct comparisons between CQAs and their metabolites (3-caffeoylquinic, caffeic, and quinic acids) revealed that the caffeic acid component alone was responsible for the effects observed [<xref rid="B416-pharmaceutics-16-00454" ref-type="bibr">416</xref>]. Further analysis suggested that the activation of the PI3K (phosphoinositide 3-kinases) and MAPK pathways to control gene expression was common in caffeoylquinic and caffeic acids (<xref rid="pharmaceutics-16-00454-t001" ref-type="table">Table 1</xref>). These compounds promoted increased mitochondrial respiration and cellular metabolism, inducing oxidative phosphorylation and proton leakage [<xref rid="B416-pharmaceutics-16-00454" ref-type="bibr">416</xref>].</p><p>In a study by Azay-Milhau et al. (2013), the antihyperglycaemic effect of three hydroxycinnamic acids present in the roots of <italic toggle="yes">C. intybus</italic> was also tested (<xref rid="pharmaceutics-16-00454-t001" ref-type="table">Table 1</xref>). In vitro experiments were carried out to compare the results of two hydroxycinnamic acids, caffeic and ferulic acids, with those obtained with chicoric acid extracted (CAE) (50 and 100 &#181;g/mL) on the three main tissues involved in blood sugar regulation (pancreas, muscle, and liver) [<xref rid="B414-pharmaceutics-16-00454" ref-type="bibr">414</xref>]. </p><p>In vivo experiments were performed on WR given a daily intraperitoneal injection of CAE (3, 15, or 30 mg/kg) for four days (<xref rid="pharmaceutics-16-00454-t003" ref-type="table">Table 3</xref>). An intraperitoneal glucose tolerance test (1 g/kg) was performed on the fourth day. The results showed that the three compounds used could induce an original response. Caffeic acid mainly reduces hepatic glycogenolysis [<xref rid="B414-pharmaceutics-16-00454" ref-type="bibr">414</xref>]. Ferulic acid caused a marked increase in insulin release and a reduction in hepatic glycogenolysis. However, this compound also inhibited muscle glucose uptake. CAE increased insulin release and glucose uptake without affecting hepatic glycogenolysis (<xref rid="pharmaceutics-16-00454-t003" ref-type="table">Table 3</xref>). The study showed that none of these compounds involved hepatic G6Pase, unlike chlorogenic acid, which is known to inhibit the enzyme and can reduce glucose production by hepatocytes [<xref rid="B414-pharmaceutics-16-00454" ref-type="bibr">414</xref>]. These results underline that CAE can lower blood glucose levels without affecting the liver. The in vivo experiments provide evidence that daily i.p. administration of CAE improves i.p. glucose tolerance in a dose-dependent manner and mainly via an insulin sensitization effect [<xref rid="B414-pharmaceutics-16-00454" ref-type="bibr">414</xref>].</p><table-wrap position="anchor" id="pharmaceutics-16-00454-t003" orientation="portrait"><object-id pub-id-type="pii">pharmaceutics-16-00454-t003_Table 3</object-id><label>Table 3</label><caption><p>Medicinal plants in NPSE for diabetes management with scientific validation of the claimed antidiabetic effects (in vivo).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Part Used/Extract Tested</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Model/Parameters Studies</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Intervention and Duration</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Observations</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr><tr><th colspan="5" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Asteraceae</italic>
</th></tr></thead><tbody><tr><td colspan="5" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1"><italic toggle="yes">Arctium minus</italic> (Hill) Bernh</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">R/DEC</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Male diabetic GK (Goto-kakizak) rats.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">125 g/L<break/><break/>DR ad libitum/4 weeks.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The DEC led to a GK rats&#8217; occasional glycaemia decrease. It did not significantly affect glycemic control; long-lasting treatments induced toxic effects. The DEC decreased several parameters of GK liver mitochondria respiratory activity.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B182-pharmaceutics-16-00454" ref-type="bibr">182</xref>]</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">R/L/AQ </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ALLO-induced diabetic rats.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">RAQ (500 mg/kg) and LAQ (200 mg/kg)<break/><break/>OG/21 days.</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">RAQ was reduced by 34.6 &#177; 5.8%, and LAQ was reduced by 6.2 &#177; 22.9%.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B174-pharmaceutics-16-00454" ref-type="bibr">174</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of biochemical parameters (B1)</td></tr><tr><td colspan="5" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Achillea millefolium</italic>
</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">NI/HET</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STZ-induced diabetic rats.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">25 mg/kg/day and 100 mg/kg/day<break/><break/>OG/28 days.</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Compared with Metformin, the HET reduces lipid abnormality, HYG and hepatic enzymes with a dose-dependent effect in diabetic rats.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B402-pharmaceutics-16-00454" ref-type="bibr">402</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of biochemical parameters (B2)</td></tr><tr><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">NI/AQ/MET</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OGTT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">250 and 500 mg&#183;kg<sup>&#8722;1</sup> BW<break/><break/>DR/18h.</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">The AQ/MET at dose levels of 250 and 500 mg/kg BW showed a significant decrease in BG level, TGL, VLDL, cholesterol, SGOT, SGPT, and ALP in diabetic rats.</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B404-pharmaceutics-16-00454" ref-type="bibr">404</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ALLO-induced diabetic rats.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">250 and 500 mg/kg BW<break/><break/>DR/14 days.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of biochemical parameters (B3)</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">AP/HET (70%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OGTT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100 mg/kg<break/><break/>0, 0.5, 1, 1.5, 2, and 3 h</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">The HET showed significant glucose diminution on oral glucose tolerance tests and in acute experimental T2DM assay. It reduced the BG levels in a dose-dependent manner.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B407-pharmaceutics-16-00454" ref-type="bibr">407</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STZ-induced diabetic mice.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33, 100 and 330 mg/kg<break/><break/>1, 3, 5, and 7 h</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">AP/HET</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STZ-induced diabetic rats.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">100 mg/kg/day<break/><break/>i.p./14 days</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">The HET significantly reduced the expression of both IL-1&#946; and iNOS genes. The serum INS levels in the HET group animals increased while the BG levels decreased significantly. The HET enhanced overexpression of IL-1&#946; and iNOS genes, which may have a protective effect on &#946;-cells.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B408-pharmaceutics-16-00454" ref-type="bibr">408</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of biochemical parameters (B4) and IL-1&#946;/iNOS gene expression.</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">NI/HET</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STZ-induced diabetic rats.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">250 mg/kg<break/><break/>NI/21 days</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">The results indicated that the HET improves renal function due to antioxidant activity and modulates some biochemical factors in diabetic rats.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B406-pharmaceutics-16-00454" ref-type="bibr">406</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of biochemical parameters (B5)<break/>Analysis of oxidative stress-related factors (O1).</td></tr><tr><td colspan="5" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1"><italic toggle="yes">Anthemis canescens</italic> (syn. <italic toggle="yes">Matricaria aurea</italic>)</td></tr><tr><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">ET/EA/DCM/HEX</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STZ-induced diabetic rats.</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">ETH1 = 100 mg/kg, ETH2 = 200 mg/kg<break/>EA1 = 100 mg/kg, EA2 = 200 mg/kg<break/>DCM1 = 100 mg/kg, DCM2 = 200 mg/kg<break/>HEX1 = 100 mg/kg, HEX2 = 200 mg/kg<break/><break/>OG/4 weeks.</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Treatment with either ETH1/2 extracts or pioglitazone successfully ameliorated INS resistance, hyperlipidemia, and fatty liver without significantly affecting fasting INS levels or pancreatic secretory capacity. It increased liver protection from injury associated with T2DM, as evidenced by a significant decrease in ALT and AST.</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B217-pharmaceutics-16-00454" ref-type="bibr">217</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of biochemical parameters (B6).</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oxidative stress and antioxidant markers in the liver (O2)</td></tr><tr><td colspan="5" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Bellis perennis</italic>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">L/F/<break/>EXT4404/EXT4407/HMET</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Avian embryos in the first two-thirds of embryonic development (lasting 21 days)<break/>Hens egg test-chorioallantoic membrane (HET-CAM) assay.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EXT4404 (300 mg/L), EXT4407 (300 mg/L), HMET (300 mg/L).</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">All three extracts resulted in a comparable decrease in BG levels (~20% after 1 h and 30% after 2 h) and were statistically significant after 2 h incubation.<break/>The three extracts significantly reduced BG levels at both time points with comparable efficacy (~12% after 1 and 2 h).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B411-pharmaceutics-16-00454" ref-type="bibr">411</xref>]</td></tr><tr><td colspan="5" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Bidens frondosa</italic>
</td></tr><tr><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">AP/ET (80%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OGTT</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">250 and 500 mg/kg BW<break/><break/>OG/7 days</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">ET exhibited weak to moderate hypoglycaemic effects on normoglycemic rats at the tested doses. In OGTT, higher doses of the extract indicated significant inhibitory activities. The ET lowered BG levels in varying ratios. The body weight of the animals was not changed significantly during this experiment.</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B413-pharmaceutics-16-00454" ref-type="bibr">413</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Healthy and STZ-induced diabetic rats.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of biochemical parameters (B1)</td></tr><tr><td colspan="5" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1"><italic toggle="yes">Chamaemelum nobile</italic> (syn. <italic toggle="yes">Anthemis nobilis</italic> L. or <italic toggle="yes">Chamomilla nobilis</italic>)</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">AP/AQ</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STZ-induced diabetic rats.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">20 mg/kg BW<break/><break/>OG/15 days.</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Single oral administration of AQ reduced BG levels in normal and STZ diabetic rats. BG levels were decreased in normal and STZ diabetic rats, respectively, after 15 days of treatment.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B451-pharmaceutics-16-00454" ref-type="bibr">451</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of biochemical parameters (B7)</td></tr><tr><td colspan="5" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Cichorium intybus</italic>
</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">R/AQ</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ALLO-induced diabetic rat</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">2.5, 5, 10, and 15 g DPM/kg<break/><break/>OG/2 weeks</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Treatment with 10 g/kg of the herbal mixture significantly lowered glycaemic values compared with the diabetic controls. The treatment with the highest tested concentration (15 g/kg) completely restored BG level to normoglycemic values in experimental groups. The lipid status of treated animals and serum AST, ALT, ALP, CRE, URE, and MDA were completely normalised. The polyherbal mixture completely restored the histopathological changes in the liver, kidneys, and hippocampus.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B458-pharmaceutics-16-00454" ref-type="bibr">458</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of physiological and biochemical parameters (P1)</td></tr><tr><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">WP/ET (80%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STZ-induced diabetic rats (male Sprague&#8211;Dawley rats)</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">125 mg of plant extract/kg BW<break/><break/>OG/14 days</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Daily administration of ET (125 mg/kg) for 14 days to diabetic rats attenuated BG by 20%, TG by 91%, and tTC by 16%.</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B455-pharmaceutics-16-00454" ref-type="bibr">455</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OGTT</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of biochemical parameters (B8)</td></tr><tr><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">R/AQ</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STZ- niacinamide (NIA/STZ) induced diabetic rats</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">125 mg/kg BW<break/><break/>i.p. injections/28 days.</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">The extract prevented body-weight loss and decreased BG level. ALT activities and TG, TC, and HbA1c levels decreased, and NO concentration increased in the chicory-treated groups. Unlike late-stage diabetes, fasting serum INS concentrations were higher, and the OGTT pattern was approximated to normal in chicory-treated early-stage diabetic rats.</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B456-pharmaceutics-16-00454" ref-type="bibr">456</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of biochemical parameters (B9)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OGTT</td></tr><tr><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">AP/CAE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Healthy rats</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">3, 15 or 30 mg/kg<break/><break/>i.p. injections/4 days.</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">The CAE can decrease BG without any effect hepatic effect. Daily i.p. administrations of CAE improve i.p. glucose tolerance in a dose-dependent manner, mainly via an INS sensitising effect.</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B414-pharmaceutics-16-00454" ref-type="bibr">414</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OGTT</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of biochemical parameters (B10)</td></tr><tr><td rowspan="4" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">S/CQA-ET</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Healthy rats</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Diet with CQA-ET<break/><break/>FEE/28 days</td><td rowspan="4" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">The CQA-ET was found to decrease the atherogenic index to the level observed in the control rats&#8217; group and to increase blood antioxidant status. Both dietary supplements reduced the content of thiobarbituric acid-reactive substances in kidney and heart tissue compared with the experimental group.</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B457-pharmaceutics-16-00454" ref-type="bibr">457</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">High-fructose diets</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of physiological and biochemical parameters (P2)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antioxidant status of rats (O3)</td></tr><tr><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">NCRAE, SCCAM </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STZ-induced diabetic rats</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">15 mg/kg<break/><break/>i.p. injections/7 days.</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Both NCRAE and SCCAM can improve glucose tolerance in STZ diabetic rats after a subchronic administration of seven days. Alone, NCRAE significantly decreases the basal HYG after six days of treatment.</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B419-pharmaceutics-16-00454" ref-type="bibr">419</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OGTT</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of biochemical parameters (B11).</td></tr><tr><td colspan="5" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1"><italic toggle="yes">Dittrichia viscosa</italic> subsp. <italic toggle="yes">iscosa</italic> (Syn. <italic toggle="yes">Inula viscosa</italic>)</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">L/AuNPs </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">High-fat diet (HFD)/STZ-induced diabetes in rats</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">2.5 mg/kg<break/><break/>i.p. injections/21 days.</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Treatment with AuNP significantly lowered the BG level, the gene expression, and the activity of hepatic PEPCK in comparison with the untreated diabetic group. The AuNPs synthesised can alleviate HYG in HFD/STZ-induced diabetes in rats by reducing hepatic gluconeogenesis by inhibiting the expression and activity of the hepatic PEPCK gene.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B472-pharmaceutics-16-00454" ref-type="bibr">472</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of biochemical parameters (B12)</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">AP/AQ</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Normal and STZ-induced diabetes rats</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">20 mg/kg<break/><break/>OG/for 2 weeks.</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">A significant reduction in BG levels was observed in normal rats 2 h after a single oral administration. Repeated daily oral administration significantly reduced BG levels after 4 days of treatment.<break/>In diabetic rats, a significant reduction in BG levels was observed 1 h after a single oral administration.<break/>Repeated oral administration reduced BG levels on the 4th day. No change in TC and TG levels was observed after a single and repeated oral administration in both normal and diabetic rats. Plasma INS levels and body weight remained unchanged after 15 days of repeated oral administration in normal and diabetic rats.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B473-pharmaceutics-16-00454" ref-type="bibr">473</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of biochemical parameters (B13)</td></tr><tr><td colspan="5" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Galinsoga parviflora</italic>
</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">WP/HET 80%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STZ-induced diabetic rats.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">400 mg/kg BW<break/><break/>NI</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">The extract reduced the BG level equivalent to GLIB (5 mg/kg BW) in diabetic rats.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B474-pharmaceutics-16-00454" ref-type="bibr">474</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of biochemical parameters (B13)</td></tr><tr><td colspan="5" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Lactuca serriola</italic>
</td></tr><tr><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">L/AQ</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STZ-induced diabetic rats.</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">200 and 500 mg/kg BW<break/><break/>OG/NI</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Both doses of extracts restored &#946; -cell function and<break/>INS secretion.</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B475-pharmaceutics-16-00454" ref-type="bibr">475</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OGTT</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of biochemical parameters (B14)</td></tr><tr><td colspan="5" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Onopordum acanthium</italic>
</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">L/MET</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STZ-induced diabetic rats</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">200 and 400 mg/kg<break/><break/>OG/8 days</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Administration of extracts significantly increased INS content in &#946;-cells with a marked enhancement of pancreatic islet structure, significantly reducing BG level and BW loss. Extract treatment suppressed the increase in inflammatory cell score in myocardial tissue with an M2&#8211;like macrophage elevation.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B476-pharmaceutics-16-00454" ref-type="bibr">476</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of biochemical parameters (B15)</td></tr><tr><td colspan="5" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Solidago virgaurea</italic>
</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">AP/HE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ALLO-induced diabetic rat.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">250 mg/kg BW<break/><break/>OG 15 days</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Extract significantly reduced BG level, serum AMY activity, TNF-&#945; level, and pancreatic MDA level, as well as increasing the serum INS, liver GLY level, pancreatic SOD, and CAT activities in comparison with their corresponding diabetic rats.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B477-pharmaceutics-16-00454" ref-type="bibr">477</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of physiological and biochemical parameters (P3)</td></tr><tr><td colspan="5" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Sonchus asper</italic>
</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">NI/ME</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STZ-induced diabetic rats.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">200 mg/kg<break/><break/>21 days</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">The ME improve the activity of the antioxidant enzymes, TBARS contents, and cholesterol profile of the diabetic rats. DTR&#8217;s BG and INS levels were significantly lower in treatment than the diabetic rats on day 21.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B478-pharmaceutics-16-00454" ref-type="bibr">478</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of physiological and biochemical parameters (P4)</td></tr><tr><td colspan="5" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Sonchus oleraceus</italic>
</td></tr><tr><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">WP/ME</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STZ-induced diabetic rats.</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">75, 150, 300 mg/kg<break/>14 days</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">The Me (150 mg/kg) treatment exhibited 39.40% glycaemia reduction. The measurement of stress markers in plasma, liver, and kidney after ME administration showed a significant reduction in MDA and hydrogen peroxide levels, coupled with a substantial increase in CAT activity.</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B479-pharmaceutics-16-00454" ref-type="bibr">479</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OGTT</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antioxidant status of rats (O4)</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">L/HET (90%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STZ-induced diabetes in rats</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">100, 200, 400 mg/kg/day BW<break/><break/>6 weeks</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">HET significantly increased both SOD activity and GSH levels while causing a reduction of MDA levels in the liver. Moreover, HET ameliorates STZ-induced liver function and pathological damage. DTR fed with HET daily for 6 weeks showed significantly decreased levels of TNF-&#945; and IL-1&#946; in the liver. HET decreased MyD88, TGF-&#946;, and TLR4 expression levels in the liver of DTR.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B480-pharmaceutics-16-00454" ref-type="bibr">480</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of physiological and biochemical parameters (P5)</td></tr><tr><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">L/HET (90%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HFD/STZ-induced diabetes in rats</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">100, 200, 400 mg/kg/day BW<break/><break/>6 weeks</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">In DTR treated by HET (400 mg/kg/day for 6 weeks), TG, TC, and LDL-c were reduced by 43%, 22%, and 16%, respectively. Meanwhile, it was also found that daily feeding of DTR decreased plasma glucose levels by approximately 23%. DTR with HET at 400 mg/kg/day for 6 weeks show portal tract and mild fibrous expansion without sep inflammation formed of lymphocytes. The administration of HET exhibited a protective effect against the hepatic damage induced by STZ, which was also corroborated by the apparent condition and colour observed in HET-administered rats.</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B427-pharmaceutics-16-00454" ref-type="bibr">427</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OGTT</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of physiological and biochemical parameters (P6)</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">L/ET (80%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ALLO-induced diabetic rat</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">100, 200, and 300 mg/kg BW<break/><break/>56 days</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">The treatment of SOE 200 and 300 mg/kg in diabetic rats for two months dramatically decreased BG, total lipid, TC, TG, and LDLc, while HDLc levels improved liver and kidney functions. The histological assay revealed that the treatment of SOE 300 mg/kg significantly improved the pancreas tissues.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B481-pharmaceutics-16-00454" ref-type="bibr">481</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of physiological and biochemical parameters (P7)</td></tr><tr><td colspan="5" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>
<italic toggle="yes">Lamiaceae</italic>
</bold>
</td></tr><tr><td colspan="5" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Lavandula pedunculata</italic>
</td></tr><tr><td rowspan="4" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">FTO/AQ</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Healthy rats</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">1 g/kg BW<break/><break/>NI</td><td rowspan="4" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Acute and chronic oral administration of extract reduced the peak of the BG (30 min) and the area under the curve. The effect was at the same amplitude as the positive control Metformin.</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B430-pharmaceutics-16-00454" ref-type="bibr">430</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Acute OGTT and chronic </td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OGTT for plant mixtures</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of biochemical parameters (B13)</td></tr><tr><td colspan="5" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Lavandula stoechas</italic>
</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">AP/EO</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ALLO-induced diabetic rat</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">50 mg/kg BW<break/><break/>i.p. injections/15 days.</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Subacute EO administration prevented BW gain decline and protected against alloxan-induced increase in hepatic and renal relative weights.<break/>EO treatment corrected the BG level significantly, protected against lipoperoxidation and decreased (&#8722;SH) group levels, and reversed antioxidant enzyme depletion. Induced by alloxan treatment. Treatment with EO significantly protected against hepatic and renal dysfunctions and the disturbance of lipid metabolic parameters induced by alloxan treatment.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B482-pharmaceutics-16-00454" ref-type="bibr">482</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of biochemical parameters (B16)</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">AP/EO</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ALLO-induced diabetic rat </td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">50 mg and 160 mg/kg BW<break/><break/>i.p. injections/15 days</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">EO treatment protects against decreased BW gain, relative reproductive organ weights, testosterone level, and sperm quality decline. EO treatment protects against oxidative damage to DTR&#8217;s male reproductive organ systems. </td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B483-pharmaceutics-16-00454" ref-type="bibr">483</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of physiological and biochemical parameters (P8)</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">R/ET (70%) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ALLO-induced diabetic rat</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">50, 100, and 150 mg/kg BW<break/><break/>i.p. injections/NI</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">The extract significantly reduced BG levels of DTR in a dose-dependent manner.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B484-pharmaceutics-16-00454" ref-type="bibr">484</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of biochemical parameters (B13)</td></tr><tr><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">NI/EO</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STZ-induced diabetic rats</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.05 mL<break/><break/>DDR/21 days</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">The percentage of healing was highest in the EO group on Days 7, 14, and 21. Microscopic examination of the biopsies supported accelerated wound healing on Days 7 and 14. Reduced mononuclear cell density and increased hair follicle and adipose tissue development were observed in the T2DM-EO group on Day 7. On Day 14, the T2DM-EO group increased collagen levels and hair follicles.</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B485-pharmaceutics-16-00454" ref-type="bibr">485</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wound healing test</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of physiological and biochemical parameters (P9)</td></tr><tr><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">AP/AQ</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ALLO-induced diabetic rat</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">150 mg/kg<break/><break/>OG/NI</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Oral extract administration reduced HYG induced by sucrose and starch in normal and diabetic rats. </td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B431-pharmaceutics-16-00454" ref-type="bibr">431</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OGTT</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of biochemical parameters (B13)</td></tr><tr><td colspan="5" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Melissa officinalis</italic>
</td></tr><tr><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">EO</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">db/db mice</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.0125 mg EO/d<break/><break/>FEE/6 weeks</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Mice administered EO for 6 weeks showed significantly reduced BG (65%; <italic toggle="yes">p</italic> &lt; 0.05) and TG concentrations, improved glucose tolerance, as assessed by an OGTT, and significantly higher serum INS levels than the CGr. All the genes were significantly upregulated, whereas G6Pase and PEPCK expression was downregulated in the livers of the EO group.</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B486-pharmaceutics-16-00454" ref-type="bibr">486</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of biochemical parameters (B17)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OGTT</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">L/ET</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HFD C57BL/6 mice</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">200 mg/kg/day<break/><break/>FEE/6 weeks</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">The DTR revealed significantly reduced fasting BG concentrations (14% decrease versus vehicle).<break/>The extract showed no significant effects on FPIL.<break/>It significantly decreased the HFD-induced INS resistance by 35%. It reduced the HFD-provoked rise in fasting plasma concentrations of nonesterified FAs by 59% and plasma TAG gain by 66%. The extract-fed mice showed reduced plasma levels of LDL/VLDL-c (32% decrease) and a slight decrease in TC (8% decrease). The extract treatment led to an increase in the HDL/LDL ratio of 56%.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B487-pharmaceutics-16-00454" ref-type="bibr">487</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of biochemical parameters (B18)</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">NI/EO</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STZ-induced diabetic rats</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.01, 0.02 and 0.04 mg/day<break/><break/>FEE/4 weeks</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">EO at both high doses restored glycemia and reduced the BW of DTR compared with untreated diabetic animals.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B488-pharmaceutics-16-00454" ref-type="bibr">488</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of biochemical parameters (B1)</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">L/HAE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ALLO-induced diabetic rat</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">20, 100 or 500 mg/kg BW<break/><break/>OG/4 weeks</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">There was a significant decrease in blood sugar levels, TC, TG, and LDL in DTR with HAE. An increase in HDL levels was observed in HAE-DTR.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B489-pharmaceutics-16-00454" ref-type="bibr">489</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of biochemical parameters (B19)</td></tr><tr><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">L/HE-EA (ALS-L1023)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HFD C57BL/6 mice</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">HFD supplemented with 0.4% (<italic toggle="yes">w</italic>/<italic toggle="yes">w</italic>) ALS-L1023 (HFD-ALS)<break/><break/>FEE/12 weeks</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Administration of ALS-L1023 to high-fat-diet-induced OMI caused reductions in BW gain, VFM, and VAS without changes in FC profiles. ALS-L1023 improved HYG, HYIN, BG, and INIT and normalised INS-positive &#946;-cell area in OMI. ALS-L1023 decreased hepatic LIA and concomitantly increased the expression of PPAR&#945; target genes responsible for fatty acid &#946;-oxidation in livers.</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B490-pharmaceutics-16-00454" ref-type="bibr">490</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of physiological and biochemical parameters (P10)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OGTT and IPITT</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">L/HE/EA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Otsuka Long-Evans Tokushima fatty (OLETF) rats</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">HFD with 0.4% or 0.8% (<italic toggle="yes">w</italic>/<italic toggle="yes">w</italic>) of extract<break/><break/>FEE/4 weeks</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">The EAE administration resulted in a BW reduction without changes in FI. It also markedly inhibited HYG and HYIN, restoring the &#946;-cell mass severely impaired in OLETF rats. There was a decrease in LIA in the liver and skeletal muscle of the ORAT after treatment with EAE. After EAE treatment, the liver and skeletal muscle increases the expression levels of FAs-oxidizing enzymes (AMPK&#945;2, ACOX, MCAD, and VLCAD). The EAE attenuated the pancreatic inflammation, including the infiltration of CD68-positive macrophages and mast cells, and attenuated the expression of inflammatory factors (IL-6 and CD68).</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B491-pharmaceutics-16-00454" ref-type="bibr">491</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of physiological and biochemical parameters (P111)</td></tr><tr><td colspan="5" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Mentha aquatica</italic>
</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">L/AQ</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STZ-induced diabetic rats</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">50 mg, 100 mg and 150 mg<break/>OG/90 days.</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">FBG and HbA1c levels decreased in DTR. The BW and INS levels of DTR were significantly increased. The levels of TC TG were reduced, and the levels of HDL were significantly increased.<break/>The ALB of DTR were significantly increased. However, the levels of UR and CREA were decreased in DTR. TBARS/MDA level formation significantly decreased in DTR. The activities of CAT, SOD, GPx, and GST were increased in DTR. DTR at a dose of 100 mg/kg bw/day showed normal glomeruli, normal intertubular vessels, and tubular epithelial cells, indicating degenerative changes in the kidney.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B492-pharmaceutics-16-00454" ref-type="bibr">492</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of physiological and biochemical parameters (P12)</td></tr><tr><td colspan="5" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Mentha pulegium</italic>
</td></tr><tr><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">AP/AQ</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STZ-induced diabetic rats</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">20 mg/kg BW<break/><break/>OG/15 days</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">The AQE caused a significant reduction in BG levels in DTR. The morphometric analysis and histological sections realised in the pancreas and liver have shown the beneficial effect of AQE in the cellular population. According to OGTT, the AQE has improved glucose tolerance in normal rats.</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B493-pharmaceutics-16-00454" ref-type="bibr">493</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OGTT</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of physiological and biochemical parameters (P13)</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">AP/AQ</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STZ-induced diabetic rats</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">20 mg/kg BW<break/><break/>OG/15 days</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">The AQE alleviated hyperlipidemia in diabetic rats by lowering significantly the TC levels without affecting the TG levels significantly. It exerted some increasing activity on plasma HDL-c level.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B494-pharmaceutics-16-00454" ref-type="bibr">494</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of biochemical parameters (B20)</td></tr><tr><td colspan="5" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Mentha suaveolens</italic>
</td></tr><tr><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">AP/AQ</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STZ-induced diabetic rats.</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">20 mg/kg BW<break/><break/>OG/15 days</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">The AQE decrease the BG, TC, and TG levels in both normal and diabetic rats. The AQE treatment was demonstrated to act positively on the liver and pancreas histopathological tissues.</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B495-pharmaceutics-16-00454" ref-type="bibr">495</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OGTT</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of physiological and biochemical parameters (P14)</td></tr><tr><td colspan="5" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1"><italic toggle="yes">Origanum vulgare</italic> L.</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">L/AQ</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STZ-induced diabetic rats</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">20 mg/kg<break/><break/>OG/2 weeks</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">The AQE produced a significant decrease in BG levels in DTR. The BG levels were normalised from the fourth day after daily repeated oral administration of AQE. No changes in basal plasma INS concentrations were observed after treatment in either normal or DTR.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B496-pharmaceutics-16-00454" ref-type="bibr">496</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of biochemical parameters (B4)</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">L/AQ</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STZ-induced diabetic rats</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">20 mg/kg<break/><break/>OG/6 weeks</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Administration of AQE significantly decreased BG levels, HbA1c, and AMY in DTR.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B497-pharmaceutics-16-00454" ref-type="bibr">497</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of biochemical parameters (B21).</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">L/ME/AQ</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STZ-induced diabetic rats</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">5 mg/kg per day<break/><break/>i.p. injections/10 days</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">ME reduced diabetes incidence and preserved normal insulin secretion. ME scavenged reactive oxygen and nitrogen species and alleviated the need to upregulate antioxidant enzymes. ME treatment attenuated the pro-inflammatory response mediated by T helper 17 cells. It enhanced anti-inflammatory T helper 2 and T regulatory cells by impacting specific signalling pathways and transcription factors.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B394-pharmaceutics-16-00454" ref-type="bibr">394</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of physiological and biochemical parameters (P15)</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">L/EtOAc</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STZ-induced diabetic rats</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">2 mg/mouse<break/><break/>OG/10 days</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">EtOAc treatment significantly preserved pancreatic islets and reduced diabetes incidence in DTR. Besides the down-modulatory effect on macrophages, EtOAc reduced the number of total CD4+ and activated CD4+ CD25+ T cells. EtOAc affected the number of T helper 1 (Th1) and T helper 17 (Th17) cells by downregulating their key transcription factors T-bet and ROR&#947;T.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B498-pharmaceutics-16-00454" ref-type="bibr">498</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of physiological and biochemical parameters (P16)</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">L/AQ</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ALLO-induced diabetic rat</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">150 mg/kg, 300 mg/kg BW<break/>300 mg/kg Equal mixture<break/>(150 mg chamomile + 150 mg oregano)<break/><break/>OG/6 weeks</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Treatment with higher or lower doses or a mixture of extracts had significant weight gain, hypoglycemic effect, decreased AMY activity, and increased INS levels. Restoration of the renal profile and lipid profile with an increase in HDL-C and the reversal of Bax and Bcl-2 were well observed, with a 300 mg/kg mixture showing synergistic activity of the extracts compared with individual low doses of 150 mg/kg.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B499-pharmaceutics-16-00454" ref-type="bibr">499</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of biochemical parameters (B22)</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">L/HE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glucose-induced-diabetic zebrafish</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">10 &#956;g/L<break/><break/>FEE/24H</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">The BG level, TC, and TG were significantly reduced in diabetic zebrafish treated.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B500-pharmaceutics-16-00454" ref-type="bibr">500</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of biochemical parameters (B23)</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">L/INF</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ALLO-induced diabetic rat</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">55 mL<break/><break/>OG/40 days</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">The INF reduced BG levels after the first day of treatment, compared with the diabetic CGr. The INF appears to stimulate INS secretion.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B501-pharmaceutics-16-00454" ref-type="bibr">501</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of biochemical parameters (B10)</td></tr><tr><td colspan="5" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Prunella vulgaris</italic>
</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">WP/AQ</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">db/db mice HCF/HFD</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">100 mg, 200 mg/kg/day<break/><break/>DR/8 weeks</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">AQE treatment markedly lowered BG and SBP. The CRE clearance was restored by treatment with AQE. The AQE markedly decreased TC, TG, LDL-c, MDA, and TGF&#946;1 and increased HDL-c and NO levels. AQE ameliorated vascular relaxation of aortic rings by acetylcholine or SNP-inducement in a dose-dependent manner. AQE treatment significantly reduced the aortic expressions of ICAM-1, VCAM-1, ET-1, and nitrotyrosine. The expression of eNOS in aortic was increased by AQE treatment.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B502-pharmaceutics-16-00454" ref-type="bibr">502</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of physiological and biochemical parameters (P17)</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Fr/HE/TAP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STZ-induced diabetic rats</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">50 mg/kg, 100 mg/kg, 200 mg/kg of TAP<break/><break/>OG/6 weeks</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">The BW and the levels of BG, FMN, MDA, NO, and the activity of NOS in serum decreased significantly compared with the STZ group in a dose-dependent manner. The activity of SOD in serum and BW increased significantly compared with the STZ group in a dose-dependent manner. The DTR showed a significant increase in SOD mRNA expression in pancreatic &#946; cells. Histopathological examination also showed the protective effect of TAP on pancreatic &#946; cells.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B503-pharmaceutics-16-00454" ref-type="bibr">503</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of physiological and biochemical parameters (P18)</td></tr><tr><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">HFOR/HE/AQ</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Male CD-1 (ICR) mice/FFF</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">8.02 g/kg<break/><break/>OG/10 weeks</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">HEE could improve glucose intolerance and normalise the lipid profile. HEE provokes an increase in peripheral and hepatic INS sensitivity, a decrease in FAs level, enhanced GLUK activity and GLY content, and improved serum antioxidant activity. Hepatic histopathological examination showed that HEE administration markedly decreased fatty deposits in the liver of mice.</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B504-pharmaceutics-16-00454" ref-type="bibr">504</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OGTT and IPITT</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of physiological and biochemical parameters (P19)</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">IF/PV(HE)/CARF/CA/RA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ALLO-induced diabetic rat model</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">50, 100, 150 mg/kg<break/><break/>i.p. injections/8 weeks</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">CARF reduced BG levels and improved in vivo oxidative stress. CARF reduced HbA1c levels more significantly than PV and equivalent amounts of CA or RA. CARF had significantly increased serum-INS, and ameliorated thermal hyperalgesia and tactile allodynia more significantly than the effects of PV and equivalent amounts of CA or RA. The tested compounds showed potential restoration of the lipid peroxide levels.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B448-pharmaceutics-16-00454" ref-type="bibr">448</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of physiological and biochemical parameters (P20)</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">WP/AQ</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Male Sprague-Dawley (SD) STZ-induced diabetic rats</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">100 mg, 300 mg/kg/day<break/><break/>DR/8 weeks</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">In DTR, AQE significantly decreased BG and BUN and ameliorated plasma CRE. AQE reduced the PAS positivity staining intensity and basement membrane thickening in the glomeruli of DTR.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B505-pharmaceutics-16-00454" ref-type="bibr">505</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measurement of physiological and biochemical parameters (P21)</td></tr></tbody></table><table-wrap-foot><fn><p>ACOX: Acyl-CoA oxidase, ALB: Albumin, ALLO: Alloxan, ALP: Alkaline Phosphatase, ALT: Alanine aminotransferase, AMPK&#945;2: AMP-activated protein kinase &#945;2, AMY: Amylase, AP: Arial parts, AQ: Aqueous extract, AST: Aspartate aminotransferase, AuNPs: Gold particles of dried leaf aqueous extract, BG: Blood glucose, BUN: Urea nitrogen, BW: Body weight, CA: Caffeic acid, CAE: Chicoric acid extracted and purified from water extract, CARF: Caffeic acid-rich fraction, CAT: Catalase, CGr: Control group, CQA-ET: Caffeoylquinic acids-rich ethanol extract (75%) from chicory seeds (9.6% of CQA), CRA: L-chicoric acid, CRE: Creatinine, CGA: Chlorogenic acid, DCM: Dichloromethane extract, DDR: Daily dressings, DPM: Dry plant material, DR: Drinking, DTR: Diabetic treated rats, EA: Ethyl Acetate extract, EO: Essential oil, ET: Ethanol extract, EXT4404: Mixture of flowers and leaves ethanolic extracts, EXT4407: Ethanolic extract of flowers alone, FBG: Fasting blood glucose, FC: Food consumption, FEE: Feeding, FFF: Fed with a fructose/fat-rich combination diet, FI: Food intake, FPIL: Fasting plasma insulin levels, FTO: Flowering tops of plants, GK1: Hepatic glucokinase, GLIB: Glibenclamide, GLUT4: Glucose transporter type 4, GLUK: Glucokinase, GLY: glycogen, GPx: Glutathione peroxidase, G6Pase: Glucose-6-phosphatase, HAE: Hydroalcoholic extract, HbA1c: Glycosylated haemoglobin, HFD: High cholesterol food, HDL-c: High-density lipoprotein cholesterol, HE: Hexane extract, HET: Hydroethanolic extract, HFD: High fat diet, HFOR: Ethanolic extract of herbal formulation composed of <italic toggle="yes">R. dioscorea</italic>, <italic toggle="yes">L. barbarum</italic>, <italic toggle="yes">P. vulgaris</italic>, and hawthorn in a ratio of 6:4:2:3, HMET: Homemade ethanolic extract prepared from flowers collected locally, HYG: hyperglycemia, HYIN: Hyperinsulinemia, IL-6: Interleukin 6, INS: Insulin, INIT: Insulin tolerance, IPITT: Intraperitoneal insulin tolerance tests, LDH: Lactate dehydrogenase, LDL-c: Low-density lipoprotein cholesterol, LIA: Lipid accumulation, ME: Methanolic extract, MCAD: Medium-chain acyl-CoA dehydrogenase, MDA: Malondialdehyde, NCRAE: Natural chicoric acid extract (from hydroethanolic extract 70%), NI: Not indicated, NO: Nitric oxide, OG: Oral gavage, OGTT: Oral glucose tolerance tests, OMI: Obese mice, ORAT: Obese rats, PAL: Phosphatase alkaline, PASS: Periodic acid schiff, PEPCK: Phosphoenolpyruvate carboxykinase, PV: <italic toggle="yes">Prunella vulgaris</italic>, RA: Rosmarinic acid, SBP: Systolic blood pressure, SCCAM: Synthetic chicoric and chlorogenic acids mixture containing the two major compounds of NCRAE, in proportion of 70% of synthetic L-chicoric acid and 30% of synthetic chlorogenic acid, SGOT: Glutamic-oxaloacetic transaminase, SGPT: Serum glutamate pyruvate transaminase, SOD: Superoxide dismutase, STZ: Streptozine, TAG: Triacylglycerol, TAP: triterpenic acid from <italic toggle="yes">Prunella vulgaris</italic> hydroethanolic extract (75%), TC: Serum total cholesterol, TG: Triglycerides, TGF-&#946;: Transforming growth factor beta, TLR4: Toll-like receptor, T2DM: Type 2 diabetes, UA: Uric acid, URE: Plasma urea, VAS: Visceral adipocyte size, VFM: Visceral fat mass, VLCAD: Very long-chain acyl-CoA dehydrogenase, VLDL: Very-low-density lipoprotein levels, WP: Whole plant. Biochemical parameters studied. B1: Assessment of the body weight (BW) and blood glucose (BG) levels; B2: Assessment of the BW, BG, TG, and total-, LDL-c, and HDL-c levels, B3: Assessment of the BW, BG, TC, TG, VLDL levels, SGOT, SGPT, and ALP activities, B4: Assessment of the BW, BG, and insulin levels (INS), B5: Assessment of BG, TC, HDL-c, TG, and LDL-c levels, B6: Assessment of fasting BG and INS. Systemic insulin resistance was estimated using the homeostasis model assessment index for insulin resistance (HOMA-IR). Study the triglyceride and glucose (TyG) index, insulin sensitivity, and the secretory capacity of the pancreas (HOMA-B index). Assessment of lipid profile and liver injury markers TC, TG, HDL-c, LDL-c, ALT, and AST, B7: Assessment of BG levels and basal plasma INS concentrations, B8: Assessment of the BW, serum glucose, TG, TC, and INS levels, B9: Assessment of the BW, fasting BG, intraperitoneal glucose tolerance test (IPGTT), HbA1c, ALT, AST, NO, TAG, TC, total protein (TPRO), and INS levels, B10: Assessment of BG and INS levels, B11: Assessment of the BW, food intake (FI), and plasma/urinary glucose levels, B12: Assessment of BG level. Hepatic gene expression and activity of phosphoenolpyruvate carboxykinase (PEPCK), B13: Assessment of BW, BG, TG, and TC levels, B14: Assessment of BG, HbA1c, INS, TC, TG, and LDL-c levels. IR-HOMA and HOMA-B (&#946;-cell function) were evaluated using the homeostatic model assessment (HOMA) index, B15: Assessment of BG, BW, morphometric analysis, histopathological study, and immunohistochemical analysis, B16: Assessment of BG, biochemical determination of protein, -SH groups, MDA, and antioxidant enzyme activities (SOD, CAT) in the liver and the kidney homogenates. Assessment of liver function (AST, ALT, PAL, LDH). Assessment of renal function (URE, CRE, UA, and ALB analyses). Determination of metabolic parameters (TC, LDL-c, HDL-c, and TG concentrations), B17: Assessment of BG, INS levels, TC, TG, and HDL-c levels. GK1, GLUT4, adipocyte GLUT4, PPAR-&#947;, PPAR-&#945;, SREBP-1c, G6Pase, PEPCK expression analysis, B18: Assessment of BG, TAG, FAs, and LDL/VLDL-c levels, B19: Assessment of BG level, TC, TG, LDL, and HDL contents, B20: Assessment of TC, TG, and HDL-c levels, B21: Assessment of BG, INS, liver and muscle glycogen, URE, UA, CRE contents, and pancreatic AMY, B22: Assessment of BG, INS, HbA1c, TC, TG, HDL-C, VLDL-c, LDL-c, URE, CRE, UA, TPRO, and AMY, B23: Assessment of BG level, TC, and TG levels. </p></fn><fn><p><italic toggle="yes">Antioxidant status parameters studied</italic>. O1: Analysis of oxidative stress-related factors in renal tissue: MDA level, SOD, and glutathione peroxidase (GPx) enzyme activity, measurement of Bcl-2-associated X protein (BAX) expression, O2: Assessment of the level of MDA, reduced glutathione (GSH) levels, and catalase and SOD activities. O3: Analysis of oxidative stress-related factors: GPx, SOD, serum antioxidant capacity [hydrophilic substances, lipophilic substances, TBARS (Thiobarbituric Acid Reactive Substances) in heart, kidney, and liver tissues, O4: Titration of markers of oxidative stress in treated rats (MDA and hydrogen peroxide levels, CAT activity).</p></fn><fn><p><italic toggle="yes">Physiological and biochemical parameters studied</italic>. P1: Assessment of the BW, BG level, TC, HDL, TG, AST, ALT, ALP, CRE, and URE. Sub-chronic toxicity study and histopathological analysis, P2: Determination of diet intake, BW, the mass of selected organs of rats; indices of gut functioning of rats; basic biochemical indices of rat serum (BG, ALT, ALP, TC, HDL-c, TG, Atherogenic index), P3: Assessment of BG, INS, serum lipid profile, tumor necrosis factor-&#945; (TNF-&#945;), liver glycogen levels (GLY), and amylase activity (AMY). Histopathological study of pancreatic tissue, SOD, CAT, and MDA levels in pancreatic tissue was also assessed, P4: Assessment of BG, INS, lipase, measurement of the protein concentration of the supernatant from pancreatic tissue. Determination of lipid peroxidation enzymes, glutathione-S-transferase (GST), glutathione reductase (GR), GPx, lipid peroxidation (TBARS), CAT, and SOD activities, P5: Assessment of BG, SOD, GSH activities, MDA, GLY levels, histological analyses of the liver tissue sample, determination of the levels of IL-1&#946; and TNF-&#945; and gene expression of NF-&#954;B, TNF-&#945;, IL-1&#946;, p-TLR4, MyD88, and TGF-&#946; analysis in the liver tissue sample, P6: Assessment of BG, BW, TG, TC, HDL, LDL, GLY levels, immunohistochemistry of the liver tissues and analysis of p-AMPK/Akt/GSK3-&#946; expression in liver cells, P7: Assessment of BG, TG, TC, HDL, LDL levels, activities of liver enzymes, including (ALT) and (AST), as well as the serum total bilirubin (TB), total protein, and serum ALB, URE, UA, and CRE. Determination of MDA levels, GSH, SOD, CAT, and GST activities and histological analyses of the pancreatic tissue samples, P8: Evaluation of serum testosterone and sperm characteristics (count, motility, viability, morphology, production). Assessment of plasma glucose, relative body and reproductive organ weights, plasma acetylcholinesterase and butyrylcholinesterase activities. Biochemical determination of protein, -SH groups, MDA, and antioxidant enzyme activities (SOD, CAT), GPx in homogenates of testis, epididymis, and sperm, P9: Assessment of BG levels, BW. Macroscopic and microscopic data analysis, P10: Assessment of BW, FI, BG, HbA1c, TG, and FAs. QUICKI (quantitative insulin sensitivity check index) and HOMA-IR values were determined. Histological analysis (quantification of the visceral adipocyte sizes, INS-secreting &#946;-cells detection), P11: Assessment of BG, INS levels, TAG, FAs, and body weight. Histology (quantification of the epididymal adipocytes size, examination of the lipid accumulation in the liver and gastrocnemius muscle tissues), immunohistochemistry (detection of INS and CD68), and real-time polymerase chain reaction, P12: Assessment of BG, BW, HbA1c, TC, TG, URE, CRE, ALB, INS, HDL-c, ALB, URE, CRE levels. Determination of antioxidant enzyme activities (SOD, CAT, GPx, GST) and the kidney lipid oxidative degradation (TBARS, MDA contents), P13: Assessment of BG, the histological sections and morphometric analysis, P14: Assessment of BG, TC, TG, LDL, HDL contents and histopathological examination of pancreas and liver, P15: Assessment of BG, INS, metabolic parameters (Glutathione S-transferase), and leucocyte and erythrocyte blood counts. Isolation of pancreatic-infiltrating mononuclear cells and immunofluorescence analysis. Determination of cytokine and nitrite levels. Histology and immunohistochemistry of the pancreas. Determination of antioxidant enzyme activity (Catalase activity, Glutathione peroxidase (GSHPx), Glutathione reductase), P16: Assessment of BG, determination of cellular composition and cytokine production and histopathological examination of pancreas, P17: Assessment of BG level, BW, urine volume, urine osmolality, and electrolytes (sodium, potassium, and chloride), systolic blood pressure (SBP), INS levels, transforming growth factor-beta1 (TGF-&#946;1) and total NO levels, TC, HDL, cholesterol, LDL-c, TG, blood urea nitrogen (BUN), total bilirubin, TPRO, albumin (ALB), globulin, glutamic oxaloacetic transaminase (GOT), glutamic pyruvic transaminase (GPT), lactate dehydrogenase (LDH), AMY, and MDA levels in plasma. Histological and immuno-histological examinations, P18: Measurement of BG, BW, fructosamine (FMN), nitric oxide (NO), nitric oxide synthase (NOS), MDA, and SOD. Histopathological studies of rat pancreatic islet cells and expression of SOD mRNA in pancreatic &#946;-cells, P19: Assessment of BG, HOMA-IR index, hepatic glucokinase activity, hepatic glycogen content, serum lipid profile (TC, TG, LDL-c, HDL-c contents), FAs level, serum antioxidant status (total antioxidant capacity [T-AOC], SOD, MDA), and histological examination of liver, P20: Assessment of BG level, BW, INS level, HbA1c, diabetic neuropathy management (hot plate latency test, tail flick latency test, Von Frey filaments test), measurement of lipid peroxidation and serum catalase (CAT) levels, P21: Assessment of BG level, BUN, and creatinine (CRE). Immunohistochemistry and Western blot analysis of the kidneys.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec3dot2dot2-pharmaceutics-16-00454"><title>3.2.2. <italic toggle="yes">Lamiaceae</italic> Family</title><list list-type="bullet"><list-item><p>
<italic toggle="yes">Lavandula stoechas</italic>
</p></list-item></list><p><italic toggle="yes">Lavandula stoechas</italic> L. is widely recognised for its pharmacological properties [<xref rid="B341-pharmaceutics-16-00454" ref-type="bibr">341</xref>]. It is one of the best-known and most economically valued plants and was probably the first species to be used for its EO. The genus comprises around 39 species, numerous hybrids, and almost 400 registered cultivars [<xref rid="B506-pharmaceutics-16-00454" ref-type="bibr">506</xref>]. Phytochemical studies of its many co-products have revealed the presence of a variety of bioactive compounds (<xref rid="pharmaceutics-16-00454-t001" ref-type="table">Table 1</xref>). This plant is frequently used in traditional medicine to treat various conditions, including inflammation, neurological disorders, microbial infections, etc. [<xref rid="B159-pharmaceutics-16-00454" ref-type="bibr">159</xref>,<xref rid="B341-pharmaceutics-16-00454" ref-type="bibr">341</xref>,<xref rid="B507-pharmaceutics-16-00454" ref-type="bibr">507</xref>,<xref rid="B508-pharmaceutics-16-00454" ref-type="bibr">508</xref>]. It is the subject of much attention from diabetes scientists, and numerous in vitro, animal, and clinical studies have been carried out on its use (<xref rid="pharmaceutics-16-00454-t003" ref-type="table">Table 3</xref>).</p><p>Elrherabi et al. (2023) evaluated the antihyperglycaemic impact of the aqueous extract of <italic toggle="yes">L. stoechas</italic> and attempted to explore its mechanisms. The researchers used an OGTT on normal and diabetic WR, administering 150 mg/kg of extract. Hyperglycaemia induced by sucrose and starch was reduced under the effect of the plant in normal and diabetic rats. The extract also caused a decrease in intestinal glucose absorption in situ at 250 mg/kg. As a result, the aqueous extract would have clear antihyperglycaemic effects attributed to inhibiting intestinal glucose absorption and key enzymes in monosaccharide digestion, such as <italic toggle="yes">&#945;</italic>-amylase and <italic toggle="yes">&#945;</italic>-glucosidase [<xref rid="B431-pharmaceutics-16-00454" ref-type="bibr">431</xref>]. Indeed, the IC50 equals 0.485 &#177; 0.13 mg/mL and 168 &#177; 40.10 &#956;g/mL, respectively, for amylase and glucosidase [<xref rid="B431-pharmaceutics-16-00454" ref-type="bibr">431</xref>]. In addition, the antidiabetic potential of lavender essential oil and its main compounds was also investigated by measuring their inhibitory activity towards the two digestive enzymes [<xref rid="B344-pharmaceutics-16-00454" ref-type="bibr">344</xref>]. Camphor (76.92 &#177; 2.43 &#956;g/mL) and fenchone (69.03 &#177; 2.31 &#956;g/mL) showed the best inhibitory activities for the <italic toggle="yes">&#945;</italic>-amylase and <italic toggle="yes">&#945;</italic>-glucosidase tests, respectively. The essential oil had an IC50 equal to 98.54 &#181;g/mL. Interestingly, all the elements in this study had higher activities than acarbose, whatever the test adopted [<xref rid="B344-pharmaceutics-16-00454" ref-type="bibr">344</xref>]. </p><p>A study by Kulabas et al. (2018) aimed to elucidate the potential ameliorative effects of aqueous extracts of <italic toggle="yes">L. stoechas</italic> on insulin resistance and inflammation patterns using multi-targeted in vitro approaches and also to elucidate the mechanism of action by analysing transcriptional and metabolic responses [<xref rid="B432-pharmaceutics-16-00454" ref-type="bibr">432</xref>]. The anti-insulin-resistant effects of ethyl acetate (EE) and butanol (BE) extracts prepared from the aqueous extract were assessed on the palmitate-induced insulin resistance model of H4IIE (rat hepatoma cell line), C2C12 (immortalized mouse myoblast cell line), and 3T3L1 (murine adipocytes) cells using several metabolic parameters. Specifically, whole genome transcriptome analysis was performed using microarrays on over 55,000 genes in control-, insulin-, and EE (25 &#181;g/mL)-treated H4IIE cells. Both extracts at low doses (25&#8211;50 &#181;g/mL) significantly decreased hepatic gluconeogenesis in the H4IIE cell line by suppressing PEPCK and G6Pase expression [<xref rid="B432-pharmaceutics-16-00454" ref-type="bibr">432</xref>]. In C2C12 myotubes, both extracts increased insulin-stimulated glucose uptake more effectively than metformin. Both extracts decreased isoproterenol-induced lipolysis in the 3T3L1 cell line. In addition, they also effectively increased lipoprotein lipase protein expression in insulin-resistant myotubes at low doses. EE increased PPAR<italic toggle="yes">&#947;</italic> protein levels and stimulated AKT activation in insulin-resistant H4IIE and C2C12 cell lines [<xref rid="B432-pharmaceutics-16-00454" ref-type="bibr">432</xref>]. </p><p>The results obtained from biochemical analyses, mRNA/protein studies, and whole genome transcriptome analyses were complementary. They supported the hypothesis that EE may be biologically active against insulin resistance and act via the inhibition of hepatic gluconeogenesis and the activation of AKT. According to the study data, <italic toggle="yes">L. stoechas</italic> EE contains phytochemicals that may be effective in the treatment/prevention of insulin resistance and inflammation [<xref rid="B432-pharmaceutics-16-00454" ref-type="bibr">432</xref>].</p><p>In the study by Sebai et al. (2013), EO of <italic toggle="yes">L. stoechas</italic> (LSEO), collected in the Ain-Draham region (northwest Tunisia), were tested for their protective effects against ALO-induced diabetes and oxidative stress in rats [<xref rid="B482-pharmaceutics-16-00454" ref-type="bibr">482</xref>]. Antidiabetic and antioxidant activities were assessed after a subacute intraperitoneal injection of LSEO (50 mg/kg BW, i.p.) to rats for 15 days. They found that the EO significantly protected against increased blood glucose and decreased antioxidant enzyme activities induced by ALO treatment. Subacute treatment with EO induced a decrease in lipoperoxidation and an increase in antioxidant enzyme activities. These results suggest that LSEO protect against diabetes and oxidative stress induced by ALO treatment. These effects are partly due to its powerful antioxidant properties [<xref rid="B482-pharmaceutics-16-00454" ref-type="bibr">482</xref>].</p><p>On the other hand, two other studies blended lavender with other plants to study their joint efficacy against diabetes. The first was by Sebai et al. [<xref rid="B483-pharmaceutics-16-00454" ref-type="bibr">483</xref>], who sought to assess the protective effect of <italic toggle="yes">Rosmarinus officinalis</italic> EO (ROEO) and <italic toggle="yes">L. stoechas</italic> EO (LSEO) against ALO-induced reproductive damage and oxidative stress in diabetic male rats. The results showed that treatment with ROEO and LSEO protected against ALO-induced decreases in BW gain, relative reproductive organ weights, testosterone levels, and sperm quality. They also showed that the administration of ALO was accompanied by a state of oxidative stress assessed by an increase in levels of MDA and hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), as well as by a decrease in the sulphydril group (-SH) content and antioxidant enzyme activities such as SOD, CAT, and glutathione peroxidase (GPx) in the testes, epididymis, and spermatozoa [<xref rid="B483-pharmaceutics-16-00454" ref-type="bibr">483</xref>]. More importantly, treatment with ROEO and LSEO significantly protected against oxidative damage to male reproductive organs in ALO-induced diabetic rats. The study&#8217;s results suggest that ROEO and LSEO potentially protect against ALO-induced damage to reproductive function and oxidative stress in male rats. According to the authors, the beneficial effect of ROEO and LSEO could be linked, in part, to their antioxidant properties [<xref rid="B483-pharmaceutics-16-00454" ref-type="bibr">483</xref>].</p><p>In the other study by Mustafa et al. [<xref rid="B484-pharmaceutics-16-00454" ref-type="bibr">484</xref>], hydroalcoholic extracts of <italic toggle="yes">L. stoechas, Curcuma longa</italic>, <italic toggle="yes">Aegle marmelos</italic>, and <italic toggle="yes">Glycyrrhiza glabra</italic> and their polyherbal preparation (PHP) were tested for their antihyperglycaemic potential in ALO-induced diabetic mice. The plant extracts tested significantly reduced the blood glucose concentration of the diabetes-induced mice dose-dependently. According to the authors, all the medicinal plants studied, with mixed PHP, had antihyperglycaemic activity, possibly due to bioactive phytoconstituents in the plants. However, more extensive studies are needed to identify, isolate and characterise the bioactive phytoconstituents responsible for the antihyperglycaemic activity of the medicinal plants studied [<xref rid="B484-pharmaceutics-16-00454" ref-type="bibr">484</xref>]. </p><list list-type="bullet"><list-item><p>
<italic toggle="yes">Melissa officinalis</italic>
</p></list-item></list><p><italic toggle="yes">Melissa officinalis,</italic> or lemon balm, is a medicinal plant native to southern Europe and the southern Mediterranean, northern Africa, and western Asia [<xref rid="B509-pharmaceutics-16-00454" ref-type="bibr">509</xref>]. It is a bushy, herbaceous perennial commonly cultivated in herb and border gardens for its distinctive lemon-fragrant leaves. Numerous studies have described its therapeutic and pharmacological benefits thanks to its wealth of bioactive compounds (<xref rid="pharmaceutics-16-00454-t001" ref-type="table">Table 1</xref>). It is particularly known for managing hyperlipidaemia, diabetes, and other metabolic syndromes [<xref rid="B509-pharmaceutics-16-00454" ref-type="bibr">509</xref>,<xref rid="B510-pharmaceutics-16-00454" ref-type="bibr">510</xref>].</p><p>Numerous studies have described the antidiabetic potential of this plant (<xref rid="pharmaceutics-16-00454-t002" ref-type="table">Table 2</xref> and <xref rid="pharmaceutics-16-00454-t003" ref-type="table">Table 3</xref>). In cell models, <italic toggle="yes">M. officinalis</italic> extracts stimulated the expression of PPAR<italic toggle="yes">&#945;</italic> target genes involved in fatty acid &#946;-oxidation and lipolysis [<xref rid="B437-pharmaceutics-16-00454" ref-type="bibr">437</xref>]. Lemon balm EO significantly activated the AMPK/ACC (acetyl-CoA carboxylase) pathway. The activation of AMPK allows cells to take up more glucose from the environment and downregulate ACC, thereby inhibiting lipid accumulation in adipocytes. The effect of EO on the expression of key transcription factors, such as C/EBPR (CCAAT-enhancer-binding protein R), SREBP1 (sterol regulatory element-binding transcription factor 1), and PPAR<italic toggle="yes">&#947;</italic>, was assessed using Western blotting analysis [<xref rid="B437-pharmaceutics-16-00454" ref-type="bibr">437</xref>]. Compared with untreated adipocytes, the presence of lemon balm EO during adipogenic differentiation caused an increase in the expression levels of SREBP1 and C/EBPR but not PPAR<italic toggle="yes">&#947;</italic>. Although increased expression levels of SREBP1 and C/EBPR should increase lipid accumulation in cells, activated ACC proteins can inhibit lipid synthesis [<xref rid="B437-pharmaceutics-16-00454" ref-type="bibr">437</xref>]. </p><p>Finally, the Western blot data confirm and explain why lemon balm EO caused adipocytes to use more glucose but inhibited lipid accumulation [<xref rid="B437-pharmaceutics-16-00454" ref-type="bibr">437</xref>]. These results are supported by those obtained in vivo. Mice given EO (0.0125 mg/d) for six weeks showed a significant reduction in glycaemia and TG concentrations, improved glucose tolerance, and significantly higher serum insulin levels than the control group. In addition, of all the glucose metabolism-related genes studied, hepatic glucokinase and GLUT4 and adipocyte GLUT4, PPAR<italic toggle="yes">&#947;</italic>, PPAR<italic toggle="yes">&#945;</italic>, and SREBP-1c expression were significantly upregulated. In contrast, G6Pase and PEPCK were downregulated in the livers of the EO-treated group [<xref rid="B437-pharmaceutics-16-00454" ref-type="bibr">437</xref>]. </p><p>Another study was conducted on the hydroalcoholic extract of lemon balm (ALS-L1023) to examine its effect on the regulation of hepatic lipid accumulation, obesity, and insulin resistance and determine whether its mechanism of action involves PPAR<italic toggle="yes">&#945;</italic> [<xref rid="B490-pharmaceutics-16-00454" ref-type="bibr">490</xref>]. Indeed, excessive lipid accumulation in non-adipose tissue is thought to be responsible for developing insulin resistance. Activating the PPAR<italic toggle="yes">&#945;</italic> receptor would reduce weight gain and improve insulin sensitivity in obese mice [<xref rid="B511-pharmaceutics-16-00454" ref-type="bibr">511</xref>,<xref rid="B512-pharmaceutics-16-00454" ref-type="bibr">512</xref>]. In this study, the administration of ALS-L1023 (food supplemented with 0.4% (<italic toggle="yes">w</italic>/<italic toggle="yes">w</italic>)) to obese mice (induced by a high-fat diet) resulted in a reduction in weight gain, visceral fat mass, and visceral adipocyte size without any change in food consumption profiles [<xref rid="B490-pharmaceutics-16-00454" ref-type="bibr">490</xref>]. </p><p>ALS-L1023 improved hyperglycaemia, hyperinsulinaemia, glucose and insulin tolerance, and normalised insulin-positive <italic toggle="yes">&#946;</italic>-cell surface area in obese mice [<xref rid="B490-pharmaceutics-16-00454" ref-type="bibr">490</xref>]. ALS-L1023 decreased hepatic lipid accumulation and concomitantly increased the expression of PPAR<italic toggle="yes">&#945;</italic> target genes responsible for fatty acid <italic toggle="yes">&#946;</italic>-oxidation in the liver [<xref rid="B490-pharmaceutics-16-00454" ref-type="bibr">490</xref>]. Higher phosphorylated protein kinase B (<italic toggle="yes">p</italic>Akt)/Akt ratios and a lower expression of gluconeogenesis genes were also observed in the livers of ALS-L1023-treated mice. According to the authors, ALS-L1023 may inhibit obesity and improve insulin sensitivity in part by inhibiting hepatic lipid accumulation via hepatic PPAR<italic toggle="yes">&#945;</italic> activation [<xref rid="B490-pharmaceutics-16-00454" ref-type="bibr">490</xref>].</p><p>In a similar study by Shin et al. (2021), the administration of ALS-L1023 (HFD with 0.4% or 0.8% (<italic toggle="yes">w</italic>/<italic toggle="yes">w</italic>)) for four weeks to Otsuka Long-Evans Tokushima fatty (OLETF) rats resulted in a reduction in BW with no change in food intake [<xref rid="B491-pharmaceutics-16-00454" ref-type="bibr">491</xref>]. The extract also markedly inhibited hyperglycaemia and hypoinsulinaemia and restored <italic toggle="yes">&#946;</italic>-cell mass, severely impaired in rats. A reduction in lipid accumulation in the liver and skeletal muscle of obese rats was observed after treatment with ALS-L1023 [<xref rid="B491-pharmaceutics-16-00454" ref-type="bibr">491</xref>]. In parallel, the expression levels of fatty acid oxidising enzymes [AMPK<italic toggle="yes">&#945;</italic>2, ACOX (Acyl-CoA Oxidase), MCAD (Medium-chain acyl-coenzyme A dehydrogenase), and VLCAD (Very Long Chain Acyl-CoA Dehydrogenase Deficiency)] increased in liver and skeletal muscle after ALS-L1023 treatment. In addition, ALS-L1023 attenuated pancreatic inflammation, including the infiltration of CD68-positive macrophages and mast cells, and attenuated the expression of inflammatory factors (IL-6 and CD68) [<xref rid="B491-pharmaceutics-16-00454" ref-type="bibr">491</xref>].</p><list list-type="bullet"><list-item><p><italic toggle="yes">Mentha</italic> sp.</p></list-item></list><p>The mint family includes 25 species in Europe, Africa, America, and Australia [<xref rid="B376-pharmaceutics-16-00454" ref-type="bibr">376</xref>,<xref rid="B513-pharmaceutics-16-00454" ref-type="bibr">513</xref>]. These are the herbs most widely used in traditional medicine for nutritional and medical purposes since ancient times (<xref rid="app1-pharmaceutics-16-00454" ref-type="app">Supplementary Table S3</xref>). Because of their ability to grow rapidly and invade and tolerate a wide range of agro-climatic conditions, they are now cultivated and distributed worldwide. Their therapeutic benefits derive mainly from their chemical composition, which has many properties (<xref rid="pharmaceutics-16-00454-t001" ref-type="table">Table 1</xref>). In addition to these medicinal effects, mint and its various species are also known for their antidiabetic value (<xref rid="pharmaceutics-16-00454-t002" ref-type="table">Table 2</xref> and <xref rid="pharmaceutics-16-00454-t003" ref-type="table">Table 3</xref>). </p><p>The effect of oral administration of the aqueous extract of the three plants <italic toggle="yes">Mentha aquatica, M. pulegium</italic>, and <italic toggle="yes">M. suaveolens</italic> was evaluated on the glycemic and lipid profiles of normal and streptozotocin-induced diabetic rats. A dose of 20 mg of the aqueous extract of <italic toggle="yes">M. pulegium</italic> and <italic toggle="yes">M. suaveolens</italic> was effective against diabetes. They produced significant hypoglycaemic effects in normal and diabetic rats [<xref rid="B493-pharmaceutics-16-00454" ref-type="bibr">493</xref>,<xref rid="B494-pharmaceutics-16-00454" ref-type="bibr">494</xref>,<xref rid="B495-pharmaceutics-16-00454" ref-type="bibr">495</xref>]. In addition, a significant influence on glucose tolerance was also observed by the aqueous extract of <italic toggle="yes">M. suaveolens</italic> [<xref rid="B495-pharmaceutics-16-00454" ref-type="bibr">495</xref>]. Both extracts showed an improvement in TC (total cholesterol) and TG levels, while no significant effect of the <italic toggle="yes">M. suaveolens</italic> extract was observed on serum lipoproteins (HDL and LDL (low-density lipoprotein)] [<xref rid="B494-pharmaceutics-16-00454" ref-type="bibr">494</xref>,<xref rid="B495-pharmaceutics-16-00454" ref-type="bibr">495</xref>]. In addition, both plants acted positively on histopathological tissues of the liver and pancreas. Furthermore, in a study by Yellanur et al. (2020) a dose of 100 mg/kg bw/day of <italic toggle="yes">Mentha aquatica</italic> aqueous extract for 90 days significantly reduced levels of fasting glycaemia, HbA1c (glycated hemoglobin test), TC, TG, plasma urea, creatinine, urinary albumin, and renal lipid peroxidation, and increased BW, insulin, HDL cholesterol, plasma albumin, urinary urea, urinary creatinine, and antioxidant enzyme activities (CAT, SOD, GPx, and GST) [<xref rid="B492-pharmaceutics-16-00454" ref-type="bibr">492</xref>]. The authors demonstrated that the aqueous extract of <italic toggle="yes">M. aquatica</italic> leaves has antidiabetic activity by stimulating insulin secretion and potential nephroprotective activity by reducing lipid peroxidation and enhancing the scavenging capacity of the antioxidant defence system in the body [<xref rid="B492-pharmaceutics-16-00454" ref-type="bibr">492</xref>].</p><list list-type="bullet"><list-item><p><italic toggle="yes">Origanum vulgare</italic> L.</p></list-item></list><p><italic toggle="yes">Origanum vulgare</italic> (oregano) is another of the best-known plants in the <italic toggle="yes">Lamiaceae</italic> family, traditionally used to control and treat diabetes (<xref rid="app1-pharmaceutics-16-00454" ref-type="app">Supplementary Table S3</xref>). It is an annual, perennial, and shrubby plant native to the Mediterranean, Euro-Siberian, and Iranian-Siberian regions [<xref rid="B514-pharmaceutics-16-00454" ref-type="bibr">514</xref>]. The main constituents of oregano are quercetin, apigenin, kaempferol, naringenin, eriodictyol, salvianolic acid B, lithospermic acid B, amburosides A, luteolin, luteolin 7-<italic toggle="yes">O</italic>-glucuronide, apigenin 7-<italic toggle="yes">O</italic>-glucuronide, epigallocatechin, catechin, rutin, etc. (<xref rid="pharmaceutics-16-00454-t001" ref-type="table">Table 1</xref>). These compounds have been reported to have several pharmacological activities, including antibacterial, anti-fungal, antiviral, antiparasitic, antioxidant, anti-inflammatory, anti-tumor, and antidiabetic (<xref rid="pharmaceutics-16-00454-t001" ref-type="table">Table 1</xref>). They hold great promise for the design of new plant-based medicines, and derivatives of these compounds are being produced to assess their pharmacological effects for future use, particularly in the treatment of diabetes [<xref rid="B515-pharmaceutics-16-00454" ref-type="bibr">515</xref>]. Antidiabetic characteristics have been previously identified in oregano, and it is currently one of the most sought-after plants for treating hyperglycaemia due to its wide accessibility, potency and lack of adverse effects [<xref rid="B84-pharmaceutics-16-00454" ref-type="bibr">84</xref>].</p><p>Oregano can potentially inhibit the enzymatic activity of pancreatic amylase and glucosidase. This property may be part of the mechanism by which oregano may be used in the treatment/prevention of T2DM. According to the results of a study by McCue et al. (2004), extracts of clonal lines of oregano have strong inhibitory activity against porcine pancreatic amylase in vitro [<xref rid="B441-pharmaceutics-16-00454" ref-type="bibr">441</xref>]. The inhibition rate depended on the clonal line and varied from 9% to 57%. This difference was because the clonal lines tested were characterized by a difference in the phenolic distribution of the main components (rosmarinic acid, quercetin, protocatechuic acid, and <italic toggle="yes">p</italic>-coumaric acid) [<xref rid="B441-pharmaceutics-16-00454" ref-type="bibr">441</xref>]. However, the clonal line with the highest rosmarinic acid content (O-11Y with 114.0 &#956;g phenolic/200 &#956;g total phenolic content per extract) showed weak inhibition of <italic toggle="yes">&#945;</italic>-amylase. </p><p>According to McCue et al. (2004), the antidiabetic potential of the different clonal lines involves a synergistic role between rosmarinic acid and other identified (quercetin and <italic toggle="yes">p</italic>-coumaric acid) and unidentified phenolics [<xref rid="B441-pharmaceutics-16-00454" ref-type="bibr">441</xref>]. Gon&#231;alves et al. (2017) also reported the efficacy of methanolic extracts of oregano obtained in Portugal on the enzymatic inhibition activity of <italic toggle="yes">&#945;</italic>-glucosidase and <italic toggle="yes">&#945;</italic>-amylase [<xref rid="B333-pharmaceutics-16-00454" ref-type="bibr">333</xref>]. The results showed that inhibition was more specific and higher for &#945;-glucosidase than for <italic toggle="yes">&#945;</italic>-amylase. This observation was particularly linked to the content of phenolic compounds in oregano identified by HPLC. High contents of rosmarinic acid (23.53 mg/g dry extract), (-)-epicatechin (4.65 mg/g dry extract), 3,4-dihydroxybenzoic acid (1.97 mg/g dry extract), gallic acid (1.19 mg/g dry extract), and (+)-catechin (1.03 mg/g dry extract) were reported [<xref rid="B333-pharmaceutics-16-00454" ref-type="bibr">333</xref>]. These results are also consistent with Kwon et al.&#8217;s (2006) study on aqueous and ethanolic extracts (12%) [<xref rid="B434-pharmaceutics-16-00454" ref-type="bibr">434</xref>]. The aqueous extract showed a higher dose-dependent inhibitory activity of <italic toggle="yes">&#945;</italic>-glucosidase than the ethanolic extracts. It was also related to the phenolic content of each extract. Indeed, the aqueous oregano extracts showed a higher rosmarinic acid content than the ethanolic extract (16.5 vs. 3.78 mg/g dry weight, respectively). Rosmarinic acid was then tested and showed an inhibitory activity of 85.1% [<xref rid="B434-pharmaceutics-16-00454" ref-type="bibr">434</xref>]. </p><p>Dipeptidyl peptidase IV (DPP-IV) inhibition is another hypoglycaemic target of oregano that may be involved [<xref rid="B516-pharmaceutics-16-00454" ref-type="bibr">516</xref>]. In a study by Bower et al., 2014, it was shown that the methanolic extract of commercial Greek oregano (28.4 &#177; 6.3 &#956;M) was a better inhibitor of DPP-IV than greenhouse-grown Greek oregano extract (86.2 &#177; 18.8 &#956;M) [<xref rid="B444-pharmaceutics-16-00454" ref-type="bibr">444</xref>]. The chemical fractions designed according to flash chromatography retention times OE and OF from Greek oregano were the most potent inhibitors of DPP-IV (IC50 from 20.3 to 23.3 &#181;M) [<xref rid="B444-pharmaceutics-16-00454" ref-type="bibr">444</xref>]. As previously indicated, the oregano species&#8217; phenolic content and distribution are related to the inhibitory activity of &#945;glucosidase and <italic toggle="yes">&#945;</italic>-amylase; this is also the case for DPP-IV. Of all the greenhouse-grown herbs tested in the study, Greek oregano extracts contained the highest concentration of polyphenols (430.1 &#177; 17.1 &#956;g of GAE/mg DW). Considering the extract&#8217;s yield, the total polyphenol concentration for greenhouse-dried Greek oregano herbs was 6452 mg GAE/100 g DW. </p><p>According to these studies (<xref rid="pharmaceutics-16-00454-t001" ref-type="table">Table 1</xref>), oregano has numerous active compounds that can act through multiple actions and give rise to synergistic or antagonistic interactions (<xref rid="pharmaceutics-16-00454-t001" ref-type="table">Table 1</xref>). Thus, the utilisation of plant-derived antioxidants with antidiabetic qualities, such as the action of DPP-IV inhibitors, is considered the most effective strategy for maintaining normal <italic toggle="yes">&#946;</italic>-cell physiology and treating diabetes [<xref rid="B517-pharmaceutics-16-00454" ref-type="bibr">517</xref>]. One of the advantages of therapies based on DPP-IV inhibition is their perceived impact on improving HbA1c, fasting glycaemia, and 2 h postprandial glycaemia [<xref rid="B518-pharmaceutics-16-00454" ref-type="bibr">518</xref>]. In addition, most studies have reported its beneficial effects on regulating triglycerides (TG), HDL-c and LDL-c [<xref rid="B519-pharmaceutics-16-00454" ref-type="bibr">519</xref>,<xref rid="B520-pharmaceutics-16-00454" ref-type="bibr">520</xref>]. The DPP-IV inhibitor has fewer side effects, such as hypoglycaemia, increased BW, and gastrointestinal disorders. Glucose tolerance tests in animals have shown improved glucose tolerance and increased insulin secretion thanks to the genetic deletion of DPP-IV. In clinical observations, some DPP4 inhibitors influence enzymatic activity, reducing the baseline value by more than 50% [<xref rid="B521-pharmaceutics-16-00454" ref-type="bibr">521</xref>]. </p><p>Another important target in treating diabetes is the peroxisome proliferator-activated receptor (PPAR) <italic toggle="yes">&#947;</italic>, a key regulator of adipogenesis and glucose homeostasis. In Christensen et al.&#8217;s (2009) study, extracts of common medicinal/food plants, including oregano, were tested in a screening platform comprising a series of bioassays, including PPAR <italic toggle="yes">&#947;</italic>, <italic toggle="yes">&#945;</italic>, and <italic toggle="yes">&#948;</italic> transactivation, adipocyte differentiation, and insulin-stimulated glucose uptake, to identify plants containing potentially interesting PPAR agonists [<xref rid="B443-pharmaceutics-16-00454" ref-type="bibr">443</xref>]. Hexane (Hex), dichloromethane (DCM), and ethyl acetate (EtOAc) extracts of <italic toggle="yes">Origanum vulgare</italic> ssp. <italic toggle="yes">vulgare</italic>, dichloromethane, and methanol (MeOH) extracts of the aerial parts of <italic toggle="yes">Origanum vulgare</italic> ssp. <italic toggle="yes">hirtum</italic> were tested. According to the study results, all the extracts activated PPAR <italic toggle="yes">&#947;</italic> and increased insulin-stimulated glucose uptake. In addition, hexane and methanolic extracts activated PPAR <italic toggle="yes">&#947;</italic> and <italic toggle="yes">&#948;</italic>. However, they did not affect endothelial cells or adipocyte differentiation [<xref rid="B443-pharmaceutics-16-00454" ref-type="bibr">443</xref>].</p><p>At the cellular level, Yu et al. (2021) evaluated the hypoglycemic effect of leaf extract on HepG2 and HepG2- GFP-CYP2E1 (E47) cells [<xref rid="B393-pharmaceutics-16-00454" ref-type="bibr">393</xref>]. This work examined the plant&#8217;s potential for promoting glucose uptake, inhibiting glycosylation, and alleviating oxidative stress. The promoter activity, the mRNA and protein expression of PEPCK and SREBP-1c, and the expression of CPY2E1 and GLUT2 in the antidiabetic capacity mediated by oregano were analysed in HepG2 and E47 cells. The inhibition of PEPCK activity by the extract will effectively reduce sugar isogenesis and lower blood glucose levels, as it is a key enzyme in gluconeogenesis [<xref rid="B393-pharmaceutics-16-00454" ref-type="bibr">393</xref>]. Studying the transcriptional and translational levels of SREBP-1c in HepG2 cells is an important step in analyzing carbohydrate and lipid metabolism. Indeed, these proteins are highly expressed in most tissues of diabetic mice and humans, including liver, adipose tissue, and skeletal muscle. Therefore, the inhibition of SREBP-1c promoter activity and mRNA and protein expression in HepG2 cells would indicate that oregano extract could inhibit hepatic lipogenesis in vitro. The overexpression of cytochrome P450 2E1 (CYP2E1) indicates the presence of oxidative stress caused by excess glucose in the blood [<xref rid="B393-pharmaceutics-16-00454" ref-type="bibr">393</xref>]. The use of oregano would, therefore, reduce the oxidative damage associated with insulin resistance and changes in glucose metabolism, particularly the activation of the glucose transporter 2 (GLUT2) function [<xref rid="B393-pharmaceutics-16-00454" ref-type="bibr">393</xref>]. </p><p>In vitro tests showed that the extract promoted glucose uptake, inhibited glycosylation, and relieved oxidative stress, suggesting that oregano leaf extract has a strong hypoglycaemic capacity [<xref rid="B393-pharmaceutics-16-00454" ref-type="bibr">393</xref>]. In addition, mechanical analysis also showed that the extract decreased promoter activity and mRNA and the protein expression of PEPCK and SREBP-1c. The extract, therefore, inhibited CPY2E1 expression and increased GLUT2 expression [<xref rid="B393-pharmaceutics-16-00454" ref-type="bibr">393</xref>]. </p><p>Several studies have demonstrated the efficacy of oregano in vivo models (<xref rid="pharmaceutics-16-00454-t001" ref-type="table">Table 1</xref>). In a rat model treated with ALO, the oral administration of an infusion of oregano leaves reduced blood glucose levels after the first day of treatment, compared with the diabetic control group [<xref rid="B501-pharmaceutics-16-00454" ref-type="bibr">501</xref>]. The results showed that the infusion exhibited hypoglycaemic activity, possibly due to the combined effect of rosmarinic acid and other minor compounds [<xref rid="B501-pharmaceutics-16-00454" ref-type="bibr">501</xref>]. According to Luis et al. (2022), oregano infusion has an antidiabetic effect by stimulating insulin secretion. In the streptozotocin-treated rat model (<xref rid="pharmaceutics-16-00454-t003" ref-type="table">Table 3</xref>), aqueous leaf extract (20 mg/kg) slightly decreased blood glucose levels in normal rats 6 h after single oral administration and 15 days after repeated daily oral administration [<xref rid="B496-pharmaceutics-16-00454" ref-type="bibr">496</xref>]. The treatment also caused a significant reduction in blood glucose levels in STZ diabetic rats. Blood glucose levels normalised from the fourth day after treatment. However, this effect was less pronounced two weeks later, and no change was observed in basal plasma insulin concentrations after treatment in normal or STZ diabetic rats, indicating that aqueous oregano extract exhibited a blood glucose lowering activity independently of insulin secretion by pancreatic <italic toggle="yes">&#946;</italic> cells of Langerhans islets [<xref rid="B496-pharmaceutics-16-00454" ref-type="bibr">496</xref>]. </p><p>Different results were reported in another study by Mohamed and Nassier (2013), who reported that oregano extracts improved glycaemia by enhancing insulin sensitivity. The antihyperglycaemic effect of the same aqueous preparation of oregano leaves at the same dose (20 mg/kg) was tested in STZ-induced diabetic rats. Its oral administration significantly reduced blood glucose levels, glycosylated haemoglobin, and pancreatic amylase in STZ diabetic rats compared with the standard drug, Glibenclamide (0.9 mg/kg BW) [<xref rid="B497-pharmaceutics-16-00454" ref-type="bibr">497</xref>]. Liver weight/BW ratios were also reduced, while kidney weight/BW ratios, urea, uric acid, and creatinine levels were partially improved. Oral treatment with the extract reduced serum insulin, liver and muscle glycogen levels, and body weight in STZ diabetic rats. This evidence suggests that the modulation of insulin secretion and/or action mechanisms may be involved in oregano&#8217;s antidiabetic effect (Mohamed and Nassier, 2013). </p><p>Furthermore, according to Mohamed and Nassier (2013), oregano&#8217;s hypoglycaemic effect may be mediated by interference with the absorption of dietary carbohydrates in the small intestine or by stimulation of glucose utilisation by peripheral tissues [<xref rid="B497-pharmaceutics-16-00454" ref-type="bibr">497</xref>]. The results showed that oregano leaves contain phenolic glucosides that help control blood sugar levels and stimulate the <italic toggle="yes">&#946;</italic>-cells of the pancreas to produce insulin. The reduced HbA1c levels in treated diabetic rats could be due to an improvement in insulin secretion by the remaining pancreatic <italic toggle="yes">&#946;</italic> cells in diabetic rats, resulting in improved glycaemic control [<xref rid="B497-pharmaceutics-16-00454" ref-type="bibr">497</xref>]. A decrease in liver and muscle glycogen has also been observed in diabetic rats, possibly attributable to insulin insufficiency and the inactivation of the glycogen synthase system in the diabetic. However, after oregano treatment, there was a significant increase in liver and muscle glycogen levels in diabetic rats [<xref rid="B497-pharmaceutics-16-00454" ref-type="bibr">497</xref>]. According to the authors, the higher liver glycogen levels in treated diabetic rats could be caused by increased insulin levels, which increased glycogenesis and decreased glycogenolysis and gluconeogenesis. Thus, the antihyperglycaemic effect of aqueous oregano extract may protect surviving pancreatic &#946; cells and increase insulin secretion and glycogen storage [<xref rid="B497-pharmaceutics-16-00454" ref-type="bibr">497</xref>].</p><p>In the study by Vujicic et al. (2015), methanolic (ME) and aqueous (AQ) extracts were administered to C57BL/6 mice treated with multiple low doses of STZ for the induction of diabetes (MLDS) (<xref rid="pharmaceutics-16-00454-t003" ref-type="table">Table 3</xref>). According to the study results, prophylactic treatment with the AQ extract had no impact on diabetes induction [<xref rid="B394-pharmaceutics-16-00454" ref-type="bibr">394</xref>]. On the other hand, ME extract reduced the incidence of diabetes and preserved normal insulin secretion. In addition, it specifically attenuated the pro-inflammatory response mediated by T-helper 17 cells (Th17) [<xref rid="B394-pharmaceutics-16-00454" ref-type="bibr">394</xref>]. It enhanced anti-inflammatory T helper 2 (Th2) and regulatory T cells by activating specific signalling pathways and transcription factors. Finally, it also preserved <italic toggle="yes">&#946;</italic> cells from apoptosis in vitro by blocking caspase 3. Rosmarinic acid, a predominant compound in the ME extract, was also tested and showed only partial protection against the induction of diabetes [<xref rid="B394-pharmaceutics-16-00454" ref-type="bibr">394</xref>]. According to the authors, through its antioxidant, immunomodulatory, and anti-apoptotic properties, oregano protected the mice against the development of diabetes. </p><p>In addition, this efficacy could be mediated by the influence of additional chemical compounds [<xref rid="B394-pharmaceutics-16-00454" ref-type="bibr">394</xref>]. In a comparable efficacy study, the immunomodulatory effect of oregano ethyl acetate extract (EtOAc) was assessed by measuring immune cell proliferation or cytokine secretion [<xref rid="B498-pharmaceutics-16-00454" ref-type="bibr">498</xref>]. In addition, it was administered intraperitoneally for ten days in male MLDS-treated C57BL/6 mice. EtOAc extract suppressed macrophage and lymphocyte function in vitro. The in vivo oregano treatment significantly preserved pancreatic islets and reduced the incidence of diabetes in mice with MLDS [<xref rid="B498-pharmaceutics-16-00454" ref-type="bibr">498</xref>]. In addition to the modulatory effect on macrophages, EtOAc reduced the number of total CD4+ T cells and activated CD4+CD25+ T cells. It also affected the number of T helper 1 (Th1) and Th17 cells by downregulating their key transcription factors T-bet and ROR<italic toggle="yes">&#947;</italic>T (RAR-related orphan receptor gamma). Treatment with EtOAc thus protected the mice against the development of hyperglycaemia by reducing the pro-inflammatory macrophage/Th1/Th17 response and shifting the macrophage population to the protective M2 form [<xref rid="B498-pharmaceutics-16-00454" ref-type="bibr">498</xref>]. The EtOAc extract is reported to exert a wide range of immunomodulatory effects that appear to be useful for attenuating islet-directed inflammation [<xref rid="B498-pharmaceutics-16-00454" ref-type="bibr">498</xref>], unlike the methanolic extract of oregano tested by Vujicic et al. (2015), which showed very specific effects on IL-17-producing T lymphocytes [<xref rid="B394-pharmaceutics-16-00454" ref-type="bibr">394</xref>]. According to Vujicic et al. (2016), the possible interaction of EtOAc with TLR4 (Toll-like receptor 4) function would make this extract a possible candidate for the treatment of immunoinflammatory and autoimmune diseases such as systemic lupus erythematosus, uveitis, inflammatory bowel disease, arthritis, and diabetic nephropathy, which seem to benefit from TLR4 blockade in the preclinical setting [<xref rid="B498-pharmaceutics-16-00454" ref-type="bibr">498</xref>].</p><list list-type="bullet"><list-item><p>
<italic toggle="yes">Prunella vulgaris</italic>
</p></list-item></list><p>Around 20 species of <italic toggle="yes">Prunella</italic> are in the world, found in the temperate regions and tropical mountains of Europe and Asia, northwest Africa, and North America [<xref rid="B522-pharmaceutics-16-00454" ref-type="bibr">522</xref>,<xref rid="B523-pharmaceutics-16-00454" ref-type="bibr">523</xref>]. They are herbaceous perennials that grow mainly in forests, bare mountains, ridges, and roadsides. In common with other members of the <italic toggle="yes">Prunella</italic> genus, which is currently attracting great interest due to its important new therapeutic application [<xref rid="B523-pharmaceutics-16-00454" ref-type="bibr">523</xref>,<xref rid="B524-pharmaceutics-16-00454" ref-type="bibr">524</xref>]. <italic toggle="yes">Prunella vulgaris</italic> L. (PV) has been used worldwide for centuries as an alternative medicine for various illnesses [<xref rid="B172-pharmaceutics-16-00454" ref-type="bibr">172</xref>]. It is a native plant that grows mainly in the temperate biome, extending from the temperate and subtropical northern hemisphere to Central America [<xref rid="B116-pharmaceutics-16-00454" ref-type="bibr">116</xref>]. Its dried fruit spikes have been used in folk medicine, particularly in China, for thousands of years to relieve sore throats as an antipyretic and accelerate wound healing (<xref rid="app1-pharmaceutics-16-00454" ref-type="app">Supplementary Table S3</xref>). As a result, it is listed in the Chinese Pharmacopoeia as a commonly used Chinese medicinal material [<xref rid="B524-pharmaceutics-16-00454" ref-type="bibr">524</xref>,<xref rid="B525-pharmaceutics-16-00454" ref-type="bibr">525</xref>]. It has also been classified as one of the new Chinese herbal medicines in the list of medicinal and food homologies by the National Health Commission of the People&#8217;s Republic of China [<xref rid="B524-pharmaceutics-16-00454" ref-type="bibr">524</xref>,<xref rid="B526-pharmaceutics-16-00454" ref-type="bibr">526</xref>].</p><p>Several pharmacological and/or clinical studies have demonstrated the efficacy of PV, including its antiviral, antibacterial, anti-inflammatory, immunomodulatory, anti-cancer, antioxidant, hypolipidaemic, anti-tumor, hypotensive, and sedative actions (<xref rid="pharmaceutics-16-00454-t003" ref-type="table">Table 3</xref>). It has great value in terms of application and research into treating hyperglycaemia. Numerous researchers have been attracted to exploring and studying its effects on diabetes (<xref rid="pharmaceutics-16-00454-t002" ref-type="table">Table 2</xref> and <xref rid="pharmaceutics-16-00454-t003" ref-type="table">Table 3</xref>). </p><p>Fructosamine (FMN) is a non-enzymatic glycation product that can monitor glucose control [<xref rid="B527-pharmaceutics-16-00454" ref-type="bibr">527</xref>]. This parameter is correlated with blood glucose levels. It reflects the state of glycaemic control over the last 2&#8211;3 weeks, and its increase favors the development of diabetes [<xref rid="B503-pharmaceutics-16-00454" ref-type="bibr">503</xref>]. These observations were observed in STZ-induced diabetic rats in a study by Zhou et al. (2013). However, after six weeks of treatment with 100 mg/kg and 200 mg/kg of PV triterpene acid, blood glucose and FMN levels were significantly reduced in STZ-induced diabetic rats and improved body weight was observed compared with the control group [<xref rid="B503-pharmaceutics-16-00454" ref-type="bibr">503</xref>]. These data indicate that PV has a dose-dependent antihyperglycaemic effect. Other parameters were also investigated in this study. An increase in nitric oxide (NO) concentration and nitric oxide synthase (NOS) activity was observed in STZ-induced diabetic rats [<xref rid="B503-pharmaceutics-16-00454" ref-type="bibr">503</xref>]. The increase in oxygen free radicals is linked to the development of hyperglycemia. In the study, the oral administration of Prunella to diabetic rats significantly decreased NO levels and NOS activity. In addition, PV has the effect of increasing the concentration of MDA, serum SOD activity, and total SOD mRNA expression in pancreatic islet <italic toggle="yes">&#946;</italic>-cells, demonstrating that the plant may have an antioxidant capacity to enhance the oxidative stress response to eliminate the increase in free radicals and prevent radical damage [<xref rid="B503-pharmaceutics-16-00454" ref-type="bibr">503</xref>].</p><p>In a study by Raafat et al. (2016), PV&#8217;s caffeic acid-rich fraction (CARF) reduced blood glucose levels and improved oxidative stress in vivo [<xref rid="B448-pharmaceutics-16-00454" ref-type="bibr">448</xref>]. It inhibited alpha-amylase and alpha-glucosidase enzymes and reduced HbA1c levels more significantly than hydroethanolic extract and equivalent amounts of caffeic acid (CA) or rosmarinic acid (RA) [<xref rid="B448-pharmaceutics-16-00454" ref-type="bibr">448</xref>], indicating that CARF provides continuing glycemic restoration in diabetic animals. For longer durations, it significantly increased serum insulin and improved thermal hyperalgesia and tactile allodynia more significantly than the effects of hydroethanolic extract and equivalent amounts of caffeic acid or rosmarinic acid. In addition, the compounds tested showed potential for restoring lipid peroxide levels. As a result, CARF and the hydroethanolic extract observed an increase in serum insulin, the attenuation of alpha-amylase and alpha-glucosidase, and their antioxidant potential could be responsible for their antidiabetogenic and antinociceptive properties. RP-HPLC and <sup>1</sup>H and <sup>13</sup>C NMR experiments showed that CARF isolated from PV contained CA (93.4%) and RA (6.6%). According to the authors, the acute and subchronic hypoglycemic activity of CARF was 1.27 and 2.72 folds more effective than Glibenclamide&#8217;s, respectively. Subchronically, it has significantly improved body weight, indicating its long-term efficacy in T1D (Type 1 Diabetes) amelioration [<xref rid="B448-pharmaceutics-16-00454" ref-type="bibr">448</xref>].</p><p>According to existing research, diabetic patients are at greater risk of developing atherosclerosis [<xref rid="B528-pharmaceutics-16-00454" ref-type="bibr">528</xref>,<xref rid="B529-pharmaceutics-16-00454" ref-type="bibr">529</xref>]. Diabetes mellitus, in both its forms, is an independent risk factor for the accelerated development of atherosclerosis [<xref rid="B530-pharmaceutics-16-00454" ref-type="bibr">530</xref>]. Diabetes and atherosclerosis appear to be linked by multiple pathogenic mechanisms [<xref rid="B528-pharmaceutics-16-00454" ref-type="bibr">528</xref>]. Dyslipidemia with high levels of atherogenic LDL, hyperglycaemia, oxidative stress, and increased inflammation are possible explanations for this acceleration [<xref rid="B530-pharmaceutics-16-00454" ref-type="bibr">530</xref>]. <italic toggle="yes">Prunella vulgaris</italic> can improve impaired insulin secretion, vascular dysfunction, and metabolic abnormalities and markedly attenuate hyperglycaemia and vascular inflammatory processes in db/db T2DM mice. The study by Hwang et al. (2012) was conducted to determine whether <italic toggle="yes">Prunella vulgaris</italic> could inhibit diabetic atherosclerosis in db/db mice fed a high-fat, high-cholesterol (HFHC) diet [<xref rid="B502-pharmaceutics-16-00454" ref-type="bibr">502</xref>]. This eight-week regimen increased body weight, blood glucose, and insulin levels to study the relationship between hyperglycaemia, which may also contribute to atherogenesis in db/db mice and the efficacy of PV in treating this dysfunction [<xref rid="B502-pharmaceutics-16-00454" ref-type="bibr">502</xref>]. According to the authors, treatment with an aqueous extract (100 and 200 mg/kg/day) reduced glycaemia and systolic blood pressure. A clear improvement in renal function markers such as creatinine clearance and blood urea nitrogen was also observed. These results suggest the possible beneficial effects of using PV in treating nephropathy in T2DM [<xref rid="B502-pharmaceutics-16-00454" ref-type="bibr">502</xref>]. The groups treated with the plant also had a reduction in glucose and lipid levels and body weight, even though food intake did not change. According to the authors, the improvement in diabetic complications by PV is independent of diet. It involves energy consumption and additional factors outside the scope of insulin resistance and hyperlipidaemia and is necessary to mediate the effects of vascular complications on HFHC-db/db mice. </p><p>In Hwang et al. (2012) study, PV&#8217;s antioxidant effect also improved diabetic atherosclerosis [<xref rid="B502-pharmaceutics-16-00454" ref-type="bibr">502</xref>]. Chronic plant treatment of db/db mice significantly reduced malondialdehyde levels, a naturally occurring reactive species marker of oxidative stress. By improving lipid levels and attenuating oxidative stress, PV could be one of the potential therapeutic strategies for the early management and prevention of coronary heart disease [<xref rid="B502-pharmaceutics-16-00454" ref-type="bibr">502</xref>]. The NO levels were increased by PV treatment, suggesting an association with vascular dysfunction. The vascular relaxation of the aortic rings induced by acetylcholine or SNP (sodium nitroprusside) was improved by PV in a dose-dependent manner. In addition, PV ameliorated the dysfunction associated with vascular intimal injury and media hypertrophy observed in db/db mice. The aortic expression of ICAM-1 (the intercellular adhesion molecule-1), VCAM-1 (vascular cell adhesion protein 1), ET-1 (endothelin 1), and nitrotyrosine was significantly reduced by PV. In addition, eNOS expression in the aorta was remarkably increased by PV treatment [<xref rid="B502-pharmaceutics-16-00454" ref-type="bibr">502</xref>].</p><p>PV also has a significant protective effect against diabetic renal dysfunction, including inflammation and fibrosis, by disrupting TGF-<italic toggle="yes">&#946;</italic> (transforming growth factor-beta)/Smad signalling [<xref rid="B505-pharmaceutics-16-00454" ref-type="bibr">505</xref>]. In human mesangial cells (HMCs), PV pre-treatment attenuated the suppression of TGF-<italic toggle="yes">&#946;</italic> and Smad-2/4 expression induced by 25 mM high glucose and increased the level of Smad-7 expression. PV significantly reduced connective tissue growth factor (CTGF) and collagen IV, fibrosis biomarkers [<xref rid="B505-pharmaceutics-16-00454" ref-type="bibr">505</xref>]. In addition, it suppressed inflammatory factors such as intracellular cell adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (MCP-1). PV inhibited the activation and translocation of NF-&#954;B in high glucose-stimulated HMCs. In addition, PV significantly reduced high glucose-induced ROS dose-dependently [<xref rid="B505-pharmaceutics-16-00454" ref-type="bibr">505</xref>].</p><p>The aim of a study by Jiao et al. (2021) was to investigate the active ingredients, potential targets, and signalling pathways of PV and to explore the &#8216;multi-target, multi-pathway&#8217; molecular mechanism of <italic toggle="yes">Prunella vulgaris</italic> L. on diabetes mellitus complicated by hypertension (DH) [<xref rid="B158-pharmaceutics-16-00454" ref-type="bibr">158</xref>]. This work was based on network pharmacology and molecular docking analyses. According to the analysis results, 11 active compounds, 41 key targets, and 16 significant signalling pathways were identified from <italic toggle="yes">P. vulgaris</italic>. The main active components of PV against DH that were discovered were beta-sitosterol, kaempferol, spinasterol, stigmasterol, delphinidin, luteolin, vulgaxanthin-I, poriferasterol monoglucoside_qt, stigmast-7-enol, morin, and quercetin [<xref rid="B158-pharmaceutics-16-00454" ref-type="bibr">158</xref>]. The potential action targets identified are diverse, including IL-6 and INS (Insulin), MAPK3, ALB (Albumin), AKT1, TNF, etc. The most active signalling pathways are AGE-RAGE (advanced glycation endproducts/receptor for AGE), the TNF signalling pathway, the MAPK signalling pathway, the PI3K-AKT signalling pathway, etc. PV is involved in biological processes such as cell proliferation, apoptosis, and inflammatory response [<xref rid="B158-pharmaceutics-16-00454" ref-type="bibr">158</xref>]. According to the authors, the main molecular mechanism of <italic toggle="yes">P. vulgaris</italic> against DH is via sterols and flavonoids, which play an active role in affecting the TNF signalling pathway, the AGE-RAGE signalling pathway, the MAPK pathway, the PI3K-Akt pathway, and targets linked to the IL-6 and INS pathways [<xref rid="B158-pharmaceutics-16-00454" ref-type="bibr">158</xref>].</p></sec></sec></sec><sec sec-type="conclusions" id="sec4-pharmaceutics-16-00454"><title>4. Conclusions and Perspectives</title><p>In this review, we have described the botanical diversity of the NPSE. We have tried to investigate the traditional, therapeutic, and antidiabetic uses, and the chemical composition, of the various plants found there. It was noted that there are few or no existing studies on medicinal plants in this region. Therefore, we have tried to collect all the relevant information concerning worldwide traditional and modern medicine in medicinal plants of the NPSE to enhance their value and explore their therapeutic and chemical potential for possible application in preventing and treating diabetes. It has been noted that several plants used in traditional medicine have not yet been tested for their antidiabetic effects. Therefore, further research is needed on these medicinal plants&#8217; in vitro and in vivo antidiabetic effects. Some of them have been tested against diabetes without having had any subsequent traditional use. We found that the two families, <italic toggle="yes">Asteraceae</italic> and <italic toggle="yes">Lamiaceae</italic>, are the two plant groups most present in the Park with the highest number of citations of traditional use against diabetes. Studies of the hypoglycemic potential of members of these two families have revealed numerous remarkable properties against diabetes. Several mechanisms of action have been implicated. However, further research, particularly of a clinical nature, is required. Phytochemical characterisation has shown that these medicinal plants contain numerous bioactive compounds from different chemical groups. Pharmacological studies of these remedies have shown that they have interesting therapeutic effects. Given this information, we need to study the possibilities for successfully integrating the medicinal plants of the NPSE into a public health framework. Studies should be conducted to develop new antidiabetic drugs based specifically on medicinal plants from the Park and their respective bioactive compounds.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#8217;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-pharmaceutics-16-00454"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.mdpi.com/article/10.3390/pharmaceutics16040454/s1">https://www.mdpi.com/article/10.3390/pharmaceutics16040454/s1</uri>, Table S1: Description of botanical data and search methodology for Serra da Estrela Natural Park plants in the Flora-on database; Table S2: Analysis of the plant number with anti-diabetic potential in Serra da Estrela Natural Park; Table S3. Traditional uses of NPSE medicinal plants with antidiabetic potential; Table S4: Species of plants in Serra da Estrela Natural Park reported to have anti-diabetic potential.</p><supplementary-material id="pharmaceutics-16-00454-s001" position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pharmaceutics-16-00454-s001.zip" position="float" orientation="portrait"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, R.A.L. and L.R.S.; methodology, R.A.L. and L.R.S.; investigation, R.A.L. and F.C.; writing&#8212;original draft preparation, R.A.L.; writing&#8212;review and editing, R.A.L.; supervision, L.R.S.; project administration, L.R.S., M.J.P., and J.L.; funding acquisition, L.R.S., M.J.P., and J.L. All authors have read and agreed to the published version of the manuscript.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-pharmaceutics-16-00454"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maleki</surname><given-names>V.</given-names></name><name name-style="western"><surname>Jafari-Vayghan</surname><given-names>H.</given-names></name><name name-style="western"><surname>Saleh-Ghadimi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Adibian</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kheirouri</surname><given-names>S.</given-names></name><name name-style="western"><surname>Alizadeh</surname><given-names>M.</given-names></name></person-group><article-title>Effects of Royal Jelly on Metabolic Variables in Diabetes Mellitus: A Systematic Review</article-title><source>Complement. Ther. Med.</source><year>2019</year><volume>43</volume><fpage>20</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1016/j.ctim.2018.12.022</pub-id><pub-id pub-id-type="pmid">30935531</pub-id></element-citation></ref><ref id="B2-pharmaceutics-16-00454"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>ADA 15</collab></person-group><article-title>Diabetes Advocacy: Standards of Medical Care in Diabetes-2018</article-title><source>Diabetes Care</source><year>2018</year><volume>41</volume><fpage>S152</fpage><lpage>S153</lpage><pub-id pub-id-type="doi">10.2337/dc18-S015</pub-id><pub-id pub-id-type="pmid">29222386</pub-id></element-citation></ref><ref id="B3-pharmaceutics-16-00454"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Be&#322;towski</surname><given-names>J.</given-names></name><name name-style="western"><surname>W&#243;jcicka</surname><given-names>G.</given-names></name><name name-style="western"><surname>Jamroz-Wi&#347;niewska</surname><given-names>A.</given-names></name></person-group><article-title>Hydrogen Sulfide in the Regulation of Insulin Secretion and Insulin Sensitivity: Implications for the Pathogenesis and Treatment of Diabetes Mellitus</article-title><source>Biochem. Pharmacol.</source><year>2018</year><volume>149</volume><fpage>60</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/j.bcp.2018.01.004</pub-id><pub-id pub-id-type="pmid">29307653</pub-id></element-citation></ref><ref id="B4-pharmaceutics-16-00454"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elsayed</surname><given-names>N.A.</given-names></name><name name-style="western"><surname>Aleppo</surname><given-names>G.</given-names></name><name name-style="western"><surname>Aroda</surname><given-names>V.R.</given-names></name><name name-style="western"><surname>Bannuru</surname><given-names>R.R.</given-names></name><name name-style="western"><surname>Brown</surname><given-names>F.M.</given-names></name><name name-style="western"><surname>Bruemmer</surname><given-names>D.</given-names></name><name name-style="western"><surname>Collins</surname><given-names>B.S.</given-names></name><name name-style="western"><surname>Gaglia</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Hilliard</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Isaacs</surname><given-names>D.</given-names></name><etal/></person-group><article-title>2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes&#8212;2023</article-title><source>Am. Diabetes Assoc.</source><year>2022</year><volume>46</volume><fpage>S19</fpage><lpage>S40</lpage><pub-id pub-id-type="doi">10.2337/dc23-S002</pub-id><pub-id pub-id-type="pmid">36507649</pub-id><pub-id pub-id-type="pmcid">PMC9810477</pub-id></element-citation></ref><ref id="B5-pharmaceutics-16-00454"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Halim</surname><given-names>M.</given-names></name><name name-style="western"><surname>Halim</surname><given-names>A.</given-names></name></person-group><article-title>The Effects of Inflammation, Aging and Oxidative Stress on the Pathogenesis of Diabetes Mellitus (Type 2 Diabetes)</article-title><source>Diabetes Metab. Syndr. Clin. Res. Rev.</source><year>2019</year><volume>13</volume><fpage>1165</fpage><lpage>1172</lpage><pub-id pub-id-type="doi">10.1016/j.dsx.2019.01.040</pub-id><pub-id pub-id-type="pmid">31336460</pub-id></element-citation></ref><ref id="B6-pharmaceutics-16-00454"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ighodaro</surname><given-names>O.M.</given-names></name></person-group><article-title>Molecular Pathways Associated with Oxidative Stress in Diabetes Mellitus</article-title><source>Biomed. Pharmacother.</source><year>2018</year><volume>108</volume><fpage>656</fpage><lpage>662</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2018.09.058</pub-id><pub-id pub-id-type="pmid">30245465</pub-id></element-citation></ref><ref id="B7-pharmaceutics-16-00454"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Asmat</surname><given-names>U.</given-names></name><name name-style="western"><surname>Abad</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ismail</surname><given-names>K.</given-names></name></person-group><article-title>Diabetes Mellitus and Oxidative Stress&#8212;A Concise Review</article-title><source>Saudi Pharm. J.</source><year>2016</year><volume>24</volume><fpage>547</fpage><lpage>553</lpage><pub-id pub-id-type="doi">10.1016/j.jsps.2015.03.013</pub-id><pub-id pub-id-type="pmid">27752226</pub-id><pub-id pub-id-type="pmcid">PMC5059829</pub-id></element-citation></ref><ref id="B8-pharmaceutics-16-00454"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>LeRoith</surname><given-names>D.</given-names></name></person-group><article-title>&#946;-Cell Dysfunction and Insulin Resistance in Type 2 Diabetes: Role of Metabolic and Genetic Abnormalities</article-title><source>Am. J. Med.</source><year>2002</year><volume>113</volume><fpage>3</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/S0002-9343(02)01276-7</pub-id><pub-id pub-id-type="pmid">12431757</pub-id></element-citation></ref><ref id="B9-pharmaceutics-16-00454"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mooradian</surname><given-names>A.D.</given-names></name></person-group><article-title>Diabetes-Related Perturbations in the Integrity of Physiologic Barriers</article-title><source>J. Diabetes Complicat.</source><year>2023</year><volume>37</volume><fpage>108552</fpage><pub-id pub-id-type="doi">10.1016/j.jdiacomp.2023.108552</pub-id><pub-id pub-id-type="pmid">37356233</pub-id></element-citation></ref><ref id="B10-pharmaceutics-16-00454"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>M.G.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Park</surname><given-names>K.</given-names></name><name name-style="western"><surname>King</surname><given-names>G.L.</given-names></name></person-group><article-title>Insulin&#8217;s Actions on Vascular Tissues: Physiological Effects and Pathophysiological Contributions to Vascular Complications of Diabetes</article-title><source>Mol. Metab.</source><year>2021</year><volume>52</volume><fpage>101236</fpage><pub-id pub-id-type="doi">10.1016/j.molmet.2021.101236</pub-id><pub-id pub-id-type="pmid">33878400</pub-id><pub-id pub-id-type="pmcid">PMC8513152</pub-id></element-citation></ref><ref id="B11-pharmaceutics-16-00454"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cooper</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Whaley-Connell</surname><given-names>A.</given-names></name><name name-style="western"><surname>Habibi</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lastra</surname><given-names>G.</given-names></name><name name-style="western"><surname>Manrique</surname><given-names>C.</given-names></name><name name-style="western"><surname>Stas</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sowers</surname><given-names>J.R.</given-names></name></person-group><article-title>Renin-Angiotensin-Aldosterone System and Oxidative Stress in Cardiovascular Insulin Resistance</article-title><source>Am. J. Physiol. Heart Circ. Physiol.</source><year>2007</year><volume>293</volume><fpage>H2009</fpage><lpage>H2023</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00522.2007</pub-id><pub-id pub-id-type="pmid">17586614</pub-id></element-citation></ref><ref id="B12-pharmaceutics-16-00454"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rawshani</surname><given-names>A.</given-names></name><name name-style="western"><surname>Rawshani</surname><given-names>A.</given-names></name><name name-style="western"><surname>Franz&#233;n</surname><given-names>S.</given-names></name><name name-style="western"><surname>Eliasson</surname><given-names>B.</given-names></name><name name-style="western"><surname>Svensson</surname><given-names>A.-M.</given-names></name><name name-style="western"><surname>Miftaraj</surname><given-names>M.</given-names></name><name name-style="western"><surname>McGuire</surname><given-names>D.K.</given-names></name><name name-style="western"><surname>Sattar</surname><given-names>N.</given-names></name><name name-style="western"><surname>Rosengren</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gudbj&#246;rnsdottir</surname><given-names>S.</given-names></name></person-group><article-title>Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes</article-title><source>N. Engl. J. Med.</source><year>2017</year><volume>376</volume><fpage>1407</fpage><lpage>1418</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1608664</pub-id><pub-id pub-id-type="pmid">28402770</pub-id></element-citation></ref><ref id="B13-pharmaceutics-16-00454"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nabrdalik</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kwiendacz</surname><given-names>H.</given-names></name><name name-style="western"><surname>Moos</surname><given-names>J.</given-names></name><name name-style="western"><surname>Moos</surname><given-names>&#321;.</given-names></name><name name-style="western"><surname>Kulpa</surname><given-names>J.</given-names></name><name name-style="western"><surname>Brzoza</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Stomp&#243;r</surname><given-names>T.</given-names></name><name name-style="western"><surname>Gumprecht</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lip</surname><given-names>G.Y.H.</given-names></name></person-group><article-title>Diabetic Peripheral Neuropathy Is Associated with Diabetic Kidney Disease and Cardiovascular Disease: The Silesia Diabetes-Heart Project</article-title><source>Curr. Probl. Cardiol.</source><year>2023</year><volume>48</volume><fpage>101726</fpage><pub-id pub-id-type="doi">10.1016/j.cpcardiol.2023.101726</pub-id><pub-id pub-id-type="pmid">36967071</pub-id></element-citation></ref><ref id="B14-pharmaceutics-16-00454"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koulis</surname><given-names>C.</given-names></name><name name-style="western"><surname>Watson</surname><given-names>A.M.D.</given-names></name><name name-style="western"><surname>Gray</surname><given-names>S.P.</given-names></name><name name-style="western"><surname>Jandeleit-Dahm</surname><given-names>K.A.</given-names></name></person-group><article-title>Linking RAGE and Nox in Diabetic Micro- and Macrovascular Complications</article-title><source>Diabetes Metab.</source><year>2015</year><volume>41</volume><fpage>272</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1016/j.diabet.2015.01.006</pub-id><pub-id pub-id-type="pmid">26323666</pub-id></element-citation></ref><ref id="B15-pharmaceutics-16-00454"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>C.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Ji</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Ran</surname><given-names>X.</given-names></name><name name-style="western"><surname>Kuang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Fang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Xue</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Prevalence of Painful Diabetic Peripheral Neuropathy in Type 2 Diabetes Mellitus and Diabetic Peripheral Neuropathy: A Nationwide Cross-Sectional Study in Mainland China</article-title><source>Diabetes Res. Clin. Pract.</source><year>2023</year><volume>198</volume><fpage>110602</fpage><pub-id pub-id-type="doi">10.1016/j.diabres.2023.110602</pub-id><pub-id pub-id-type="pmid">36871876</pub-id></element-citation></ref><ref id="B16-pharmaceutics-16-00454"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ebrahimpour</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zakeri</surname><given-names>M.</given-names></name><name name-style="western"><surname>Esmaeili</surname><given-names>A.</given-names></name></person-group><article-title>Crosstalk between Obesity, Diabetes, and Alzheimer&#8217;s Disease: Introducing Quercetin as an Effective Triple Herbal Medicine</article-title><source>Ageing Res. Rev.</source><year>2020</year><volume>62</volume><fpage>101095</fpage><pub-id pub-id-type="doi">10.1016/j.arr.2020.101095</pub-id><pub-id pub-id-type="pmid">32535272</pub-id></element-citation></ref><ref id="B17-pharmaceutics-16-00454"><label>17.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>The International Diabetes Federation</collab></person-group><source>IDF Diabetes Atlas</source><publisher-name>The International Diabetes Federation</publisher-name><publisher-loc>Brussels, Belgium</publisher-loc><year>2021</year></element-citation></ref><ref id="B18-pharmaceutics-16-00454"><label>18.</label><element-citation publication-type="webpage"><article-title>World Health Organisation Diabetes</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.who.int/health-topics/diabetes#tab=tab_1" ext-link-type="uri">https://www.who.int/health-topics/diabetes#tab=tab_1</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2023-07-23">(accessed on 23 July 2023)</date-in-citation></element-citation></ref><ref id="B19-pharmaceutics-16-00454"><label>19.</label><element-citation publication-type="gov"><article-title>SNS Servico National de Saude-Diabetes</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.sns.gov.pt/noticias/2018/05/14/diabetes/" ext-link-type="uri">https://www.sns.gov.pt/noticias/2018/05/14/diabetes/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2023-07-23">(accessed on 23 July 2023)</date-in-citation></element-citation></ref><ref id="B20-pharmaceutics-16-00454"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soares</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>Coelho</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tracey</surname><given-names>M.</given-names></name><name name-style="western"><surname>Carvalho</surname><given-names>D.</given-names></name><name name-style="western"><surname>Silva-Nunes</surname><given-names>J.</given-names></name></person-group><article-title>Epidemiological, Social and Economic Burden of Severe Hypoglycaemia in Patients with Diabetes Mellitus in Portugal: A Structured Literature Review</article-title><source>Diabetes Ther.</source><year>2023</year><volume>14</volume><fpage>265</fpage><pub-id pub-id-type="doi">10.1007/s13300-022-01358-1</pub-id><pub-id pub-id-type="pmid">36680681</pub-id><pub-id pub-id-type="pmcid">PMC9943814</pub-id></element-citation></ref><ref id="B21-pharmaceutics-16-00454"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jo&#227;o Filipe</surname><given-names>R.</given-names></name></person-group><article-title>Diabetes: Factos e N&#250;meros 2016, 2017 e 2018</article-title><source>Rev. Port. Diabetes</source><year>2020</year><volume>15</volume><fpage>19</fpage><lpage>27</lpage></element-citation></ref><ref id="B22-pharmaceutics-16-00454"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kyrou</surname><given-names>I.</given-names></name><name name-style="western"><surname>Tsigos</surname><given-names>C.</given-names></name><name name-style="western"><surname>Mavrogianni</surname><given-names>C.</given-names></name><name name-style="western"><surname>Cardon</surname><given-names>G.</given-names></name><name name-style="western"><surname>Van Stappen</surname><given-names>V.</given-names></name><name name-style="western"><surname>Latomme</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kivel&#228;</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wikstr&#246;m</surname><given-names>K.</given-names></name><name name-style="western"><surname>Tsochev</surname><given-names>K.</given-names></name><name name-style="western"><surname>Nanasi</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Sociodemographic and Lifestyle-Related Risk Factors for Identifying Vulnerable Groups for Type 2 Diabetes: A Narrative Review with Emphasis on Data from Europe</article-title><source>BMC Endocr. Disord.</source><year>2020</year><volume>20</volume><elocation-id>134</elocation-id><pub-id pub-id-type="doi">10.1186/s12902-019-0463-3</pub-id><pub-id pub-id-type="pmcid">PMC7066728</pub-id><pub-id pub-id-type="pmid">32164656</pub-id></element-citation></ref><ref id="B23-pharmaceutics-16-00454"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ojo</surname><given-names>O.A.</given-names></name><name name-style="western"><surname>Ibrahim</surname><given-names>H.S.</given-names></name><name name-style="western"><surname>Rotimi</surname><given-names>D.E.</given-names></name><name name-style="western"><surname>Ogunlakin</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Ojo</surname><given-names>A.B.</given-names></name></person-group><article-title>Diabetes Mellitus: From Molecular Mechanism to Pathophysiology and Pharmacology</article-title><source>Med. Nov. Technol. Devices</source><year>2023</year><volume>19</volume><fpage>100247</fpage><pub-id pub-id-type="doi">10.1016/j.medntd.2023.100247</pub-id></element-citation></ref><ref id="B24-pharmaceutics-16-00454"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wo&#322;os-K&#322;osowicz</surname><given-names>K.</given-names></name><name name-style="western"><surname>Bandurska-Stankiewicz</surname><given-names>E.</given-names></name></person-group><article-title>Effects of Common Weight Loss Plans on Diabetes Mellitus and Cardiovascular Risk Factors</article-title><source>Prim. Care Diabetes</source><year>2022</year><volume>16</volume><fpage>252</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1016/j.pcd.2021.11.003</pub-id><pub-id pub-id-type="pmid">34802979</pub-id></element-citation></ref><ref id="B25-pharmaceutics-16-00454"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>X.</given-names></name><name name-style="western"><surname>Meng</surname><given-names>E.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>S.</given-names></name></person-group><article-title>A Meta-Analysis of Passive Smoking and Risk of Developing Type 2 Diabetes Mellitus</article-title><source>Diabetes Res. Clin. Pract.</source><year>2015</year><volume>107</volume><fpage>9</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/j.diabres.2014.09.019</pub-id><pub-id pub-id-type="pmid">25488377</pub-id></element-citation></ref><ref id="B26-pharmaceutics-16-00454"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lai</surname><given-names>Y.J.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>H.Y.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>Y.L.</given-names></name><name name-style="western"><surname>Ko</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Ku</surname><given-names>P.W.</given-names></name><name name-style="western"><surname>Yen</surname><given-names>Y.F.</given-names></name><name name-style="western"><surname>Chu</surname><given-names>D.</given-names></name></person-group><article-title>Frequency of Alcohol Consumption and Risk of Type 2 Diabetes Mellitus: A Nationwide Cohort Study</article-title><source>Clin. Nutr.</source><year>2019</year><volume>38</volume><fpage>1368</fpage><lpage>1372</lpage><pub-id pub-id-type="doi">10.1016/j.clnu.2018.06.930</pub-id><pub-id pub-id-type="pmid">30448092</pub-id></element-citation></ref><ref id="B27-pharmaceutics-16-00454"><label>27.</label><element-citation publication-type="journal"><article-title>The Lancet Type 2 Diabetes: The Urgent Need to Protect Young People</article-title><source>Lancet</source><year>2018</year><volume>392</volume><fpage>2325</fpage><pub-id pub-id-type="doi">10.1016/S0140-6736(18)33015-0</pub-id><pub-id pub-id-type="pmid">30527598</pub-id></element-citation></ref><ref id="B28-pharmaceutics-16-00454"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ortiz</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Cabieses</surname><given-names>B.</given-names></name><name name-style="western"><surname>Repetto</surname><given-names>P.</given-names></name></person-group><article-title>Type 2 Diabetes in Young People: Adding Socioeconomic Inequality to the Discussion</article-title><source>Diabetes Res. Clin. Pract.</source><year>2019</year><volume>156</volume><fpage>107795</fpage><pub-id pub-id-type="doi">10.1016/j.diabres.2019.107795</pub-id><pub-id pub-id-type="pmid">31369763</pub-id></element-citation></ref><ref id="B29-pharmaceutics-16-00454"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wong</surname><given-names>N.D.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Patel</surname><given-names>R.</given-names></name><name name-style="western"><surname>Patao</surname><given-names>C.</given-names></name><name name-style="western"><surname>Malik</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bertoni</surname><given-names>A.G.</given-names></name><name name-style="western"><surname>Correa</surname><given-names>A.</given-names></name><name name-style="western"><surname>Folsom</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>Kachroo</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mukherjee</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Cardiovascular Risk Factor Targets and Cardiovascular Disease Event Risk in Diabetes: A Pooling Project of the Atherosclerosis Risk in Communities Study, Multi-Ethnic Study of Atherosclerosis, and Jackson Heart Study</article-title><source>Diabetes Care</source><year>2016</year><volume>39</volume><fpage>668</fpage><lpage>676</lpage><pub-id pub-id-type="doi">10.2337/dc15-2439</pub-id><pub-id pub-id-type="pmid">27208374</pub-id><pub-id pub-id-type="pmcid">PMC4839178</pub-id></element-citation></ref><ref id="B30-pharmaceutics-16-00454"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meeks</surname><given-names>K.A.C.</given-names></name><name name-style="western"><surname>Freitas-Da-Silva</surname><given-names>D.</given-names></name><name name-style="western"><surname>Adeyemo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Beune</surname><given-names>E.J.A.J.</given-names></name><name name-style="western"><surname>Modesti</surname><given-names>P.A.</given-names></name><name name-style="western"><surname>Stronks</surname><given-names>K.</given-names></name><name name-style="western"><surname>Zafarmand</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Agyemang</surname><given-names>C.</given-names></name></person-group><article-title>Disparities in Type 2 Diabetes Prevalence among Ethnic Minority Groups Resident in Europe: A Systematic Review and Meta-Analysis</article-title><source>Intern. Emerg. Med.</source><year>2016</year><volume>11</volume><fpage>327</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1007/s11739-015-1302-9</pub-id><pub-id pub-id-type="pmid">26370238</pub-id></element-citation></ref><ref id="B31-pharmaceutics-16-00454"><label>31.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Centers for Disease Control and Prevention</collab></person-group><source>National Diabetes Statistics Report</source><publisher-name>Centers for Disease Control and Prevention</publisher-name><publisher-loc>Atlanta, GA, USA</publisher-loc><year>2020</year></element-citation></ref><ref id="B32-pharmaceutics-16-00454"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ciarambino</surname><given-names>T.</given-names></name><name name-style="western"><surname>Crispino</surname><given-names>P.</given-names></name><name name-style="western"><surname>Leto</surname><given-names>G.</given-names></name><name name-style="western"><surname>Mastrolorenzo</surname><given-names>E.</given-names></name><name name-style="western"><surname>Para</surname><given-names>O.</given-names></name><name name-style="western"><surname>Giordano</surname><given-names>M.</given-names></name></person-group><article-title>Influence of Gender in Diabetes Mellitus and Its Complication</article-title><source>Int. J. Mol. Sci.</source><year>2022</year><volume>23</volume><elocation-id>8850</elocation-id><pub-id pub-id-type="doi">10.3390/ijms23168850</pub-id><pub-id pub-id-type="pmid">36012115</pub-id><pub-id pub-id-type="pmcid">PMC9408508</pub-id></element-citation></ref><ref id="B33-pharmaceutics-16-00454"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kautzky-Willer</surname><given-names>A.</given-names></name><name name-style="western"><surname>Leutner</surname><given-names>M.</given-names></name><name name-style="western"><surname>Harreiter</surname><given-names>J.</given-names></name></person-group><article-title>Sex Differences in Type 2 Diabetes</article-title><source>Diabetologia</source><year>2023</year><volume>66</volume><fpage>986</fpage><lpage>1002</lpage><pub-id pub-id-type="doi">10.1007/s00125-023-05891-x</pub-id><pub-id pub-id-type="pmid">36897358</pub-id><pub-id pub-id-type="pmcid">PMC10163139</pub-id></element-citation></ref><ref id="B34-pharmaceutics-16-00454"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gerdts</surname><given-names>E.</given-names></name><name name-style="western"><surname>Regitz-Zagrosek</surname><given-names>V.</given-names></name></person-group><article-title>Sex Differences in Cardiometabolic Disorders</article-title><source>Nat. Med.</source><year>2019</year><volume>25</volume><fpage>1657</fpage><lpage>1666</lpage><pub-id pub-id-type="doi">10.1038/s41591-019-0643-8</pub-id><pub-id pub-id-type="pmid">31700185</pub-id></element-citation></ref><ref id="B35-pharmaceutics-16-00454"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tramunt</surname><given-names>B.</given-names></name><name name-style="western"><surname>Smati</surname><given-names>S.</given-names></name><name name-style="western"><surname>Grandgeorge</surname><given-names>N.</given-names></name><name name-style="western"><surname>Lenfant</surname><given-names>F.</given-names></name><name name-style="western"><surname>Arnal</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Montagner</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gourdy</surname><given-names>P.</given-names></name></person-group><article-title>Sex Differences in Metabolic Regulation and Diabetes Susceptibility</article-title><source>Diabetologia</source><year>2020</year><volume>63</volume><fpage>453</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1007/s00125-019-05040-3</pub-id><pub-id pub-id-type="pmid">31754750</pub-id><pub-id pub-id-type="pmcid">PMC6997275</pub-id></element-citation></ref><ref id="B36-pharmaceutics-16-00454"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Geer</surname><given-names>E.B.</given-names></name><name name-style="western"><surname>Shen</surname><given-names>W.</given-names></name></person-group><article-title>Gender Differences in Insulin Resistance, Body Composition, and Energy Balance</article-title><source>Gend. Med.</source><year>2009</year><volume>6</volume><fpage>60</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1016/j.genm.2009.02.002</pub-id><pub-id pub-id-type="pmid">19318219</pub-id><pub-id pub-id-type="pmcid">PMC2908522</pub-id></element-citation></ref><ref id="B37-pharmaceutics-16-00454"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Christen</surname><given-names>T.</given-names></name><name name-style="western"><surname>Trompet</surname><given-names>S.</given-names></name><name name-style="western"><surname>Noordam</surname><given-names>R.</given-names></name><name name-style="western"><surname>van Klinken</surname><given-names>J.B.</given-names></name><name name-style="western"><surname>van Dijk</surname><given-names>K.W.</given-names></name><name name-style="western"><surname>Lamb</surname><given-names>H.J.</given-names></name><name name-style="western"><surname>Cobbaert</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>den Heijer</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jazet</surname><given-names>I.M.</given-names></name><name name-style="western"><surname>Jukema</surname><given-names>J.W.</given-names></name><etal/></person-group><article-title>Sex Differences in Body Fat Distribution Are Related to Sex Differences in Serum Leptin and Adiponectin</article-title><source>Peptides</source><year>2018</year><volume>107</volume><fpage>25</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.peptides.2018.07.008</pub-id><pub-id pub-id-type="pmid">30076861</pub-id></element-citation></ref><ref id="B38-pharmaceutics-16-00454"><label>38.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Senthil Kumar</surname><given-names>S.P.D.</given-names></name></person-group><article-title>Sex Differences in Obesity-Related Glucose Intolerance and Insulin Resistance</article-title><source>Glucose Tolerance</source><publisher-name>InTech</publisher-name><publisher-loc>London, UK</publisher-loc><year>2012</year><pub-id pub-id-type="doi">10.5772/52972</pub-id></element-citation></ref><ref id="B39-pharmaceutics-16-00454"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Palmisano</surname><given-names>B.T.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Eckel</surname><given-names>R.H.</given-names></name><name name-style="western"><surname>Stafford</surname><given-names>J.M.</given-names></name></person-group><article-title>Sex Differences in Lipid and Lipoprotein Metabolism</article-title><source>Mol. Metab.</source><year>2018</year><volume>15</volume><fpage>45</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1016/j.molmet.2018.05.008</pub-id><pub-id pub-id-type="pmid">29858147</pub-id><pub-id pub-id-type="pmcid">PMC6066747</pub-id></element-citation></ref><ref id="B40-pharmaceutics-16-00454"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Colditz</surname><given-names>G.A.</given-names></name><name name-style="western"><surname>Willett</surname><given-names>W.C.</given-names></name><name name-style="western"><surname>Rotnitzky</surname><given-names>A.</given-names></name><name name-style="western"><surname>Manson</surname><given-names>J.E.</given-names></name></person-group><article-title>Weight Gain as a Risk Factor for Clinical Diabetes Mellitus in Women</article-title><source>Ann. Intern. Med.</source><year>1995</year><volume>122</volume><fpage>481</fpage><lpage>486</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-122-7-199504010-00001</pub-id><pub-id pub-id-type="pmid">7872581</pub-id></element-citation></ref><ref id="B41-pharmaceutics-16-00454"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klein</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gastaldelli</surname><given-names>A.</given-names></name><name name-style="western"><surname>Yki-J&#228;rvinen</surname><given-names>H.</given-names></name><name name-style="western"><surname>Scherer</surname><given-names>P.E.</given-names></name></person-group><article-title>Why Does Obesity Cause Diabetes?</article-title><source>Cell Metab.</source><year>2022</year><volume>34</volume><fpage>11</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2021.12.012</pub-id><pub-id pub-id-type="pmid">34986330</pub-id><pub-id pub-id-type="pmcid">PMC8740746</pub-id></element-citation></ref><ref id="B42-pharmaceutics-16-00454"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Li</surname><given-names>M.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>J.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X.-L.</given-names></name></person-group><article-title>Prevalence of Type 2 Diabetes and Pre-diabetes among Overweight or Obese Children in Tianjin, China</article-title><source>Diabet. Med.</source><year>2013</year><volume>30</volume><fpage>1457</fpage><lpage>1465</lpage><pub-id pub-id-type="doi">10.1111/dme.12269</pub-id><pub-id pub-id-type="pmid">23815511</pub-id></element-citation></ref><ref id="B43-pharmaceutics-16-00454"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>Q.X.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>L.</given-names></name><name name-style="western"><surname>Tong</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>X.Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>R.N.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>P.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>X.H.</given-names></name></person-group><article-title>The Impact of Obesity Epidemic on Type 2 Diabetes in Children and Adolescents: A Systematic Review and Meta-Analysis</article-title><source>Prim. Care Diabetes</source><year>2022</year><volume>16</volume><fpage>736</fpage><lpage>744</lpage><pub-id pub-id-type="doi">10.1016/j.pcd.2022.09.006</pub-id><pub-id pub-id-type="pmid">36184528</pub-id></element-citation></ref><ref id="B44-pharmaceutics-16-00454"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hossain</surname><given-names>M.F.</given-names></name><name name-style="western"><surname>Rashid</surname><given-names>M.</given-names></name><name name-style="western"><surname>Burniston</surname><given-names>T.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>M.A.W.</given-names></name><name name-style="western"><surname>Kataye</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Sidhu</surname><given-names>R.</given-names></name><name name-style="western"><surname>Justice</surname><given-names>M.</given-names></name><name name-style="western"><surname>Abdelfattah</surname><given-names>S.</given-names></name></person-group><article-title>Evaluation of Fucoxanthin Content in Popular Weight Loss Supplements: The Case for Stricter Regulation of Dietary Supplements</article-title><source>J. Obes. Weight Loss Medicat.</source><year>2019</year><volume>5</volume><fpage>31</fpage><pub-id pub-id-type="doi">10.23937/2572-4010.1510031</pub-id></element-citation></ref><ref id="B45-pharmaceutics-16-00454"><label>45.</label><element-citation publication-type="gov"><person-group person-group-type="author"><collab>North Dakota Legislative</collab></person-group><article-title>North Dakota 2022 Diabetes Report. North Dakota Century Code 23-01-40-North Dakota Health, US Statutes, Codes, and Regulations</article-title><year>2022</year><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://ndlegis.gov/files/committees/67-2021/23_5151_03000appendixd.pdf" ext-link-type="uri">https://ndlegis.gov/files/committees/67-2021/23_5151_03000appendixd.pdf</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2023-07-23">(accessed on 23 July 2023)</date-in-citation></element-citation></ref><ref id="B46-pharmaceutics-16-00454"><label>46.</label><element-citation publication-type="webpage"><article-title>Word Health Organization Obesity and Overweight</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight" ext-link-type="uri">https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2023-07-23">(accessed on 23 July 2023)</date-in-citation></element-citation></ref><ref id="B47-pharmaceutics-16-00454"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aras</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tchang</surname><given-names>B.G.</given-names></name><name name-style="western"><surname>Pape</surname><given-names>J.</given-names></name></person-group><article-title>Obesity and Diabetes</article-title><source>Nurs. Clin. N. Am.</source><year>2021</year><volume>56</volume><fpage>527</fpage><lpage>541</lpage><pub-id pub-id-type="doi">10.1016/j.cnur.2021.07.008</pub-id><pub-id pub-id-type="pmid">34749892</pub-id></element-citation></ref><ref id="B48-pharmaceutics-16-00454"><label>48.</label><element-citation publication-type="gov"><person-group person-group-type="author"><collab>North Dakota Legislative</collab></person-group><article-title>Title 23. Health and Safety. Chapter 23-01, Section 23-01-40&#8212;Diabetes Goals and Plans&#8212;Report to Legislative Management. US Statutes, Codes, and Regulations</article-title><year>2022</year><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://ndlegis.gov/cencode/t23c01.pdf" ext-link-type="uri">https://ndlegis.gov/cencode/t23c01.pdf</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2023-07-23">(accessed on 23 July 2023)</date-in-citation></element-citation></ref><ref id="B49-pharmaceutics-16-00454"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>The</surname><given-names>N.S.</given-names></name><name name-style="western"><surname>Richardson</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gordon-Larsen</surname><given-names>P.</given-names></name></person-group><article-title>Timing and Duration of Obesity in Relation to Diabetes: Findings from an Ethnically Diverse, Nationally Representative Sample</article-title><source>Diabetes Care</source><year>2001</year><volume>36</volume><fpage>865</fpage><lpage>872</lpage><pub-id pub-id-type="doi">10.2337/dc12-0536</pub-id><pub-id pub-id-type="pmid">23223352</pub-id><pub-id pub-id-type="pmcid">PMC3609525</pub-id></element-citation></ref><ref id="B50-pharmaceutics-16-00454"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Di Cesare</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bentham</surname><given-names>J.</given-names></name><name name-style="western"><surname>Stevens</surname><given-names>G.A.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>B.</given-names></name><name name-style="western"><surname>Danaei</surname><given-names>G.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Bixby</surname><given-names>H.</given-names></name><name name-style="western"><surname>Cowan</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Riley</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Hajifathalian</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Trends in Adult Body-Mass Index in 200 Countries from 1975 to 2014: A Pooled Analysis of 1698 Population-Based Measurement Studies with 19&#183;2 Million Participants</article-title><source>Lancet</source><year>2016</year><volume>387</volume><fpage>1377</fpage><lpage>1396</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(16)30054-X</pub-id><pub-id pub-id-type="pmid">27115820</pub-id><pub-id pub-id-type="pmcid">PMC7615134</pub-id></element-citation></ref><ref id="B51-pharmaceutics-16-00454"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Power</surname><given-names>C.</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>C.</given-names></name></person-group><article-title>Changes in BMI, Duration of Overweight and Obesity, and Glucose Metabolism: 45 Years of Follow-up of a Birth Cohort</article-title><source>Diabetes Care</source><year>2011</year><volume>34</volume><fpage>1986</fpage><lpage>1991</lpage><pub-id pub-id-type="doi">10.2337/dc10-1482</pub-id><pub-id pub-id-type="pmid">21775760</pub-id><pub-id pub-id-type="pmcid">PMC3161304</pub-id></element-citation></ref><ref id="B52-pharmaceutics-16-00454"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dandona</surname><given-names>P.</given-names></name><name name-style="western"><surname>Aljada</surname><given-names>A.</given-names></name></person-group><article-title>A Rational Approach to Pathogenesis and Treatment of Type 2 Diabetes Mellitus, Insulin Resistance, Inflammation, and Atherosclerosis</article-title><source>Am. J. Cardiol.</source><year>2002</year><volume>90</volume><fpage>27</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1016/S0002-9149(02)02556-0</pub-id><pub-id pub-id-type="pmid">12231076</pub-id></element-citation></ref><ref id="B53-pharmaceutics-16-00454"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Incalza</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>D&#8217;Oria</surname><given-names>R.</given-names></name><name name-style="western"><surname>Natalicchio</surname><given-names>A.</given-names></name><name name-style="western"><surname>Perrini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Laviola</surname><given-names>L.</given-names></name><name name-style="western"><surname>Giorgino</surname><given-names>F.</given-names></name></person-group><article-title>Oxidative Stress and Reactive Oxygen Species in Endothelial Dysfunction Associated with Cardiovascular and Metabolic Diseases</article-title><source>Vascul. Pharmacol.</source><year>2018</year><volume>100</volume><fpage>1</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/j.vph.2017.05.005</pub-id><pub-id pub-id-type="pmid">28579545</pub-id></element-citation></ref><ref id="B54-pharmaceutics-16-00454"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hopps</surname><given-names>E.</given-names></name><name name-style="western"><surname>Noto</surname><given-names>D.</given-names></name><name name-style="western"><surname>Caimi</surname><given-names>G.</given-names></name><name name-style="western"><surname>Averna</surname><given-names>M.R.</given-names></name></person-group><article-title>A Novel Component of the Metabolic Syndrome: The Oxidative Stress</article-title><source>Nutr. Metab. Cardiovasc. Dis.</source><year>2010</year><volume>20</volume><fpage>72</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.numecd.2009.06.002</pub-id><pub-id pub-id-type="pmid">19747805</pub-id></element-citation></ref><ref id="B55-pharmaceutics-16-00454"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salas-Salvad&#243;</surname><given-names>J.</given-names></name><name name-style="western"><surname>Martinez-Gonz&#225;lez</surname><given-names>M.&#193;.</given-names></name><name name-style="western"><surname>Bull&#243;</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ros</surname><given-names>E.</given-names></name></person-group><article-title>The Role of Diet in the Prevention of Type 2 Diabetes</article-title><source>Nutr. Metab. Cardiovasc. Dis.</source><year>2011</year><volume>21</volume><fpage>B32</fpage><lpage>B48</lpage><pub-id pub-id-type="doi">10.1016/j.numecd.2011.03.009</pub-id><pub-id pub-id-type="pmid">21745730</pub-id></element-citation></ref><ref id="B56-pharmaceutics-16-00454"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Testa</surname><given-names>R.</given-names></name><name name-style="western"><surname>Bonfigli</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>Prattichizzo</surname><given-names>F.</given-names></name><name name-style="western"><surname>La Sala</surname><given-names>L.</given-names></name><name name-style="western"><surname>De Nigris</surname><given-names>V.</given-names></name><name name-style="western"><surname>Ceriello</surname><given-names>A.</given-names></name></person-group><article-title>The &#8220;Metabolic Memory&#8221; Theory and the Early Treatment of Hyperglycemia in Prevention of Diabetic Complications</article-title><source>Nutrients</source><year>2017</year><volume>9</volume><elocation-id>437</elocation-id><pub-id pub-id-type="doi">10.3390/nu9050437</pub-id><pub-id pub-id-type="pmid">28452927</pub-id><pub-id pub-id-type="pmcid">PMC5452167</pub-id></element-citation></ref><ref id="B57-pharmaceutics-16-00454"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ni</surname><given-names>H.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Halim</surname><given-names>M.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>D.</given-names></name></person-group><article-title>ROS-Mediated Glucose Metabolic Reprogram Induces Insulin Resistance in Type 2 Diabetes</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2016</year><volume>476</volume><fpage>204</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2016.05.087</pub-id><pub-id pub-id-type="pmid">27207834</pub-id></element-citation></ref><ref id="B58-pharmaceutics-16-00454"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nita</surname><given-names>M.</given-names></name><name name-style="western"><surname>Grzybowski</surname><given-names>A.</given-names></name></person-group><article-title>The Role of the Reactive Oxygen Species and Oxidative Stress in the Pathomechanism of the Age-Related Ocular Diseases and Other Pathologies of the Anterior and Posterior Eye Segments in Adults</article-title><source>Oxidative Med. Cell. Longev.</source><year>2016</year><volume>2016</volume><fpage>3164734</fpage><pub-id pub-id-type="doi">10.1155/2016/3164734</pub-id><pub-id pub-id-type="pmcid">PMC4736974</pub-id><pub-id pub-id-type="pmid">26881021</pub-id></element-citation></ref><ref id="B59-pharmaceutics-16-00454"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rolo</surname><given-names>A.P.</given-names></name><name name-style="western"><surname>Palmeira</surname><given-names>C.M.</given-names></name></person-group><article-title>Diabetes and Mitochondrial Function: Role of Hyperglycemia and Oxidative Stress</article-title><source>Toxicol. Appl. Pharmacol.</source><year>2006</year><volume>212</volume><fpage>167</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1016/j.taap.2006.01.003</pub-id><pub-id pub-id-type="pmid">16490224</pub-id></element-citation></ref><ref id="B60-pharmaceutics-16-00454"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luca</surname><given-names>P.</given-names></name></person-group><article-title>Pros and Cons of Selective Inhibition of Cyclooxygenase-2 versus Dual/Cyclooxygenase Inhibition: Is Two Better than One?</article-title><source>J. Rheumatol.</source><year>2001</year><volume>28</volume><fpage>2375</fpage><lpage>2382</lpage><pub-id pub-id-type="pmid">11708405</pub-id></element-citation></ref><ref id="B61-pharmaceutics-16-00454"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hakim</surname><given-names>J.</given-names></name></person-group><article-title>Reactive Oxygen Species and Inflammation</article-title><source>Comptes Rendus Seances Soc. Biol. Fil.</source><year>1993</year><volume>187</volume><fpage>286</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1249/01.MSS.0000272256.65493.BB</pub-id><pub-id pub-id-type="pmid">8019908</pub-id></element-citation></ref><ref id="B62-pharmaceutics-16-00454"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pickup</surname><given-names>J.C.</given-names></name></person-group><article-title>Inflammation and Activated Innate Immunity in the Pathogenesis of Type 2 Diabetes</article-title><source>Diabetes Care</source><year>2004</year><volume>27</volume><fpage>813</fpage><lpage>823</lpage><pub-id pub-id-type="doi">10.2337/diacare.27.3.813</pub-id><pub-id pub-id-type="pmid">14988310</pub-id></element-citation></ref><ref id="B63-pharmaceutics-16-00454"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>American Diabetes Association</collab></person-group><article-title>5. Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes-2018</article-title><source>Diabetes Care</source><year>2018</year><volume>41</volume><fpage>S51</fpage><lpage>S54</lpage><pub-id pub-id-type="doi">10.2337/dc18-S005</pub-id><pub-id pub-id-type="pmid">29222376</pub-id></element-citation></ref><ref id="B64-pharmaceutics-16-00454"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raptis</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Dimitriadis</surname><given-names>G.D.</given-names></name></person-group><article-title>Oral Hypoglycemic Agents: Insulin Secretagogues, &#945;-Glucosidase Inhibitors and Insulin Sensitizers</article-title><source>Exp. Clin. Endocrinol. Diabetes</source><year>2001</year><volume>109</volume><pub-id pub-id-type="doi">10.1055/s-2001-18588</pub-id><pub-id pub-id-type="pmid">11460577</pub-id></element-citation></ref><ref id="B65-pharmaceutics-16-00454"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sudhir</surname><given-names>R.</given-names></name><name name-style="western"><surname>Mohan</surname><given-names>V.</given-names></name></person-group><article-title>Postprandial Hyperglycemia in Patients with Type 2 Diabetes Mellitus</article-title><source>Treat. Endocrinol.</source><year>2002</year><volume>1</volume><fpage>105</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.2165/00024677-200201020-00004</pub-id><pub-id pub-id-type="pmid">15765626</pub-id></element-citation></ref><ref id="B66-pharmaceutics-16-00454"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chehade</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Mooradian</surname><given-names>A.D.</given-names></name></person-group><article-title>A Rational Approach to Drug Therapy of Type 2 Diabetes Mellitus</article-title><source>Drugs</source><year>2000</year><volume>60</volume><fpage>95</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.2165/00003495-200060010-00006</pub-id><pub-id pub-id-type="pmid">10929931</pub-id></element-citation></ref><ref id="B67-pharmaceutics-16-00454"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sheehan</surname><given-names>M.T.</given-names></name></person-group><article-title>Current Therapeutic Options in Type 2 Diabetes Mellitus: A Practical Approach</article-title><source>Clin. Med. Res.</source><year>2003</year><volume>1</volume><fpage>189</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.3121/cmr.1.3.189</pub-id><pub-id pub-id-type="pmid">15931309</pub-id><pub-id pub-id-type="pmcid">PMC1069045</pub-id></element-citation></ref><ref id="B68-pharmaceutics-16-00454"><label>68.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Feingold</surname><given-names>K.R.</given-names></name></person-group><article-title>Oral and Injectable (Non-Insulin) Pharmacological Agents for the Treatment of Type 2 Diabetes</article-title><source>Endotext</source><publisher-name>MDText.com, Inc.</publisher-name><publisher-loc>South Dartmouth, MA, USA</publisher-loc><year>2022</year><pub-id pub-id-type="pmid">25905364</pub-id></element-citation></ref><ref id="B69-pharmaceutics-16-00454"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McFarlane</surname><given-names>S.I.</given-names></name></person-group><article-title>Insulin Therapy and Type 2 Diabetes: Management of Weight Gain</article-title><source>J. Clin. Hypertens.</source><year>2009</year><volume>11</volume><fpage>601</fpage><pub-id pub-id-type="doi">10.1111/j.1751-7176.2009.00063.x</pub-id><pub-id pub-id-type="pmcid">PMC8673427</pub-id><pub-id pub-id-type="pmid">19817944</pub-id></element-citation></ref><ref id="B70-pharmaceutics-16-00454"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chentli</surname><given-names>F.</given-names></name><name name-style="western"><surname>Azzoug</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mahgoun</surname><given-names>S.</given-names></name></person-group><article-title>Diabetes Mellitus in Elderly</article-title><source>Indian J. Endocrinol. Metab.</source><year>2015</year><volume>19</volume><fpage>744</fpage><lpage>752</lpage><pub-id pub-id-type="doi">10.4103/2230-8210.167553</pub-id><pub-id pub-id-type="pmid">26693423</pub-id><pub-id pub-id-type="pmcid">PMC4673801</pub-id></element-citation></ref><ref id="B71-pharmaceutics-16-00454"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bastaki</surname><given-names>S.</given-names></name></person-group><article-title>Diabetes Mellitus and Its Treatment</article-title><source>Int. J. Diabetes Metab.</source><year>2005</year><volume>13</volume><fpage>111</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1159/000497580</pub-id></element-citation></ref><ref id="B72-pharmaceutics-16-00454"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pandey</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tripathi</surname><given-names>P.</given-names></name><name name-style="western"><surname>Pandey</surname><given-names>R.</given-names></name><name name-style="western"><surname>Srivatava</surname><given-names>R.</given-names></name><name name-style="western"><surname>Goswami</surname><given-names>S.</given-names></name></person-group><article-title>Alternative Therapies Useful in the Management of Diabetes: A Systematic Review</article-title><source>J. Pharm. Bioallied Sci.</source><year>2011</year><volume>3</volume><fpage>504</fpage><lpage>512</lpage><pub-id pub-id-type="doi">10.4103/0975-7406.90103</pub-id><pub-id pub-id-type="pmid">22219583</pub-id><pub-id pub-id-type="pmcid">PMC3249697</pub-id></element-citation></ref><ref id="B73-pharmaceutics-16-00454"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gurib-Fakim</surname><given-names>A.</given-names></name></person-group><article-title>Medicinal Plants: Traditions of Yesterday and Drugs of Tomorrow</article-title><source>Mol. Aspects Med.</source><year>2006</year><volume>27</volume><fpage>1</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/j.mam.2005.07.008</pub-id><pub-id pub-id-type="pmid">16105678</pub-id></element-citation></ref><ref id="B74-pharmaceutics-16-00454"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kouretas</surname><given-names>D.</given-names></name><name name-style="western"><surname>Skaperda</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>P.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name></person-group><article-title>Natural Drugs: A New Direction for the Prevention and Treatment of Diabetes</article-title><source>Molecules</source><year>2023</year><volume>28</volume><elocation-id>5525</elocation-id><pub-id pub-id-type="doi">10.3390/MOLECULES28145525</pub-id><pub-id pub-id-type="pmid">37513397</pub-id><pub-id pub-id-type="pmcid">PMC10385698</pub-id></element-citation></ref><ref id="B75-pharmaceutics-16-00454"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tripathy</surname><given-names>B.</given-names></name><name name-style="western"><surname>Sahoo</surname><given-names>N.</given-names></name><name name-style="western"><surname>Sahoo</surname><given-names>S.K.</given-names></name></person-group><article-title>Trends in Diabetes Care with Special Emphasis to Medicinal Plants: Advancement and Treatment</article-title><source>Biocatal. Agric. Biotechnol.</source><year>2021</year><volume>33</volume><elocation-id>102014</elocation-id><pub-id pub-id-type="doi">10.1016/j.bcab.2021.102014</pub-id><pub-id pub-id-type="pmid">35342487</pub-id><pub-id pub-id-type="pmcid">PMC8941016</pub-id></element-citation></ref><ref id="B76-pharmaceutics-16-00454"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shabab</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gholamnezhad</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Mahmoudabady</surname><given-names>M.</given-names></name></person-group><article-title>Protective Effects of Medicinal Plant against Diabetes Induced Cardiac Disorder: A Review</article-title><source>J. Ethnopharmacol.</source><year>2021</year><volume>265</volume><fpage>113328</fpage><pub-id pub-id-type="doi">10.1016/j.jep.2020.113328</pub-id><pub-id pub-id-type="pmid">32871233</pub-id></element-citation></ref><ref id="B77-pharmaceutics-16-00454"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yuan</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Ye</surname><given-names>L.</given-names></name><name name-style="western"><surname>Piao</surname><given-names>G.</given-names></name></person-group><article-title>The Traditional Medicine and Modern Medicine from Natural Products</article-title><source>Molecules</source><year>2016</year><volume>21</volume><elocation-id>559</elocation-id><pub-id pub-id-type="doi">10.3390/molecules21050559</pub-id><pub-id pub-id-type="pmid">27136524</pub-id><pub-id pub-id-type="pmcid">PMC6273146</pub-id></element-citation></ref><ref id="B78-pharmaceutics-16-00454"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Swamy</surname><given-names>M.K.</given-names></name><name name-style="western"><surname>Sinniah</surname><given-names>U.R.</given-names></name></person-group><article-title>Patchouli (Pogostemon Cablin Benth.): Botany, Agrotechnology and Biotechnological Aspects</article-title><source>Ind. Crops Prod.</source><year>2016</year><volume>87</volume><fpage>161</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1016/j.indcrop.2016.04.032</pub-id></element-citation></ref><ref id="B79-pharmaceutics-16-00454"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohanty</surname><given-names>S.</given-names></name><name name-style="western"><surname>Swamy</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sinniah</surname><given-names>U.</given-names></name><name name-style="western"><surname>Anuradha</surname><given-names>M.</given-names></name></person-group><article-title>Leptadenia Reticulata (Retz.) Wight &amp; Arn. (Jivanti): Botanical, Agronomical, Phytochemical, Pharmacological, and Biotechnological Aspects</article-title><source>Molecules</source><year>2017</year><volume>22</volume><elocation-id>1019</elocation-id><pub-id pub-id-type="doi">10.3390/molecules22061019</pub-id><pub-id pub-id-type="pmid">28629185</pub-id><pub-id pub-id-type="pmcid">PMC6152761</pub-id></element-citation></ref><ref id="B80-pharmaceutics-16-00454"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bansal</surname><given-names>A.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>V.</given-names></name><name name-style="western"><surname>Chopra</surname><given-names>T.</given-names></name><name name-style="western"><surname>Poddar</surname><given-names>J.</given-names></name></person-group><article-title>Flavonoids, Alkaloids and Terpenoids: A New Hope for the Treatment of Diabetes Mellitus</article-title><source>J. Diabetes Metab. Disord.</source><year>2022</year><volume>21</volume><fpage>941</fpage><pub-id pub-id-type="doi">10.1007/s40200-021-00943-8</pub-id><pub-id pub-id-type="pmid">35673446</pub-id><pub-id pub-id-type="pmcid">PMC9167359</pub-id></element-citation></ref><ref id="B81-pharmaceutics-16-00454"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Choudhury</surname><given-names>H.</given-names></name><name name-style="western"><surname>Pandey</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hua</surname><given-names>C.K.</given-names></name><name name-style="western"><surname>Mun</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>Jing</surname><given-names>J.K.</given-names></name><name name-style="western"><surname>Kong</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ern</surname><given-names>L.Y.</given-names></name><name name-style="western"><surname>Ashraf</surname><given-names>N.A.</given-names></name><name name-style="western"><surname>Kit</surname><given-names>S.W.</given-names></name><name name-style="western"><surname>Yee</surname><given-names>T.S.</given-names></name><etal/></person-group><article-title>An Update on Natural Compounds in the Remedy of Diabetes Mellitus: A Systematic Review</article-title><source>J. Tradit. Complement. Med.</source><year>2018</year><volume>8</volume><fpage>361</fpage><pub-id pub-id-type="doi">10.1016/j.jtcme.2017.08.012</pub-id><pub-id pub-id-type="pmid">29992107</pub-id><pub-id pub-id-type="pmcid">PMC6035310</pub-id></element-citation></ref><ref id="B82-pharmaceutics-16-00454"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>L.</given-names></name><name name-style="western"><surname>Gnanaraj</surname><given-names>C.</given-names></name><name name-style="western"><surname>Arulselvan</surname><given-names>P.</given-names></name><name name-style="western"><surname>El-Seedi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Teng</surname><given-names>H.</given-names></name></person-group><article-title>A Review on Advanced Microencapsulation Technology to Enhance Bioavailability of Phenolic Compounds: Based on Its Activity in the Treatment of Type 2 Diabetes</article-title><source>Trends Food Sci. Technol.</source><year>2019</year><volume>85</volume><fpage>149</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1016/j.tifs.2018.11.026</pub-id></element-citation></ref><ref id="B83-pharmaceutics-16-00454"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Akhlaghipour</surname><given-names>I.</given-names></name><name name-style="western"><surname>Nasimi Shad</surname><given-names>A.</given-names></name><name name-style="western"><surname>Askari</surname><given-names>V.R.</given-names></name><name name-style="western"><surname>Maharati</surname><given-names>A.</given-names></name><name name-style="western"><surname>Baradaran Rahimi</surname><given-names>V.</given-names></name></person-group><article-title>How Caffeic Acid and Its Derivatives Combat Diabetes and Its Complications: A Systematic Review</article-title><source>J. Funct. Foods</source><year>2023</year><volume>110</volume><fpage>105862</fpage><pub-id pub-id-type="doi">10.1016/j.jff.2023.105862</pub-id></element-citation></ref><ref id="B84-pharmaceutics-16-00454"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salehi</surname><given-names>B.</given-names></name><name name-style="western"><surname>Ata</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>N.V.A.</given-names></name><name name-style="western"><surname>Sharopov</surname><given-names>F.</given-names></name><name name-style="western"><surname>Ram&#237;rez-Alarc&#243;n</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ruiz-Ortega</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ayatollahi</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Fokou</surname><given-names>P.V.T.</given-names></name><name name-style="western"><surname>Kobarfard</surname><given-names>F.</given-names></name><name name-style="western"><surname>Zakaria</surname><given-names>Z.A.</given-names></name><etal/></person-group><article-title>Antidiabetic Potential of Medicinal Plants and Their Active Components</article-title><source>Biomolecules</source><year>2019</year><volume>9</volume><elocation-id>551</elocation-id><pub-id pub-id-type="doi">10.3390/biom9100551</pub-id><pub-id pub-id-type="pmid">31575072</pub-id><pub-id pub-id-type="pmcid">PMC6843349</pub-id></element-citation></ref><ref id="B85-pharmaceutics-16-00454"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khan</surname><given-names>V.</given-names></name><name name-style="western"><surname>Najmi</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Akhtar</surname><given-names>M.</given-names></name><name name-style="western"><surname>Aqil</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mujeeb</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pillai</surname><given-names>K.K.</given-names></name></person-group><article-title>A Pharmacological Appraisal of Medicinal Plants with Antidiabetic Potential</article-title><source>J. Pharm. Bioallied Sci.</source><year>2012</year><volume>4</volume><elocation-id>27</elocation-id><pub-id pub-id-type="doi">10.4103/0975-7406.92727</pub-id><pub-id pub-id-type="pmid">22368396</pub-id><pub-id pub-id-type="pmcid">PMC3283954</pub-id></element-citation></ref><ref id="B86-pharmaceutics-16-00454"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yeung</surname><given-names>A.W.K.</given-names></name><name name-style="western"><surname>Heinrich</surname><given-names>M.</given-names></name><name name-style="western"><surname>Atanasov</surname><given-names>A.G.</given-names></name></person-group><article-title>Ethnopharmacology-A Bibliometric Analysis of a Field of Research Meandering between Medicine and Food Science?</article-title><source>Front. Pharmacol.</source><year>2018</year><volume>9</volume><fpage>347011</fpage><pub-id pub-id-type="doi">10.3389/fphar.2018.00215</pub-id><pub-id pub-id-type="pmcid">PMC5862826</pub-id><pub-id pub-id-type="pmid">29599720</pub-id></element-citation></ref><ref id="B87-pharmaceutics-16-00454"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weckerle</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>de Boer</surname><given-names>H.J.</given-names></name><name name-style="western"><surname>Puri</surname><given-names>R.K.</given-names></name><name name-style="western"><surname>van Andel</surname><given-names>T.</given-names></name><name name-style="western"><surname>Bussmann</surname><given-names>R.W.</given-names></name><name name-style="western"><surname>Leonti</surname><given-names>M.</given-names></name></person-group><article-title>Recommended Standards for Conducting and Reporting Ethnopharmacological Field Studies</article-title><source>J. Ethnopharmacol.</source><year>2018</year><volume>210</volume><fpage>125</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2017.08.018</pub-id><pub-id pub-id-type="pmid">28834697</pub-id></element-citation></ref><ref id="B88-pharmaceutics-16-00454"><label>88.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Jansen</surname><given-names>J.</given-names></name></person-group><source>Geobotanical Guide of the Serra Da Estrela</source><publisher-name>Instituto da Conserva&#231;ao da Natureza</publisher-name><publisher-loc>Lisbon, Portugal</publisher-loc><year>2002</year><size units="pages">276p</size></element-citation></ref><ref id="B89-pharmaceutics-16-00454"><label>89.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Vieira</surname><given-names>G.</given-names></name><name name-style="western"><surname>Jansen</surname><given-names>J.</given-names></name></person-group><article-title>Environmental Setting of the Serra Da Estrela, Portugal: A Short-Note</article-title><source>Landscape Ecology and Management of Atlantic Mountains</source><person-group person-group-type="editor"><name name-style="western"><surname>Correia</surname><given-names>T.P.</given-names></name><name name-style="western"><surname>Bunce</surname><given-names>R.G.H.</given-names></name><name name-style="western"><surname>Howard</surname><given-names>D.C.</given-names></name></person-group><publisher-name>IALE</publisher-name><publisher-loc>Logan, UT, USA</publisher-loc><year>2005</year><isbn>9780954713003</isbn></element-citation></ref><ref id="B90-pharmaceutics-16-00454"><label>90.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Marques</surname><given-names>P.P.</given-names></name></person-group><source>Serra Da Estrela: Management and Conservation of Priority Habitats</source><publisher-name>Associa&#231;&#227;o;</publisher-name><publisher-name>Gr&#225;fica do Tortosendo, Lda</publisher-name><publisher-loc>Vila Real, Portugal</publisher-loc><year>2006</year></element-citation></ref><ref id="B91-pharmaceutics-16-00454"><label>91.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Alexandre</surname><given-names>S.</given-names></name><name name-style="western"><surname>Catarina</surname><given-names>M.</given-names></name><name name-style="western"><surname>Claudia</surname><given-names>D.</given-names></name><name name-style="western"><surname>Fatima</surname><given-names>S.J.C.L.S.T.B.</given-names></name></person-group><source>Plantas Arom&#225;ticas e Medicinais Do Parque Natural Da Serra Da Estrela: Guia Etnobot&#226;nico</source><publisher-name>CISE-Munic&#237;pio de Seia</publisher-name><publisher-loc>Seia, Portugal</publisher-loc><year>2011</year><fpage>1</fpage><lpage>225</lpage></element-citation></ref><ref id="B92-pharmaceutics-16-00454"><label>92.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Da Cunha</surname><given-names>A.P.</given-names></name><name name-style="western"><surname>Ribeiro</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Roque</surname><given-names>O.R.</given-names></name></person-group><source>Plantas Arom&#225;ticas Em Portugal: Caracteriza&#231;&#227;o e Utiliza&#231;&#245;es</source><publisher-name>Funda&#231;&#227;o Calouste Gulbenkian</publisher-name><publisher-loc>Lisbon, Portugal</publisher-loc><year>2007</year></element-citation></ref><ref id="B93-pharmaceutics-16-00454"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fernandes</surname><given-names>R.B.</given-names></name></person-group><article-title>As Explora&#231;&#245;es Bot&#226;nicas Do Instituto Bot&#226;nico Da Universidade de Coimbra No Parque Natural Da Serra Da Estrela Nos &#218;ltimos 50 Anos</article-title><source>Anu. Soc. Brot.</source><year>1992</year><volume>58</volume><fpage>1</fpage><lpage>12</lpage></element-citation></ref><ref id="B94-pharmaceutics-16-00454"><label>94.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Jansen</surname><given-names>J.</given-names></name></person-group><article-title>Stands of Cytisus Oromediterraneus in the Serra Da Estrela, with Some Remarks on the Habitats of the Bluethroat (Luscinia Svecica Cyanecula)</article-title><source>11 Semin&#225;rio T&#233;cnico Conserva&#231;ao da Natureza na Serra da Estrela, Parque Natural da Serra da Estrela, Manteigas</source><publisher-name>Elsevier</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>1994</year></element-citation></ref><ref id="B95-pharmaceutics-16-00454"><label>95.</label><element-citation publication-type="confproc"><person-group person-group-type="author"><name name-style="western"><surname>Boa</surname><given-names>V.</given-names></name><name name-style="western"><surname>Coelho</surname><given-names>H.</given-names></name><name name-style="western"><surname>Amaro</surname><given-names>C.</given-names></name><name name-style="western"><surname>Castanheira</surname><given-names>I.</given-names></name><name name-style="western"><surname>Delgado</surname><given-names>F.</given-names></name><name name-style="western"><surname>Jacinto</surname><given-names>P.</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Caldeira</surname><given-names>R.E.</given-names></name></person-group><article-title>Inventaria&#231;&#227;o e Propaga&#231;&#227;o de <italic toggle="yes">Thymus mastichina</italic> Na Beira Interior</article-title><source>Proceedings of the II Congresso Nacional de Plnatas Arom&#225;ticas e Medicinais</source><conf-loc>Ger&#234;s, Portugal</conf-loc><conf-date>28&#8211;29 September 2007</conf-date><fpage>46</fpage><lpage>51</lpage></element-citation></ref><ref id="B96-pharmaceutics-16-00454"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gil</surname><given-names>C.</given-names></name><name name-style="western"><surname>Duarte</surname><given-names>A.P.</given-names></name></person-group><article-title>Antioxidant Activity of Extracts of Portuguese Shrubs: Pterospartum Tridentatum, Cytisus Scoparius and Erica Spp.</article-title><source>J. Med. Plants Res.</source><year>2009</year><volume>3</volume><fpage>886</fpage><lpage>893</lpage></element-citation></ref><ref id="B97-pharmaceutics-16-00454"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carocho</surname><given-names>M.</given-names></name><name name-style="western"><surname>Barros</surname><given-names>L.</given-names></name><name name-style="western"><surname>Barreira</surname><given-names>J.C.M.</given-names></name><name name-style="western"><surname>Calhelha</surname><given-names>R.C.</given-names></name><name name-style="western"><surname>Sokovi&#263;</surname><given-names>M.</given-names></name><name name-style="western"><surname>Fern&#225;ndez-Ruiz</surname><given-names>V.</given-names></name><name name-style="western"><surname>Buelga</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>Morales</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>I.C.F.R.</given-names></name></person-group><article-title>Basil as Functional and Preserving Ingredient in &#8220;Serra Da Estrela&#8221; Cheese</article-title><source>Food Chem.</source><year>2016</year><volume>207</volume><fpage>51</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2016.03.085</pub-id><pub-id pub-id-type="pmid">27080879</pub-id></element-citation></ref><ref id="B98-pharmaceutics-16-00454"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carocho</surname><given-names>M.</given-names></name><name name-style="western"><surname>Barreira</surname><given-names>J.C.M.</given-names></name><name name-style="western"><surname>Antonio</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Bento</surname><given-names>A.</given-names></name><name name-style="western"><surname>Morales</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>I.C.F.R.</given-names></name></person-group><article-title>The Incorporation of Plant Materials in &#8220;Serra Da Estrela&#8221; Cheese Improves Antioxidant Activity without Changing the Fatty Acid Profile and Visual Appearance</article-title><source>Eur. J. Lipid Sci. Technol.</source><year>2015</year><volume>117</volume><fpage>1607</fpage><lpage>1614</lpage><pub-id pub-id-type="doi">10.1002/ejlt.201500018</pub-id></element-citation></ref><ref id="B99-pharmaceutics-16-00454"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mora</surname><given-names>C.</given-names></name></person-group><article-title>A Synthetic Map of the Climatopes of the Serra Da Estrela (Portugal)</article-title><source>J. Maps</source><year>2010</year><volume>6</volume><fpage>591</fpage><lpage>608</lpage><pub-id pub-id-type="doi">10.4113/jom.2010.1112</pub-id></element-citation></ref><ref id="B100-pharmaceutics-16-00454"><label>100.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Presid&#234;ncia do Conselho de Ministros</collab></person-group><source>Resolu&#231;&#227;o Do Conselho de Ministros 76/2000 Proposto Para. Integrar o S&#237;tio &#8220;Serra Da Estrela&#8221; a Rede Natura 2000</source><publisher-name>Presid&#234;ncia do Conselho de Ministros</publisher-name><publisher-loc>Lisbon, Portugal</publisher-loc><year>1976</year></element-citation></ref><ref id="B101-pharmaceutics-16-00454"><label>101.</label><element-citation publication-type="webpage"><article-title>Minist&#233;rio do Ambiente Decreto Regulamentar 50/97, Reclassifica o Parque Natural Da Serra Da Estrela</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://dre.tretas.org/dre/88089/decreto-regulamentar-50-97-de-20-de-novembro" ext-link-type="uri">https://dre.tretas.org/dre/88089/decreto-regulamentar-50-97-de-20-de-novembro</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2023-06-20">(accessed on 20 June 2023)</date-in-citation></element-citation></ref><ref id="B102-pharmaceutics-16-00454"><label>102.</label><element-citation publication-type="webpage"><article-title>CISE Centro de Interpreta&#231;&#227;o Da Serra Da Estrela</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.cise.pt/pt/index.php/cise/missao" ext-link-type="uri">http://www.cise.pt/pt/index.php/cise/missao</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2023-06-20">(accessed on 20 June 2023)</date-in-citation></element-citation></ref><ref id="B103-pharmaceutics-16-00454"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jansen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sequeire</surname><given-names>M.P.S.M.</given-names></name></person-group><article-title>The Vegetation of Shallow Waters and Seasonally Inundated Habitats (Littorelletea and Isoeto-Nanojuncetea) in the Higher Parts of the Serra Da Estrela</article-title><source>Mitteilungen Badischen Landesver. Naturkunde</source><year>1999</year><volume>17</volume><fpage>449</fpage><lpage>462</lpage></element-citation></ref><ref id="B104-pharmaceutics-16-00454"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garcia</surname><given-names>C.</given-names></name><name name-style="western"><surname>S&#233;rgio</surname><given-names>C.</given-names></name><name name-style="western"><surname>Jansen</surname><given-names>J.</given-names></name></person-group><article-title>The Bryophyte Flora of the Natural Park of Serra Da Estrela (Portugal): Conservation and Biogeographical Approaches</article-title><source>Cryptogam. Bryol.</source><year>2008</year><volume>29</volume><fpage>49</fpage><lpage>73</lpage></element-citation></ref><ref id="B105-pharmaceutics-16-00454"><label>105.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Daveau</surname><given-names>S.</given-names></name><name name-style="western"><surname>Coelho</surname><given-names>C.</given-names></name><name name-style="western"><surname>Costa</surname><given-names>V.G.E.</given-names></name><name name-style="western"><surname>Carvalho</surname><given-names>L.</given-names></name></person-group><source>Repartition et Rythme Des Precipitations Au Portugal</source><person-group person-group-type="editor"><name name-style="western"><surname>Daveau</surname><given-names>D.</given-names></name></person-group><publisher-name>Mem. CEG.</publisher-name><publisher-loc>Lisbon, Portugal</publisher-loc><year>1977</year><volume>Volume 3</volume></element-citation></ref><ref id="B106-pharmaceutics-16-00454"><label>106.</label><element-citation publication-type="webpage"><article-title>Google Maps Serra Da Estrela</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.google.com/maps/place/Serra+da+Estrela/@40.32303,-7.5960533,15z/data=!3m1!4b1!4m6!3m5!1s0xd3d28a0408be839:0x1d00ebbed2102ce0!8m2!3d40.3230306!4d-7.5960533!16zL20vMDNqdHNw?entry=ttu" ext-link-type="uri">https://www.google.com/maps/place/Serra+da+Estrela/@40.32303,-7.5960533,15z/data=!3m1!4b1!4m6!3m5!1s0xd3d28a0408be839:0x1d00ebbed2102ce0!8m2!3d40.3230306!4d-7.5960533!16zL20vMDNqdHNw?entry=ttu</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2023-12-12">(accessed on 12 December 2023)</date-in-citation></element-citation></ref><ref id="B107-pharmaceutics-16-00454"><label>107.</label><element-citation publication-type="webpage"><article-title>WCVP The World Checklist of Vascular Plants</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://powo.science.kew.org/about-wcvp" ext-link-type="uri">https://powo.science.kew.org/about-wcvp</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2023-06-22">(accessed on 22 June 2023)</date-in-citation></element-citation></ref><ref id="B108-pharmaceutics-16-00454"><label>108.</label><element-citation publication-type="webpage"><article-title>Sociedade Portuguesa de Bot&#226;nica Flora-On</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://flora-on.pt/" ext-link-type="uri">https://flora-on.pt/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2023-06-22">(accessed on 22 June 2023)</date-in-citation></element-citation></ref><ref id="B109-pharmaceutics-16-00454"><label>109.</label><element-citation publication-type="webpage"><article-title>INaturalist INaturalist</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.inaturalist.org/pages/what+is+it" ext-link-type="uri">https://www.inaturalist.org/pages/what+is+it</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2023-06-22">(accessed on 22 June 2023)</date-in-citation></element-citation></ref><ref id="B110-pharmaceutics-16-00454"><label>110.</label><element-citation publication-type="webpage"><article-title>IPCC Intergovernmental Panel on Climate Change</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ipcc.ch/" ext-link-type="uri">https://www.ipcc.ch/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2023-11-29">(accessed on 29 November 2023)</date-in-citation></element-citation></ref><ref id="B111-pharmaceutics-16-00454"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adler</surname><given-names>C.</given-names></name><name name-style="western"><surname>Huggel</surname><given-names>C.</given-names></name><name name-style="western"><surname>Orlove</surname><given-names>B.</given-names></name><name name-style="western"><surname>Nolin</surname><given-names>A.</given-names></name></person-group><article-title>Climate Change in the Mountain Cryosphere: Impacts and Responses</article-title><source>Reg. Environ. Chang.</source><year>2019</year><volume>19</volume><fpage>1225</fpage><lpage>1228</lpage><pub-id pub-id-type="doi">10.1007/s10113-019-01507-6</pub-id></element-citation></ref><ref id="B112-pharmaceutics-16-00454"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abram</surname><given-names>N.J.</given-names></name><name name-style="western"><surname>Henley</surname><given-names>B.J.</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Lippmann</surname><given-names>T.J.R.</given-names></name><name name-style="western"><surname>Clarke</surname><given-names>H.</given-names></name><name name-style="western"><surname>Dowdy</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Sharples</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Nolan</surname><given-names>R.H.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>T.</given-names></name><name name-style="western"><surname>Wooster</surname><given-names>M.J.</given-names></name><etal/></person-group><article-title>Connections of Climate Change and Variability to Large and Extreme Forest Fires in Southeast Australia</article-title><source>Commun. Earth Environ.</source><year>2021</year><volume>2</volume><fpage>8</fpage><pub-id pub-id-type="doi">10.1038/s43247-020-00065-8</pub-id></element-citation></ref><ref id="B113-pharmaceutics-16-00454"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Albrich</surname><given-names>K.</given-names></name><name name-style="western"><surname>Rammer</surname><given-names>W.</given-names></name><name name-style="western"><surname>Seidl</surname><given-names>R.</given-names></name></person-group><article-title>Climate Change Causes Critical Transitions and Irreversible Alterations of Mountain Forests</article-title><source>Glob. Chang. Biol.</source><year>2020</year><volume>26</volume><fpage>4013</fpage><lpage>4027</lpage><pub-id pub-id-type="doi">10.1111/gcb.15118</pub-id><pub-id pub-id-type="pmid">32301569</pub-id><pub-id pub-id-type="pmcid">PMC7317840</pub-id></element-citation></ref><ref id="B114-pharmaceutics-16-00454"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>K&#246;rner</surname><given-names>C.</given-names></name></person-group><article-title>Mountain Ecosystems in a Changing Environment</article-title><source>Eco Mont</source><year>2014</year><volume>6</volume><fpage>71</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1553/ecomont-6-1s71</pub-id></element-citation></ref><ref id="B115-pharmaceutics-16-00454"><label>115.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Badola</surname><given-names>R.</given-names></name><name name-style="western"><surname>Chettri</surname><given-names>N.</given-names></name><name name-style="western"><surname>Chaudhary</surname><given-names>R.P.</given-names></name><name name-style="western"><surname>Zomer</surname><given-names>R.</given-names></name><name name-style="western"><surname>Pokhrel</surname><given-names>B.</given-names></name><name name-style="western"><surname>Hussain</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Pradhan</surname><given-names>S.</given-names></name><name name-style="western"><surname>Pradhan</surname><given-names>R.</given-names></name></person-group><article-title>Sustaining Biodiversity and Ecosystem Services in the Hindu Kush Himalaya</article-title><source>The Hindu Kush Himalaya Assessment: Mountains, Climate Change, Sustainability and People</source><publisher-name>Springer</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>2019</year><fpage>127</fpage><lpage>165</lpage></element-citation></ref><ref id="B116-pharmaceutics-16-00454"><label>116.</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>The Royal Botanic Gardens Kew</collab></person-group><article-title>Plants of the World Online</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://powo.science.kew.org/results?q=Prunella%20vulgaris" ext-link-type="uri">https://powo.science.kew.org/results?q=Prunella%20vulgaris</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2023-12-07">(accessed on 7 December 2023)</date-in-citation></element-citation></ref><ref id="B117-pharmaceutics-16-00454"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cabral</surname><given-names>C.</given-names></name><name name-style="western"><surname>Cavaleiro</surname><given-names>C.</given-names></name><name name-style="western"><surname>Gon&#231;alves</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Cruz</surname><given-names>M.T.</given-names></name><name name-style="western"><surname>Lopes</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Salgueiro</surname><given-names>L.</given-names></name></person-group><article-title><italic toggle="yes">Otanthus maritimus</italic> (L.) Hoffmanns. &amp; Link as a Source of a Bioactive and Fragrant Oil</article-title><source>Ind. Crops Prod.</source><year>2013</year><volume>43</volume><fpage>484</fpage><lpage>489</lpage><pub-id pub-id-type="doi">10.1016/J.INDCROP.2012.07.057</pub-id></element-citation></ref><ref id="B118-pharmaceutics-16-00454"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kenny</surname><given-names>O.</given-names></name><name name-style="western"><surname>Smyth</surname><given-names>T.J.</given-names></name><name name-style="western"><surname>Walsh</surname><given-names>D.</given-names></name><name name-style="western"><surname>Kelleher</surname><given-names>C.T.</given-names></name><name name-style="western"><surname>Hewage</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Brunton</surname><given-names>N.P.</given-names></name></person-group><article-title>Investigating the Potential of Under-Utilised Plants from the <italic toggle="yes">Asteraceae</italic> Family as a Source of Natural Antimicrobial and Antioxidant Extracts</article-title><source>Food Chem.</source><year>2014</year><volume>161</volume><fpage>79</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2014.03.126</pub-id><pub-id pub-id-type="pmid">24837924</pub-id></element-citation></ref><ref id="B119-pharmaceutics-16-00454"><label>119.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Simpson</surname><given-names>M.G.</given-names></name></person-group><article-title>Diversity and Classification of Flowering Plants: Eudicots</article-title><source>Plant Systematics</source><publisher-name>Academic Press</publisher-name><publisher-loc>Cambridge, MA, USA</publisher-loc><year>2010</year><fpage>275</fpage><lpage>448</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-374380-0.50008-7</pub-id></element-citation></ref><ref id="B120-pharmaceutics-16-00454"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Broholm</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Teeri</surname><given-names>T.H.</given-names></name><name name-style="western"><surname>Elomaa</surname><given-names>P.</given-names></name></person-group><article-title>Molecular Control of Inflorescence Development in <italic toggle="yes">Asteraceae</italic></article-title><source>Adv. Bot. Res.</source><year>2014</year><volume>72</volume><fpage>297</fpage><lpage>333</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-417162-6.00010-9</pub-id></element-citation></ref><ref id="B121-pharmaceutics-16-00454"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harris</surname><given-names>E.M.</given-names></name></person-group><article-title>Inflorescence and Floral Ontogeny in <italic toggle="yes">Asteraceae</italic>: A Syn (Doctoral Dissertation, Thesis of Historical and Current Concepts)</article-title><source>Bot. Rev.</source><year>1995</year><volume>61</volume><fpage>93</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1007/BF02887192</pub-id></element-citation></ref><ref id="B122-pharmaceutics-16-00454"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohanta</surname><given-names>Y.K.</given-names></name><name name-style="western"><surname>Mishra</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Nongbet</surname><given-names>A.</given-names></name><name name-style="western"><surname>Chakrabartty</surname><given-names>I.</given-names></name><name name-style="western"><surname>Mahanta</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sarma</surname><given-names>B.</given-names></name><name name-style="western"><surname>Panda</surname><given-names>J.</given-names></name><name name-style="western"><surname>Panda</surname><given-names>S.K.</given-names></name></person-group><article-title>Potential Use of the <italic toggle="yes">Asteraceae</italic> Family as a Cure for Diabetes: A Review of Ethnopharmacology to Modern Day Drug and Nutraceuticals Developments</article-title><source>Front. Pharmacol.</source><year>2023</year><volume>14</volume><fpage>1153600</fpage><pub-id pub-id-type="doi">10.3389/fphar.2023.1153600</pub-id><pub-id pub-id-type="pmid">37608892</pub-id><pub-id pub-id-type="pmcid">PMC10441548</pub-id></element-citation></ref><ref id="B123-pharmaceutics-16-00454"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garcia-Oliveira</surname><given-names>P.</given-names></name><name name-style="western"><surname>Barral</surname><given-names>M.</given-names></name><name name-style="western"><surname>Carpena</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gull&#243;n</surname><given-names>P.</given-names></name><name name-style="western"><surname>Fraga-Corral</surname><given-names>M.</given-names></name><name name-style="western"><surname>Otero</surname><given-names>P.</given-names></name><name name-style="western"><surname>Prieto</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Simal-Gandara</surname><given-names>J.</given-names></name></person-group><article-title>Traditional Plants from <italic toggle="yes">Asteraceae</italic> Family as Potential Candidates for Functional Food Industry</article-title><source>Food Funct.</source><year>2021</year><volume>12</volume><fpage>2850</fpage><lpage>2873</lpage><pub-id pub-id-type="doi">10.1039/D0FO03433A</pub-id><pub-id pub-id-type="pmid">33683253</pub-id></element-citation></ref><ref id="B124-pharmaceutics-16-00454"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Woldeamanuel</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Geda</surname><given-names>M.K.</given-names></name><name name-style="western"><surname>Mohapatra</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bastia</surname><given-names>T.K.</given-names></name><name name-style="western"><surname>Rath</surname><given-names>P.</given-names></name><name name-style="western"><surname>Panda</surname><given-names>A.K.</given-names></name></person-group><article-title>Ethnobotanical Study of Endemic and Non-Endemic Medicinal Plants Used by Indigenous People in Environs of Gullele Botanical Garden Addis Ababa, Central Ethiopia: A Major Focus on <italic toggle="yes">Asteraceae</italic> Family</article-title><source>Front. Pharmacol.</source><year>2022</year><volume>13</volume><fpage>1020097</fpage><pub-id pub-id-type="doi">10.3389/fphar.2022.1020097</pub-id><pub-id pub-id-type="pmid">36506590</pub-id><pub-id pub-id-type="pmcid">PMC9727095</pub-id></element-citation></ref><ref id="B125-pharmaceutics-16-00454"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Michel</surname><given-names>J.</given-names></name><name name-style="western"><surname>Abd Rani</surname><given-names>N.Z.</given-names></name><name name-style="western"><surname>Husain</surname><given-names>K.</given-names></name></person-group><article-title>A Review on the Potential Use of Medicinal Plants From <italic toggle="yes">Asteraceae</italic> and <italic toggle="yes">Lamiaceae</italic> Plant Family in Cardiovascular Diseases</article-title><source>Front. Pharmacol.</source><year>2020</year><volume>11</volume><fpage>484919</fpage><pub-id pub-id-type="doi">10.3389/fphar.2020.00852</pub-id><pub-id pub-id-type="pmcid">PMC7291392</pub-id><pub-id pub-id-type="pmid">32581807</pub-id></element-citation></ref><ref id="B126-pharmaceutics-16-00454"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Panda</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Da Silva</surname><given-names>L.C.N.</given-names></name><name name-style="western"><surname>Sahal</surname><given-names>D.</given-names></name><name name-style="western"><surname>Leonti</surname><given-names>M.</given-names></name></person-group><article-title>Editorial: Ethnopharmacological Studies for the Development of Drugs with Special Reference to <italic toggle="yes">Asteraceae</italic></article-title><source>Front. Pharmacol.</source><year>2019</year><volume>10</volume><fpage>483288</fpage><pub-id pub-id-type="doi">10.3389/fphar.2019.00955</pub-id><pub-id pub-id-type="pmcid">PMC6737279</pub-id><pub-id pub-id-type="pmid">31551771</pub-id></element-citation></ref><ref id="B127-pharmaceutics-16-00454"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bessada</surname><given-names>S.M.F.</given-names></name><name name-style="western"><surname>Barreira</surname><given-names>J.C.M.</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>M.B.P.P.</given-names></name></person-group><article-title><italic toggle="yes">Asteraceae</italic> Species with Most Prominent Bioactivity and Their Potential Applications: A Review</article-title><source>Ind. Crops Prod.</source><year>2015</year><volume>76</volume><fpage>604</fpage><lpage>615</lpage><pub-id pub-id-type="doi">10.1016/j.indcrop.2015.07.073</pub-id></element-citation></ref><ref id="B128-pharmaceutics-16-00454"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Panda</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Luyten</surname><given-names>W.</given-names></name></person-group><article-title>Antiparasitic Activity in <italic toggle="yes">Asteraceae</italic> with Special Attention to Ethnobotanical Use by the Tribes of Odisha, India</article-title><source>Parasite</source><year>2018</year><volume>25</volume><fpage>10</fpage><pub-id pub-id-type="doi">10.1051/parasite/2018008</pub-id><pub-id pub-id-type="pmid">29528842</pub-id><pub-id pub-id-type="pmcid">PMC5847338</pub-id></element-citation></ref><ref id="B129-pharmaceutics-16-00454"><label>129.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Devkota</surname><given-names>H.P.</given-names></name><name name-style="western"><surname>Aftab</surname><given-names>T.</given-names></name></person-group><source>Medicinal Plants of the Asteraceae Family: Traditional Uses, Phytochemistry and Pharmacological Activities</source><publisher-name>Springer</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>2022</year><fpage>1</fpage><lpage>230</lpage></element-citation></ref><ref id="B130-pharmaceutics-16-00454"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mouhid</surname><given-names>L.</given-names></name><name name-style="western"><surname>G&#243;mez De Cedr&#243;n</surname><given-names>M.</given-names></name><name name-style="western"><surname>Vargas</surname><given-names>T.</given-names></name><name name-style="western"><surname>Garc&#237;a-Carrascosa</surname><given-names>E.</given-names></name><name name-style="western"><surname>Herranz</surname><given-names>N.</given-names></name><name name-style="western"><surname>Garc&#237;a-Risco</surname><given-names>M.</given-names></name><name name-style="western"><surname>Reglero</surname><given-names>G.</given-names></name><name name-style="western"><surname>Fornari</surname><given-names>T.</given-names></name><name name-style="western"><surname>De Molina</surname><given-names>A.R.</given-names></name></person-group><article-title>Identification of Antitumoral Agents against Human Pancreatic Cancer Cells from <italic toggle="yes">Asteraceae</italic> and <italic toggle="yes">Lamiaceae</italic> Plant Extracts</article-title><source>BMC Complement. Altern. Med.</source><year>2018</year><volume>18</volume><elocation-id>254</elocation-id><pub-id pub-id-type="doi">10.1186/s12906-018-2322-6</pub-id><pub-id pub-id-type="pmid">30223811</pub-id><pub-id pub-id-type="pmcid">PMC6142333</pub-id></element-citation></ref><ref id="B131-pharmaceutics-16-00454"><label>131.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Lorenzi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Matos</surname><given-names>F.J.A.</given-names></name></person-group><source>Plantas Medicinais No Brasil: Nativas e Exoticas</source><person-group person-group-type="editor"><name name-style="western"><surname>Instituto Plantarum</surname></name></person-group><publisher-name>Instituto Plantarum de Estudos da Flora</publisher-name><publisher-loc>Nova Odessa, Brazil</publisher-loc><year>2002</year></element-citation></ref><ref id="B132-pharmaceutics-16-00454"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Petlevski</surname><given-names>R.</given-names></name><name name-style="western"><surname>Had&#382;ija</surname><given-names>M.</given-names></name><name name-style="western"><surname>Slijep&#269;evi&#269;</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jureti&#269;</surname><given-names>D.</given-names></name></person-group><article-title>Effect of &#8220;antidiabetis&#8221; Herbal Preparation on Serum Glucose and Fructosamine in NOD Mice</article-title><source>J. Ethnopharmacol.</source><year>2001</year><volume>75</volume><fpage>181</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(01)00177-5</pub-id><pub-id pub-id-type="pmid">11297848</pub-id></element-citation></ref><ref id="B133-pharmaceutics-16-00454"><label>133.</label><element-citation publication-type="patent"><person-group person-group-type="author"><name name-style="western"><surname>Paradise</surname><given-names>L.</given-names></name></person-group><article-title>Homeopathic Pharmaceutical Compositions</article-title><source>U.S. Patent</source><patent>5795573A</patent><day>18</day><month>August</month><year>1998</year></element-citation></ref><ref id="B134-pharmaceutics-16-00454"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chaachouay</surname><given-names>N.</given-names></name><name name-style="western"><surname>Benkhnigue</surname><given-names>O.</given-names></name><name name-style="western"><surname>Fadli</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ibaoui</surname><given-names>H.E.</given-names></name><name name-style="western"><surname>Zidane</surname><given-names>L.</given-names></name></person-group><article-title>Ethnobotanical and Ethnopharmacological Studies of Medicinal and Aromatic Plants Used in the Treatment of Metabolic Diseases in the Moroccan Rif</article-title><source>Heliyon</source><year>2019</year><volume>5</volume><fpage>e02191</fpage><pub-id pub-id-type="doi">10.1016/j.heliyon.2019.e02191</pub-id><pub-id pub-id-type="pmid">31720440</pub-id><pub-id pub-id-type="pmcid">PMC6838988</pub-id></element-citation></ref><ref id="B135-pharmaceutics-16-00454"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wazaify</surname><given-names>M.</given-names></name><name name-style="western"><surname>Afifi</surname><given-names>F.</given-names></name><name name-style="western"><surname>El-Khateeb</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ajlouni</surname><given-names>K.</given-names></name></person-group><article-title>Complementary and Alternative Medicine Use among Jordanian Patients with Diabetes</article-title><source>Complement. Ther. Clin. Pract.</source><year>2011</year><volume>17</volume><fpage>71</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1016/j.ctcp.2011.02.002</pub-id><pub-id pub-id-type="pmid">21457894</pub-id></element-citation></ref><ref id="B136-pharmaceutics-16-00454"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dei Cas</surname><given-names>L.</given-names></name><name name-style="western"><surname>Pugni</surname><given-names>F.</given-names></name><name name-style="western"><surname>Fico</surname><given-names>G.</given-names></name></person-group><article-title>Tradition of Use on Medicinal Species in Valfurva (Sondrio, Italy)</article-title><source>J. Ethnopharmacol.</source><year>2015</year><volume>163</volume><fpage>113</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2014.12.054</pub-id><pub-id pub-id-type="pmid">25617749</pub-id></element-citation></ref><ref id="B137-pharmaceutics-16-00454"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Errajraji</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ouhdouch</surname><given-names>F.</given-names></name><name name-style="western"><surname>El-Anssari</surname><given-names>N.</given-names></name></person-group><article-title>Usage Des Plantes M&#233;dicinales Dans Le Traitement Du Diab&#232;te de Type 2 Au Maroc: Use of Medicinal Plants for Type 2 Diabetes Treatment, in Morocco</article-title><source>M&#233;decine Des Mal. M&#233;taboliques</source><year>2010</year><volume>4</volume><fpage>301</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1016/S1957-2557(10)70064-X</pub-id></element-citation></ref><ref id="B138-pharmaceutics-16-00454"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trojan-Rodrigues</surname><given-names>M.</given-names></name><name name-style="western"><surname>Alves</surname><given-names>T.L.S.</given-names></name><name name-style="western"><surname>Soares</surname><given-names>G.L.G.</given-names></name><name name-style="western"><surname>Ritter</surname><given-names>M.R.</given-names></name></person-group><article-title>Plants Used as Antidiabetics in Popular Medicine in Rio Grande Do Sul, Southern Brazil</article-title><source>J. Ethnopharmacol.</source><year>2012</year><volume>139</volume><fpage>155</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2011.10.034</pub-id><pub-id pub-id-type="pmid">22079795</pub-id></element-citation></ref><ref id="B139-pharmaceutics-16-00454"><label>139.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Pullaiah</surname><given-names>T.</given-names></name></person-group><source>Encyclopedia of World Medicinal Plants</source><publisher-name>Regency Publications</publisher-name><publisher-loc>Delhi, India</publisher-loc><year>2006</year></element-citation></ref><ref id="B140-pharmaceutics-16-00454"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>M&#243;ricz</surname><given-names>&#193;.M.</given-names></name><name name-style="western"><surname>Ott</surname><given-names>P.G.</given-names></name><name name-style="western"><surname>H&#228;be</surname><given-names>T.T.</given-names></name><name name-style="western"><surname>Darcsi</surname><given-names>A.</given-names></name><name name-style="western"><surname>B&#246;sz&#246;rm&#233;nyi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Alberti</surname><given-names>&#193;.</given-names></name><name name-style="western"><surname>Kr&#252;zselyi</surname><given-names>D.</given-names></name><name name-style="western"><surname>Csontos</surname><given-names>P.</given-names></name><name name-style="western"><surname>B&#233;ni</surname><given-names>S.</given-names></name><name name-style="western"><surname>Morlock</surname><given-names>G.E.</given-names></name></person-group><article-title>Effect-Directed Discovery of Bioactive Compounds Followed by Highly Targeted Characterization, Isolation and Identification, Exemplarily Shown for <italic toggle="yes">Solidago virgaurea</italic></article-title><source>Anal. Chem.</source><year>2016</year><volume>88</volume><fpage>8202</fpage><lpage>8209</lpage><pub-id pub-id-type="doi">10.1021/acs.analchem.6b02007</pub-id><pub-id pub-id-type="pmid">27433973</pub-id></element-citation></ref><ref id="B141-pharmaceutics-16-00454"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kamau</surname><given-names>L.N.</given-names></name><name name-style="western"><surname>Mbaabu</surname><given-names>M.P.</given-names></name><name name-style="western"><surname>Mbaria</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Karuri</surname><given-names>G.P.</given-names></name><name name-style="western"><surname>Kiama</surname><given-names>S.G.</given-names></name></person-group><article-title>Knowledge and Demand for Medicinal Plants Used in the Treatment and Management of Diabetes in Nyeri County, Kenya</article-title><source>J. Ethnopharmacol.</source><year>2016</year><volume>189</volume><fpage>218</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2016.05.021</pub-id><pub-id pub-id-type="pmid">27180316</pub-id></element-citation></ref><ref id="B142-pharmaceutics-16-00454"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cornara</surname><given-names>L.</given-names></name><name name-style="western"><surname>La Rocca</surname><given-names>A.</given-names></name><name name-style="western"><surname>Marsili</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mariotti</surname><given-names>M.G.</given-names></name></person-group><article-title>Traditional Uses of Plants in the Eastern Riviera (Liguria, Italy)</article-title><source>J. Ethnopharmacol.</source><year>2009</year><volume>125</volume><fpage>16</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2009.06.021</pub-id><pub-id pub-id-type="pmid">19563876</pub-id></element-citation></ref><ref id="B143-pharmaceutics-16-00454"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Benkhnigue</surname><given-names>O.</given-names></name><name name-style="western"><surname>Akka</surname><given-names>B.</given-names></name><name name-style="western"><surname>Salhi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Fadli</surname><given-names>M.</given-names></name><name name-style="western"><surname>Douira</surname><given-names>A.</given-names></name><name name-style="western"><surname>Zidane</surname><given-names>L.</given-names></name></person-group><article-title>Catalogue Des Plantes M&#233;dicinales Utilis&#233;es Dans Le Traitement Du Diab&#232;te Dans La R&#233;gion d&#8217;Al Haouz-Rhamna (Maroc)</article-title><source>J. Anim. Plant Sci.</source><year>2014</year><volume>23</volume><fpage>3539</fpage><lpage>3568</lpage></element-citation></ref><ref id="B144-pharmaceutics-16-00454"><label>144.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Tamokou</surname><given-names>J.D.D.</given-names></name><name name-style="western"><surname>Mbaveng</surname><given-names>A.T.</given-names></name><name name-style="western"><surname>Kuete</surname><given-names>V.</given-names></name></person-group><article-title>Antimicrobial Activities of African Medicinal Spices and Vegetables</article-title><source>Medicinal Spices and Vegetables from Africa: Therapeutic Potential. Against Metabolic, Inflammatory, Infectious and Systemic Diseases</source><publisher-name>Academic Press</publisher-name><publisher-loc>Cambridge, MA, USA</publisher-loc><year>2017</year><fpage>207</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-809286-6.00008-X</pub-id></element-citation></ref><ref id="B145-pharmaceutics-16-00454"><label>145.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Kokkini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Karousou</surname><given-names>R.</given-names></name><name name-style="western"><surname>Hanlidou</surname><given-names>E.</given-names></name></person-group><article-title>HERBS|Herbs of the Labiatae</article-title><source>Encyclopedia of Food Sciences and Nutrition</source><publisher-name>Academic Press</publisher-name><publisher-loc>Cambridge, MA, USA</publisher-loc><year>2003</year><fpage>3082</fpage><lpage>3090</lpage><pub-id pub-id-type="doi">10.1016/B0-12-227055-X/00593-9</pub-id></element-citation></ref><ref id="B146-pharmaceutics-16-00454"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Etsassala</surname><given-names>N.G.E.R.</given-names></name><name name-style="western"><surname>Hussein</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Nchu</surname><given-names>F.</given-names></name></person-group><article-title>Potential Application of Some <italic toggle="yes">Lamiaceae</italic> Species in the Management of Diabetes</article-title><source>Plants</source><year>2021</year><volume>10</volume><elocation-id>279</elocation-id><pub-id pub-id-type="doi">10.3390/plants10020279</pub-id><pub-id pub-id-type="pmid">33535455</pub-id><pub-id pub-id-type="pmcid">PMC7912742</pub-id></element-citation></ref><ref id="B147-pharmaceutics-16-00454"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghourri</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zidane</surname><given-names>L.</given-names></name><name name-style="western"><surname>Douira</surname><given-names>A.</given-names></name></person-group><article-title>Catalogue Des Plantes M&#233;dicinales Utilis&#233;es Dans Le Traitement de La Lithiase R&#233;nale Dans La Province de Tan-Tan (Maroc Saharien)</article-title><source>Int. J. Biol. Chem. Sci.</source><year>2014</year><volume>7</volume><elocation-id>1688</elocation-id><pub-id pub-id-type="doi">10.4314/ijbcs.v7i4.24</pub-id></element-citation></ref><ref id="B148-pharmaceutics-16-00454"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Skalli</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hassikou</surname><given-names>R.</given-names></name><name name-style="western"><surname>Arahou</surname><given-names>M.</given-names></name></person-group><article-title>An Ethnobotanical Survey of Medicinal Plants Used for Diabetes Treatment in Rabat, Morocco</article-title><source>Heliyon</source><year>2019</year><volume>5</volume><fpage>e01421</fpage><pub-id pub-id-type="doi">10.1016/j.heliyon.2019.e01421</pub-id><pub-id pub-id-type="pmid">30976694</pub-id><pub-id pub-id-type="pmcid">PMC6441794</pub-id></element-citation></ref><ref id="B149-pharmaceutics-16-00454"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Idm&#8217;hand</surname><given-names>E.</given-names></name><name name-style="western"><surname>Msanda</surname><given-names>F.</given-names></name><name name-style="western"><surname>Cherifi</surname><given-names>K.</given-names></name></person-group><article-title>Ethnopharmacological Review of Medicinal Plants Used to Manage Diabetes in Morocco</article-title><source>Clin. Phytosci.</source><year>2020</year><volume>6</volume><fpage>18</fpage><pub-id pub-id-type="doi">10.1186/s40816-020-00166-z</pub-id></element-citation></ref><ref id="B150-pharmaceutics-16-00454"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arifah</surname><given-names>F.H.</given-names></name><name name-style="western"><surname>Nugroho</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>Rohman</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sujarwo</surname><given-names>W.</given-names></name></person-group><article-title>A Review of Medicinal Plants for the Treatment of Diabetes Mellitus: The Case of Indonesia</article-title><source>S. Afr. J. Bot.</source><year>2022</year><volume>149</volume><fpage>537</fpage><lpage>558</lpage><pub-id pub-id-type="doi">10.1016/j.sajb.2022.06.042</pub-id></element-citation></ref><ref id="B151-pharmaceutics-16-00454"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tahraoui</surname><given-names>A.</given-names></name><name name-style="western"><surname>El-Hilaly</surname><given-names>J.</given-names></name><name name-style="western"><surname>Israili</surname><given-names>Z.H.</given-names></name><name name-style="western"><surname>Lyoussi</surname><given-names>B.</given-names></name></person-group><article-title>Ethnopharmacological Survey of Plants Used in the Traditional Treatment of Hypertension and Diabetes in South-Eastern Morocco (Errachidia Province)</article-title><source>J. Ethnopharmacol.</source><year>2007</year><volume>110</volume><fpage>105</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2006.09.011</pub-id><pub-id pub-id-type="pmid">17052873</pub-id></element-citation></ref><ref id="B152-pharmaceutics-16-00454"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eddouks</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ajebli</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hebi</surname><given-names>M.</given-names></name></person-group><article-title>Ethnopharmacological Survey of Medicinal Plants Used in Daraa-Tafilalet Region (Province of Errachidia), Morocco</article-title><source>J. Ethnopharmacol.</source><year>2017</year><volume>198</volume><fpage>516</fpage><lpage>530</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2016.12.017</pub-id><pub-id pub-id-type="pmid">28003130</pub-id></element-citation></ref><ref id="B153-pharmaceutics-16-00454"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ziyyat</surname><given-names>A.</given-names></name><name name-style="western"><surname>Legssyer</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mekhfi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Dassouli</surname><given-names>A.</given-names></name><name name-style="western"><surname>Serhrouchni</surname><given-names>M.</given-names></name><name name-style="western"><surname>Benjelloun</surname><given-names>W.</given-names></name></person-group><article-title>Phytotherapy of Hypertension and Diabetes in Oriental Morocco</article-title><source>J. Ethnopharmacol.</source><year>1997</year><volume>58</volume><fpage>45</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(97)00077-9</pub-id><pub-id pub-id-type="pmid">9324004</pub-id></element-citation></ref><ref id="B154-pharmaceutics-16-00454"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andrade-Cetto</surname><given-names>A.</given-names></name><name name-style="western"><surname>Heinrich</surname><given-names>M.</given-names></name></person-group><article-title>Mexican Plants with Hypoglycaemic Effect Used in the Treatment of Diabetes</article-title><source>J. Ethnopharmacol.</source><year>2005</year><volume>99</volume><fpage>325</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2005.04.019</pub-id><pub-id pub-id-type="pmid">15964161</pub-id></element-citation></ref><ref id="B155-pharmaceutics-16-00454"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mahomoodally</surname><given-names>M.F.</given-names></name><name name-style="western"><surname>Mootoosamy</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wambugu</surname><given-names>S.</given-names></name></person-group><article-title>Traditional Therapies Used to Manage Diabetes and Related Complications in Mauritius: A Comparative Ethnoreligious Study</article-title><source>Evid. Based Complement. Altern. Med.</source><year>2016</year><volume>2016</volume><fpage>4523828</fpage><pub-id pub-id-type="doi">10.1155/2016/4523828</pub-id><pub-id pub-id-type="pmid">27200100</pub-id><pub-id pub-id-type="pmcid">PMC4856945</pub-id></element-citation></ref><ref id="B156-pharmaceutics-16-00454"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheung</surname><given-names>H.Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Q.F.</given-names></name></person-group><article-title>Enhanced Analysis of Triterpenes, Flavonoids and Phenolic Compounds in <italic toggle="yes">Prunella vulgaris</italic> L. by Capillary Zone Electrophoresis with the Addition of Running Buffer Modifiers</article-title><source>J. Chromatogr. A</source><year>2008</year><volume>1213</volume><fpage>231</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1016/j.chroma.2008.10.033</pub-id><pub-id pub-id-type="pmid">18980769</pub-id></element-citation></ref><ref id="B157-pharmaceutics-16-00454"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Orch</surname><given-names>H.</given-names></name><name name-style="western"><surname>Douira</surname><given-names>A.</given-names></name><name name-style="western"><surname>Zidane</surname><given-names>L.</given-names></name></person-group><article-title>&#201;tude Ethnobotanique Des Plantes M&#233;dicinales Utilis&#233;es Dans Le Traitement Du Diab&#232;te, et Des Maladies Cardiaques Dans La R&#233;gion d&#8217;Izar&#232;ne (Nord Du Maroc)</article-title><source>J. Appl. Biosci.</source><year>2015</year><volume>86</volume><elocation-id>7940</elocation-id><pub-id pub-id-type="doi">10.4314/jab.v86i1.3</pub-id></element-citation></ref><ref id="B158-pharmaceutics-16-00454"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiao</surname><given-names>X.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>F.</given-names></name><name name-style="western"><surname>Zuo</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name></person-group><article-title>Study on the Mechanism of <italic toggle="yes">Prunella vulgaris</italic> L on Diabetes Mellitus Complicated with Hypertension Based on Network Pharmacology and Molecular Docking Analyses</article-title><source>J. Diabetes Res.</source><year>2021</year><volume>2021</volume><fpage>9949302</fpage><pub-id pub-id-type="doi">10.1155/2021/9949302</pub-id><pub-id pub-id-type="pmid">34692849</pub-id><pub-id pub-id-type="pmcid">PMC8536441</pub-id></element-citation></ref><ref id="B159-pharmaceutics-16-00454"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sokovic</surname><given-names>M.</given-names></name><name name-style="western"><surname>Marin</surname><given-names>P.D.</given-names></name><name name-style="western"><surname>Brkic</surname><given-names>D.</given-names></name><name name-style="western"><surname>van Griensven</surname><given-names>L.J.</given-names></name></person-group><article-title>Chemical Composition and Antibacterial Activity of Essential Oils against Human Pathogenic Bacteria</article-title><source>Food</source><year>2008</year><volume>1</volume><fpage>220</fpage><lpage>226</lpage></element-citation></ref><ref id="B160-pharmaceutics-16-00454"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nadon</surname><given-names>B.</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>S.</given-names></name></person-group><article-title>The Polyploid Origins of Crop Genomes and Their Implications: A Case Study in Legumes</article-title><source>Adv. Agron.</source><year>2020</year><volume>159</volume><fpage>275</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1016/BS.AGRON.2019.08.006</pub-id></element-citation></ref><ref id="B161-pharmaceutics-16-00454"><label>161.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Harris</surname><given-names>S.</given-names></name></person-group><article-title>TROPICAL FORESTS|Woody Legumes (Excluding Acacias)</article-title><source>Encyclopedia of Forest Sciences</source><publisher-name>Academic Press</publisher-name><publisher-loc>Cambridge, MA, USA</publisher-loc><year>2004</year><fpage>1793</fpage><lpage>1797</lpage><pub-id pub-id-type="doi">10.1016/B0-12-145160-7/00198-8</pub-id></element-citation></ref><ref id="B162-pharmaceutics-16-00454"><label>162.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Tekdal</surname><given-names>D.</given-names></name></person-group><article-title>Plant Genes for Abiotic Stress in Legumes</article-title><source>Abiotic Stress and Legumes: Tolerance and Management</source><publisher-name>Elsevier</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>2021</year><fpage>291</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-815355-0.00015-1</pub-id></element-citation></ref><ref id="B163-pharmaceutics-16-00454"><label>163.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bamboriya</surname><given-names>S.D.</given-names></name><name name-style="western"><surname>Rani</surname><given-names>K.</given-names></name><name name-style="western"><surname>Meena</surname><given-names>R.S.</given-names></name><name name-style="western"><surname>Sheoran</surname><given-names>S.</given-names></name><name name-style="western"><surname>Loyal</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kumawat</surname><given-names>A.</given-names></name><name name-style="western"><surname>Jhariya</surname><given-names>M.K.</given-names></name></person-group><article-title>Grain Legumes: A Diversified Diet for Sustainable Livelihood, Food, and Nutritional Security</article-title><source>Advances in Legumes for Sustainable Intensification</source><publisher-name>Elsevier</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>2022</year><fpage>157</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1016/B978-0-323-85797-0.00007-0</pub-id></element-citation></ref><ref id="B164-pharmaceutics-16-00454"><label>164.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Serrano-Sandoval</surname><given-names>S.N.</given-names></name><name name-style="western"><surname>Guardado-Felix</surname><given-names>D.</given-names></name><name name-style="western"><surname>Guti&#233;rrez-Uribe</surname><given-names>J.A.</given-names></name></person-group><article-title>Legumes in Human Health and Nutrition</article-title><source>Encyclopedia of Human Nutrition</source><edition>4th ed.</edition><publisher-name>Elsevier</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>2023</year><volume>Volume 1&#8211;4</volume><fpage>430</fpage><lpage>437</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-821848-8.00061-5</pub-id></element-citation></ref><ref id="B165-pharmaceutics-16-00454"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>B.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Kaur</surname><given-names>A.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>N.</given-names></name></person-group><article-title>Phenolic Composition and Antioxidant Potential of Grain Legume Seeds: A Review</article-title><source>Food Res. Int.</source><year>2017</year><volume>101</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1016/j.foodres.2017.09.026</pub-id><pub-id pub-id-type="pmid">28941672</pub-id></element-citation></ref><ref id="B166-pharmaceutics-16-00454"><label>166.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Hummer</surname><given-names>K.E.</given-names></name><name name-style="western"><surname>Janick</surname><given-names>J.</given-names></name></person-group><article-title><italic toggle="yes">Rosaceae</italic>: Taxonomy, Economic Importance, Genomics</article-title><source>Genetics and Genomics of Rosaceae</source><publisher-name>Springer</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>2009</year><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1007/978-0-387-77491-6_1</pub-id></element-citation></ref><ref id="B167-pharmaceutics-16-00454"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>George</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Konrad</surname><given-names>H.</given-names></name><name name-style="western"><surname>Collin</surname><given-names>E.</given-names></name><name name-style="western"><surname>Thevenet</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ballian</surname><given-names>D.</given-names></name><name name-style="western"><surname>Idzojtic</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kamm</surname><given-names>U.</given-names></name><name name-style="western"><surname>Zhelev</surname><given-names>P.</given-names></name><name name-style="western"><surname>Geburek</surname><given-names>T.</given-names></name></person-group><article-title>High Molecular Diversity in the True Service Tree (<italic toggle="yes">Sorbus domestica</italic>) despite Rareness: Data from Europe with Special Reference to the Austrian Occurrence</article-title><source>Ann. Bot.</source><year>2015</year><volume>115</volume><fpage>1105</fpage><lpage>1115</lpage><pub-id pub-id-type="doi">10.1093/aob/mcv047</pub-id><pub-id pub-id-type="pmid">25878141</pub-id><pub-id pub-id-type="pmcid">PMC4648458</pub-id></element-citation></ref><ref id="B168-pharmaceutics-16-00454"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cachi</surname><given-names>A.</given-names></name><name name-style="western"><surname>W&#252;nsch</surname><given-names>A.</given-names></name><name name-style="western"><surname>Vilanova</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gu&#224;rdia</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ciordia</surname><given-names>M.</given-names></name><name name-style="western"><surname>Alet&#224;</surname><given-names>N.</given-names></name></person-group><article-title>S-locus Diversity and Cross-compatibility of Wild Prunus Avium for Timber Breeding</article-title><source>Plant Breed.</source><year>2017</year><volume>136</volume><fpage>126</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1111/pbr.12450</pub-id></element-citation></ref><ref id="B169-pharmaceutics-16-00454"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chandra</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rawat</surname><given-names>D.S.</given-names></name></person-group><article-title>Medicinal Plants of the Family <italic toggle="yes">Caryophyllaceae</italic>: A Review of Ethno-Medicinal Uses and Pharmacological Properties</article-title><source>Integr. Med. Res.</source><year>2015</year><volume>4</volume><fpage>123</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1016/j.imr.2015.06.004</pub-id><pub-id pub-id-type="pmid">28664118</pub-id><pub-id pub-id-type="pmcid">PMC5481791</pub-id></element-citation></ref><ref id="B170-pharmaceutics-16-00454"><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>B&#246;ttger</surname><given-names>S.</given-names></name><name name-style="western"><surname>Melzig</surname><given-names>M.F.</given-names></name></person-group><article-title>Triterpenoid Saponins of the <italic toggle="yes">Caryophyllaceae</italic> and Illecebraceae Family</article-title><source>Phytochem. Lett.</source><year>2011</year><volume>4</volume><fpage>59</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1016/j.phytol.2010.08.003</pub-id></element-citation></ref><ref id="B171-pharmaceutics-16-00454"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Forest</surname><given-names>F.</given-names></name><name name-style="western"><surname>Chase</surname><given-names>M.W.</given-names></name><name name-style="western"><surname>Persson</surname><given-names>C.</given-names></name><name name-style="western"><surname>Crane</surname><given-names>P.R.</given-names></name><name name-style="western"><surname>Hawkins</surname><given-names>J.A.</given-names></name></person-group><article-title>The role of biotic and abiotic factors in evolution of ant dispersal in the milkwort family (<italic toggle="yes">Polygalaceae</italic>)</article-title><source>Evolution</source><year>2007</year><volume>61</volume><fpage>1675</fpage><lpage>1694</lpage><pub-id pub-id-type="doi">10.1111/j.1558-5646.2007.00138.x</pub-id><pub-id pub-id-type="pmid">17598748</pub-id></element-citation></ref><ref id="B172-pharmaceutics-16-00454"><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>D.</given-names></name><name name-style="western"><surname>B&#259;d&#259;rau</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Swamy</surname><given-names>M.K.</given-names></name><name name-style="western"><surname>Shaw</surname><given-names>S.</given-names></name><name name-style="western"><surname>Maggi</surname><given-names>F.</given-names></name><name name-style="western"><surname>da Silva</surname><given-names>L.E.</given-names></name><name name-style="western"><surname>L&#243;pez</surname><given-names>V.</given-names></name><name name-style="western"><surname>Yeung</surname><given-names>A.W.K.</given-names></name><name name-style="western"><surname>Mocan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Atanasov</surname><given-names>A.G.</given-names></name></person-group><article-title>Arctium Species Secondary Metabolites Chemodiversity and Bioactivities</article-title><source>Front. Plant Sci.</source><year>2019</year><volume>10</volume><fpage>439246</fpage><pub-id pub-id-type="doi">10.3389/fpls.2019.00834</pub-id><pub-id pub-id-type="pmcid">PMC6629911</pub-id><pub-id pub-id-type="pmid">31338098</pub-id></element-citation></ref><ref id="B173-pharmaceutics-16-00454"><label>173.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>&#304;lg&#252;n</surname><given-names>S.</given-names></name><name name-style="western"><surname>Karatoprak</surname><given-names>G.&#350;.</given-names></name><name name-style="western"><surname>Polat</surname><given-names>D.&#199;.</given-names></name><name name-style="western"><surname>&#350;afak</surname><given-names>E.K.</given-names></name><name name-style="western"><surname>Y&#305;ld&#305;z</surname><given-names>G.</given-names></name><name name-style="western"><surname>K&#252;peli Akkol</surname><given-names>E.</given-names></name><name name-style="western"><surname>Sobarzo-S&#225;nchez</surname><given-names>E.</given-names></name></person-group><article-title>Phytochemical Composition and Biological Activities of <italic toggle="yes">Arctium minus</italic> (Hill) Bernh.: A Potential Candidate as Antioxidant, Enzyme Inhibitor, and Cytotoxic Agent</article-title><source>Antioxidants</source><year>2022</year><volume>11</volume><elocation-id>1852</elocation-id><pub-id pub-id-type="doi">10.3390/antiox11101852</pub-id><pub-id pub-id-type="pmid">36290576</pub-id><pub-id pub-id-type="pmcid">PMC9598467</pub-id></element-citation></ref><ref id="B174-pharmaceutics-16-00454"><label>174.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Liz Oliveira Cavalli</surname><given-names>V.L.</given-names></name><name name-style="western"><surname>Sordi</surname><given-names>C.</given-names></name><name name-style="western"><surname>Tonini</surname><given-names>K.</given-names></name><name name-style="western"><surname>Grando</surname><given-names>A.</given-names></name><name name-style="western"><surname>Muneron</surname><given-names>T.</given-names></name><name name-style="western"><surname>Guigi</surname><given-names>A.</given-names></name><name name-style="western"><surname>J&#250;nior</surname><given-names>W.A.R.</given-names></name></person-group><article-title>Avalia&#231;&#227;o In Vivo Do Efeito Hipoglicemiante de Extratos Obtidos Da Raiz e Folha de Bardana <italic toggle="yes">Arctium minus</italic> (Hill.) Bernh</article-title><source>Rev. Bras. Farmacogn.</source><year>2007</year><volume>17</volume><fpage>64</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1590/S0102-695X2007000100014</pub-id></element-citation></ref><ref id="B175-pharmaceutics-16-00454"><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tawfick</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>C.</given-names></name><name name-style="western"><surname>Shao</surname><given-names>P.</given-names></name><name name-style="western"><surname>Farag</surname><given-names>M.A.</given-names></name></person-group><article-title>Inulin Fructans in Diet: Role in Gut Homeostasis, Immunity, Health Outcomes and Potential Therapeutics</article-title><source>Int. J. Biol. Macromol.</source><year>2022</year><volume>208</volume><fpage>948</fpage><lpage>961</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2022.03.218</pub-id><pub-id pub-id-type="pmid">35381290</pub-id></element-citation></ref><ref id="B176-pharmaceutics-16-00454"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Akram</surname><given-names>W.</given-names></name><name name-style="western"><surname>Garud</surname><given-names>N.</given-names></name><name name-style="western"><surname>Joshi</surname><given-names>R.</given-names></name></person-group><article-title>Role of Inulin as Prebiotics on Inflammatory Bowel Disease</article-title><source>Drug Discov. Ther.</source><year>2019</year><volume>13</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.5582/ddt.2019.01000</pub-id><pub-id pub-id-type="pmid">30880316</pub-id></element-citation></ref><ref id="B177-pharmaceutics-16-00454"><label>177.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roberfroid</surname><given-names>M.B.</given-names></name></person-group><article-title>Prebiotics: Preferential Substrates for Specific Germs?</article-title><source>Am. J. Clin. Nutr.</source><year>2001</year><volume>73</volume><fpage>406s</fpage><lpage>409s</lpage><pub-id pub-id-type="doi">10.1093/ajcn/73.2.406s</pub-id><pub-id pub-id-type="pmid">11157349</pub-id></element-citation></ref><ref id="B178-pharmaceutics-16-00454"><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miao</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Fan</surname><given-names>C.</given-names></name><name name-style="western"><surname>Luan</surname><given-names>T.</given-names></name><name name-style="western"><surname>Yan</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>X.</given-names></name><name name-style="western"><surname>Dai</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>P.</given-names></name></person-group><article-title>The Protective Effects of Inulin-Type Fructans Against High-Fat/Sucrose Diet-Induced Gestational Diabetes Mice in Association with Gut Microbiota Regulation</article-title><source>Front. Microbiol.</source><year>2022</year><volume>13</volume><elocation-id>832151</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2022.832151</pub-id><pub-id pub-id-type="pmid">35495651</pub-id><pub-id pub-id-type="pmcid">PMC9048744</pub-id></element-citation></ref><ref id="B179-pharmaceutics-16-00454"><label>179.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>L.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>J.</given-names></name><name name-style="western"><surname>Cai</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Li</surname><given-names>W.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Dong</surname><given-names>R.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Tu</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Inulin-Type Fructans Change the Gut Microbiota and Prevent the Development of Diabetic Nephropathy</article-title><source>Pharmacol. Res.</source><year>2022</year><volume>183</volume><fpage>106367</fpage><pub-id pub-id-type="doi">10.1016/j.phrs.2022.106367</pub-id><pub-id pub-id-type="pmid">35882293</pub-id></element-citation></ref><ref id="B180-pharmaceutics-16-00454"><label>180.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>K.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Xue</surname><given-names>J.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Dong</surname><given-names>X.</given-names></name><name name-style="western"><surname>Sha</surname><given-names>L.</given-names></name><name name-style="western"><surname>Lei</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>Dietary Inulin Alleviates Diverse Stages of Type 2 Diabetes Mellitus via Anti-Inflammation and Modulating Gut Microbiota in Db/Db Mice</article-title><source>Food Funct.</source><year>2019</year><volume>10</volume><fpage>1915</fpage><lpage>1927</lpage><pub-id pub-id-type="doi">10.1039/C8FO02265H</pub-id><pub-id pub-id-type="pmid">30869673</pub-id></element-citation></ref><ref id="B181-pharmaceutics-16-00454"><label>181.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Fernanda</surname><given-names>M.F.</given-names></name><name name-style="western"><surname>Peixoto</surname><given-names>F.P.</given-names></name><name name-style="western"><surname>Sei&#231;ad</surname><given-names>R.</given-names></name><name name-style="western"><surname>Santos</surname><given-names>M.S.</given-names></name></person-group><article-title>Diabetes and Medicinal Plants in Portugal</article-title><source>Natural Products: Research Reviews</source><person-group person-group-type="editor"><name name-style="western"><surname>Gupta</surname><given-names>V.K.</given-names></name></person-group><publisher-name>Daya Publisher</publisher-name><publisher-loc>Delhi, India</publisher-loc><year>2012</year><volume>Volume 1</volume><fpage>1</fpage><lpage>41</lpage></element-citation></ref><ref id="B182-pharmaceutics-16-00454"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferreira</surname><given-names>F.M.</given-names></name><name name-style="western"><surname>Peixoto</surname><given-names>F.P.</given-names></name><name name-style="western"><surname>Nunes</surname><given-names>E.</given-names></name><name name-style="western"><surname>Sena</surname><given-names>C.</given-names></name><name name-style="western"><surname>Sei&#231;a</surname><given-names>R.</given-names></name><name name-style="western"><surname>Santos</surname><given-names>S.M.</given-names></name></person-group><article-title>Inhibitory Effect of <italic toggle="yes">Arctium minus</italic> on Mitochondrial Bioenergetics in Diabetic Goto-Kakizaki Rats</article-title><source>Sci. Res. Essay</source><year>2010</year><volume>5</volume><fpage>2136</fpage><lpage>2142</lpage></element-citation></ref><ref id="B183-pharmaceutics-16-00454"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fischer</surname><given-names>S.P.M.</given-names></name><name name-style="western"><surname>Brusco</surname><given-names>I.</given-names></name><name name-style="western"><surname>Camponogara</surname><given-names>C.</given-names></name><name name-style="western"><surname>Piana</surname><given-names>M.</given-names></name><name name-style="western"><surname>Faccin</surname><given-names>H.</given-names></name><name name-style="western"><surname>Gobo</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>de Carvalho</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>S.M.</given-names></name></person-group><article-title><italic toggle="yes">Arctium minus</italic> Crude Extract Presents Antinociceptive Effect in a Mice Acute Gout Attack Model</article-title><source>Inflammopharmacology</source><year>2018</year><volume>26</volume><fpage>505</fpage><lpage>519</lpage><pub-id pub-id-type="doi">10.1007/s10787-017-0384-6</pub-id><pub-id pub-id-type="pmid">28801728</pub-id></element-citation></ref><ref id="B184-pharmaceutics-16-00454"><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Erdemoglu</surname><given-names>N.</given-names></name><name name-style="western"><surname>Turan</surname><given-names>N.N.</given-names></name><name name-style="western"><surname>Akkol</surname><given-names>E.K.</given-names></name><name name-style="western"><surname>Sener</surname><given-names>B.</given-names></name><name name-style="western"><surname>Abacioglu</surname><given-names>N.</given-names></name></person-group><article-title>Estimation of Anti-Inflammatory, Antinociceptive and Antioxidant Activities on <italic toggle="yes">Arctium minus</italic> (Hill) Bernh. Ssp. Minus</article-title><source>J. Ethnopharmacol.</source><year>2009</year><volume>121</volume><fpage>318</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2008.11.009</pub-id><pub-id pub-id-type="pmid">19061945</pub-id></element-citation></ref><ref id="B185-pharmaceutics-16-00454"><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guettaf</surname><given-names>S.</given-names></name><name name-style="western"><surname>Benmerzoug</surname><given-names>A.</given-names></name><name name-style="western"><surname>Chawki</surname><given-names>B.</given-names></name><name name-style="western"><surname>&#199;akmak</surname><given-names>Y.S.</given-names></name><name name-style="western"><surname>Dahamna</surname><given-names>S.</given-names></name><name name-style="western"><surname>Baghiani</surname><given-names>A.</given-names></name><name name-style="western"><surname>Harzallah</surname><given-names>D.</given-names></name></person-group><article-title>Contribution to Pharmacological Valorisation of Algerian <italic toggle="yes">Arctium minus</italic> (Hill) Bernh. Subsp</article-title><source>Atlanticum (Pomel) Maire; Antioxidant an d Acetylcholinesterase Inhibitory Activities. Curr. Enzym. Inhib.</source><year>2022</year><volume>18</volume><fpage>135</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.2174/1573408018666220324101521</pub-id></element-citation></ref><ref id="B186-pharmaceutics-16-00454"><label>186.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>C.</given-names></name><name name-style="western"><surname>Guven</surname><given-names>E.C.</given-names></name><name name-style="western"><surname>Paoli</surname><given-names>P.</given-names></name><name name-style="western"><surname>Simal-Gandara</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ramkumar</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Buleu</surname><given-names>F.</given-names></name><name name-style="western"><surname>Pah</surname><given-names>A.</given-names></name><name name-style="western"><surname>Turi</surname><given-names>V.</given-names></name><etal/></person-group><article-title>Dietary Polyphenols as Antidiabetic Agents: Advances and Opportunities</article-title><source>Food Front.</source><year>2020</year><volume>1</volume><fpage>18</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1002/fft2.15</pub-id></element-citation></ref><ref id="B187-pharmaceutics-16-00454"><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alam</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sarker</surname><given-names>M.M.R.</given-names></name><name name-style="western"><surname>Sultana</surname><given-names>T.N.</given-names></name><name name-style="western"><surname>Chowdhury</surname><given-names>M.N.R.</given-names></name><name name-style="western"><surname>Rashid</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Chaity</surname><given-names>N.I.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>C.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hafez</surname><given-names>E.E.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>S.A.</given-names></name><etal/></person-group><article-title>Antidiabetic Phytochemicals From Medicinal Plants: Prospective Candidates for New Drug Discovery and Development</article-title><source>Front Endocrinol</source><year>2022</year><volume>13</volume><fpage>800714</fpage><pub-id pub-id-type="doi">10.3389/fendo.2022.800714</pub-id><pub-id pub-id-type="pmcid">PMC8907382</pub-id><pub-id pub-id-type="pmid">35282429</pub-id></element-citation></ref><ref id="B188-pharmaceutics-16-00454"><label>188.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saleh</surname><given-names>N.A.M.</given-names></name><name name-style="western"><surname>Bohm</surname><given-names>B.A.</given-names></name></person-group><article-title>Flavonoids of <italic toggle="yes">Arctium minus</italic> (Compositae)</article-title><source>Experientia</source><year>1971</year><volume>27</volume><fpage>1494</fpage><pub-id pub-id-type="doi">10.1007/BF02154314</pub-id><pub-id pub-id-type="pmid">5144881</pub-id></element-citation></ref><ref id="B189-pharmaceutics-16-00454"><label>189.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Watkins</surname><given-names>F.</given-names></name><name name-style="western"><surname>Pendry</surname><given-names>B.</given-names></name><name name-style="western"><surname>Sanchez-Medina</surname><given-names>A.</given-names></name><name name-style="western"><surname>Corcoran</surname><given-names>O.</given-names></name></person-group><article-title>Antimicrobial Assays of Three Native British Plants Used in Anglo-Saxon Medicine for Wound Healing Formulations in 10th Century England</article-title><source>J. Ethnopharmacol.</source><year>2012</year><volume>144</volume><fpage>408</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2012.09.031</pub-id><pub-id pub-id-type="pmid">23026307</pub-id></element-citation></ref><ref id="B190-pharmaceutics-16-00454"><label>190.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vitalini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Beretta</surname><given-names>G.</given-names></name><name name-style="western"><surname>Iriti</surname><given-names>M.</given-names></name><name name-style="western"><surname>Orsenigo</surname><given-names>S.</given-names></name><name name-style="western"><surname>Basilico</surname><given-names>N.</given-names></name><name name-style="western"><surname>Dall&#8217;Acqua</surname><given-names>S.</given-names></name><name name-style="western"><surname>Iorizzi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Fico</surname><given-names>G.</given-names></name></person-group><article-title>Phenolic Compounds from <italic toggle="yes">Achillea millefolium</italic> L. and Their Bioactivity</article-title><source>Acta Biochim. Pol.</source><year>2011</year><volume>58</volume><fpage>203</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.18388/abp.2011_2266</pub-id><pub-id pub-id-type="pmid">21503279</pub-id></element-citation></ref><ref id="B191-pharmaceutics-16-00454"><label>191.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trumbeckaite</surname><given-names>S.</given-names></name><name name-style="western"><surname>Benetis</surname><given-names>R.</given-names></name><name name-style="western"><surname>Bumblauskiene</surname><given-names>L.</given-names></name><name name-style="western"><surname>Burdulis</surname><given-names>D.</given-names></name><name name-style="western"><surname>Janulis</surname><given-names>V.</given-names></name><name name-style="western"><surname>Toleikis</surname><given-names>A.</given-names></name><name name-style="western"><surname>Vi&#353;kelis</surname><given-names>P.</given-names></name><name name-style="western"><surname>Jak&#353;tas</surname><given-names>V.</given-names></name></person-group><article-title><italic toggle="yes">Achillea millefolium</italic> L. s.l. Herb Extract: Antioxidant Activity and Effect on the Rat Heart Mitochondrial Functions</article-title><source>Food Chem.</source><year>2011</year><volume>127</volume><fpage>1540</fpage><lpage>1548</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2011.02.014</pub-id></element-citation></ref><ref id="B192-pharmaceutics-16-00454"><label>192.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Souza</surname><given-names>P.</given-names></name><name name-style="western"><surname>Gasparotto</surname><given-names>A.</given-names></name><name name-style="western"><surname>Crestani</surname><given-names>S.</given-names></name><name name-style="western"><surname>Stefanello</surname><given-names>M.&#201;.A.</given-names></name><name name-style="western"><surname>Marques</surname><given-names>M.C.A.</given-names></name><name name-style="western"><surname>Da Silva-Santos</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Kassuya</surname><given-names>C.A.L.</given-names></name></person-group><article-title>Hypotensive Mechanism of the Extracts and Artemetin Isolated from <italic toggle="yes">Achillea millefolium</italic> L. (Asteraceae) in Rats</article-title><source>Phytomedicine</source><year>2011</year><volume>18</volume><fpage>819</fpage><lpage>825</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2011.02.005</pub-id><pub-id pub-id-type="pmid">21420289</pub-id></element-citation></ref><ref id="B193-pharmaceutics-16-00454"><label>193.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Potrich</surname><given-names>F.B.</given-names></name><name name-style="western"><surname>Allemand</surname><given-names>A.</given-names></name><name name-style="western"><surname>da Silva</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>dos Santos</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Baggio</surname><given-names>C.H.</given-names></name><name name-style="western"><surname>Freitas</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>Mendes</surname><given-names>D.A.G.B.</given-names></name><name name-style="western"><surname>Andre</surname><given-names>E.</given-names></name><name name-style="western"><surname>de Paula Werner</surname><given-names>M.F.</given-names></name><name name-style="western"><surname>Marques</surname><given-names>M.C.A.</given-names></name></person-group><article-title>Antiulcerogenic Activity of Hydroalcoholic Extract of <italic toggle="yes">Achillea millefolium</italic> L.: Involvement of the Antioxidant System</article-title><source>J. Ethnopharmacol.</source><year>2010</year><volume>130</volume><fpage>85</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2010.04.014</pub-id><pub-id pub-id-type="pmid">20420892</pub-id></element-citation></ref><ref id="B194-pharmaceutics-16-00454"><label>194.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gharibi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tabatabaei</surname><given-names>B.E.S.</given-names></name><name name-style="western"><surname>Saeidi</surname><given-names>G.</given-names></name><name name-style="western"><surname>Goli</surname><given-names>S.A.H.</given-names></name><name name-style="western"><surname>Talebi</surname><given-names>M.</given-names></name></person-group><article-title>Total Phenolic Content and Antioxidant Activity of Three Iranian Endemic Achillea Species</article-title><source>Ind. Crops Prod.</source><year>2013</year><volume>50</volume><fpage>154</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1016/j.indcrop.2013.07.038</pub-id></element-citation></ref><ref id="B195-pharmaceutics-16-00454"><label>195.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dias</surname><given-names>M.I.</given-names></name><name name-style="western"><surname>Barros</surname><given-names>L.</given-names></name><name name-style="western"><surname>Due&#241;as</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pereira</surname><given-names>E.</given-names></name><name name-style="western"><surname>Carvalho</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Alves</surname><given-names>R.C.</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>M.B.P.P.</given-names></name><name name-style="western"><surname>Santos-Buelga</surname><given-names>C.</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>I.C.F.R.</given-names></name></person-group><article-title>Chemical Composition of Wild and Commercial <italic toggle="yes">Achillea millefolium</italic> L. and Bioactivity of the Methanolic Extract, Infusion and Decoction</article-title><source>Food Chem.</source><year>2013</year><volume>141</volume><fpage>4152</fpage><lpage>4160</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2013.07.018</pub-id><pub-id pub-id-type="pmid">23993599</pub-id></element-citation></ref><ref id="B196-pharmaceutics-16-00454"><label>196.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dall&#8217;Acqua</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bolego</surname><given-names>C.</given-names></name><name name-style="western"><surname>Cignarella</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gaion</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Innocenti</surname><given-names>G.</given-names></name></person-group><article-title>Vasoprotective Activity of Standardized <italic toggle="yes">Achillea millefolium</italic> Extract</article-title><source>Phytomedicine</source><year>2011</year><volume>18</volume><fpage>1031</fpage><lpage>1036</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2011.05.005</pub-id><pub-id pub-id-type="pmid">21684130</pub-id></element-citation></ref><ref id="B197-pharmaceutics-16-00454"><label>197.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Candan</surname><given-names>F.</given-names></name><name name-style="western"><surname>Unlu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tepe</surname><given-names>B.</given-names></name><name name-style="western"><surname>Daferera</surname><given-names>D.</given-names></name><name name-style="western"><surname>Polissiou</surname><given-names>M.</given-names></name><name name-style="western"><surname>S&#246;kmen</surname><given-names>A.</given-names></name><name name-style="western"><surname>Akpulat</surname><given-names>H.A.</given-names></name></person-group><article-title>Antioxidant and Antimicrobial Activity of the <italic toggle="yes">Essential Oil</italic> and Methanol Extracts of <italic toggle="yes">Achillea millefolium</italic> Subsp. Millefolium Afan. (<italic toggle="yes">Asteraceae</italic>)</article-title><source>J. Ethnopharmacol.</source><year>2003</year><volume>87</volume><fpage>215</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(03)00149-1</pub-id><pub-id pub-id-type="pmid">12860311</pub-id></element-citation></ref><ref id="B198-pharmaceutics-16-00454"><label>198.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baretta</surname><given-names>I.P.</given-names></name><name name-style="western"><surname>Felizardo</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Bimbato</surname><given-names>V.F.</given-names></name><name name-style="western"><surname>Dos Santos</surname><given-names>M.G.J.</given-names></name><name name-style="western"><surname>Kassuya</surname><given-names>C.A.L.</given-names></name><name name-style="western"><surname>Gasparotto Junior</surname><given-names>A.</given-names></name><name name-style="western"><surname>Da Silva</surname><given-names>C.R.</given-names></name><name name-style="western"><surname>De Oliveira</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>J.</given-names></name><name name-style="western"><surname>Andreatini</surname><given-names>R.</given-names></name></person-group><article-title>Anxiolytic-like Effects of Acute and Chronic Treatment with <italic toggle="yes">Achillea millefolium</italic> L. Extract</article-title><source>J. Ethnopharmacol.</source><year>2012</year><volume>140</volume><fpage>46</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2011.11.047</pub-id><pub-id pub-id-type="pmid">22155391</pub-id></element-citation></ref><ref id="B199-pharmaceutics-16-00454"><label>199.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jonsdottir</surname><given-names>G.</given-names></name><name name-style="western"><surname>Omarsdottir</surname><given-names>S.</given-names></name><name name-style="western"><surname>Vikingsson</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hardardottir</surname><given-names>I.</given-names></name><name name-style="western"><surname>Freysdottir</surname><given-names>J.</given-names></name></person-group><article-title>Aqueous Extracts from Menyanthes Trifoliate and <italic toggle="yes">Achillea millefolium</italic> Affect Maturation of Human Dendritic Cells and Their Activation of Allogeneic CD4 + T Cells In Vitro</article-title><source>J. Ethnopharmacol.</source><year>2011</year><volume>136</volume><fpage>88</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2011.04.006</pub-id><pub-id pub-id-type="pmid">21511021</pub-id></element-citation></ref><ref id="B200-pharmaceutics-16-00454"><label>200.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cavalcanti</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Baggio</surname><given-names>C.H.</given-names></name><name name-style="western"><surname>Freitas</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>Rieck</surname><given-names>L.</given-names></name><name name-style="western"><surname>de Sousa</surname><given-names>R.S.</given-names></name><name name-style="western"><surname>Da Silva-Santos</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Mesia-Vela</surname><given-names>S.</given-names></name><name name-style="western"><surname>Marques</surname><given-names>M.C.A.</given-names></name></person-group><article-title>Safety and Antiulcer Efficacy Studies of <italic toggle="yes">Achillea millefolium</italic> L. after Chronic Treatment in Wistar Rats</article-title><source>J. Ethnopharmacol.</source><year>2006</year><volume>107</volume><fpage>277</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2006.03.011</pub-id><pub-id pub-id-type="pmid">16647233</pub-id></element-citation></ref><ref id="B201-pharmaceutics-16-00454"><label>201.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Csupor-L&#246;ffler</surname><given-names>B.</given-names></name><name name-style="western"><surname>Hajd&#250;</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zupk&#243;</surname><given-names>I.</given-names></name><name name-style="western"><surname>R&#233;thy</surname><given-names>B.</given-names></name><name name-style="western"><surname>Falkay</surname><given-names>G.</given-names></name><name name-style="western"><surname>Forgo</surname><given-names>P.</given-names></name><name name-style="western"><surname>Hohmann</surname><given-names>J.</given-names></name></person-group><article-title>Antiproliferative Effect of Flavonoids and Sesquiterpenoids from <italic toggle="yes">Achillea millefolium</italic> s.l. on Cultured Human Tumour Cell Lines</article-title><source>Phytother. Res.</source><year>2009</year><volume>23</volume><fpage>672</fpage><lpage>676</lpage><pub-id pub-id-type="doi">10.1002/ptr.2697</pub-id><pub-id pub-id-type="pmid">19107850</pub-id></element-citation></ref><ref id="B202-pharmaceutics-16-00454"><label>202.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chanishvili</surname><given-names>S.</given-names></name><name name-style="western"><surname>Badridze</surname><given-names>G.</given-names></name><name name-style="western"><surname>Rapava</surname><given-names>L.</given-names></name><name name-style="western"><surname>Janukashvili</surname><given-names>N.</given-names></name></person-group><article-title>Effect of Altitude on the Contents of Antioxidants in Leaves of Some Herbaceous Plants</article-title><source>Russ. J. Ecol.</source><year>2007</year><volume>38</volume><fpage>367</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1134/S1067413607050128</pub-id></element-citation></ref><ref id="B203-pharmaceutics-16-00454"><label>203.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Si</surname><given-names>X.T.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Q.W.</given-names></name><name name-style="western"><surname>Kiyota</surname><given-names>H.</given-names></name></person-group><article-title>Chemical Constituents of the Plants in the Genus Achillea</article-title><source>Chem. Biodivers.</source><year>2006</year><volume>3</volume><fpage>1163</fpage><lpage>1180</lpage><pub-id pub-id-type="doi">10.1002/cbdv.200690119</pub-id><pub-id pub-id-type="pmid">17193231</pub-id></element-citation></ref><ref id="B204-pharmaceutics-16-00454"><label>204.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jenabi</surname><given-names>E.</given-names></name><name name-style="western"><surname>Fereidoony</surname><given-names>B.</given-names></name></person-group><article-title>Effect of <italic toggle="yes">Achillea millefolium</italic> on Relief of Primary Dysmenorrhea: A Double-Blind Randomized Clinical Trial</article-title><source>J. Pediatr. Adolesc. Gynecol.</source><year>2015</year><volume>28</volume><fpage>402</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1016/j.jpag.2014.12.008</pub-id><pub-id pub-id-type="pmid">26238568</pub-id></element-citation></ref><ref id="B205-pharmaceutics-16-00454"><label>205.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arias-Dur&#225;n</surname><given-names>L.</given-names></name><name name-style="western"><surname>Estrada-Soto</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hern&#225;ndez-Morales</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ch&#225;vez-Silva</surname><given-names>F.</given-names></name><name name-style="western"><surname>Navarrete-V&#225;zquez</surname><given-names>G.</given-names></name><name name-style="western"><surname>Le&#243;n-Rivera</surname><given-names>I.</given-names></name><name name-style="western"><surname>Perea-Arango</surname><given-names>I.</given-names></name><name name-style="western"><surname>Villalobos-Molina</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ibarra-Barajas</surname><given-names>M.</given-names></name></person-group><article-title>Tracheal Relaxation through Calcium Channel Blockade of <italic toggle="yes">Achillea millefolium</italic> Hexanic Extract and Its Main Bioactive Compounds</article-title><source>J. Ethnopharmacol.</source><year>2020</year><volume>253</volume><fpage>112643</fpage><pub-id pub-id-type="doi">10.1016/j.jep.2020.112643</pub-id><pub-id pub-id-type="pmid">32035218</pub-id></element-citation></ref><ref id="B206-pharmaceutics-16-00454"><label>206.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Farhadi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Babaei</surname><given-names>K.</given-names></name><name name-style="western"><surname>Farsaraei</surname><given-names>S.</given-names></name><name name-style="western"><surname>Moghaddam</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ghasemi Pirbalouti</surname><given-names>A.</given-names></name></person-group><article-title>Changes in Essential Oil Compositions, Total Phenol, Flavonoids and Antioxidant Capacity of <italic toggle="yes">Achillea millefolium</italic> at Different Growth Stages</article-title><source>Ind. Crops Prod.</source><year>2020</year><volume>152</volume><fpage>112570</fpage><pub-id pub-id-type="doi">10.1016/j.indcrop.2020.112570</pub-id></element-citation></ref><ref id="B207-pharmaceutics-16-00454"><label>207.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arias-Dur&#225;n</surname><given-names>L.</given-names></name><name name-style="western"><surname>Estrada-Soto</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hern&#225;ndez-Morales</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mill&#225;n-Pacheco</surname><given-names>C.</given-names></name><name name-style="western"><surname>Navarrete-V&#225;zquez</surname><given-names>G.</given-names></name><name name-style="western"><surname>Villalobos-Molina</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ibarra-Barajas</surname><given-names>M.</given-names></name><name name-style="western"><surname>Almanza-P&#233;rez</surname><given-names>J.C.</given-names></name></person-group><article-title>Antihypertensive and Vasorelaxant Effect of Leucodin and Achillin Isolated from <italic toggle="yes">Achillea millefolium</italic> through Calcium Channel Blockade and NO Production: In Vivo, Functional Ex Vivo and in Silico Studies</article-title><source>J. Ethnopharmacol.</source><year>2021</year><volume>273</volume><fpage>113948</fpage><pub-id pub-id-type="doi">10.1016/j.jep.2021.113948</pub-id><pub-id pub-id-type="pmid">33610712</pub-id></element-citation></ref><ref id="B208-pharmaceutics-16-00454"><label>208.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>H.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>G.</given-names></name><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name><name name-style="western"><surname>Aisa</surname><given-names>H.A.</given-names></name></person-group><article-title>Chlorine-Containing Guaianolide Sesquiterpenoids from <italic toggle="yes">Achillea millefolium</italic> L. with Inhibitory Effects against LPS-Induced NO Release in BV-2 Microglial Cells</article-title><source>Phytochemistry</source><year>2023</year><volume>207</volume><fpage>113567</fpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2022.113567</pub-id><pub-id pub-id-type="pmid">36549383</pub-id></element-citation></ref><ref id="B209-pharmaceutics-16-00454"><label>209.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mahmoudi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Seyedsadeghi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Miran</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ahari</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Layegh</surname><given-names>H.</given-names></name><name name-style="western"><surname>Mostafalou</surname><given-names>S.</given-names></name></person-group><article-title>Therapeutic Effect of <italic toggle="yes">Achillea millefolium</italic> on the Hemorrhoids; A Randomized Double-Blind Placebo-Controlled Clinical Trial</article-title><source>J. Herb. Med.</source><year>2023</year><volume>39</volume><fpage>100657</fpage><pub-id pub-id-type="doi">10.1016/j.hermed.2023.100657</pub-id></element-citation></ref><ref id="B210-pharmaceutics-16-00454"><label>210.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohammadhosseini</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sarker</surname><given-names>S.D.</given-names></name><name name-style="western"><surname>Akbarzadeh</surname><given-names>A.</given-names></name></person-group><article-title>Chemical Composition of the <italic toggle="yes">Essential oils</italic> and Extracts of Achillea Species and Their Biological Activities: A Review</article-title><source>J. Ethnopharmacol.</source><year>2017</year><volume>199</volume><fpage>257</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2017.02.010</pub-id><pub-id pub-id-type="pmid">28179115</pub-id></element-citation></ref><ref id="B211-pharmaceutics-16-00454"><label>211.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Asgary</surname><given-names>S.</given-names></name><name name-style="western"><surname>Naderi</surname><given-names>G.</given-names></name><name name-style="western"><surname>Ghannadi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gharipour</surname><given-names>M.</given-names></name><name name-style="western"><surname>Golbon</surname><given-names>S.</given-names></name></person-group><article-title>Protective Effect of <italic toggle="yes">Achillea millefolium</italic>, Crataegus Curvisepala and <italic toggle="yes">Matricaria chamomilla</italic> on Oxidative Hemolysis of Human Erythrocytes and-SH Capacity</article-title><source>J. Med. Plants</source><year>2003</year><volume>2</volume><fpage>41</fpage><lpage>48</lpage></element-citation></ref><ref id="B212-pharmaceutics-16-00454"><label>212.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nematy</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mazidi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jafari</surname><given-names>A.</given-names></name><name name-style="western"><surname>Baghban</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rakhshandeh</surname><given-names>H.</given-names></name><name name-style="western"><surname>Norouzy</surname><given-names>A.</given-names></name><name name-style="western"><surname>Esmaily</surname><given-names>H.</given-names></name><name name-style="western"><surname>Etemad</surname><given-names>L.</given-names></name><name name-style="western"><surname>Patterson</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mohammadpour</surname><given-names>A.H.</given-names></name></person-group><article-title>The Effect of Hydro-Alcoholic Extract of <italic toggle="yes">Achillea millefolium</italic> on Appetite Hormone in Rats</article-title><source>Avicenna J. Phytomed.</source><year>2017</year><volume>7</volume><fpage>10</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">28265542</pub-id><pub-id pub-id-type="pmcid">PMC5329172</pub-id></element-citation></ref><ref id="B213-pharmaceutics-16-00454"><label>213.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ali</surname><given-names>S.I.</given-names></name><name name-style="western"><surname>Gopalakrishnan</surname><given-names>B.</given-names></name><name name-style="western"><surname>Venkatesalu</surname><given-names>V.</given-names></name></person-group><article-title>Pharmacognosy, Phytochemistry and Pharmacological Properties of <italic toggle="yes">Achillea millefolium</italic> L.: A Review</article-title><source>Phytother. Res.</source><year>2017</year><volume>31</volume><fpage>1140</fpage><lpage>1161</lpage><pub-id pub-id-type="doi">10.1002/ptr.5840</pub-id><pub-id pub-id-type="pmid">28618131</pub-id></element-citation></ref><ref id="B214-pharmaceutics-16-00454"><label>214.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>D&#252;sman</surname><given-names>E.</given-names></name><name name-style="western"><surname>Almeida</surname><given-names>I.V.D.</given-names></name><name name-style="western"><surname>Coelho</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Balbi</surname><given-names>T.J.</given-names></name><name name-style="western"><surname>D&#252;sman Tonin</surname><given-names>L.T.</given-names></name><name name-style="western"><surname>Vicentini</surname><given-names>V.E.P.</given-names></name></person-group><article-title>Antimutagenic Effect of Medicinal Plants <italic toggle="yes">Achillea millefolium</italic> and Bauhinia Forficata in Vivo</article-title><source>Evid.-Based Complement. Altern. Med.</source><year>2013</year><volume>2013</volume><fpage>893050</fpage><pub-id pub-id-type="doi">10.1155/2013/893050</pub-id><pub-id pub-id-type="pmid">24459532</pub-id><pub-id pub-id-type="pmcid">PMC3891236</pub-id></element-citation></ref><ref id="B215-pharmaceutics-16-00454"><label>215.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kazemi</surname><given-names>M.</given-names></name></person-group><article-title>Chemical Composition and Antimicrobial, Antioxidant Activities and Anti-Inflammatory Potential of <italic toggle="yes">Achillea millefolium</italic> L., <italic toggle="yes">Anethum graveolens</italic> L., and <italic toggle="yes">Carum copticum</italic> L.</article-title><source>Essential oils. J. Herb. Med.</source><year>2015</year><volume>5</volume><fpage>217</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1016/j.hermed.2015.09.001</pub-id></element-citation></ref><ref id="B216-pharmaceutics-16-00454"><label>216.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gharibi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tabatabaei</surname><given-names>B.E.S.</given-names></name><name name-style="western"><surname>Saeidi</surname><given-names>G.</given-names></name><name name-style="western"><surname>Goli</surname><given-names>S.A.H.</given-names></name></person-group><article-title>Effect of Drought Stress on Total Phenolic, Lipid Peroxidation, and Antioxidant Activity of Achillea Species</article-title><source>Appl. Biochem. Biotechnol.</source><year>2016</year><volume>178</volume><fpage>796</fpage><lpage>809</lpage><pub-id pub-id-type="doi">10.1007/s12010-015-1909-3</pub-id><pub-id pub-id-type="pmid">26541161</pub-id></element-citation></ref><ref id="B217-pharmaceutics-16-00454"><label>217.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ismail</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Fahmy</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Ghattas</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Zehry</surname><given-names>W.</given-names></name><name name-style="western"><surname>Saleh</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Abo-elmatty</surname><given-names>D.M.</given-names></name></person-group><article-title>Integrating Experimental Model, LC-MS/MS Chemical Analysis, and Systems Biology Approach to Investigate the Possible Antidiabetic Effect and Mechanisms of <italic toggle="yes">Matricaria aurea</italic> (Golden Chamomile) in Type 2 Diabetes Mellitus</article-title><source>Front. Pharmacol.</source><year>2022</year><volume>13</volume><fpage>924478</fpage><pub-id pub-id-type="doi">10.3389/fphar.2022.924478</pub-id><pub-id pub-id-type="pmid">36160451</pub-id><pub-id pub-id-type="pmcid">PMC9490514</pub-id></element-citation></ref><ref id="B218-pharmaceutics-16-00454"><label>218.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yousefbeyk</surname><given-names>F.</given-names></name><name name-style="western"><surname>Hemmati</surname><given-names>G.</given-names></name><name name-style="western"><surname>Gholipour</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Ghasemi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Evazalipour</surname><given-names>M.</given-names></name><name name-style="western"><surname>Schubert</surname><given-names>C.</given-names></name><name name-style="western"><surname>Koohi</surname><given-names>D.E.</given-names></name><name name-style="western"><surname>B&#246;hm</surname><given-names>V.</given-names></name></person-group><article-title>Phytochemical Analysis, Antioxidant, Cytotoxic, and Antimicrobial Activities of Golden Chamomile (<italic toggle="yes">Matricaria aurea</italic> (Loefl.) Schultz Bip)</article-title><source>Z. Fur Naturforschung C</source><year>2022</year><volume>77</volume><fpage>331</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1515/znc-2021-0269</pub-id><pub-id pub-id-type="pmid">35231163</pub-id></element-citation></ref><ref id="B219-pharmaceutics-16-00454"><label>219.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rizwana</surname><given-names>H.</given-names></name><name name-style="western"><surname>Soliman Alwahibi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Soliman</surname><given-names>D.</given-names></name></person-group><article-title>Antimicrobial Activity and Chemical Composition of Flowers of <italic toggle="yes">Matricaria aurea</italic> a Native Herb of Saudi Arabia Article In</article-title><source>Int. J. Pharmacol.</source><year>2016</year><volume>12</volume><fpage>576</fpage><lpage>586</lpage><pub-id pub-id-type="doi">10.3923/ijp.2016.576.586</pub-id></element-citation></ref><ref id="B220-pharmaceutics-16-00454"><label>220.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kheder</surname><given-names>F.B.H.</given-names></name><name name-style="western"><surname>Mahjoub</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Zaghrouni</surname><given-names>F.</given-names></name><name name-style="western"><surname>Kwaja</surname><given-names>S.</given-names></name><name name-style="western"><surname>Helal</surname><given-names>A.N.</given-names></name><name name-style="western"><surname>Mighri</surname><given-names>Z.</given-names></name></person-group><article-title>Chemical Composition Antioxidant and Antimicrobial Activities of the Essential Oils of <italic toggle="yes">Matricaria aurea</italic> Loefl. Growing in Tunisia</article-title><source>J. Essent. Oil Bear. Plants</source><year>2014</year><volume>17</volume><fpage>493</fpage><lpage>505</lpage><pub-id pub-id-type="doi">10.1080/0972060X.2014.884777</pub-id></element-citation></ref><ref id="B221-pharmaceutics-16-00454"><label>221.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khan</surname><given-names>M.</given-names></name><name name-style="western"><surname>Abdullah</surname><given-names>M.M.S.</given-names></name><name name-style="western"><surname>Mahmood</surname><given-names>A.</given-names></name><name name-style="western"><surname>Al-Mayouf</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Alkhathlan</surname><given-names>H.Z.</given-names></name></person-group><article-title>Evaluation of <italic toggle="yes">Matricaria aurea</italic> Extracts as Effective Anti-Corrosive Agent for Mild Steel in 1.0 M HCl and Isolation of Their Active Ingredients</article-title><source>Sustainability</source><year>2019</year><volume>11</volume><elocation-id>7174</elocation-id><pub-id pub-id-type="doi">10.3390/su11247174</pub-id></element-citation></ref><ref id="B222-pharmaceutics-16-00454"><label>222.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Bohm</surname><given-names>B.A.</given-names></name><name name-style="western"><surname>Stuessy</surname><given-names>T.F.</given-names></name></person-group><article-title>Flavonoids of the Sunflower Family (<italic toggle="yes">Asteraceae</italic>)</article-title><source>Flavonoids of the Sunflower Family (Asteraceae)</source><publisher-name>Springer</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>2001</year><pub-id pub-id-type="doi">10.1007/978-3-7091-6181-4</pub-id></element-citation></ref><ref id="B223-pharmaceutics-16-00454"><label>223.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kriplani</surname><given-names>P.</given-names></name><name name-style="western"><surname>Guarve</surname><given-names>K.</given-names></name><name name-style="western"><surname>Baghael</surname><given-names>U.S.</given-names></name></person-group><article-title><italic toggle="yes">Arnica montana</italic> L.&#8212;A Plant of Healing: Review</article-title><source>J. Pharm. Pharmacol.</source><year>2017</year><volume>69</volume><fpage>925</fpage><lpage>945</lpage><pub-id pub-id-type="doi">10.1111/jphp.12724</pub-id><pub-id pub-id-type="pmid">28401567</pub-id></element-citation></ref><ref id="B224-pharmaceutics-16-00454"><label>224.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duthen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gad&#233;a</surname><given-names>A.</given-names></name><name name-style="western"><surname>Trempat</surname><given-names>P.</given-names></name><name name-style="western"><surname>Boujedaini</surname><given-names>N.</given-names></name><name name-style="western"><surname>Fabre</surname><given-names>N.</given-names></name></person-group><article-title>Comparison of the Phytochemical Variation of Non-Volatile Metabolites within Mother Tinctures of <italic toggle="yes">Arnica montana</italic> Prepared from Fresh and Dried Whole Plant Using UHPLC-HRMS Fingerprinting and Chemometric Analysis</article-title><source>Molecules</source><year>2022</year><volume>27</volume><elocation-id>2737</elocation-id><pub-id pub-id-type="doi">10.3390/molecules27092737</pub-id><pub-id pub-id-type="pmid">35566089</pub-id><pub-id pub-id-type="pmcid">PMC9103735</pub-id></element-citation></ref><ref id="B225-pharmaceutics-16-00454"><label>225.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bai</surname><given-names>R.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Kan</surname><given-names>J.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>C.</given-names></name></person-group><article-title>Isolation, Structural Characterization and Bioactivities of Naturally Occurring Polysaccharide&#8211;Polyphenolic Conjugates from Medicinal Plants&#8212;A Reivew</article-title><source>Int. J. Biol. Macromol.</source><year>2018</year><volume>107</volume><fpage>2242</fpage><lpage>2250</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2017.10.097</pub-id><pub-id pub-id-type="pmid">29051102</pub-id></element-citation></ref><ref id="B226-pharmaceutics-16-00454"><label>226.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sch&#246;pke</surname><given-names>T.</given-names></name><name name-style="western"><surname>Wray</surname><given-names>V.</given-names></name><name name-style="western"><surname>Rzazewska</surname><given-names>B.</given-names></name><name name-style="western"><surname>Hiller</surname><given-names>K.</given-names></name></person-group><article-title>Bellissaponins BA1 and BA2, Acylated Saponins from <italic toggle="yes">Bellis perennis</italic></article-title><source>Phytochemistry</source><year>1991</year><volume>30</volume><fpage>627</fpage><lpage>631</lpage><pub-id pub-id-type="doi">10.1016/0031-9422(91)83740-C</pub-id></element-citation></ref><ref id="B227-pharmaceutics-16-00454"><label>227.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scognamiglio</surname><given-names>M.</given-names></name><name name-style="western"><surname>Esposito</surname><given-names>A.</given-names></name><name name-style="western"><surname>D&#8217;Abrosca</surname><given-names>B.</given-names></name><name name-style="western"><surname>Pacifico</surname><given-names>S.</given-names></name><name name-style="western"><surname>Fiumano</surname><given-names>V.</given-names></name><name name-style="western"><surname>Tsafantakis</surname><given-names>N.</given-names></name><name name-style="western"><surname>Monaco</surname><given-names>P.</given-names></name><name name-style="western"><surname>Fiorentino</surname><given-names>A.</given-names></name></person-group><article-title>Isolation, Distribution and Allelopathic Effect of Caffeic Acid Derivatives from <italic toggle="yes">Bellis perennis</italic> L.</article-title><source>Biochem. Syst. Ecol.</source><year>2012</year><volume>43</volume><fpage>108</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1016/j.bse.2012.02.025</pub-id></element-citation></ref><ref id="B228-pharmaceutics-16-00454"><label>228.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Avato</surname><given-names>P.</given-names></name><name name-style="western"><surname>Tava</surname><given-names>A.</given-names></name></person-group><article-title>Acetylenes and Terpenoids of <italic toggle="yes">Bellis perennis</italic></article-title><source>Phytochemistry</source><year>1995</year><volume>40</volume><fpage>141</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1016/0031-9422(95)00183-8</pub-id></element-citation></ref><ref id="B229-pharmaceutics-16-00454"><label>229.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoshikawa</surname><given-names>M.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>Nishida</surname><given-names>E.</given-names></name><name name-style="western"><surname>Nakamura</surname><given-names>S.</given-names></name><name name-style="western"><surname>Matsuda</surname><given-names>H.</given-names></name><name name-style="western"><surname>Muraoka</surname><given-names>O.</given-names></name><name name-style="western"><surname>Morikawa</surname><given-names>T.</given-names></name></person-group><article-title>Medicinal Flowers. XXI. Structures of Perennisaponins A, B, C, D, E, and F, Acylated Oleanane-Type Triterpene Oligoglycosides, from the Flowers of <italic toggle="yes">Bellis perennis</italic></article-title><source>Chem. Pharm. Bull.</source><year>2008</year><volume>56</volume><fpage>559</fpage><lpage>568</lpage><pub-id pub-id-type="doi">10.1248/cpb.56.559</pub-id><pub-id pub-id-type="pmid">18379108</pub-id></element-citation></ref><ref id="B230-pharmaceutics-16-00454"><label>230.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Toki</surname><given-names>K.</given-names></name><name name-style="western"><surname>Saito</surname><given-names>N.</given-names></name><name name-style="western"><surname>Honda</surname><given-names>T.</given-names></name></person-group><article-title>Three Cyanidin 3-Glucuronylglucosides from Red Flowers of <italic toggle="yes">Bellis perennis</italic></article-title><source>Phytochemistry</source><year>1991</year><volume>30</volume><fpage>3769</fpage><lpage>3771</lpage><pub-id pub-id-type="doi">10.1016/0031-9422(91)80107-C</pub-id></element-citation></ref><ref id="B231-pharmaceutics-16-00454"><label>231.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morikawa</surname><given-names>T.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>Nishida</surname><given-names>E.</given-names></name><name name-style="western"><surname>Ito</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Matsuda</surname><given-names>H.</given-names></name><name name-style="western"><surname>Nakamura</surname><given-names>S.</given-names></name><name name-style="western"><surname>Muraoka</surname><given-names>O.</given-names></name><name name-style="western"><surname>Yoshikawa</surname><given-names>M.</given-names></name></person-group><article-title>Perennisosides I-VII, Acylated Triterpene Saponins with Antihyperlipidemic Activities from the Flowers of <italic toggle="yes">Bellis perennis</italic></article-title><source>J. Nat. Prod.</source><year>2008</year><volume>71</volume><fpage>828</fpage><lpage>835</lpage><pub-id pub-id-type="doi">10.1021/np8000333</pub-id><pub-id pub-id-type="pmid">18363378</pub-id></element-citation></ref><ref id="B232-pharmaceutics-16-00454"><label>232.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gudej</surname><given-names>J.</given-names></name><name name-style="western"><surname>Nazaruk</surname><given-names>J.</given-names></name></person-group><article-title>Flavonol Glycosides from the Flowers of <italic toggle="yes">Bellis perennis</italic></article-title><source>Fitoterapia</source><year>2001</year><volume>72</volume><fpage>839</fpage><lpage>840</lpage><pub-id pub-id-type="doi">10.1016/S0367-326X(01)00309-4</pub-id><pub-id pub-id-type="pmid">11677029</pub-id></element-citation></ref><ref id="B233-pharmaceutics-16-00454"><label>233.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karakas</surname><given-names>F.</given-names></name><name name-style="western"><surname>Karakas</surname><given-names>A.</given-names></name><name name-style="western"><surname>Co&#197;&#376;kun</surname><given-names>H.</given-names></name><name name-style="western"><surname>Turker</surname><given-names>U.</given-names></name></person-group><article-title>Effects of Common Daisy (<italic toggle="yes">Bellis perennis</italic> L.) Aqueous Extracts on Anxiety-like Behaviour and Spatial Memory Performance in Wistar Albino Rats</article-title><source>Afr. J. Pharm. Pharmacol.</source><year>2011</year><volume>5</volume><fpage>1378</fpage><lpage>1388</lpage><pub-id pub-id-type="doi">10.5897/AJPP11.262</pub-id></element-citation></ref><ref id="B234-pharmaceutics-16-00454"><label>234.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pehlivan Karaka&#351;</surname><given-names>F.</given-names></name><name name-style="western"><surname>Karaka&#351;</surname><given-names>A.</given-names></name><name name-style="western"><surname>Boran</surname><given-names>&#199;.</given-names></name><name name-style="western"><surname>U&#231;ar T&#252;rker</surname><given-names>A.</given-names></name><name name-style="western"><surname>Nuray Yal&#231;in</surname><given-names>F.</given-names></name><name name-style="western"><surname>Bilensoy</surname><given-names>E.</given-names></name></person-group><article-title>The Evaluation of Topical Administration of <italic toggle="yes">Bellis perennis</italic> Fraction on Circular Excision Wound Healing in Wistar Albino Rats</article-title><source>Pharm. Biol.</source><year>2012</year><volume>50</volume><fpage>1031</fpage><lpage>1037</lpage><pub-id pub-id-type="doi">10.3109/13880209.2012.656200</pub-id><pub-id pub-id-type="pmid">22775421</pub-id></element-citation></ref><ref id="B235-pharmaceutics-16-00454"><label>235.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karakas</surname><given-names>F.P.</given-names></name><name name-style="western"><surname>Turker</surname><given-names>A.U.</given-names></name></person-group><article-title>An Efficient in Vitro Regeneration System for <italic toggle="yes">Bellis perennis</italic> L. and Comparison of Phenolic Contents of Field-Grown and in Vitro-Grown Leaves by LC-MS/MS</article-title><source>Ind. Crops Prod.</source><year>2013</year><volume>48</volume><fpage>162</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1016/j.indcrop.2013.04.008</pub-id></element-citation></ref><ref id="B236-pharmaceutics-16-00454"><label>236.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karakas</surname><given-names>F.P.</given-names></name><name name-style="western"><surname>Turker</surname><given-names>A.U.</given-names></name><name name-style="western"><surname>Karakas</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mshvildadze</surname><given-names>V.</given-names></name><name name-style="western"><surname>Pichette</surname><given-names>A.</given-names></name><name name-style="western"><surname>Legault</surname><given-names>J.</given-names></name></person-group><article-title>In Vitro Cytotoxic, Antibacterial, Anti-Inflammatory and Antioxidant Activities and Phenolic Content in Wild-Grown Flowers of Common Daisy&#8212;A Medicinal Plant</article-title><source>J. Herb. Med.</source><year>2017</year><volume>8</volume><fpage>31</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1016/j.hermed.2016.11.003</pub-id></element-citation></ref><ref id="B237-pharmaceutics-16-00454"><label>237.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>W.</given-names></name><name name-style="western"><surname>Asada</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Koike</surname><given-names>K.</given-names></name><name name-style="western"><surname>Nikaido</surname><given-names>T.</given-names></name><name name-style="western"><surname>Furuya</surname><given-names>T.</given-names></name><name name-style="western"><surname>Yoshikawa</surname><given-names>T.</given-names></name></person-group><article-title>Bellisosides A&#8211;F, Six Novel Acylated Triterpenoid Saponins from <italic toggle="yes">Bellis perennis</italic> (Compositae)</article-title><source>Tetrahedron</source><year>2005</year><volume>61</volume><fpage>2921</fpage><lpage>2929</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2005.01.026</pub-id></element-citation></ref><ref id="B238-pharmaceutics-16-00454"><label>238.</label><element-citation publication-type="confproc"><person-group person-group-type="author"><name name-style="western"><surname>Lapava</surname><given-names>N.</given-names></name></person-group><article-title>Bidens Frondosa: Component Composition and Pharmacological Profile</article-title><source>Proceedings of the International Scientific Conference of Young Scientists &#8220;Current Development of Health Care Technology&#8221;</source><conf-loc>Vilar, Moscow</conf-loc><conf-date>1&#8211;4 June 2021</conf-date><fpage>475</fpage><lpage>484</lpage></element-citation></ref><ref id="B239-pharmaceutics-16-00454"><label>239.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brand&#227;o</surname><given-names>M.G.L.</given-names></name><name name-style="western"><surname>Krettli</surname><given-names>A.U.</given-names></name><name name-style="western"><surname>Soares</surname><given-names>L.S.R.</given-names></name><name name-style="western"><surname>Nery</surname><given-names>C.G.C.</given-names></name><name name-style="western"><surname>Marinuzzi</surname><given-names>H.C.</given-names></name></person-group><article-title>Antimalarial Activity of Extracts and Fractions from Bidens Pilosa and Other Bidens Species (<italic toggle="yes">Asteraceae</italic>) Correlated with the Presence of Acetylene and Flavonoid Compounds</article-title><source>J. Ethnopharmacol.</source><year>1997</year><volume>57</volume><fpage>131</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(97)00060-3</pub-id><pub-id pub-id-type="pmid">9254115</pub-id></element-citation></ref><ref id="B240-pharmaceutics-16-00454"><label>240.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Le</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W.</given-names></name></person-group><article-title>Anti-Inflammatory Constituents from Bidens Frondosa</article-title><source>Molecules</source><year>2015</year><volume>20</volume><fpage>18496</fpage><lpage>18510</lpage><pub-id pub-id-type="doi">10.3390/molecules201018496</pub-id><pub-id pub-id-type="pmid">26473814</pub-id><pub-id pub-id-type="pmcid">PMC6332032</pub-id></element-citation></ref><ref id="B241-pharmaceutics-16-00454"><label>241.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rahman</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bajpai</surname><given-names>V.K.</given-names></name><name name-style="western"><surname>Dung</surname><given-names>N.T.</given-names></name><name name-style="western"><surname>Kang</surname><given-names>S.C.</given-names></name></person-group><article-title>Antibacterial and Antioxidant Activities of the Essential Oil and Methanol Extracts of Bidens Frondosa Linn</article-title><source>Int. J. Food Sci. Technol.</source><year>2011</year><volume>46</volume><fpage>1238</fpage><lpage>1244</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2621.2011.02615.x</pub-id></element-citation></ref><ref id="B242-pharmaceutics-16-00454"><label>242.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Venkateswarlu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Panchagnula</surname><given-names>G.K.</given-names></name><name name-style="western"><surname>Subbaraju</surname><given-names>G.V.</given-names></name></person-group><article-title>Synthesis and Antioxidative Activity of 3&#8242;,4&#8242;,6,7-Tetrahydroxyaurone, a Metabolite of Bidens Frondosa</article-title><source>Biosci. Biotechnol. Biochem.</source><year>2004</year><volume>68</volume><fpage>2183</fpage><lpage>2185</lpage><pub-id pub-id-type="doi">10.1271/bbb.68.2183</pub-id><pub-id pub-id-type="pmid">15502366</pub-id></element-citation></ref><ref id="B243-pharmaceutics-16-00454"><label>243.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khouchlaa</surname><given-names>A.</given-names></name><name name-style="western"><surname>El Baaboua</surname><given-names>A.</given-names></name><name name-style="western"><surname>El Moudden</surname><given-names>H.</given-names></name><name name-style="western"><surname>Lakhdar</surname><given-names>F.</given-names></name><name name-style="western"><surname>Bakrim</surname><given-names>S.</given-names></name><name name-style="western"><surname>El Menyiy</surname><given-names>N.</given-names></name><name name-style="western"><surname>Belmehdi</surname><given-names>O.</given-names></name><name name-style="western"><surname>Harhar</surname><given-names>H.</given-names></name><name name-style="western"><surname>El Omari</surname><given-names>N.</given-names></name><name name-style="western"><surname>Balahbib</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Traditional Uses, Bioactive Compounds, and Pharmacological Investigations of Calendula Arvensis L.: A Comprehensive Review</article-title><source>Adv. Pharmacol. Pharm. Sci.</source><year>2023</year><volume>2023</volume><fpage>2482544</fpage><pub-id pub-id-type="doi">10.1155/2023/2482544</pub-id><pub-id pub-id-type="pmid">36636465</pub-id><pub-id pub-id-type="pmcid">PMC9831710</pub-id></element-citation></ref><ref id="B244-pharmaceutics-16-00454"><label>244.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guimar&#227;es</surname><given-names>R.</given-names></name><name name-style="western"><surname>Barros</surname><given-names>L.</given-names></name><name name-style="western"><surname>Due&#241;as</surname><given-names>M.</given-names></name><name name-style="western"><surname>Calhelha</surname><given-names>R.C.</given-names></name><name name-style="western"><surname>Carvalho</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Santos-Buelga</surname><given-names>C.</given-names></name><name name-style="western"><surname>Queiroz</surname><given-names>M.J.R.P.</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>I.C.F.R.</given-names></name></person-group><article-title>Nutrients, Phytochemicals and Bioactivity of Wild Roman Chamomile: A Comparison between the Herb and Its Preparations</article-title><source>Food Chem.</source><year>2013</year><volume>136</volume><fpage>718</fpage><lpage>725</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2012.08.025</pub-id><pub-id pub-id-type="pmid">23122119</pub-id></element-citation></ref><ref id="B245-pharmaceutics-16-00454"><label>245.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Committee on Herbal Medicinal Products (HMPC)</collab></person-group><source>Assessment Report on Chamaemelum nobile (L.) All., Flos</source><publisher-name>Committee on Herbal Medicinal Products (HMPC)</publisher-name><publisher-loc>London, UK</publisher-loc><year>2012</year></element-citation></ref><ref id="B246-pharmaceutics-16-00454"><label>246.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Al-Snafi</surname><given-names>A.E.</given-names></name></person-group><article-title>Medical Importance of Anthemis Nobilis (<italic toggle="yes">Chamaemelum nobile</italic>)&#8212;A Review. Some of the Authors of This Publication Are Also Working on These Related Projects: Pharmacology of Medicinal Plants View Project Immunological Effects of Medicinal Plants: A Review (Part 2). View Project</article-title><source>Asian J. Pharm. Sci. Technol.</source><year>2016</year><volume>6</volume><fpage>89</fpage><lpage>95</lpage></element-citation></ref><ref id="B247-pharmaceutics-16-00454"><label>247.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aisa</surname><given-names>H.A.</given-names></name><name name-style="western"><surname>Xin</surname><given-names>X.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>D.</given-names></name></person-group><article-title>Chemical Constituents and Their Pharmacological Activities of Plants from Cichorium Genus</article-title><source>Chin. Herb. Med.</source><year>2020</year><volume>12</volume><fpage>224</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1016/j.chmed.2020.05.001</pub-id><pub-id pub-id-type="pmid">36119016</pub-id><pub-id pub-id-type="pmcid">PMC9476815</pub-id></element-citation></ref><ref id="B248-pharmaceutics-16-00454"><label>248.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Puhlmann</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>de Vos</surname><given-names>W.M.</given-names></name></person-group><article-title>Back to the Roots: Revisiting the Use of the Fiber-Rich <italic toggle="yes">Cichorium intybus</italic> L. Taproots</article-title><source>Adv. Nutr.</source><year>2020</year><volume>11</volume><fpage>878</fpage><lpage>890</lpage><pub-id pub-id-type="doi">10.1093/advances/nmaa025</pub-id><pub-id pub-id-type="pmid">32199025</pub-id><pub-id pub-id-type="pmcid">PMC7360457</pub-id></element-citation></ref><ref id="B249-pharmaceutics-16-00454"><label>249.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brahmi-Chendouh</surname><given-names>N.</given-names></name><name name-style="western"><surname>Piccolella</surname><given-names>S.</given-names></name><name name-style="western"><surname>Crescente</surname><given-names>G.</given-names></name><name name-style="western"><surname>Pacifico</surname><given-names>F.</given-names></name><name name-style="western"><surname>Boulekbache</surname><given-names>L.</given-names></name><name name-style="western"><surname>Hamri-Zeghichi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Akkal</surname><given-names>S.</given-names></name><name name-style="western"><surname>Madani</surname><given-names>K.</given-names></name><name name-style="western"><surname>Pacifico</surname><given-names>S.</given-names></name></person-group><article-title>A Nutraceutical Extract from <italic toggle="yes">Inula viscosa</italic> Leaves: UHPLC-HR-MS/MS Based Polyphenol Profile, and Antioxidant and Cytotoxic Activities</article-title><source>J. Food Drug Anal.</source><year>2019</year><volume>27</volume><fpage>692</fpage><pub-id pub-id-type="doi">10.1016/j.jfda.2018.11.006</pub-id><pub-id pub-id-type="pmid">31324285</pub-id><pub-id pub-id-type="pmcid">PMC9307043</pub-id></element-citation></ref><ref id="B250-pharmaceutics-16-00454"><label>250.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vuko</surname><given-names>E.</given-names></name><name name-style="western"><surname>Dunki&#263;</surname><given-names>V.</given-names></name><name name-style="western"><surname>Maravi&#263;</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ru&#353;&#269;i&#263;</surname><given-names>M.</given-names></name><name name-style="western"><surname>Nazli&#263;</surname><given-names>M.</given-names></name><name name-style="western"><surname>Radan</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ljubenkov</surname><given-names>I.</given-names></name><name name-style="western"><surname>Soldo</surname><given-names>B.</given-names></name><name name-style="western"><surname>Fredotovi&#263;</surname><given-names>&#381;.</given-names></name></person-group><article-title>Not Only a Weed Plant&#8212;Biological Activities of Essential Oil and Hydrosol of <italic toggle="yes">Dittrichia viscosa</italic> (L.) Greuter</article-title><source>Plants</source><year>2021</year><volume>10</volume><elocation-id>1837</elocation-id><pub-id pub-id-type="doi">10.3390/plants10091837</pub-id><pub-id pub-id-type="pmid">34579370</pub-id><pub-id pub-id-type="pmcid">PMC8470837</pub-id></element-citation></ref><ref id="B251-pharmaceutics-16-00454"><label>251.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kheyar-Kraouche</surname><given-names>N.</given-names></name><name name-style="western"><surname>da Silva</surname><given-names>A.B.</given-names></name><name name-style="western"><surname>Serra</surname><given-names>A.T.</given-names></name><name name-style="western"><surname>Bedjou</surname><given-names>F.</given-names></name><name name-style="western"><surname>Bronze</surname><given-names>M.R.</given-names></name></person-group><article-title>Characterization by Liquid Chromatography&#8211;Mass Spectrometry and Antioxidant Activity of an Ethanolic Extract of <italic toggle="yes">Inula viscosa</italic> Leaves</article-title><source>J. Pharm. Biomed. Anal.</source><year>2018</year><volume>156</volume><fpage>297</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1016/j.jpba.2018.04.047</pub-id><pub-id pub-id-type="pmid">29730339</pub-id></element-citation></ref><ref id="B252-pharmaceutics-16-00454"><label>252.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parolin</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ion Scotta</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bresch</surname><given-names>C.</given-names></name></person-group><article-title>Biolog&#237;a de <italic toggle="yes">Dittrichia viscosa</italic>, Una Planta Ruderal Del Mediterr&#225;neo: Revisi&#243;n</article-title><source>Phyton</source><year>2014</year><volume>83</volume><fpage>251</fpage><lpage>262</lpage></element-citation></ref><ref id="B253-pharmaceutics-16-00454"><label>253.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ozkan</surname><given-names>E.</given-names></name><name name-style="western"><surname>Karakas</surname><given-names>F.P.</given-names></name><name name-style="western"><surname>Yildirim</surname><given-names>A.B.</given-names></name><name name-style="western"><surname>Tas</surname><given-names>I.</given-names></name><name name-style="western"><surname>Eker</surname><given-names>I.</given-names></name><name name-style="western"><surname>Yavuz</surname><given-names>M.Z.</given-names></name><name name-style="western"><surname>Turker</surname><given-names>A.U.</given-names></name></person-group><article-title>Promising Medicinal Plant <italic toggle="yes">Inula viscosa</italic> L.: Antiproliferative, Antioxidant, Antibacterial and Phenolic Profiles</article-title><source>Prog. Nutr.</source><year>2019</year><volume>21</volume><fpage>652</fpage><lpage>661</lpage><pub-id pub-id-type="doi">10.23751/PN.V21I3.7186</pub-id></element-citation></ref><ref id="B254-pharmaceutics-16-00454"><label>254.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rozenblat</surname><given-names>S.</given-names></name><name name-style="western"><surname>Grossman</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bergman</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gottlieb</surname><given-names>H.</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Dovrat</surname><given-names>S.</given-names></name></person-group><article-title>Induction of G2/M Arrest and Apoptosis by Sesquiterpene Lactones in Human Melanoma Cell Lines</article-title><source>Biochem. Pharmacol.</source><year>2008</year><volume>75</volume><fpage>369</fpage><lpage>382</lpage><pub-id pub-id-type="doi">10.1016/j.bcp.2007.08.024</pub-id><pub-id pub-id-type="pmid">17919456</pub-id></element-citation></ref><ref id="B255-pharmaceutics-16-00454"><label>255.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kheyar-Kraouche</surname><given-names>N.</given-names></name><name name-style="western"><surname>Boucheffa</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bellik</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Farida</surname><given-names>K.</given-names></name><name name-style="western"><surname>Brahmi-Chendouh</surname><given-names>N.</given-names></name></person-group><article-title>Exploring the Potential of <italic toggle="yes">Inula viscosa</italic> Extracts for Antioxidant, Antiproliferative and Apoptotic Effects on Human Liver Cancer Cells and a Molecular Docking Study</article-title><source>BioTechnologia</source><year>2023</year><volume>104</volume><elocation-id>183</elocation-id><pub-id pub-id-type="doi">10.5114/bta.2023.127207</pub-id><pub-id pub-id-type="pmid">37427027</pub-id><pub-id pub-id-type="pmcid">PMC10323743</pub-id></element-citation></ref><ref id="B256-pharmaceutics-16-00454"><label>256.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Asraoui</surname><given-names>F.</given-names></name><name name-style="western"><surname>Kounnoun</surname><given-names>A.</given-names></name><name name-style="western"><surname>Cacciola</surname><given-names>F.</given-names></name><name name-style="western"><surname>Mansouri</surname><given-names>F.E.</given-names></name><name name-style="western"><surname>Kabach</surname><given-names>I.</given-names></name><name name-style="western"><surname>Majdoub</surname><given-names>Y.O.E.</given-names></name><name name-style="western"><surname>Alibrando</surname><given-names>F.</given-names></name><name name-style="western"><surname>Arena</surname><given-names>K.</given-names></name><name name-style="western"><surname>Trovato</surname><given-names>E.</given-names></name><name name-style="western"><surname>Mondello</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Phytochemical Profile, Antioxidant Capacity, &#945;-Amylase and &#945;-Glucosidase Inhibitory Potential of Wild Moroccan <italic toggle="yes">Inula viscosa</italic> (L.) Aiton Leaves</article-title><source>Molecules</source><year>2021</year><volume>26</volume><elocation-id>3134</elocation-id><pub-id pub-id-type="doi">10.3390/molecules26113134</pub-id><pub-id pub-id-type="pmid">34073905</pub-id><pub-id pub-id-type="pmcid">PMC8197302</pub-id></element-citation></ref><ref id="B257-pharmaceutics-16-00454"><label>257.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rotundo</surname><given-names>G.</given-names></name><name name-style="western"><surname>Paventi</surname><given-names>G.</given-names></name><name name-style="western"><surname>Barberio</surname><given-names>A.</given-names></name><name name-style="western"><surname>De Cristofaro</surname><given-names>A.</given-names></name><name name-style="western"><surname>Notardonato</surname><given-names>I.</given-names></name><name name-style="western"><surname>Russo</surname><given-names>M.V.</given-names></name><name name-style="western"><surname>Germinara</surname><given-names>G.S.</given-names></name></person-group><article-title>Biological Activity of <italic toggle="yes">Dittrichia viscosa</italic> (L.) Greuter Extracts against Adult <italic toggle="yes">Sitophilus granarius</italic> (L.) (Coleoptera, Curculionidae) and Identification of Active Compounds</article-title><source>Sci. Rep.</source><year>2019</year><volume>9</volume><fpage>6429</fpage><pub-id pub-id-type="doi">10.1038/s41598-019-42886-4</pub-id><pub-id pub-id-type="pmid">31015563</pub-id><pub-id pub-id-type="pmcid">PMC6478880</pub-id></element-citation></ref><ref id="B258-pharmaceutics-16-00454"><label>258.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mrid</surname><given-names>R.B.</given-names></name><name name-style="western"><surname>Bouchmaa</surname><given-names>N.</given-names></name><name name-style="western"><surname>Kabach</surname><given-names>I.</given-names></name><name name-style="western"><surname>Zouaoui</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Chtibi</surname><given-names>H.</given-names></name><name name-style="western"><surname>El Maadoudi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kounnoun</surname><given-names>A.</given-names></name><name name-style="western"><surname>Cacciola</surname><given-names>F.</given-names></name><name name-style="western"><surname>El Majdoub</surname><given-names>Y.O.</given-names></name><name name-style="western"><surname>Mondello</surname><given-names>L.</given-names></name><etal/></person-group><article-title><italic toggle="yes">Dittrichia viscosa</italic> L. Leaves: A Valuable Source of Bioactive Compounds with Multiple Pharmacological Effects</article-title><source>Molecules</source><year>2022</year><volume>27</volume><elocation-id>2108</elocation-id><pub-id pub-id-type="doi">10.3390/molecules27072108</pub-id><pub-id pub-id-type="pmid">35408507</pub-id><pub-id pub-id-type="pmcid">PMC9000642</pub-id></element-citation></ref><ref id="B259-pharmaceutics-16-00454"><label>259.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meng</surname><given-names>X.-H.</given-names></name><name name-style="western"><surname>Pan</surname><given-names>Y.-A.</given-names></name><name name-style="western"><surname>Lv</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ding</surname><given-names>X.-Q.</given-names></name><name name-style="western"><surname>Yin</surname><given-names>D.-Q.</given-names></name><name name-style="western"><surname>Gai</surname><given-names>Y.-N.</given-names></name><name name-style="western"><surname>Niu</surname><given-names>G.-T.</given-names></name><name name-style="western"><surname>Ren</surname><given-names>B.-R.</given-names></name><name name-style="western"><surname>Qian</surname><given-names>X.-G.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J.</given-names></name><etal/></person-group><article-title>One New 12, 8-Guaianolide Sesquiterpene Lactone with Antihyperglycemic Activity from the Roots of <italic toggle="yes">Cichorium intybus</italic></article-title><source>Nat. Prod. Res.</source><year>2023</year><comment><italic toggle="yes">epub ahead of print</italic></comment><pub-id pub-id-type="doi">10.1080/14786419.2023.2230606</pub-id><pub-id pub-id-type="pmid">37395502</pub-id></element-citation></ref><ref id="B260-pharmaceutics-16-00454"><label>260.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ripanda</surname><given-names>A.</given-names></name><name name-style="western"><surname>Luanda</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sule</surname><given-names>K.S.</given-names></name><name name-style="western"><surname>Mtabazi</surname><given-names>G.S.</given-names></name><name name-style="western"><surname>Makangara</surname><given-names>J.J.</given-names></name></person-group><article-title><italic toggle="yes">Galinsoga parviflora</italic> (Cav.): A Comprehensive Review on Ethnomedicinal, Phytochemical and Pharmacological Studies</article-title><source>Heliyon</source><year>2023</year><volume>9</volume><fpage>e13517</fpage><pub-id pub-id-type="doi">10.1016/j.heliyon.2023.e13517</pub-id><pub-id pub-id-type="pmid">36846665</pub-id><pub-id pub-id-type="pmcid">PMC9946856</pub-id></element-citation></ref><ref id="B261-pharmaceutics-16-00454"><label>261.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Les</surname><given-names>F.</given-names></name><name name-style="western"><surname>Venditti</surname><given-names>A.</given-names></name><name name-style="western"><surname>C&#225;sedas</surname><given-names>G.</given-names></name><name name-style="western"><surname>Frezza</surname><given-names>C.</given-names></name><name name-style="western"><surname>Guiso</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sciubba</surname><given-names>F.</given-names></name><name name-style="western"><surname>Serafini</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bianco</surname><given-names>A.</given-names></name><name name-style="western"><surname>Valero</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>L&#243;pez</surname><given-names>V.</given-names></name></person-group><article-title>Everlasting Flower (Helichrysum Stoechas Moench) as a Potential Source of Bioactive Molecules with Antiproliferative, Antioxidant, Antidiabetic and Neuroprotective Properties</article-title><source>Ind. Crops Prod.</source><year>2017</year><volume>108</volume><fpage>295</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1016/j.indcrop.2017.06.043</pub-id></element-citation></ref><ref id="B262-pharmaceutics-16-00454"><label>262.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Albayrak</surname><given-names>S.</given-names></name><name name-style="western"><surname>Aksoy</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sagdic</surname><given-names>O.</given-names></name><name name-style="western"><surname>Hamzaoglu</surname><given-names>E.</given-names></name></person-group><article-title>Compositions, Antioxidant and Antimicrobial Activities of Helichrysum (<italic toggle="yes">Asteraceae</italic>) Species Collected from Turkey</article-title><source>Food Chem.</source><year>2010</year><volume>119</volume><fpage>114</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2009.06.003</pub-id></element-citation></ref><ref id="B263-pharmaceutics-16-00454"><label>263.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Onaran</surname><given-names>M.</given-names></name><name name-style="western"><surname>Orhan</surname><given-names>N.</given-names></name><name name-style="western"><surname>Farahvash</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ekin</surname><given-names>H.N.I.</given-names></name><name name-style="western"><surname>Kocabiyik</surname><given-names>M.</given-names></name><name name-style="western"><surname>G&#246;n&#252;l</surname><given-names>I.I.</given-names></name><name name-style="western"><surname>&#350;en</surname><given-names>I.</given-names></name><name name-style="western"><surname>Aslan</surname><given-names>M.</given-names></name></person-group><article-title>Successful Treatment of Sodium Oxalate Induced Urolithiasis with Helichrysum Flowers</article-title><source>J. Ethnopharmacol.</source><year>2016</year><volume>186</volume><fpage>322</fpage><lpage>328</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2016.04.003</pub-id><pub-id pub-id-type="pmid">27085940</pub-id></element-citation></ref><ref id="B264-pharmaceutics-16-00454"><label>264.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bremner</surname><given-names>P.</given-names></name><name name-style="western"><surname>Rivera</surname><given-names>D.</given-names></name><name name-style="western"><surname>Calzado</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Ob&#243;n</surname><given-names>C.</given-names></name><name name-style="western"><surname>Inocencio</surname><given-names>C.</given-names></name><name name-style="western"><surname>Beckwith</surname><given-names>C.</given-names></name><name name-style="western"><surname>Fiebich</surname><given-names>B.L.</given-names></name><name name-style="western"><surname>Mu&#241;oz</surname><given-names>E.</given-names></name><name name-style="western"><surname>Heinrich</surname><given-names>M.</given-names></name></person-group><article-title>Assessing Medicinal Plants from South-Eastern Spain for Potential Anti-Inflammatory Effects Targeting Nuclear Factor-Kappa B and Other pro-Inflammatory Mediators</article-title><source>J. Ethnopharmacol.</source><year>2009</year><volume>124</volume><fpage>295</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2009.04.035</pub-id><pub-id pub-id-type="pmid">19397975</pub-id></element-citation></ref><ref id="B265-pharmaceutics-16-00454"><label>265.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jamuna</surname><given-names>S.</given-names></name><name name-style="western"><surname>Karthika</surname><given-names>K.</given-names></name><name name-style="western"><surname>Paulsamy</surname><given-names>S.</given-names></name><name name-style="western"><surname>Thenmozhi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kathiravan</surname><given-names>S.</given-names></name><name name-style="western"><surname>Venkatesh</surname><given-names>R.</given-names></name></person-group><article-title>Confertin and Scopoletin from Leaf and Root Extracts of <italic toggle="yes">Hypochaeris radicata</italic> Have Anti-Inflammatory and Antioxidant Activities</article-title><source>Ind. Crops Prod.</source><year>2015</year><volume>70</volume><fpage>221</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.1016/j.indcrop.2015.03.039</pub-id></element-citation></ref><ref id="B266-pharmaceutics-16-00454"><label>266.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shulha</surname><given-names>O.</given-names></name><name name-style="western"><surname>&#199;i&#231;ek</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Wangensteen</surname><given-names>H.</given-names></name><name name-style="western"><surname>Kroes</surname><given-names>J.</given-names></name><name name-style="western"><surname>M&#228;der</surname><given-names>M.</given-names></name><name name-style="western"><surname>Girreser</surname><given-names>U.</given-names></name><name name-style="western"><surname>Sendker</surname><given-names>J.</given-names></name><name name-style="western"><surname>J&#246;hrer</surname><given-names>K.</given-names></name><name name-style="western"><surname>Greil</surname><given-names>R.</given-names></name><name name-style="western"><surname>Sch&#252;hly</surname><given-names>W.</given-names></name><etal/></person-group><article-title>Lignans and Sesquiterpene Lactones from <italic toggle="yes">Hypochaeris radicata</italic> Subsp. Neapolitana (<italic toggle="yes">Asteraceae</italic>, Cichorieae)</article-title><source>Phytochemistry</source><year>2019</year><volume>165</volume><fpage>112047</fpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2019.05.020</pub-id><pub-id pub-id-type="pmid">31203102</pub-id></element-citation></ref><ref id="B267-pharmaceutics-16-00454"><label>267.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sicari</surname><given-names>V.</given-names></name><name name-style="western"><surname>Loizzo</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Silva</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Romeo</surname><given-names>R.</given-names></name><name name-style="western"><surname>Spampinato</surname><given-names>G.</given-names></name><name name-style="western"><surname>Tundis</surname><given-names>R.</given-names></name><name name-style="western"><surname>Leporini</surname><given-names>M.</given-names></name><name name-style="western"><surname>Musarella</surname><given-names>C.M.</given-names></name></person-group><article-title>The Effect of Blanching on Phytochemical Content and Bioactivity of Hypochaeris and Hyoseris Species (<italic toggle="yes">Asteraceae</italic>), Vegetables Traditionally Used in Southern Italy</article-title><source>Foods</source><year>2020</year><volume>10</volume><elocation-id>32</elocation-id><pub-id pub-id-type="doi">10.3390/foods10010032</pub-id><pub-id pub-id-type="pmid">33374396</pub-id><pub-id pub-id-type="pmcid">PMC7824150</pub-id></element-citation></ref><ref id="B268-pharmaceutics-16-00454"><label>268.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Senguttuvan</surname><given-names>J.</given-names></name><name name-style="western"><surname>Paulsamy</surname><given-names>S.</given-names></name><name name-style="western"><surname>Karthika</surname><given-names>K.</given-names></name></person-group><article-title>Phytochemical Analysis and Evaluation of Leaf and Root Parts of the Medicinal Herb, <italic toggle="yes">Hypochaeris radicata</italic> L. for In Vitro Antioxidant Activities</article-title><source>Asian Pac. J. Trop. Biomed.</source><year>2014</year><volume>4</volume><elocation-id>S359</elocation-id><pub-id pub-id-type="doi">10.12980/APJTB.4.2014C1030</pub-id><pub-id pub-id-type="pmid">25183112</pub-id><pub-id pub-id-type="pmcid">PMC4025295</pub-id></element-citation></ref><ref id="B269-pharmaceutics-16-00454"><label>269.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shoaib Akhtar</surname><given-names>M.</given-names></name><name name-style="western"><surname>Naveed Mushtaq</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ali</surname><given-names>I.</given-names></name><name name-style="western"><surname>Pharm Sci</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Farooq Awan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Anjum</surname><given-names>I.</given-names></name><name name-style="western"><surname>Fatima</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mannan</surname><given-names>A.</given-names></name></person-group><article-title>Anti-Oxidant and Hepatoprotective Effects of <italic toggle="yes">Lactuca serriola</italic> and Its Phytochemical Screening by HPLC and FTIR Analysis</article-title><source>Pak. J. Pharm. Sci.</source><year>2020</year><volume>33</volume><fpage>2823</fpage><lpage>2830</lpage><pub-id pub-id-type="doi">10.36721/PJPS.2020.33.6.SUP.2823-2830.1</pub-id><pub-id pub-id-type="pmid">33879443</pub-id></element-citation></ref><ref id="B270-pharmaceutics-16-00454"><label>270.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fatah</surname><given-names>N.H.A.</given-names></name><name name-style="western"><surname>Amen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Abdel Bar</surname><given-names>F.M.</given-names></name><name name-style="western"><surname>Halim</surname><given-names>A.F.</given-names></name><name name-style="western"><surname>Saad</surname><given-names>H.-E.A.</given-names></name></person-group><article-title>Supporting Information Antioxidants and &#945;-Glucosidase Inhibitors from <italic toggle="yes">Lactuca serriola</italic> L.</article-title><source>Nat. Prod.</source><year>2020</year><volume>14</volume><fpage>410</fpage><lpage>415</lpage></element-citation></ref><ref id="B271-pharmaceutics-16-00454"><label>271.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abd-ElGawad</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Elshamy</surname><given-names>A.I.</given-names></name><name name-style="western"><surname>El-Nasser El Gendy</surname><given-names>A.</given-names></name><name name-style="western"><surname>Al-Rowaily</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Assaeed</surname><given-names>A.M.</given-names></name></person-group><article-title>Preponderance of Oxygenated Sesquiterpenes and Diterpenes in the Volatile Oil Constituents of <italic toggle="yes">Lactuca serriola</italic> L. Revealed Antioxidant and Allelopathic Activity</article-title><source>Chem. Biodivers.</source><year>2019</year><volume>16</volume><elocation-id>e1900278</elocation-id><pub-id pub-id-type="doi">10.1002/cbdv.201900278</pub-id><pub-id pub-id-type="pmid">31207097</pub-id></element-citation></ref><ref id="B272-pharmaceutics-16-00454"><label>272.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nabavi</surname><given-names>S.F.</given-names></name><name name-style="western"><surname>Nabavi</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Latifi</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Mirzaei</surname><given-names>M.</given-names></name><name name-style="western"><surname>Habtemariam</surname><given-names>S.</given-names></name><name name-style="western"><surname>Moghaddam</surname><given-names>A.H.</given-names></name></person-group><article-title>Mitigating Role of Quercetin against Sodium Fluoride-Induced Oxidative Stress in the Rat Brain</article-title><source>Pharm. Biol.</source><year>2012</year><volume>50</volume><fpage>1380</fpage><lpage>1383</lpage><pub-id pub-id-type="doi">10.3109/13880209.2012.675341</pub-id><pub-id pub-id-type="pmid">22870923</pub-id></element-citation></ref><ref id="B273-pharmaceutics-16-00454"><label>273.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elsharkawy</surname><given-names>E.</given-names></name><name name-style="western"><surname>Aljohar</surname><given-names>H.</given-names></name></person-group><article-title>Anticancer Screening of Medicinal Plants Growing in the Northern Region of Saudi Arabia</article-title><source>Natl. J. Physiol. Pharm. Pharmacol.</source><year>2016</year><volume>6</volume><fpage>241</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.5455/njppp.2016.6.10022016122</pub-id></element-citation></ref><ref id="B274-pharmaceutics-16-00454"><label>274.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>El-Esawi</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Elkelish</surname><given-names>A.</given-names></name><name name-style="western"><surname>Elansary</surname><given-names>H.O.</given-names></name><name name-style="western"><surname>Ali</surname><given-names>H.M.</given-names></name><name name-style="western"><surname>Elshikh</surname><given-names>M.</given-names></name><name name-style="western"><surname>Witczak</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>M.</given-names></name></person-group><article-title>Genetic Transformation and Hairy Root Induction Enhance the Antioxidant Potential of <italic toggle="yes">Lactuca serriola</italic> L.</article-title><source>Oxidative Med. Cell. Longev.</source><year>2017</year><volume>2017</volume><fpage>5604746</fpage><pub-id pub-id-type="doi">10.1155/2017/5604746</pub-id><pub-id pub-id-type="pmcid">PMC5556996</pub-id><pub-id pub-id-type="pmid">28835782</pub-id></element-citation></ref><ref id="B275-pharmaceutics-16-00454"><label>275.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohammad</surname><given-names>A.</given-names></name></person-group><article-title>Traditional Use of Kahu (<italic toggle="yes">Lactuca scariola</italic> L.)&#8212;A Review</article-title><source>Glob. J. Res. Med. Plants Indig. Med.</source><year>2013</year><volume>2</volume><fpage>465</fpage><lpage>474</lpage></element-citation></ref><ref id="B276-pharmaceutics-16-00454"><label>276.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ullah</surname><given-names>M.I.</given-names></name><name name-style="western"><surname>Anwar</surname><given-names>R.</given-names></name><name name-style="western"><surname>Kamran</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gul</surname><given-names>B.</given-names></name><name name-style="western"><surname>Elhady</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Youssef</surname><given-names>F.S.</given-names></name></person-group><article-title>Evaluation of the Anxiolytic and Anti-Epileptogenic Potential of <italic toggle="yes">Lactuca serriola</italic> Seed Using Pentylenetetrazol-Induced Kindling in Mice and Metabolic Profiling of Its Bioactive Extract</article-title><source>Antioxidants</source><year>2022</year><volume>11</volume><elocation-id>2232</elocation-id><pub-id pub-id-type="doi">10.3390/antiox11112232</pub-id><pub-id pub-id-type="pmid">36421417</pub-id><pub-id pub-id-type="pmcid">PMC9686728</pub-id></element-citation></ref><ref id="B277-pharmaceutics-16-00454"><label>277.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghods</surname><given-names>R.</given-names></name><name name-style="western"><surname>Gharouni</surname><given-names>M.</given-names></name><name name-style="western"><surname>Amanlou</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sharifi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Ghobadi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Amin</surname><given-names>G.</given-names></name></person-group><article-title>Effect of <italic toggle="yes">Onopordon acanthium</italic> L. as Add on Antihypertensive Therapy in Patients with Primary Hypertension Taking Losartan: A Pilot Study</article-title><source>Adv. Pharm. Bull.</source><year>2018</year><volume>8</volume><fpage>69</fpage><pub-id pub-id-type="doi">10.15171/apb.2018.009</pub-id><pub-id pub-id-type="pmid">29670841</pub-id><pub-id pub-id-type="pmcid">PMC5896397</pub-id></element-citation></ref><ref id="B278-pharmaceutics-16-00454"><label>278.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bande-De Le&#243;n</surname><given-names>C.</given-names></name><name name-style="western"><surname>Buend&#237;a-Moreno</surname><given-names>L.</given-names></name><name name-style="western"><surname>Abell&#225;n</surname><given-names>A.</given-names></name><name name-style="western"><surname>Manzi</surname><given-names>P.</given-names></name><name name-style="western"><surname>Al Mohandes Dridi</surname><given-names>B.</given-names></name><name name-style="western"><surname>Essaidi</surname><given-names>I.</given-names></name><name name-style="western"><surname>Aquilanti</surname><given-names>L.</given-names></name><name name-style="western"><surname>Tejada</surname><given-names>L.</given-names></name></person-group><article-title>Clotting and Proteolytic Activity of Freeze-Dried Crude Extracts Obtained from Wild Thistles <italic toggle="yes">Cynara humilis</italic> L. and <italic toggle="yes">Onopordum platylepis</italic> Murb</article-title><source>Foods</source><year>2023</year><volume>12</volume><elocation-id>2325</elocation-id><pub-id pub-id-type="doi">10.3390/foods12122325</pub-id><pub-id pub-id-type="pmid">37372535</pub-id><pub-id pub-id-type="pmcid">PMC10296898</pub-id></element-citation></ref><ref id="B279-pharmaceutics-16-00454"><label>279.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moln&#225;r</surname><given-names>J.</given-names></name><name name-style="western"><surname>Szebeni</surname><given-names>G.J.</given-names></name><name name-style="western"><surname>Csupor-L&#246;ffler</surname><given-names>B.</given-names></name><name name-style="western"><surname>Hajd&#250;</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Szekeres</surname><given-names>T.</given-names></name><name name-style="western"><surname>Saiko</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ocsovszki</surname><given-names>I.</given-names></name><name name-style="western"><surname>Pusk&#225;s</surname><given-names>L.G.</given-names></name><name name-style="western"><surname>Hohmann</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zupk&#243;</surname><given-names>I.</given-names></name></person-group><article-title>Investigation of the Antiproliferative Properties of Natural Sesquiterpenes from Artemisia Asiatica and <italic toggle="yes">Onopordum acanthium</italic> on HL-60 Cells In Vitro</article-title><source>Int. J. Mol. Sci.</source><year>2016</year><volume>17</volume><elocation-id>83</elocation-id><pub-id pub-id-type="doi">10.3390/ijms17020083</pub-id><pub-id pub-id-type="pmid">26901188</pub-id><pub-id pub-id-type="pmcid">PMC4783873</pub-id></element-citation></ref><ref id="B280-pharmaceutics-16-00454"><label>280.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>S.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Shao</surname><given-names>H.</given-names></name></person-group><article-title>Chemical Profile and Phytotoxic Action of <italic toggle="yes">Onopordum acanthium Essential oil</italic></article-title><source>Sci. Rep.</source><year>2020</year><volume>10</volume><fpage>13568</fpage><pub-id pub-id-type="doi">10.1038/s41598-020-70463-7</pub-id><pub-id pub-id-type="pmid">32782298</pub-id><pub-id pub-id-type="pmcid">PMC7419562</pub-id></element-citation></ref><ref id="B281-pharmaceutics-16-00454"><label>281.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garsiya</surname><given-names>E.R.</given-names></name><name name-style="western"><surname>Konovalov</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Shamilov</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Glushko</surname><given-names>M.P.</given-names></name><name name-style="western"><surname>Orynbasarova</surname><given-names>K.K.</given-names></name></person-group><article-title>Traditional Medicine Plant, <italic toggle="yes">Onopordum acanthium</italic> L. (<italic toggle="yes">Asteraceae</italic>): Chemical Composition and Pharmacological Research</article-title><source>Plants</source><year>2019</year><volume>8</volume><elocation-id>40</elocation-id><pub-id pub-id-type="doi">10.3390/PLANTS8020040</pub-id><pub-id pub-id-type="pmid">30759795</pub-id><pub-id pub-id-type="pmcid">PMC6410315</pub-id></element-citation></ref><ref id="B282-pharmaceutics-16-00454"><label>282.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Esmaeili</surname><given-names>A.</given-names></name><name name-style="western"><surname>Saremnia</surname><given-names>B.</given-names></name></person-group><article-title>Preparation of Extract-Loaded Nanocapsules from <italic toggle="yes">Onopordon leptolepis</italic> DC</article-title><source>Ind. Crops Prod.</source><year>2012</year><volume>37</volume><fpage>259</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1016/j.indcrop.2011.12.010</pub-id></element-citation></ref><ref id="B283-pharmaceutics-16-00454"><label>283.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khalilov</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Khalilova</surname><given-names>A.Z.</given-names></name><name name-style="western"><surname>Shakurova</surname><given-names>E.R.</given-names></name><name name-style="western"><surname>Nuriev</surname><given-names>I.F.</given-names></name><name name-style="western"><surname>Kachala</surname><given-names>V.V.</given-names></name><name name-style="western"><surname>Shashkov</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Dzhemilev</surname><given-names>U.M.</given-names></name></person-group><article-title>PMR and 13C NMR Spectra of Biologically Active Compounds. XII. Taraxasterol and Its Acetate from the Aerial Part of <italic toggle="yes">Onopordum acanthium</italic></article-title><source>Chem. Nat. Compd.</source><year>2003</year><volume>39</volume><fpage>285</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1023/A:1025478720459</pub-id></element-citation></ref><ref id="B284-pharmaceutics-16-00454"><label>284.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tyumkina</surname><given-names>T.V.</given-names></name><name name-style="western"><surname>Nuriev</surname><given-names>I.F.</given-names></name><name name-style="western"><surname>Khalilov</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Akhmetova</surname><given-names>V.R.</given-names></name><name name-style="western"><surname>Dzhemilev</surname><given-names>U.M.</given-names></name></person-group><article-title>PMR and 13C NMR Spectra of Biologically Active Compounds. XIII. Structure and Stereochemistry of a New Phenylpropanoid Glycoside Isolated from <italic toggle="yes">Onopordum acanthium</italic> Seeds</article-title><source>Chem. Nat. Compd.</source><year>2009</year><volume>45</volume><fpage>61</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1007/s10600-009-9254-9</pub-id></element-citation></ref><ref id="B285-pharmaceutics-16-00454"><label>285.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>A.</given-names></name><name name-style="western"><surname>Li</surname><given-names>D.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name></person-group><article-title>Authentication of Senecio Scandens and S. Vulgaris Based on the Comprehensive Secondary Metabolic Patterns Gained by UPLC&#8211;DAD/ESI-MS</article-title><source>J. Pharm. Biomed. Anal.</source><year>2011</year><volume>56</volume><fpage>165</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1016/j.jpba.2011.05.004</pub-id><pub-id pub-id-type="pmid">21664784</pub-id></element-citation></ref><ref id="B286-pharmaceutics-16-00454"><label>286.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Conforti</surname><given-names>F.</given-names></name><name name-style="western"><surname>Loizzo</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Statti</surname><given-names>G.</given-names></name><name name-style="western"><surname>Houghton</surname><given-names>P.</given-names></name><name name-style="western"><surname>Menichini</surname><given-names>F.</given-names></name></person-group><article-title>Biological Properties of Different Extracts of Two Senecio Species</article-title><source>Int. J. Food Sci. Nutr.</source><year>2006</year><volume>57</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1080/09637480500131236</pub-id><pub-id pub-id-type="pmid">16849109</pub-id></element-citation></ref><ref id="B287-pharmaceutics-16-00454"><label>287.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Acito</surname><given-names>M.</given-names></name><name name-style="western"><surname>Russo</surname><given-names>C.</given-names></name><name name-style="western"><surname>Fatigoni</surname><given-names>C.</given-names></name><name name-style="western"><surname>Mercanti</surname><given-names>F.</given-names></name><name name-style="western"><surname>Moretti</surname><given-names>M.</given-names></name><name name-style="western"><surname>Villarini</surname><given-names>M.</given-names></name></person-group><article-title>Cytotoxicity and Genotoxicity of <italic toggle="yes">Senecio vulgaris</italic> L. Extracts: An In Vitro Assessment in HepG2 Liver Cells</article-title><source>Int. J. Environ. Res. Public Health</source><year>2022</year><volume>19</volume><elocation-id>14824</elocation-id><pub-id pub-id-type="doi">10.3390/ijerph192214824</pub-id><pub-id pub-id-type="pmid">36429544</pub-id><pub-id pub-id-type="pmcid">PMC9690910</pub-id></element-citation></ref><ref id="B288-pharmaceutics-16-00454"><label>288.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Loizzo</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Statti</surname><given-names>G.A.</given-names></name><name name-style="western"><surname>Tundis</surname><given-names>R.</given-names></name><name name-style="western"><surname>Conforti</surname><given-names>F.</given-names></name><name name-style="western"><surname>Bonesi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Autelitano</surname><given-names>G.</given-names></name><name name-style="western"><surname>Houghton</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Miljkovic-Brake</surname><given-names>A.</given-names></name><name name-style="western"><surname>Menichini</surname><given-names>F.</given-names></name></person-group><article-title>Antibacterial and Antifungal Activity of <italic toggle="yes">Senecio inaequidens</italic> DC. and <italic toggle="yes">Senecio vulgaris</italic> L.</article-title><source>Phytother. Res.</source><year>2004</year><volume>18</volume><fpage>777</fpage><lpage>779</lpage><pub-id pub-id-type="doi">10.1002/ptr.1562</pub-id><pub-id pub-id-type="pmid">15478193</pub-id></element-citation></ref><ref id="B289-pharmaceutics-16-00454"><label>289.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fursenco</surname><given-names>C.</given-names></name><name name-style="western"><surname>Calalb</surname><given-names>T.</given-names></name><name name-style="western"><surname>Uncu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Dinu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ancuceanu</surname><given-names>R.</given-names></name></person-group><article-title><italic toggle="yes">Solidago virgaurea</italic> L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities</article-title><source>Biomolecules</source><year>2020</year><volume>10</volume><elocation-id>1619</elocation-id><pub-id pub-id-type="doi">10.3390/biom10121619</pub-id><pub-id pub-id-type="pmid">33266185</pub-id><pub-id pub-id-type="pmcid">PMC7761148</pub-id></element-citation></ref><ref id="B290-pharmaceutics-16-00454"><label>290.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khan</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Sahreen</surname><given-names>S.</given-names></name></person-group><article-title>Brain Antioxidant Markers, Cognitive Performance and Acetylcholinesterase Activity of Rats: Efficiency of <italic toggle="yes">Sonchus asper</italic></article-title><source>Behav. Brain Funct.</source><year>2012</year><volume>8</volume><fpage>21</fpage><pub-id pub-id-type="doi">10.1186/1744-9081-8-21</pub-id><pub-id pub-id-type="pmid">22591917</pub-id><pub-id pub-id-type="pmcid">PMC3527136</pub-id></element-citation></ref><ref id="B291-pharmaceutics-16-00454"><label>291.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khan</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Sahreen</surname><given-names>S.</given-names></name></person-group><article-title>Protective Effect of <italic toggle="yes">Sonchus asper</italic> Extracts against Experimentally Induced Lung Injuries in Rats: A Novel Study</article-title><source>Exp. Toxicol. Pathol.</source><year>2012</year><volume>64</volume><fpage>725</fpage><lpage>731</lpage><pub-id pub-id-type="doi">10.1016/j.etp.2011.01.007</pub-id><pub-id pub-id-type="pmid">21315567</pub-id></element-citation></ref><ref id="B292-pharmaceutics-16-00454"><label>292.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khan</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Sahreen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bokhari</surname><given-names>J.</given-names></name></person-group><article-title>Prevention of CCl4-Induced Nephrotoxicity with <italic toggle="yes">Sonchus asper</italic> in Rat</article-title><source>Food Chem. Toxicol.</source><year>2010</year><volume>48</volume><fpage>2469</fpage><lpage>2476</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2010.06.016</pub-id><pub-id pub-id-type="pmid">20550952</pub-id></element-citation></ref><ref id="B293-pharmaceutics-16-00454"><label>293.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khan</surname><given-names>R.A.</given-names></name></person-group><article-title>Protective Effects of <italic toggle="yes">Sonchus asper</italic> (L.) Hill, (<italic toggle="yes">Asteraceae</italic>) against CCl4-Induced Oxidative Stress in the Thyroid Tissue of Rats</article-title><source>BMC Complement. Altern. Med.</source><year>2012</year><volume>12</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1186/1472-6882-12-181</pub-id><pub-id pub-id-type="pmid">23043630</pub-id><pub-id pub-id-type="pmcid">PMC3485175</pub-id></element-citation></ref><ref id="B294-pharmaceutics-16-00454"><label>294.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khan</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Badar</surname><given-names>I.</given-names></name><name name-style="western"><surname>Siddiquah</surname><given-names>A.</given-names></name></person-group><article-title>Prevention of Hepatorenal Toxicity with <italic toggle="yes">Sonchus asper</italic> in Gentamicin Treated Rats</article-title><source>BMC Complement. Altern. Med.</source><year>2011</year><volume>11</volume><elocation-id>113</elocation-id><pub-id pub-id-type="doi">10.1186/1472-6882-11-113</pub-id><pub-id pub-id-type="pmid">22082144</pub-id><pub-id pub-id-type="pmcid">PMC3305921</pub-id></element-citation></ref><ref id="B295-pharmaceutics-16-00454"><label>295.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tripathi</surname><given-names>A.N.</given-names></name><name name-style="western"><surname>Sati</surname><given-names>S.C.</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>P.</given-names></name></person-group><article-title>An Invasive Plant <italic toggle="yes">Sonchus asper</italic> (L.) Hill: A Review of Its Ethnopharmacology, Phytochemistry, and Pharmacological Properties</article-title><source>Indian J. Nat. Prod. Resour.</source><year>2022</year><volume>13</volume><fpage>468</fpage><lpage>473</lpage><pub-id pub-id-type="doi">10.56042/IJNPR.V13I4.44111</pub-id></element-citation></ref><ref id="B296-pharmaceutics-16-00454"><label>296.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khan</surname><given-names>I.U.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>F.U.</given-names></name><name name-style="western"><surname>Hussain</surname><given-names>J.</given-names></name><name name-style="western"><surname>Badshah</surname><given-names>S.</given-names></name><name name-style="western"><surname>Muhammad</surname><given-names>N.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Kait</surname><given-names>C.F.</given-names></name><name name-style="western"><surname>Ali</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>H.</given-names></name><name name-style="western"><surname>Aslam</surname><given-names>M.W.</given-names></name><etal/></person-group><article-title>Asperal: A New Clerodane Diterpene from <italic toggle="yes">Sonchus asper</italic></article-title><source>Asian J. Chem.</source><year>2014</year><volume>26</volume><fpage>2699</fpage><lpage>2701</lpage><pub-id pub-id-type="doi">10.14233/ajchem.2014.16008</pub-id></element-citation></ref><ref id="B297-pharmaceutics-16-00454"><label>297.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Helal</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Nakamura</surname><given-names>N.</given-names></name><name name-style="western"><surname>El-Askary</surname><given-names>H.</given-names></name><name name-style="western"><surname>Hattori</surname><given-names>M.</given-names></name></person-group><article-title>Sesquiterpene Lactone Glucosides from <italic toggle="yes">Sonchus asper</italic></article-title><source>Phytochemistry</source><year>2000</year><volume>53</volume><fpage>473</fpage><lpage>477</lpage><pub-id pub-id-type="doi">10.1016/S0031-9422(99)00516-6</pub-id><pub-id pub-id-type="pmid">10731026</pub-id></element-citation></ref><ref id="B298-pharmaceutics-16-00454"><label>298.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xia</surname><given-names>D.Z.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>X.F.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Z.Y.</given-names></name><name name-style="western"><surname>Zou</surname><given-names>Z.D.</given-names></name></person-group><article-title>Antioxidant and Antibacterial Activity of Six Edible Wild Plants (<italic toggle="yes">Sonchus</italic> spp.) in China</article-title><source>Nat. Prod. Res.</source><year>2011</year><volume>25</volume><fpage>1893</fpage><lpage>1901</lpage><pub-id pub-id-type="doi">10.1080/14786419.2010.534093</pub-id><pub-id pub-id-type="pmid">21793765</pub-id></element-citation></ref><ref id="B299-pharmaceutics-16-00454"><label>299.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>X.M.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>P.L.</given-names></name></person-group><article-title>Research Progress of Sonchus Species</article-title><source>Int. J. Food Prop.</source><year>2018</year><volume>21</volume><fpage>147</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1080/10942912.2017.1415931</pub-id></element-citation></ref><ref id="B300-pharmaceutics-16-00454"><label>300.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M.H.</given-names></name></person-group><article-title><italic toggle="yes">Sonchus asper</italic> Extract Inhibits LPS-Induced Oxidative Stress and pro-Inflammatory Cytokine Production in RAW264.7 Macrophages</article-title><source>Nutr. Res. Pract.</source><year>2015</year><volume>9</volume><fpage>579</fpage><lpage>585</lpage><pub-id pub-id-type="doi">10.4162/nrp.2015.9.6.579</pub-id><pub-id pub-id-type="pmid">26634045</pub-id><pub-id pub-id-type="pmcid">PMC4667197</pub-id></element-citation></ref><ref id="B301-pharmaceutics-16-00454"><label>301.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>L.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>X.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>J.</given-names></name><name name-style="western"><surname>Tian</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>B.</given-names></name><name name-style="western"><surname>Teng</surname><given-names>H.</given-names></name></person-group><article-title><italic toggle="yes">Sonchus oleraceus</italic> Linn Protects against LPS-Induced Sepsis and Inhibits Inflammatory Responses in RAW264.7 Cells</article-title><source>J. Ethnopharmacol.</source><year>2019</year><volume>236</volume><fpage>63</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2019.02.039</pub-id><pub-id pub-id-type="pmid">30802614</pub-id></element-citation></ref><ref id="B302-pharmaceutics-16-00454"><label>302.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lei</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>B.</given-names></name><name name-style="western"><surname>Che</surname><given-names>Y.</given-names></name></person-group><article-title>Two New Sesquiterpenes from <italic toggle="yes">Sonchus oleraceus</italic> and Inhibitory Mechanism on Murine Haemangioendothelioma (EOMA) Cell Lines</article-title><source>Nat. Prod. Res.</source><year>2021</year><volume>36</volume><fpage>2814</fpage><lpage>2820</lpage><pub-id pub-id-type="doi">10.1080/14786419.2021.1931186</pub-id><pub-id pub-id-type="pmid">34039229</pub-id></element-citation></ref><ref id="B303-pharmaceutics-16-00454"><label>303.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nobela</surname><given-names>O.</given-names></name><name name-style="western"><surname>Ndhlala</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>Tugizimana</surname><given-names>F.</given-names></name><name name-style="western"><surname>Njobeh</surname><given-names>P.</given-names></name><name name-style="western"><surname>Raphasha</surname><given-names>D.G.</given-names></name><name name-style="western"><surname>Ncube</surname><given-names>B.</given-names></name><name name-style="western"><surname>Madala</surname><given-names>N.E.</given-names></name></person-group><article-title>Tapping into the Realm of Underutilised Green Leafy Vegetables: Using LC-IT-Tof-MS Based Methods to Explore Phytochemical Richness of <italic toggle="yes">Sonchus oleraceus</italic> (L.) L.</article-title><source>S. Afr. J. Bot.</source><year>2022</year><volume>145</volume><fpage>207</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1016/j.sajb.2021.03.010</pub-id></element-citation></ref><ref id="B304-pharmaceutics-16-00454"><label>304.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huyan</surname><given-names>T.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.L.</given-names></name><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.X.</given-names></name><name name-style="western"><surname>Shahid</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Li</surname><given-names>H.Q.</given-names></name></person-group><article-title>Anti-Tumor Effect of Hot Aqueous Extracts from <italic toggle="yes">Sonchus oleraceus</italic> (L.) L. and <italic toggle="yes">Juniperus sabina</italic> L&#8212;Two Traditional Medicinal Plants in China</article-title><source>J. Ethnopharmacol.</source><year>2016</year><volume>185</volume><fpage>289</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2016.03.044</pub-id><pub-id pub-id-type="pmid">27001625</pub-id></element-citation></ref><ref id="B305-pharmaceutics-16-00454"><label>305.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>El-Desouky</surname><given-names>T.A.</given-names></name></person-group><article-title>Evaluation of Effectiveness Aqueous Extract for Some Leaves of Wild Edible Plants in Egypt as Anti-Fungal and Anti-Toxigenic</article-title><source>Heliyon</source><year>2021</year><volume>7</volume><fpage>e06209</fpage><pub-id pub-id-type="doi">10.1016/j.heliyon.2021.e06209</pub-id><pub-id pub-id-type="pmid">33659741</pub-id><pub-id pub-id-type="pmcid">PMC7892916</pub-id></element-citation></ref><ref id="B306-pharmaceutics-16-00454"><label>306.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vilela</surname><given-names>F.C.</given-names></name><name name-style="western"><surname>De Mesquita Padilha</surname><given-names>M.</given-names></name><name name-style="western"><surname>Alves-Da-Silva</surname><given-names>G.</given-names></name><name name-style="western"><surname>Soncini</surname><given-names>R.</given-names></name><name name-style="western"><surname>Giusti-Paiva</surname><given-names>A.</given-names></name></person-group><article-title>Antidepressant-Like Activity of <italic toggle="yes">Sonchus oleraceus</italic> in Mouse Models of Immobility Tests</article-title><source>J. Med. Food</source><year>2010</year><volume>13</volume><fpage>219</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1089/jmf.2008.0303</pub-id><pub-id pub-id-type="pmid">20136459</pub-id></element-citation></ref><ref id="B307-pharmaceutics-16-00454"><label>307.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>V&#233;gh</surname><given-names>K.</given-names></name><name name-style="western"><surname>Riethm&#252;ller</surname><given-names>E.</given-names></name><name name-style="western"><surname>Hossz&#250;</surname><given-names>L.</given-names></name><name name-style="western"><surname>Darcsi</surname><given-names>A.</given-names></name><name name-style="western"><surname>M&#252;ller</surname><given-names>J.</given-names></name><name name-style="western"><surname>Alberti</surname><given-names>&#193;.</given-names></name><name name-style="western"><surname>T&#243;th</surname><given-names>A.</given-names></name><name name-style="western"><surname>B&#233;ni</surname><given-names>S.</given-names></name><name name-style="western"><surname>K&#246;ncz&#246;l</surname><given-names>&#193;.</given-names></name><name name-style="western"><surname>Balogh</surname><given-names>G.T.</given-names></name><etal/></person-group><article-title>Three Newly Identified Lipophilic Flavonoids in <italic toggle="yes">Tanacetum parthenium</italic> Supercritical Fluid Extract Penetrating the Blood-Brain Barrier</article-title><source>J. Pharm. Biomed. Anal.</source><year>2018</year><volume>149</volume><fpage>488</fpage><lpage>493</lpage><pub-id pub-id-type="doi">10.1016/j.jpba.2017.11.029</pub-id><pub-id pub-id-type="pmid">29182998</pub-id></element-citation></ref><ref id="B308-pharmaceutics-16-00454"><label>308.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hordiei</surname><given-names>K.</given-names></name><name name-style="western"><surname>Gontova</surname><given-names>T.</given-names></name><name name-style="western"><surname>Trumbeckaite</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yaremenko</surname><given-names>M.</given-names></name><name name-style="western"><surname>Raudone</surname><given-names>L.</given-names></name></person-group><article-title>Phenolic Composition and Antioxidant Activity of <italic toggle="yes">Tanacetum parthenium</italic> Cultivated in Different Regions of Ukraine: Insights into the Flavonoids and Hydroxycinnamic Acids Profile</article-title><source>Plants</source><year>2023</year><volume>12</volume><elocation-id>2940</elocation-id><pub-id pub-id-type="doi">10.3390/plants12162940</pub-id><pub-id pub-id-type="pmid">37631152</pub-id><pub-id pub-id-type="pmcid">PMC10458129</pub-id></element-citation></ref><ref id="B309-pharmaceutics-16-00454"><label>309.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>C&#225;rdenas</surname><given-names>J.</given-names></name><name name-style="western"><surname>Reyes-P&#233;rez</surname><given-names>V.</given-names></name><name name-style="western"><surname>Hern&#225;ndez-Navarro</surname><given-names>M.D.</given-names></name><name name-style="western"><surname>Dorantes-Barr&#243;n</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Almaz&#225;n</surname><given-names>S.</given-names></name><name name-style="western"><surname>Estrada-Reyes</surname><given-names>R.</given-names></name></person-group><article-title>Anxiolytic- and Antidepressant-like Effects of an Aqueous Extract of <italic toggle="yes">Tanacetum parthenium</italic> L. Schultz-Bip (<italic toggle="yes">Asteraceae</italic>) in Mice</article-title><source>J. Ethnopharmacol.</source><year>2017</year><volume>200</volume><fpage>22</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2017.02.023</pub-id><pub-id pub-id-type="pmid">28213105</pub-id></element-citation></ref><ref id="B310-pharmaceutics-16-00454"><label>310.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Benassi-Zanqueta</surname><given-names>&#201;.</given-names></name><name name-style="western"><surname>Marques</surname><given-names>C.F.</given-names></name><name name-style="western"><surname>Valone</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Pellegrini</surname><given-names>B.L.</given-names></name><name name-style="western"><surname>Bauermeister</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>I.C.P.</given-names></name><name name-style="western"><surname>Lopes</surname><given-names>N.P.</given-names></name><name name-style="western"><surname>Nakamura</surname><given-names>C.V.</given-names></name><name name-style="western"><surname>Dias Filho</surname><given-names>B.P.</given-names></name><name name-style="western"><surname>Natali</surname><given-names>M.R.M.</given-names></name><etal/></person-group><article-title>Evaluation of Anti-HSV-1 Activity and Toxicity of Hydroethanolic Extract of <italic toggle="yes">Tanacetum parthenium</italic> (L.) Sch.Bip. (<italic toggle="yes">Asteraceae</italic>)</article-title><source>Phytomedicine</source><year>2019</year><volume>55</volume><fpage>249</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2018.06.040</pub-id><pub-id pub-id-type="pmid">30668436</pub-id></element-citation></ref><ref id="B311-pharmaceutics-16-00454"><label>311.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>di Giacomo</surname><given-names>V.</given-names></name><name name-style="western"><surname>Ferrante</surname><given-names>C.</given-names></name><name name-style="western"><surname>Ronci</surname><given-names>M.</given-names></name><name name-style="western"><surname>Cataldi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Di Valerio</surname><given-names>V.</given-names></name><name name-style="western"><surname>Rapino</surname><given-names>M.</given-names></name><name name-style="western"><surname>Recinella</surname><given-names>L.</given-names></name><name name-style="western"><surname>Chiavaroli</surname><given-names>A.</given-names></name><name name-style="western"><surname>Leone</surname><given-names>S.</given-names></name><name name-style="western"><surname>Vladimir-Kne&#382;evi&#263;</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Multiple Pharmacological and Toxicological Investigations on <italic toggle="yes">Tanacetum parthenium</italic> and Salix Alba Extracts: Focus on Potential Application as Anti-Migraine Agents</article-title><source>Food Chem. Toxicol.</source><year>2019</year><volume>133</volume><fpage>110783</fpage><pub-id pub-id-type="doi">10.1016/j.fct.2019.110783</pub-id><pub-id pub-id-type="pmid">31491430</pub-id></element-citation></ref><ref id="B312-pharmaceutics-16-00454"><label>312.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ataollahi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Akrami</surname><given-names>E.</given-names></name><name name-style="western"><surname>Kalani</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zarei</surname><given-names>M.</given-names></name><name name-style="western"><surname>Chijan</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Sedigh-Rahimabadi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Alipanah</surname><given-names>H.</given-names></name></person-group><article-title>Evaluation of Anticoagulant and Inflammatory Effects of <italic toggle="yes">Tanacetum parthenium</italic> (L.) in a Randomized Controlled Clinical Trial</article-title><source>J. Herb. Med.</source><year>2022</year><volume>36</volume><fpage>100613</fpage><pub-id pub-id-type="doi">10.1016/j.hermed.2022.100613</pub-id></element-citation></ref><ref id="B313-pharmaceutics-16-00454"><label>313.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>F.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Dong</surname><given-names>M.</given-names></name><name name-style="western"><surname>He</surname><given-names>G.</given-names></name><name name-style="western"><surname>Galyean</surname><given-names>R.D.</given-names></name><name name-style="western"><surname>He</surname><given-names>L.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>G.</given-names></name></person-group><article-title>Identification of Antioxidant Phenolic Compounds in Feverfew (<italic toggle="yes">Tanacetum parthenium</italic>) by HPLC-ESI-MS/MS and NMR</article-title><source>Phytochem. Anal.</source><year>2007</year><volume>18</volume><fpage>401</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1002/pca.995</pub-id><pub-id pub-id-type="pmid">17624900</pub-id></element-citation></ref><ref id="B314-pharmaceutics-16-00454"><label>314.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rabito</surname><given-names>M.F.</given-names></name><name name-style="western"><surname>Britta</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Pelegrini</surname><given-names>B.L.</given-names></name><name name-style="western"><surname>Scariot</surname><given-names>D.B.</given-names></name><name name-style="western"><surname>Almeida</surname><given-names>M.B.</given-names></name><name name-style="western"><surname>Nixdorf</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Nakamura</surname><given-names>C.V.</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>I.C.P.</given-names></name></person-group><article-title>In Vitro and in Vivo Antileishmania Activity of Sesquiterpene Lactone-Rich Dichloromethane Fraction Obtained from <italic toggle="yes">Tanacetum parthenium</italic> (L.) Schultz-Bip</article-title><source>Exp. Parasitol.</source><year>2014</year><volume>143</volume><fpage>18</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1016/j.exppara.2014.04.014</pub-id><pub-id pub-id-type="pmid">24810433</pub-id></element-citation></ref><ref id="B315-pharmaceutics-16-00454"><label>315.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Cui</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name></person-group><article-title>Trends in Parthenolide Research over the Past Two Decades: A Bibliometric Analysis</article-title><source>Heliyon</source><year>2023</year><volume>9</volume><fpage>e17843</fpage><pub-id pub-id-type="doi">10.1016/j.heliyon.2023.e17843</pub-id><pub-id pub-id-type="pmid">37483705</pub-id><pub-id pub-id-type="pmcid">PMC10362189</pub-id></element-citation></ref><ref id="B316-pharmaceutics-16-00454"><label>316.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name></person-group><article-title>Recent Advances on the Structural Modification of Parthenolide and Its Derivatives as Anticancer Agents</article-title><source>Chin. J. Nat. Med.</source><year>2022</year><volume>20</volume><fpage>814</fpage><lpage>829</lpage><pub-id pub-id-type="doi">10.1016/S1875-5364(22)60238-3</pub-id><pub-id pub-id-type="pmid">36427916</pub-id></element-citation></ref><ref id="B317-pharmaceutics-16-00454"><label>317.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Toraman</surname><given-names>E.</given-names></name><name name-style="western"><surname>Budak</surname><given-names>B.</given-names></name><name name-style="western"><surname>Bayram</surname><given-names>C.</given-names></name><name name-style="western"><surname>Sezen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mokhtare</surname><given-names>B.</given-names></name><name name-style="western"><surname>Hac&#305;m&#252;ft&#252;o&#287;lu</surname><given-names>A.</given-names></name></person-group><article-title>Role of Parthenolide in Paclitaxel-Induced Oxidative Stress Injury and Impaired Reproductive Function in Rat Testicular Tissue</article-title><source>Chem. Biol. Interact.</source><year>2024</year><volume>387</volume><elocation-id>110793</elocation-id><pub-id pub-id-type="doi">10.1016/j.cbi.2023.110793</pub-id><pub-id pub-id-type="pmid">37949423</pub-id></element-citation></ref><ref id="B318-pharmaceutics-16-00454"><label>318.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cot&#233;</surname><given-names>H.</given-names></name><name name-style="western"><surname>Boucher</surname><given-names>M.-A.</given-names></name><name name-style="western"><surname>Pichette</surname><given-names>A.</given-names></name><name name-style="western"><surname>Legault</surname><given-names>J.</given-names></name></person-group><article-title>Anti-Inflammatory, Antioxidant, Antibiotic, and Cytotoxic Activities of <italic toggle="yes">Tanacetum vulgare</italic> L. Essential Oil and Its Constituents</article-title><source>Medicines</source><year>2017</year><volume>4</volume><elocation-id>34</elocation-id><pub-id pub-id-type="doi">10.3390/medicines4020034</pub-id><pub-id pub-id-type="pmid">28930249</pub-id><pub-id pub-id-type="pmcid">PMC5590070</pub-id></element-citation></ref><ref id="B319-pharmaceutics-16-00454"><label>319.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>B&#261;czek</surname><given-names>K.B.</given-names></name><name name-style="western"><surname>Kosakowska</surname><given-names>O.</given-names></name><name name-style="western"><surname>Przyby&#322;</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Pi&#243;ro-Jabrucka</surname><given-names>E.</given-names></name><name name-style="western"><surname>Costa</surname><given-names>R.</given-names></name><name name-style="western"><surname>Mondello</surname><given-names>L.</given-names></name><name name-style="western"><surname>Gniewosz</surname><given-names>M.</given-names></name><name name-style="western"><surname>Synowiec</surname><given-names>A.</given-names></name><name name-style="western"><surname>W&#281;glarz</surname><given-names>Z.</given-names></name></person-group><article-title>Antibacterial and Antioxidant Activity of Essential Oils and Extracts from Costmary (<italic toggle="yes">Tanacetum balsamita</italic> L.) and Tansy (<italic toggle="yes">Tanacetum vulgare</italic> L.)</article-title><source>Ind. Crops Prod.</source><year>2017</year><volume>102</volume><fpage>154</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1016/j.indcrop.2017.03.009</pub-id></element-citation></ref><ref id="B320-pharmaceutics-16-00454"><label>320.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schinella</surname><given-names>G.R.</given-names></name><name name-style="western"><surname>Giner</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Del Carmen Recio</surname><given-names>M.</given-names></name><name name-style="western"><surname>De Buschiazzo</surname><given-names>P.M.</given-names></name><name name-style="western"><surname>R&#237;os</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>M&#225;&#241;ez</surname><given-names>S.</given-names></name></person-group><article-title>Anti-Inflammatory Effects of South American <italic toggle="yes">Tanacetum vulgare</italic></article-title><source>J. Pharm. Pharmacol.</source><year>2011</year><volume>50</volume><fpage>1069</fpage><lpage>1074</lpage><pub-id pub-id-type="doi">10.1111/j.2042-7158.1998.tb06924.x</pub-id><pub-id pub-id-type="pmid">9811170</pub-id></element-citation></ref><ref id="B321-pharmaceutics-16-00454"><label>321.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kavallieratos</surname><given-names>N.G.</given-names></name><name name-style="western"><surname>Skourti</surname><given-names>A.</given-names></name><name name-style="western"><surname>Nika</surname><given-names>E.P.</given-names></name><name name-style="western"><surname>M&#225;rtonfi</surname><given-names>P.</given-names></name><name name-style="western"><surname>Spinozzi</surname><given-names>E.</given-names></name><name name-style="western"><surname>Maggi</surname><given-names>F.</given-names></name></person-group><article-title><italic toggle="yes">Tanacetum vulgare</italic> Essential Oil as Grain Protectant against Adults and Larvae of Four Major Stored-Product Insect Pests</article-title><source>J. Stored Prod. Res.</source><year>2021</year><volume>94</volume><fpage>101882</fpage><pub-id pub-id-type="doi">10.1016/j.jspr.2021.101882</pub-id></element-citation></ref><ref id="B322-pharmaceutics-16-00454"><label>322.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ak</surname><given-names>G.</given-names></name><name name-style="western"><surname>Gevrenova</surname><given-names>R.</given-names></name><name name-style="western"><surname>Sinan</surname><given-names>K.I.</given-names></name><name name-style="western"><surname>Zengin</surname><given-names>G.</given-names></name><name name-style="western"><surname>Zheleva</surname><given-names>D.</given-names></name><name name-style="western"><surname>Mahomoodally</surname><given-names>M.F.</given-names></name><name name-style="western"><surname>Senkardes</surname><given-names>I.</given-names></name><name name-style="western"><surname>Brunetti</surname><given-names>L.</given-names></name><name name-style="western"><surname>Leone</surname><given-names>S.</given-names></name><name name-style="western"><surname>Di Simone</surname><given-names>S.C.</given-names></name><etal/></person-group><article-title><italic toggle="yes">Tanacetum vulgare</italic> L. (Tansy) as an Effective Bioresource with Promising Pharmacological Effects from Natural Arsenal</article-title><source>Food Chem. Toxicol.</source><year>2021</year><volume>153</volume><fpage>112268</fpage><pub-id pub-id-type="doi">10.1016/j.fct.2021.112268</pub-id><pub-id pub-id-type="pmid">34015423</pub-id></element-citation></ref><ref id="B323-pharmaceutics-16-00454"><label>323.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Babich</surname><given-names>O.</given-names></name><name name-style="western"><surname>Larina</surname><given-names>V.</given-names></name><name name-style="western"><surname>Krol</surname><given-names>O.</given-names></name><name name-style="western"><surname>Ulrikh</surname><given-names>E.</given-names></name><name name-style="western"><surname>Sukhikh</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gureev</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Prosekov</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ivanova</surname><given-names>S.</given-names></name></person-group><article-title>In Vitro Study of Biological Activity of <italic toggle="yes">Tanacetum vulgare</italic> Extracts</article-title><source>Pharmaceutics</source><year>2023</year><volume>15</volume><elocation-id>616</elocation-id><pub-id pub-id-type="doi">10.3390/pharmaceutics15020616</pub-id><pub-id pub-id-type="pmid">36839938</pub-id><pub-id pub-id-type="pmcid">PMC9961778</pub-id></element-citation></ref><ref id="B324-pharmaceutics-16-00454"><label>324.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vilhelmova</surname><given-names>N.</given-names></name><name name-style="western"><surname>Simeonova</surname><given-names>L.</given-names></name><name name-style="western"><surname>Nikolova</surname><given-names>N.</given-names></name><name name-style="western"><surname>Pavlova</surname><given-names>E.</given-names></name><name name-style="western"><surname>Gospodinova</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Antov</surname><given-names>G.</given-names></name><name name-style="western"><surname>Galabov</surname><given-names>A.</given-names></name><name name-style="western"><surname>Nikolova</surname><given-names>I.</given-names></name></person-group><article-title>Antiviral, Cytotoxic and Antioxidant Effects of <italic toggle="yes">Tanacetum vulgare</italic> L. Crude Extract In Vitro</article-title><source>Folia Med.</source><year>2020</year><volume>62</volume><fpage>172</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.3897/folmed.62.e49370</pub-id><pub-id pub-id-type="pmid">32337905</pub-id></element-citation></ref><ref id="B325-pharmaceutics-16-00454"><label>325.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>&#193;lvarez</surname><given-names>&#193;.L.</given-names></name><name name-style="western"><surname>Habtemariam</surname><given-names>S.</given-names></name><name name-style="western"><surname>Juan-Badaturuge</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>C.</given-names></name><name name-style="western"><surname>Parra</surname><given-names>F.</given-names></name></person-group><article-title>In Vitro Anti HSV-1 and HSV-2 Activity of <italic toggle="yes">Tanacetum vulgare</italic> Extracts and Isolated Compounds: An Approach to Their Mechanisms of Action</article-title><source>Phytother. Res.</source><year>2011</year><volume>25</volume><fpage>296</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1002/ptr.3382</pub-id><pub-id pub-id-type="pmid">21171142</pub-id></element-citation></ref><ref id="B326-pharmaceutics-16-00454"><label>326.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lazarevic</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kostic</surname><given-names>I.</given-names></name><name name-style="western"><surname>Milanovic</surname><given-names>S.</given-names></name><name name-style="western"><surname>&#352;e&#353;lija Jovanovi&#263;</surname><given-names>D.</given-names></name><name name-style="western"><surname>Krnjajic</surname><given-names>S.</given-names></name><name name-style="western"><surname>C&#168;alic</surname><given-names>D.</given-names></name><name name-style="western"><surname>Stankovic</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kostic</surname><given-names>M.</given-names></name></person-group><article-title>Repellent Activity of <italic toggle="yes">Tanacetum parthenium</italic> (L.) and <italic toggle="yes">Tanacetum vulgare</italic> (L.) <italic toggle="yes">Essential oils</italic> against Leptinotarsa Decemlineata (Say)</article-title><source>Bull. Entomol. Res.</source><year>2021</year><volume>111</volume><fpage>190</fpage><lpage>199</lpage><pub-id pub-id-type="doi">10.1017/S0007485320000504</pub-id><pub-id pub-id-type="pmid">32778187</pub-id></element-citation></ref><ref id="B327-pharmaceutics-16-00454"><label>327.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>K&#316;avi&#326;a</surname><given-names>A.</given-names></name><name name-style="western"><surname>Keid&#257;ne</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ganola</surname><given-names>K.</given-names></name><name name-style="western"><surname>L&#363;sis</surname><given-names>I.</given-names></name><name name-style="western"><surname>&#352;ukele</surname><given-names>R.</given-names></name><name name-style="western"><surname>Bandere</surname><given-names>D.</given-names></name><name name-style="western"><surname>Kovalcuka</surname><given-names>L.</given-names></name></person-group><article-title>Anthelmintic Activity of <italic toggle="yes">Tanacetum vulgare</italic> L. (Leaf and Flower) Extracts against Trichostrongylidae Nematodes in Sheep In Vitro</article-title><source>Animals</source><year>2023</year><volume>13</volume><elocation-id>2176</elocation-id><pub-id pub-id-type="doi">10.3390/ani13132176</pub-id><pub-id pub-id-type="pmid">37443974</pub-id><pub-id pub-id-type="pmcid">PMC10339931</pub-id></element-citation></ref><ref id="B328-pharmaceutics-16-00454"><label>328.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arantes</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Pi&#231;arra</surname><given-names>A.</given-names></name><name name-style="western"><surname>Guerreiro</surname><given-names>M.</given-names></name><name name-style="western"><surname>Salvador</surname><given-names>C.</given-names></name><name name-style="western"><surname>Candeias</surname><given-names>F.</given-names></name><name name-style="western"><surname>Caldeira</surname><given-names>A.T.</given-names></name><name name-style="western"><surname>Martins</surname><given-names>M.R.</given-names></name></person-group><article-title>Toxicological and Pharmacological Properties of <italic toggle="yes">Essential oils</italic> of <italic toggle="yes">Calamintha nepeta</italic>, <italic toggle="yes">Origanum virens</italic> and <italic toggle="yes">Thymus mastichina</italic> of Alentejo (Portugal)</article-title><source>Food Chem. Toxicol.</source><year>2019</year><volume>133</volume><fpage>110747</fpage><pub-id pub-id-type="doi">10.1016/j.fct.2019.110747</pub-id><pub-id pub-id-type="pmid">31377137</pub-id></element-citation></ref><ref id="B329-pharmaceutics-16-00454"><label>329.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marongiu</surname><given-names>B.</given-names></name><name name-style="western"><surname>Piras</surname><given-names>A.</given-names></name><name name-style="western"><surname>Porcedda</surname><given-names>S.</given-names></name><name name-style="western"><surname>Falconieri</surname><given-names>D.</given-names></name><name name-style="western"><surname>Maxia</surname><given-names>A.</given-names></name><name name-style="western"><surname>Goncalves</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Cavaleiro</surname><given-names>C.</given-names></name><name name-style="western"><surname>Salgueiro</surname><given-names>L.</given-names></name></person-group><article-title>Chemical Composition and Biological Assays of Essential Oils of <italic toggle="yes">Calamintha nepeta</italic> (L.) Savi Subsp. Nepeta (<italic toggle="yes">Lamiaceae</italic>)</article-title><source>Nat. Prod. Res.</source><year>2010</year><volume>24</volume><fpage>1734</fpage><lpage>1742</lpage><pub-id pub-id-type="doi">10.1080/14786410903108944</pub-id><pub-id pub-id-type="pmid">20981614</pub-id></element-citation></ref><ref id="B330-pharmaceutics-16-00454"><label>330.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bo&#382;ovi&#263;</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ragno</surname><given-names>R.</given-names></name><name name-style="western"><surname>Tzakou</surname><given-names>O.</given-names></name></person-group><article-title><italic toggle="yes">Calamintha nepeta</italic> (L.) Savi and Its Main Essential Oil Constituent Pulegone: Biological Activities and Chemistry</article-title><source>Molecules</source><year>2017</year><volume>22</volume><elocation-id>290</elocation-id><pub-id pub-id-type="doi">10.3390/molecules22020290</pub-id><pub-id pub-id-type="pmid">28216606</pub-id><pub-id pub-id-type="pmcid">PMC6155702</pub-id></element-citation></ref><ref id="B331-pharmaceutics-16-00454"><label>331.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rodenak-Kladniew</surname><given-names>B.</given-names></name><name name-style="western"><surname>Castro</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Gambaro</surname><given-names>R.C.</given-names></name><name name-style="western"><surname>Girotti</surname><given-names>J.</given-names></name><name name-style="western"><surname>Cisneros</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Vi&#241;a</surname><given-names>S.</given-names></name><name name-style="western"><surname>Padula</surname><given-names>G.</given-names></name><name name-style="western"><surname>Crespo</surname><given-names>R.</given-names></name><name name-style="western"><surname>Castro</surname><given-names>G.R.</given-names></name><name name-style="western"><surname>Gehring</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Cytotoxic Screening and Enhanced Anticancer Activity of <italic toggle="yes">Lippia alba</italic> and <italic toggle="yes">Clinopodium nepeta</italic> Essential Oils-Loaded Biocompatible Lipid Nanoparticles against Lung and Colon Cancer Cells</article-title><source>Pharmaceutics</source><year>2023</year><volume>15</volume><elocation-id>2045</elocation-id><pub-id pub-id-type="doi">10.3390/pharmaceutics15082045</pub-id><pub-id pub-id-type="pmid">37631258</pub-id><pub-id pub-id-type="pmcid">PMC10459614</pub-id></element-citation></ref><ref id="B332-pharmaceutics-16-00454"><label>332.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beddiar</surname><given-names>H.</given-names></name><name name-style="western"><surname>Boudiba</surname><given-names>S.</given-names></name><name name-style="western"><surname>Benahmed</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tamfu</surname><given-names>A.N.</given-names></name><name name-style="western"><surname>Ceylan</surname><given-names>&#214;.</given-names></name><name name-style="western"><surname>Hanini</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kucukaydin</surname><given-names>S.</given-names></name><name name-style="western"><surname>Elomari</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bensouici</surname><given-names>C.</given-names></name><name name-style="western"><surname>Laouer</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Chemical Composition, Anti-Quorum Sensing, Enzyme Inhibitory, and Antioxidant Properties of Phenolic Extracts of <italic toggle="yes">Clinopodium nepeta</italic> L. Kuntze</article-title><source>Plants</source><year>2021</year><volume>10</volume><elocation-id>1955</elocation-id><pub-id pub-id-type="doi">10.3390/plants10091955</pub-id><pub-id pub-id-type="pmid">34579487</pub-id><pub-id pub-id-type="pmcid">PMC8468494</pub-id></element-citation></ref><ref id="B333-pharmaceutics-16-00454"><label>333.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gon&#231;alves</surname><given-names>S.</given-names></name><name name-style="western"><surname>Moreira</surname><given-names>E.</given-names></name><name name-style="western"><surname>Grosso</surname><given-names>C.</given-names></name><name name-style="western"><surname>Andrade</surname><given-names>P.B.</given-names></name><name name-style="western"><surname>Valent&#227;o</surname><given-names>P.</given-names></name><name name-style="western"><surname>Romano</surname><given-names>A.</given-names></name></person-group><article-title>Phenolic Profile, Antioxidant Activity and Enzyme Inhibitory Activities of Extracts from Aromatic Plants Used in Mediterranean Diet</article-title><source>J. Food Sci. Technol.</source><year>2017</year><volume>54</volume><fpage>219</fpage><pub-id pub-id-type="doi">10.1007/s13197-016-2453-z</pub-id><pub-id pub-id-type="pmid">28242919</pub-id><pub-id pub-id-type="pmcid">PMC5305718</pub-id></element-citation></ref><ref id="B334-pharmaceutics-16-00454"><label>334.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pacifico</surname><given-names>S.</given-names></name><name name-style="western"><surname>Galasso</surname><given-names>S.</given-names></name><name name-style="western"><surname>Piccolella</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kretschmer</surname><given-names>N.</given-names></name><name name-style="western"><surname>Pan</surname><given-names>S.P.</given-names></name><name name-style="western"><surname>Marciano</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bauer</surname><given-names>R.</given-names></name><name name-style="western"><surname>Monaco</surname><given-names>P.</given-names></name></person-group><article-title>Seasonal Variation in Phenolic Composition and Antioxidant and Anti-Inflammatory Activities of <italic toggle="yes">Calamintha nepeta</italic> (L.) Savi</article-title><source>Food Res. Int.</source><year>2015</year><volume>69</volume><fpage>121</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1016/j.foodres.2014.12.019</pub-id></element-citation></ref><ref id="B335-pharmaceutics-16-00454"><label>335.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Benabed</surname><given-names>K.H.</given-names></name><name name-style="western"><surname>Boussoussa</surname><given-names>H.</given-names></name><name name-style="western"><surname>Khacheba</surname><given-names>I.</given-names></name><name name-style="western"><surname>bekhaoua</surname><given-names>A.</given-names></name><name name-style="western"><surname>Douadji</surname><given-names>F.Z.</given-names></name><name name-style="western"><surname>Da&#239;di</surname><given-names>S.</given-names></name><name name-style="western"><surname>Dja&#226;four</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yousfi</surname><given-names>M.</given-names></name></person-group><article-title>Alpha-Amylase Inhibitory Activity of Extracts from Algerian <italic toggle="yes">Calamintha nepeta</italic> (L.)</article-title><source>Curr. Enzym. Inhib.</source><year>2023</year><volume>19</volume><fpage>136</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.2174/1573408019666230331084001</pub-id></element-citation></ref><ref id="B336-pharmaceutics-16-00454"><label>336.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Araniti</surname><given-names>F.</given-names></name><name name-style="western"><surname>Lupini</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mercati</surname><given-names>F.</given-names></name><name name-style="western"><surname>Statti</surname><given-names>G.A.</given-names></name><name name-style="western"><surname>Abenavoli</surname><given-names>M.R.</given-names></name></person-group><article-title><italic toggle="yes">Calamintha nepeta</italic> L. (Savi) as Source of Phytotoxic Compounds: Bio-Guided Fractionation in Identifying Biological Active Molecules</article-title><source>Acta Physiol. Plant</source><year>2013</year><volume>35</volume><fpage>1979</fpage><lpage>1988</lpage><pub-id pub-id-type="doi">10.1007/s11738-013-1236-7</pub-id></element-citation></ref><ref id="B337-pharmaceutics-16-00454"><label>337.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiong</surname><given-names>L.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>B.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>F.</given-names></name><name name-style="western"><surname>Mao</surname><given-names>S.</given-names></name><name name-style="western"><surname>Shen</surname><given-names>C.</given-names></name></person-group><article-title>Phenolic Compounds and Antioxidant Capacities of 10 Common Edible Flowers from China</article-title><source>J. Food Sci.</source><year>2014</year><volume>79</volume><fpage>C517</fpage><lpage>C525</lpage><pub-id pub-id-type="doi">10.1111/1750-3841.12404</pub-id><pub-id pub-id-type="pmid">24621197</pub-id></element-citation></ref><ref id="B338-pharmaceutics-16-00454"><label>338.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lopes</surname><given-names>C.L.</given-names></name><name name-style="western"><surname>Pereira</surname><given-names>E.</given-names></name><name name-style="western"><surname>Sokovi&#263;</surname><given-names>M.</given-names></name><name name-style="western"><surname>Carvalho</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Barata</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Lopes</surname><given-names>V.</given-names></name><name name-style="western"><surname>Rocha</surname><given-names>F.</given-names></name><name name-style="western"><surname>Calhelha</surname><given-names>R.C.</given-names></name><name name-style="western"><surname>Barros</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>I.C.F.R.</given-names></name></person-group><article-title>Phenolic Composition and Bioactivity of <italic toggle="yes">Lavandula pedunculata</italic> (Mill.) Cav. Samples from Different Geographical Origin</article-title><source>Molecules</source><year>2018</year><volume>23</volume><elocation-id>1037</elocation-id><pub-id pub-id-type="doi">10.3390/molecules23051037</pub-id><pub-id pub-id-type="pmid">29710781</pub-id><pub-id pub-id-type="pmcid">PMC6099610</pub-id></element-citation></ref><ref id="B339-pharmaceutics-16-00454"><label>339.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boutahiri</surname><given-names>S.</given-names></name><name name-style="western"><surname>Eto</surname><given-names>B.</given-names></name><name name-style="western"><surname>Bouhrim</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mechchate</surname><given-names>H.</given-names></name><name name-style="western"><surname>Saleh</surname><given-names>A.</given-names></name><name name-style="western"><surname>Al Kamaly</surname><given-names>O.</given-names></name><name name-style="western"><surname>Drioiche</surname><given-names>A.</given-names></name><name name-style="western"><surname>Remok</surname><given-names>F.</given-names></name><name name-style="western"><surname>Samaillie</surname><given-names>J.</given-names></name><name name-style="western"><surname>Neut</surname><given-names>C.</given-names></name><etal/></person-group><article-title><italic toggle="yes">Lavandula pedunculata</italic> (Mill.) Cav. Aqueous Extract Antibacterial Activity Improved by the Addition of <italic toggle="yes">Salvia rosmarinus</italic> Spenn., <italic toggle="yes">Salvia lavandulifolia</italic> Vahl and <italic toggle="yes">Origanum compactum</italic> Benth</article-title><source>Life</source><year>2022</year><volume>12</volume><elocation-id>328</elocation-id><pub-id pub-id-type="doi">10.3390/life12030328</pub-id><pub-id pub-id-type="pmid">35330079</pub-id><pub-id pub-id-type="pmcid">PMC8954779</pub-id></element-citation></ref><ref id="B340-pharmaceutics-16-00454"><label>340.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dobros</surname><given-names>N.</given-names></name><name name-style="western"><surname>Zawada</surname><given-names>K.D.</given-names></name><name name-style="western"><surname>Paradowska</surname><given-names>K.</given-names></name></person-group><article-title>Phytochemical Profiling, Antioxidant and Anti-Inflammatory Activity of Plants Belonging to the <italic toggle="yes">Lavandula</italic> Genus</article-title><source>Molecules</source><year>2023</year><volume>28</volume><elocation-id>256</elocation-id><pub-id pub-id-type="doi">10.3390/molecules28010256</pub-id><pub-id pub-id-type="pmcid">PMC9821988</pub-id><pub-id pub-id-type="pmid">36615453</pub-id></element-citation></ref><ref id="B341-pharmaceutics-16-00454"><label>341.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ez zoubi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Bousta</surname><given-names>D.</given-names></name><name name-style="western"><surname>Farah</surname><given-names>A.</given-names></name></person-group><article-title>A Phytopharmacological Review of a Mediterranean Plant: <italic toggle="yes">Lavandula stoechas</italic> L.</article-title><source>Clin. Phytosci.</source><year>2020</year><volume>6</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1186/s40816-019-0142-y</pub-id></element-citation></ref><ref id="B342-pharmaceutics-16-00454"><label>342.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mushtaq</surname><given-names>A.</given-names></name><name name-style="western"><surname>Anwar</surname><given-names>R.</given-names></name><name name-style="western"><surname>Gohar</surname><given-names>U.F.</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>M.</given-names></name><name name-style="western"><surname>Marc</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Mure&#351;an</surname><given-names>C.C.</given-names></name><name name-style="western"><surname>Irimie</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bobescu</surname><given-names>E.</given-names></name></person-group><article-title>Biomolecular Evaluation of <italic toggle="yes">Lavandula stoechas</italic> L. For Nootropic Activity</article-title><source>Plants</source><year>2021</year><volume>10</volume><elocation-id>1259</elocation-id><pub-id pub-id-type="doi">10.3390/plants10061259</pub-id><pub-id pub-id-type="pmid">34205806</pub-id><pub-id pub-id-type="pmcid">PMC8234844</pub-id></element-citation></ref><ref id="B343-pharmaceutics-16-00454"><label>343.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Selmi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Jallouli</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gharbi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Marzouki</surname><given-names>L.</given-names></name></person-group><article-title>Hepatoprotective and Renoprotective Effects of Lavender (<italic toggle="yes">Lavandula stoechas</italic> L.) Essential Oils Against Malathion-Induced Oxidative Stress in Young Male Mice</article-title><source>J. Med. Food</source><year>2015</year><volume>18</volume><fpage>1103</fpage><lpage>1111</lpage><pub-id pub-id-type="doi">10.1089/jmf.2014.0130</pub-id><pub-id pub-id-type="pmid">25835641</pub-id><pub-id pub-id-type="pmcid">PMC4593970</pub-id></element-citation></ref><ref id="B344-pharmaceutics-16-00454"><label>344.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Balahbib</surname><given-names>A.</given-names></name><name name-style="western"><surname>El Omari</surname><given-names>N.</given-names></name><name name-style="western"><surname>Bakrim</surname><given-names>S.</given-names></name><name name-style="western"><surname>Benali</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ullah</surname><given-names>R.</given-names></name><name name-style="western"><surname>Alotaibi</surname><given-names>A.</given-names></name><name name-style="western"><surname>El Mrabti</surname><given-names>H.N.</given-names></name><name name-style="western"><surname>Goh</surname><given-names>B.H.</given-names></name><name name-style="western"><surname>Ardianto</surname><given-names>C.</given-names></name><name name-style="western"><surname>Ming</surname><given-names>L.C.</given-names></name><etal/></person-group><article-title>Evaluation of Antioxidant, Antidiabetic, and Dermatoprotective Properties of <italic toggle="yes">Lavandula stoechas</italic> Essential Oils and Their Main Chemotypes</article-title><source>Heliyon</source><year>2023</year><fpage>1</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.2139/SSRN.4415276</pub-id></element-citation></ref><ref id="B345-pharmaceutics-16-00454"><label>345.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Benali</surname><given-names>T.</given-names></name><name name-style="western"><surname>Lemhadri</surname><given-names>A.</given-names></name><name name-style="western"><surname>Harboul</surname><given-names>K.</given-names></name><name name-style="western"><surname>Chtibi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Khabbach</surname><given-names>A.</given-names></name><name name-style="western"><surname>Jadouali</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Quesada-Romero</surname><given-names>L.</given-names></name><name name-style="western"><surname>Louahlia</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hammani</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ghaleb</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Chemical Profiling and Biological Properties of Essential Oils of <italic toggle="yes">Lavandula stoechas</italic> L. Collected from Three Moroccan Sites: In Vitro and In Silico Investigations</article-title><source>Plants</source><year>2023</year><volume>12</volume><elocation-id>1413</elocation-id><pub-id pub-id-type="doi">10.3390/plants12061413</pub-id><pub-id pub-id-type="pmid">36987101</pub-id><pub-id pub-id-type="pmcid">PMC10057000</pub-id></element-citation></ref><ref id="B346-pharmaceutics-16-00454"><label>346.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aydin</surname><given-names>T.</given-names></name><name name-style="western"><surname>Saglamtas</surname><given-names>R.</given-names></name><name name-style="western"><surname>Gumustas</surname><given-names>M.</given-names></name><name name-style="western"><surname>Genisel</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kazaz</surname><given-names>C.</given-names></name><name name-style="western"><surname>Cakir</surname><given-names>A.</given-names></name></person-group><article-title><italic toggle="yes">Lavandula stoechas</italic> L. Subsp. Stoechas, a New Herbal Source for Ursolic Acid: Quantitative Analysis, Purification and Bioactivity Studies</article-title><source>Chem. Biodivers.</source><year>2023</year><volume>20</volume><elocation-id>e202300414</elocation-id><pub-id pub-id-type="doi">10.1002/cbdv.202300414</pub-id><pub-id pub-id-type="pmid">37338138</pub-id></element-citation></ref><ref id="B347-pharmaceutics-16-00454"><label>347.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>El Hachlafi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Benkhaira</surname><given-names>N.</given-names></name><name name-style="western"><surname>Al-Mijalli</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Mrabti</surname><given-names>H.N.</given-names></name><name name-style="western"><surname>Abdnim</surname><given-names>R.</given-names></name><name name-style="western"><surname>Abdallah</surname><given-names>E.M.</given-names></name><name name-style="western"><surname>Jeddi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bnouham</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>L.H.</given-names></name><name name-style="western"><surname>Ardianto</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Phytochemical Analysis and Evaluation of Antimicrobial, Antioxidant, and Antidiabetic Activities of Essential Oils from Moroccan Medicinal Plants: <italic toggle="yes">Mentha suaveolens</italic>, <italic toggle="yes">Lavandula stoechas</italic>, and <italic toggle="yes">Ammi visnaga</italic></article-title><source>Biomed. Pharmacother.</source><year>2023</year><volume>164</volume><elocation-id>114937</elocation-id><pub-id pub-id-type="doi">10.1016/j.biopha.2023.114937</pub-id><pub-id pub-id-type="pmid">37267633</pub-id></element-citation></ref><ref id="B348-pharmaceutics-16-00454"><label>348.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shakeri</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sahebkar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Javadi</surname><given-names>B.</given-names></name></person-group><article-title><italic toggle="yes">Melissa officinalis</italic> L.&#8212;A Review of Its Traditional Uses, Phytochemistry and Pharmacology</article-title><source>J. Ethnopharmacol.</source><year>2016</year><volume>188</volume><fpage>204</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2016.05.010</pub-id><pub-id pub-id-type="pmid">27167460</pub-id></element-citation></ref><ref id="B349-pharmaceutics-16-00454"><label>349.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Petrisor</surname><given-names>G.</given-names></name><name name-style="western"><surname>Motelica</surname><given-names>L.</given-names></name><name name-style="western"><surname>Craciun</surname><given-names>L.N.</given-names></name><name name-style="western"><surname>Oprea</surname><given-names>O.C.</given-names></name><name name-style="western"><surname>Ficai</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ficai</surname><given-names>A.</given-names></name></person-group><article-title><italic toggle="yes">Melissa officinalis</italic>: Composition, Pharmacological Effects and Derived Release Systems&#8212;A Review</article-title><source>Int. J. Mol. Sci.</source><year>2022</year><volume>23</volume><elocation-id>3591</elocation-id><pub-id pub-id-type="doi">10.3390/ijms23073591</pub-id><pub-id pub-id-type="pmid">35408950</pub-id><pub-id pub-id-type="pmcid">PMC8998931</pub-id></element-citation></ref><ref id="B350-pharmaceutics-16-00454"><label>350.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alimoradi</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Jafari</surname><given-names>E.</given-names></name><name name-style="western"><surname>Abdi</surname><given-names>F.</given-names></name><name name-style="western"><surname>Griffiths</surname><given-names>M.D.</given-names></name></person-group><article-title>Therapeutic Applications of Lemon Balm (<italic toggle="yes">Melissa officinalis</italic>) for Obstetrics and Gynecological Health Issues: A Systematic Review</article-title><source>J. Herb. Med.</source><year>2023</year><volume>42</volume><fpage>100751</fpage><pub-id pub-id-type="doi">10.1016/j.hermed.2023.100751</pub-id></element-citation></ref><ref id="B351-pharmaceutics-16-00454"><label>351.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carvalho</surname><given-names>F.</given-names></name><name name-style="western"><surname>Duarte</surname><given-names>A.P.</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>S.</given-names></name></person-group><article-title>Antimicrobial Activity of <italic toggle="yes">Melissa officinalis</italic> and Its Potential Use in Food Preservation</article-title><source>Food Biosci.</source><year>2021</year><volume>44</volume><elocation-id>101437</elocation-id><pub-id pub-id-type="doi">10.1016/j.fbio.2021.101437</pub-id></element-citation></ref><ref id="B352-pharmaceutics-16-00454"><label>352.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zeljkovi&#263;</surname><given-names>S.&#262;.</given-names></name><name name-style="western"><surname>&#352;i&#353;kov&#225;</surname><given-names>J.</given-names></name><name name-style="western"><surname>Komz&#225;kov&#225;</surname><given-names>K.</given-names></name><name name-style="western"><surname>De Diego</surname><given-names>N.</given-names></name><name name-style="western"><surname>Kaffkov&#225;</surname><given-names>K.</given-names></name><name name-style="western"><surname>Tarkowski</surname><given-names>P.</given-names></name></person-group><article-title>Phenolic Compounds and Biological Activity of Selected Mentha Species</article-title><source>Plants</source><year>2021</year><volume>10</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.3390/plants10030550</pub-id><pub-id pub-id-type="pmid">33804017</pub-id><pub-id pub-id-type="pmcid">PMC8000339</pub-id></element-citation></ref><ref id="B353-pharmaceutics-16-00454"><label>353.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olsen</surname><given-names>H.T.</given-names></name><name name-style="western"><surname>Stafford</surname><given-names>G.I.</given-names></name><name name-style="western"><surname>van Staden</surname><given-names>J.</given-names></name><name name-style="western"><surname>Christensen</surname><given-names>S.B.</given-names></name><name name-style="western"><surname>J&#228;ger</surname><given-names>A.K.</given-names></name></person-group><article-title>Isolation of the MAO-Inhibitor Naringenin from <italic toggle="yes">Mentha aquatica</italic> L.</article-title><source>J. Ethnopharmacol.</source><year>2008</year><volume>117</volume><fpage>500</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2008.02.015</pub-id><pub-id pub-id-type="pmid">18372132</pub-id></element-citation></ref><ref id="B354-pharmaceutics-16-00454"><label>354.</label><element-citation publication-type="confproc"><person-group person-group-type="author"><name name-style="western"><surname>Ferreira</surname><given-names>F.M.</given-names></name><name name-style="western"><surname>Pereira</surname><given-names>O.R.</given-names></name><name name-style="western"><surname>Cardoso</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>A.J.M.</given-names></name></person-group><article-title><italic toggle="yes">Mentha aquatica</italic> L.</article-title><source>Extract Effects on Mitochondrial Bioenergetics. In Proceedings of the 18th European Bioenergetics Conference</source><conf-loc>Lisbon, Portugal</conf-loc><conf-date>12&#8211;17 July 2014</conf-date></element-citation></ref><ref id="B355-pharmaceutics-16-00454"><label>355.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hanafy</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Prenzler</surname><given-names>P.D.</given-names></name><name name-style="western"><surname>Burrows</surname><given-names>G.E.</given-names></name><name name-style="western"><surname>Ryan</surname><given-names>D.</given-names></name><name name-style="western"><surname>Nielsen</surname><given-names>S.</given-names></name><name name-style="western"><surname>El Sawi</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>El Alfy</surname><given-names>T.S.</given-names></name><name name-style="western"><surname>Abdelrahman</surname><given-names>E.H.</given-names></name><name name-style="western"><surname>Obied</surname><given-names>H.K.</given-names></name></person-group><article-title>Biophenols of Mints: Antioxidant, Acetylcholinesterase, Butyrylcholinesterase and Histone Deacetylase Inhibition Activities Targeting Alzheimer&#8217;s Disease Treatment</article-title><source>J. Funct. Foods</source><year>2017</year><volume>33</volume><fpage>345</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1016/j.jff.2017.03.027</pub-id></element-citation></ref><ref id="B356-pharmaceutics-16-00454"><label>356.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Benabdallah</surname><given-names>A.</given-names></name><name name-style="western"><surname>Boumendjel</surname><given-names>M.</given-names></name><name name-style="western"><surname>Aissi</surname><given-names>O.</given-names></name><name name-style="western"><surname>Rahmoune</surname><given-names>C.</given-names></name><name name-style="western"><surname>Boussaid</surname><given-names>M.</given-names></name><name name-style="western"><surname>Messaoud</surname><given-names>C.</given-names></name></person-group><article-title>Chemical Composition, Antioxidant Activity and Acetylcholinesterase Inhibitory of Wild Mentha Species from Northeastern Algeria</article-title><source>S. Afr. J. Bot.</source><year>2018</year><volume>116</volume><fpage>131</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.1016/j.sajb.2018.03.002</pub-id></element-citation></ref><ref id="B357-pharmaceutics-16-00454"><label>357.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pereira</surname><given-names>O.R.</given-names></name><name name-style="western"><surname>Macias</surname><given-names>R.I.R.</given-names></name><name name-style="western"><surname>Domingues</surname><given-names>M.R.M.</given-names></name><name name-style="western"><surname>Marin</surname><given-names>J.J.G.</given-names></name><name name-style="western"><surname>Cardoso</surname><given-names>S.M.</given-names></name></person-group><article-title>Hepatoprotection of <italic toggle="yes">Mentha aquatica</italic> L., <italic toggle="yes">Lavandula dentata</italic> L. and <italic toggle="yes">Leonurus cardiaca</italic> L.</article-title><source>Antioxidants</source><year>2019</year><volume>8</volume><elocation-id>267</elocation-id><pub-id pub-id-type="doi">10.3390/antiox8080267</pub-id><pub-id pub-id-type="pmid">31382408</pub-id><pub-id pub-id-type="pmcid">PMC6719046</pub-id></element-citation></ref><ref id="B358-pharmaceutics-16-00454"><label>358.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>J&#228;ger</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Almqvist</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Vangs&#248;e</surname><given-names>S.A.K.</given-names></name><name name-style="western"><surname>Stafford</surname><given-names>G.I.</given-names></name><name name-style="western"><surname>Adsersen</surname><given-names>A.</given-names></name><name name-style="western"><surname>Van Staden</surname><given-names>J.</given-names></name></person-group><article-title>Compounds from <italic toggle="yes">Mentha aquatica</italic> with Affinity to the GABA-Benzodiazepine Receptor</article-title><source>S. Afr. J. Bot.</source><year>2007</year><volume>73</volume><fpage>518</fpage><lpage>521</lpage><pub-id pub-id-type="doi">10.1016/j.sajb.2007.04.061</pub-id></element-citation></ref><ref id="B359-pharmaceutics-16-00454"><label>359.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>C.T.</given-names></name><name name-style="western"><surname>Soo</surname><given-names>W.N.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.H.</given-names></name><name name-style="western"><surname>Shyur</surname><given-names>L.F.</given-names></name></person-group><article-title>Essential Oil of <italic toggle="yes">Mentha aquatica</italic> Var. Kenting Water Mint Suppresses Two-Stage Skin Carcinogenesis Accelerated by BRAF Inhibitor Vemurafenib</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>2344</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24122344</pub-id><pub-id pub-id-type="pmid">31242703</pub-id><pub-id pub-id-type="pmcid">PMC6630265</pub-id></element-citation></ref><ref id="B360-pharmaceutics-16-00454"><label>360.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thi</surname><given-names>N.Q.N.</given-names></name><name name-style="western"><surname>Duc</surname><given-names>L.T.</given-names></name><name name-style="western"><surname>Minh</surname><given-names>L.V.</given-names></name><name name-style="western"><surname>Tien</surname><given-names>L.X.</given-names></name></person-group><article-title>Phytochemicals and Antioxidant Activity of Aqueous and Ethanolic Extracts of <italic toggle="yes">Mentha aquatica</italic> L.</article-title><source>IOP Conf. Ser. Mater. Sci. Eng.</source><year>2020</year><volume>991</volume><fpage>012027</fpage><pub-id pub-id-type="doi">10.1088/1757-899X/991/1/012027</pub-id></element-citation></ref><ref id="B361-pharmaceutics-16-00454"><label>361.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferhat</surname><given-names>M.</given-names></name><name name-style="western"><surname>Erol</surname><given-names>E.</given-names></name><name name-style="western"><surname>Beladjila</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>&#199;etinta&#351;</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Duru</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>&#214;zt&#252;rk</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kabouche</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kabouche</surname><given-names>Z.</given-names></name></person-group><article-title>Antioxidant, Anticholinesterase and Antibacterial Activities of <italic toggle="yes">Stachys guyoniana</italic> and <italic toggle="yes">Mentha aquatica</italic></article-title><source>Pharm. Biol.</source><year>2017</year><volume>55</volume><fpage>324</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1080/13880209.2016.1238488</pub-id><pub-id pub-id-type="pmid">27927090</pub-id><pub-id pub-id-type="pmcid">PMC6130750</pub-id></element-citation></ref><ref id="B362-pharmaceutics-16-00454"><label>362.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dhifi</surname><given-names>W.</given-names></name><name name-style="western"><surname>Litaiem</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jelali</surname><given-names>N.</given-names></name><name name-style="western"><surname>Hamdi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Mnif</surname><given-names>W.</given-names></name></person-group><article-title>Identification of A New Chemotye of the Plant <italic toggle="yes">Mentha aquatica</italic> Grown in Tunisia: Chemical Composition, Antioxidant and Biological Activities of Its Essential Oil</article-title><source>J. Essent. Oil Bear. Plants</source><year>2013</year><volume>14</volume><fpage>320</fpage><lpage>328</lpage><pub-id pub-id-type="doi">10.1080/0972060X.2011.10643941</pub-id></element-citation></ref><ref id="B363-pharmaceutics-16-00454"><label>363.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Oliveira Braga</surname><given-names>L.E.</given-names></name><name name-style="western"><surname>da Silva</surname><given-names>G.G.</given-names></name><name name-style="western"><surname>de Oliveira Sousa</surname><given-names>I.M.</given-names></name><name name-style="western"><surname>de Oliveira</surname><given-names>E.C.S.</given-names></name><name name-style="western"><surname>Jorge</surname><given-names>M.P.</given-names></name><name name-style="western"><surname>Monteiro</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Sedano</surname><given-names>T.C.</given-names></name><name name-style="western"><surname>Foglio</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Ruiz</surname><given-names>A.L.T.G.</given-names></name></person-group><article-title>Gastrointestinal Effects of <italic toggle="yes">Mentha aquatica</italic> L. Essential Oil</article-title><source>Inflammopharmacology</source><year>2022</year><volume>30</volume><fpage>2127</fpage><lpage>2137</lpage><pub-id pub-id-type="doi">10.1007/s10787-022-00989-x</pub-id><pub-id pub-id-type="pmid">35451723</pub-id></element-citation></ref><ref id="B364-pharmaceutics-16-00454"><label>364.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Souza</surname><given-names>L.B.</given-names></name><name name-style="western"><surname>Tinti</surname><given-names>S.V.</given-names></name><name name-style="western"><surname>Sousa</surname><given-names>I.M.D.O.</given-names></name><name name-style="western"><surname>Montanari</surname><given-names>I.</given-names></name><name name-style="western"><surname>da Costa</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>de Carvalho</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Foglio</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Ruiz</surname><given-names>A.L.T.G.</given-names></name></person-group><article-title><italic toggle="yes">Mentha aquatica</italic> L. Aerial Parts: In Vitro Anti-Proliferative Evaluation on Human Tumour and Non-Tumour Cell Lines</article-title><source>Nat. Prod. Res.</source><year>2022</year><volume>36</volume><fpage>3117</fpage><lpage>3123</lpage><pub-id pub-id-type="doi">10.1080/14786419.2021.1937152</pub-id><pub-id pub-id-type="pmid">34142601</pub-id></element-citation></ref><ref id="B365-pharmaceutics-16-00454"><label>365.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rahimifard</surname><given-names>N.</given-names></name><name name-style="western"><surname>Haji</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hedayati</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bagheri</surname><given-names>O.</given-names></name></person-group><article-title>Cytotoxic Effects of Essential Oils and Extracts of Some Mentha Species on Vero, Hela and Hep2 Cell Lines</article-title><source>J. Med. Plants</source><year>2010</year><volume>9</volume><fpage>88</fpage><lpage>92</lpage></element-citation></ref><ref id="B366-pharmaceutics-16-00454"><label>366.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>W.</given-names></name><name name-style="western"><surname>Barrows</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lopez</surname><given-names>F.</given-names></name><name name-style="western"><surname>Rogers</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ortiz-Coffie</surname><given-names>A.</given-names></name><name name-style="western"><surname>Norman</surname><given-names>D.</given-names></name><name name-style="western"><surname>Hodges</surname><given-names>J.</given-names></name><name name-style="western"><surname>McDonald</surname><given-names>K.</given-names></name><name name-style="western"><surname>Barnes</surname><given-names>D.</given-names></name><name name-style="western"><surname>McCall</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Investigation of the Anxiolytic Effects of Naringenin, a Component of <italic toggle="yes">Mentha aquatica</italic>, in the Male Sprague-Dawley Rat</article-title><source>Holist. Nurs. Pract.</source><year>2012</year><volume>26</volume><fpage>52</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1097/HNP.0b013e31823c003a</pub-id><pub-id pub-id-type="pmid">22157509</pub-id></element-citation></ref><ref id="B367-pharmaceutics-16-00454"><label>367.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Safaiee</surname><given-names>P.</given-names></name><name name-style="western"><surname>Taghipour</surname><given-names>A.</given-names></name><name name-style="western"><surname>Vahdatkhoram</surname><given-names>F.</given-names></name><name name-style="western"><surname>Movagharnejad</surname><given-names>K.</given-names></name></person-group><article-title>Extraction of Phenolic Compounds from <italic toggle="yes">Mentha aquatica</italic>: The Effects of Sonication Time, Temperature and Drying Method</article-title><source>Chem. Pap.</source><year>2019</year><volume>73</volume><fpage>3067</fpage><lpage>3073</lpage><pub-id pub-id-type="doi">10.1007/s11696-019-00843-5</pub-id></element-citation></ref><ref id="B368-pharmaceutics-16-00454"><label>368.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Venditti</surname><given-names>A.</given-names></name><name name-style="western"><surname>Frezza</surname><given-names>C.</given-names></name><name name-style="western"><surname>Celona</surname><given-names>D.</given-names></name><name name-style="western"><surname>Sciubba</surname><given-names>F.</given-names></name><name name-style="western"><surname>Foddai</surname><given-names>S.</given-names></name><name name-style="western"><surname>Delfini</surname><given-names>M.</given-names></name><name name-style="western"><surname>Serafini</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bianco</surname><given-names>A.</given-names></name><name name-style="western"><surname>Venditti</surname><given-names>A.</given-names></name><name name-style="western"><surname>Frezza</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Phytochemical Comparison with Quantitative Analysis between Two Flower Phenotypes of <italic toggle="yes">Mentha aquatica</italic> L.: Pink-Violet and White</article-title><source>AIMS Mol. Sci.</source><year>2017</year><volume>4</volume><fpage>288</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.3934/molsci.2017.3.288</pub-id></element-citation></ref><ref id="B369-pharmaceutics-16-00454"><label>369.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mimica-Duki&#263;</surname><given-names>N.</given-names></name><name name-style="western"><surname>Bo&#382;in</surname><given-names>B.</given-names></name><name name-style="western"><surname>Sokovi&#263;</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mihajlovi&#263;</surname><given-names>B.</given-names></name><name name-style="western"><surname>Matavulj</surname><given-names>M.</given-names></name></person-group><article-title>Antimicrobial and Antioxidant Activities of Three Mentha Species Essential Oils</article-title><source>Planta Med.</source><year>2003</year><volume>69</volume><fpage>413</fpage><lpage>419</lpage><pub-id pub-id-type="pmid">12802721</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1055/s-2003-39704</pub-id></element-citation></ref><ref id="B370-pharmaceutics-16-00454"><label>370.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Conforti</surname><given-names>F.</given-names></name><name name-style="western"><surname>Ioele</surname><given-names>G.</given-names></name><name name-style="western"><surname>Statti</surname><given-names>G.A.</given-names></name><name name-style="western"><surname>Marrelli</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ragno</surname><given-names>G.</given-names></name><name name-style="western"><surname>Menichini</surname><given-names>F.</given-names></name></person-group><article-title>Antiproliferative Activity against Human Tumor Cell Lines and Toxicity Test on Mediterranean Dietary Plants</article-title><source>Food Chem. Toxicol.</source><year>2008</year><volume>46</volume><fpage>3325</fpage><lpage>3332</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2008.08.004</pub-id><pub-id pub-id-type="pmid">18768152</pub-id></element-citation></ref><ref id="B371-pharmaceutics-16-00454"><label>371.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saqib</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ullah</surname><given-names>F.</given-names></name><name name-style="western"><surname>Naeem</surname><given-names>M.</given-names></name><name name-style="western"><surname>Younas</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ayaz</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ali</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zaman</surname><given-names>W.</given-names></name></person-group><article-title>Mentha: Nutritional and Health Attributes to Treat Various Ailments Including Cardiovascular Diseases</article-title><source>Molecules</source><year>2022</year><volume>27</volume><elocation-id>6728</elocation-id><pub-id pub-id-type="doi">10.3390/molecules27196728</pub-id><pub-id pub-id-type="pmid">36235263</pub-id><pub-id pub-id-type="pmcid">PMC9572119</pub-id></element-citation></ref><ref id="B372-pharmaceutics-16-00454"><label>372.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>G&#252;l&#231;in</surname><given-names>&#304;.</given-names></name><name name-style="western"><surname>G&#246;ren</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Taslimi</surname><given-names>P.</given-names></name><name name-style="western"><surname>Alwasel</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>K&#305;l&#305;c</surname><given-names>O.</given-names></name><name name-style="western"><surname>Bursal</surname><given-names>E.</given-names></name></person-group><article-title>Anticholinergic, Antidiabetic and Antioxidant Activities of Anatolian Pennyroyal (<italic toggle="yes">Mentha pulegium</italic>)-Analysis of Its Polyphenol Contents by LC-MS/MS</article-title><source>Biocatal. Agric. Biotechnol.</source><year>2020</year><volume>23</volume><elocation-id>101441</elocation-id><pub-id pub-id-type="doi">10.1016/j.bcab.2019.101441</pub-id></element-citation></ref><ref id="B373-pharmaceutics-16-00454"><label>373.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bouyahya</surname><given-names>A.</given-names></name><name name-style="western"><surname>Et-Touys</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bakri</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Talbaui</surname><given-names>A.</given-names></name><name name-style="western"><surname>Fellah</surname><given-names>H.</given-names></name><name name-style="western"><surname>Abrini</surname><given-names>J.</given-names></name><name name-style="western"><surname>Dakka</surname><given-names>N.</given-names></name></person-group><article-title>Chemical Composition of <italic toggle="yes">Mentha pulegium</italic> and <italic toggle="yes">Rosmarinus officinalis</italic> Essential Oils and Their Antileishmanial, Antibacterial and Antioxidant Activities</article-title><source>Microb. Pathog.</source><year>2017</year><volume>111</volume><fpage>41</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.micpath.2017.08.015</pub-id><pub-id pub-id-type="pmid">28821401</pub-id></element-citation></ref><ref id="B374-pharmaceutics-16-00454"><label>374.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cherrat</surname><given-names>L.</given-names></name><name name-style="western"><surname>Espina</surname><given-names>L.</given-names></name><name name-style="western"><surname>Bakkali</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pag&#225;n</surname><given-names>R.</given-names></name><name name-style="western"><surname>Laglaoui</surname><given-names>A.</given-names></name></person-group><article-title>Chemical Composition, Antioxidant and Antimicrobial Properties of <italic toggle="yes">Mentha pulegium</italic>, <italic toggle="yes">Lavandula stoechas</italic> and <italic toggle="yes">Satureja calamintha</italic> Scheele Essential Oils and an Evaluation of Their Bactericidal Effect in Combined Processes</article-title><source>Innov. Food Sci. Emerg. Technol.</source><year>2014</year><volume>22</volume><fpage>221</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1016/j.ifset.2013.12.016</pub-id></element-citation></ref><ref id="B375-pharmaceutics-16-00454"><label>375.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chraibi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Farah</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lebrazi</surname><given-names>S.</given-names></name><name name-style="western"><surname>El Amine</surname><given-names>O.</given-names></name><name name-style="western"><surname>Iraqui Houssaini</surname><given-names>M.</given-names></name><name name-style="western"><surname>Fikri-Benbrahim</surname><given-names>K.</given-names></name></person-group><article-title>Antimycobacterial Natural Products from Moroccan Medicinal Plants: Chemical Composition, Bacteriostatic and Bactericidal Profile of Thymus Satureioides and <italic toggle="yes">Mentha pulegium</italic> Essential Oils</article-title><source>Asian Pac. J. Trop. Biomed.</source><year>2016</year><volume>6</volume><fpage>836</fpage><lpage>840</lpage><pub-id pub-id-type="doi">10.1016/j.apjtb.2016.08.002</pub-id></element-citation></ref><ref id="B376-pharmaceutics-16-00454"><label>376.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eftekhari</surname><given-names>A.</given-names></name><name name-style="western"><surname>Khusro</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ahmadian</surname><given-names>E.</given-names></name><name name-style="western"><surname>Dizaj</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Dinparast</surname><given-names>L.</given-names></name><name name-style="western"><surname>Bahadori</surname><given-names>M.B.</given-names></name><name name-style="western"><surname>Hasanzadeh</surname><given-names>A.</given-names></name><name name-style="western"><surname>Cucchiarini</surname><given-names>M.</given-names></name></person-group><article-title>Phytochemical and Nutra-Pharmaceutical Attributes of <italic toggle="yes">Mentha</italic> Spp.: A Comprehensive Review</article-title><source>Arab. J. Chem.</source><year>2021</year><volume>14</volume><fpage>103106</fpage><pub-id pub-id-type="doi">10.1016/j.arabjc.2021.103106</pub-id></element-citation></ref><ref id="B377-pharmaceutics-16-00454"><label>377.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Al-Rajhi</surname><given-names>A.M.H.</given-names></name><name name-style="western"><surname>Qanash</surname><given-names>H.</given-names></name><name name-style="western"><surname>Almuhayawi</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Al Jaouni</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Bakri</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Ganash</surname><given-names>M.</given-names></name><name name-style="western"><surname>Salama</surname><given-names>H.M.</given-names></name><name name-style="western"><surname>Selim</surname><given-names>S.</given-names></name><name name-style="western"><surname>Abdelghany</surname><given-names>T.M.</given-names></name></person-group><article-title>Molecular Interaction Studies and Phytochemical Characterization of <italic toggle="yes">Mentha pulegium</italic> L. Constituents with Multiple Biological Utilities as Antioxidant, Antimicrobial, Anticancer and Anti-Hemolytic Agents</article-title><source>Molecules</source><year>2022</year><volume>27</volume><elocation-id>4824</elocation-id><pub-id pub-id-type="doi">10.3390/molecules27154824</pub-id><pub-id pub-id-type="pmid">35956775</pub-id><pub-id pub-id-type="pmcid">PMC9370026</pub-id></element-citation></ref><ref id="B378-pharmaceutics-16-00454"><label>378.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Amtaghri</surname><given-names>S.</given-names></name><name name-style="western"><surname>Slaoui</surname><given-names>M.</given-names></name><name name-style="western"><surname>Eddouks</surname><given-names>M.</given-names></name></person-group><article-title><italic toggle="yes">Mentha pulegium</italic>: A Plant with Several Medicinal Properties</article-title><source>Endocr. Metab. Immune Disord. Drug Targets</source><year>2023</year><volume>23</volume><fpage>302</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.2174/1871530323666230914103731</pub-id><pub-id pub-id-type="pmid">37711001</pub-id></element-citation></ref><ref id="B379-pharmaceutics-16-00454"><label>379.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hadi</surname><given-names>M.Y.</given-names></name><name name-style="western"><surname>Hameed</surname><given-names>I.H.</given-names></name><name name-style="western"><surname>Ibraheam</surname><given-names>I.A.</given-names></name></person-group><article-title><italic toggle="yes">Mentha pulegium</italic>: Medicinal Uses, Anti-Hepatic, Antibacterial, Antioxidant Effect and Analysis of Bioactive Natural Compounds: A Review</article-title><source>Res. J. Pharm. Technol.</source><year>2017</year><volume>10</volume><fpage>3580</fpage><lpage>3584</lpage><pub-id pub-id-type="doi">10.5958/0974-360X.2017.00648.5</pub-id></element-citation></ref><ref id="B380-pharmaceutics-16-00454"><label>380.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pietrella</surname><given-names>D.</given-names></name><name name-style="western"><surname>Angiolella</surname><given-names>L.</given-names></name><name name-style="western"><surname>Vavala</surname><given-names>E.</given-names></name><name name-style="western"><surname>Rachini</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mondello</surname><given-names>F.</given-names></name><name name-style="western"><surname>Ragno</surname><given-names>R.</given-names></name><name name-style="western"><surname>Bistoni</surname><given-names>F.</given-names></name><name name-style="western"><surname>Vecchiarelli</surname><given-names>A.</given-names></name></person-group><article-title>Beneficial Effect of <italic toggle="yes">Mentha suaveolens</italic> Essential Oil in the Treatment of Vaginal Candidiasis Assessed by Real-Time Monitoring of Infection</article-title><source>BMC Complement. Altern. Med.</source><year>2011</year><volume>11</volume><elocation-id>18</elocation-id><pub-id pub-id-type="doi">10.1186/1472-6882-11-18</pub-id><pub-id pub-id-type="pmid">21356078</pub-id><pub-id pub-id-type="pmcid">PMC3056850</pub-id></element-citation></ref><ref id="B381-pharmaceutics-16-00454"><label>381.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oumzil</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ghoulami</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rhajaoui</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ilidrissi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Fkih-Tetouani</surname><given-names>S.</given-names></name><name name-style="western"><surname>Faid</surname><given-names>M.</given-names></name><name name-style="western"><surname>Benjouad</surname><given-names>A.</given-names></name></person-group><article-title>Antibacterial and Antifungal Activity of Essential Oils of <italic toggle="yes">Mentha suaveolens</italic></article-title><source>Phytother. Res. Int. J. Devoted</source><year>2002</year><volume>16</volume><fpage>727</fpage><lpage>731</lpage><pub-id pub-id-type="doi">10.1002/ptr.1045</pub-id><pub-id pub-id-type="pmid">12458474</pub-id></element-citation></ref><ref id="B382-pharmaceutics-16-00454"><label>382.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aldogman</surname><given-names>B.</given-names></name><name name-style="western"><surname>Bilel</surname><given-names>H.</given-names></name><name name-style="western"><surname>Moustafa</surname><given-names>S.M.N.</given-names></name><name name-style="western"><surname>Elmassary</surname><given-names>K.F.</given-names></name><name name-style="western"><surname>Ali</surname><given-names>H.M.</given-names></name><name name-style="western"><surname>Alotaibi</surname><given-names>F.Q.</given-names></name><name name-style="western"><surname>Hamza</surname><given-names>M.</given-names></name><name name-style="western"><surname>Abdelgawad</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>El-Ghorab</surname><given-names>A.H.</given-names></name></person-group><article-title>Investigation of Chemical Compositions and Biological Activities of <italic toggle="yes">Mentha suaveolens</italic> L. from Saudi Arabia</article-title><source>Molecules</source><year>2022</year><volume>27</volume><elocation-id>2949</elocation-id><pub-id pub-id-type="doi">10.3390/molecules27092949</pub-id><pub-id pub-id-type="pmid">35566313</pub-id><pub-id pub-id-type="pmcid">PMC9099798</pub-id></element-citation></ref><ref id="B383-pharmaceutics-16-00454"><label>383.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sytar</surname><given-names>O.</given-names></name><name name-style="western"><surname>Hemmerich</surname><given-names>I.</given-names></name><name name-style="western"><surname>Zivcak</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rauh</surname><given-names>C.</given-names></name><name name-style="western"><surname>Brestic</surname><given-names>M.</given-names></name></person-group><article-title>Comparative Analysis of Bioactive Phenolic Compounds Composition from 26 Medicinal Plants</article-title><source>Saudi J. Biol. Sci.</source><year>2018</year><volume>25</volume><fpage>631</fpage><lpage>641</lpage><pub-id pub-id-type="doi">10.1016/j.sjbs.2016.01.036</pub-id><pub-id pub-id-type="pmid">29740227</pub-id><pub-id pub-id-type="pmcid">PMC5937015</pub-id></element-citation></ref><ref id="B384-pharmaceutics-16-00454"><label>384.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Al-Mijalli</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Assaggaf</surname><given-names>H.</given-names></name><name name-style="western"><surname>Qasem</surname><given-names>A.</given-names></name><name name-style="western"><surname>El-Shemi</surname><given-names>A.G.</given-names></name><name name-style="western"><surname>Abdallah</surname><given-names>E.M.</given-names></name><name name-style="western"><surname>Mrabti</surname><given-names>H.N.</given-names></name><name name-style="western"><surname>Bouyahya</surname><given-names>A.</given-names></name></person-group><article-title>Antioxidant, Antidiabetic, and Antibacterial Potentials and Chemical Composition of <italic toggle="yes">Salvia officinalis</italic> and <italic toggle="yes">Mentha suaveolens</italic> Grown Wild in Morocco</article-title><source>Adv. Pharmacol. Pharm. Sci.</source><year>2022</year><volume>2022</volume><fpage>2844880</fpage><pub-id pub-id-type="doi">10.1155/2022/2844880</pub-id><pub-id pub-id-type="pmid">35755940</pub-id><pub-id pub-id-type="pmcid">PMC9217590</pub-id></element-citation></ref><ref id="B385-pharmaceutics-16-00454"><label>385.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yeom</surname><given-names>M.</given-names></name><name name-style="western"><surname>Shin</surname><given-names>S.</given-names></name><name name-style="western"><surname>Jeon</surname><given-names>K.</given-names></name><name name-style="western"><surname>Park</surname><given-names>D.</given-names></name><name name-style="western"><surname>Jung</surname><given-names>E.</given-names></name></person-group><article-title>Protective Effects of Aqueous Extract of <italic toggle="yes">Mentha suaveolens</italic> against Oxidative Stress-Induced Damages in Human Keratinocyte HaCaT Cells</article-title><source>Evid.-Based Complement. Altern. Med.</source><year>2019</year><volume>2019</volume><fpage>5045491</fpage><pub-id pub-id-type="doi">10.1155/2019/5045491</pub-id><pub-id pub-id-type="pmid">31662774</pub-id><pub-id pub-id-type="pmcid">PMC6778877</pub-id></element-citation></ref><ref id="B386-pharmaceutics-16-00454"><label>386.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moreno</surname><given-names>L.</given-names></name><name name-style="western"><surname>Bello</surname><given-names>R.</given-names></name><name name-style="western"><surname>Primo-Y&#250;fera</surname><given-names>E.</given-names></name><name name-style="western"><surname>Esplugues</surname><given-names>J.</given-names></name></person-group><article-title>Pharmacological Properties of the Methanol Extract from <italic toggle="yes">Mentha suaveolens</italic> Ehrh</article-title><source>Phytother. Res.</source><year>2002</year><volume>16</volume><fpage>10</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1002/ptr.744</pub-id><pub-id pub-id-type="pmid">11933132</pub-id></element-citation></ref><ref id="B387-pharmaceutics-16-00454"><label>387.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>El-Akhal</surname><given-names>J.</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>A.P.</given-names></name><name name-style="western"><surname>Bencheikh</surname><given-names>R.</given-names></name><name name-style="western"><surname>Valent&#227;o</surname><given-names>P.</given-names></name><name name-style="western"><surname>Andrade</surname><given-names>P.B.</given-names></name><name name-style="western"><surname>Morato</surname><given-names>M.</given-names></name></person-group><article-title>Vasorelaxant Mechanism of Herbal Extracts from <italic toggle="yes">Mentha suaveolens</italic>, <italic toggle="yes">Conyza canadensis</italic>, <italic toggle="yes">Teucrium polium</italic> and <italic toggle="yes">Salvia verbenaca</italic> in the Aorta of Wistar Rats</article-title><source>Molecules</source><year>2022</year><volume>27</volume><elocation-id>8752</elocation-id><pub-id pub-id-type="doi">10.3390/molecules27248752</pub-id><pub-id pub-id-type="pmid">36557886</pub-id><pub-id pub-id-type="pmcid">PMC9784123</pub-id></element-citation></ref><ref id="B388-pharmaceutics-16-00454"><label>388.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oniga</surname><given-names>I.</given-names></name><name name-style="western"><surname>Pus</surname><given-names>C.</given-names></name><name name-style="western"><surname>Silaghi-Dumitrescu</surname><given-names>R.</given-names></name><name name-style="western"><surname>Olah</surname><given-names>N.K.</given-names></name><name name-style="western"><surname>Sevastre</surname><given-names>B.</given-names></name><name name-style="western"><surname>Marica</surname><given-names>R.</given-names></name><name name-style="western"><surname>Marcus</surname><given-names>I.</given-names></name><name name-style="western"><surname>Sevastre-Berghian</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Benedec</surname><given-names>D.</given-names></name><name name-style="western"><surname>Pop</surname><given-names>C.E.</given-names></name><etal/></person-group><article-title><italic toggle="yes">Origanum vulgare</italic> ssp. Vulgare: Chemical Composition and Biological Studies</article-title><source>Molecules</source><year>2018</year><volume>23</volume><elocation-id>2077</elocation-id><pub-id pub-id-type="doi">10.3390/molecules23082077</pub-id><pub-id pub-id-type="pmid">30126246</pub-id><pub-id pub-id-type="pmcid">PMC6222339</pub-id></element-citation></ref><ref id="B389-pharmaceutics-16-00454"><label>389.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lombrea</surname><given-names>A.</given-names></name><name name-style="western"><surname>Antal</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ardelean</surname><given-names>F.</given-names></name><name name-style="western"><surname>Avram</surname><given-names>S.</given-names></name><name name-style="western"><surname>Pavel</surname><given-names>I.Z.</given-names></name><name name-style="western"><surname>Vlaia</surname><given-names>L.</given-names></name><name name-style="western"><surname>Mut</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Diaconeasa</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Dehelean</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Soica</surname><given-names>C.</given-names></name><etal/></person-group><article-title>A Recent Insight Regarding the Phytochemistry and Bioactivity of <italic toggle="yes">Origanum vulgare</italic> L. Essential Oil</article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><elocation-id>9653</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21249653</pub-id><pub-id pub-id-type="pmid">33348921</pub-id><pub-id pub-id-type="pmcid">PMC7765853</pub-id></element-citation></ref><ref id="B390-pharmaceutics-16-00454"><label>390.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sarikurkcu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zengin</surname><given-names>G.</given-names></name><name name-style="western"><surname>Oskay</surname><given-names>M.</given-names></name><name name-style="western"><surname>Uysal</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ceylan</surname><given-names>R.</given-names></name><name name-style="western"><surname>Aktumsek</surname><given-names>A.</given-names></name></person-group><article-title>Composition, Antioxidant, Antimicrobial and Enzyme Inhibition Activities of Two <italic toggle="yes">Origanum vulgare</italic> Subspecies (Subsp</article-title><source>Vulgare and Subsp. Hirtum) Essential Oils. Ind. Crops Prod.</source><year>2015</year><volume>70</volume><fpage>178</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1016/j.indcrop.2015.03.030</pub-id></element-citation></ref><ref id="B391-pharmaceutics-16-00454"><label>391.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Milos</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mastelic</surname><given-names>J.</given-names></name><name name-style="western"><surname>Jerkovic</surname><given-names>I.</given-names></name></person-group><article-title>Chemical Composition and Antioxidant Effect of Glycosidically Bound Volatile Compounds from Oregano (<italic toggle="yes">Origanum vulgare</italic> L. Ssp. Hirtum)</article-title><source>Food Chem.</source><year>2000</year><volume>71</volume><fpage>79</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/S0308-8146(00)00144-8</pub-id></element-citation></ref><ref id="B392-pharmaceutics-16-00454"><label>392.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jafari Khorsand</surname><given-names>G.</given-names></name><name name-style="western"><surname>Morshedloo</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Mumivand</surname><given-names>H.</given-names></name><name name-style="western"><surname>Emami Bistgani</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Maggi</surname><given-names>F.</given-names></name><name name-style="western"><surname>Khademi</surname><given-names>A.</given-names></name></person-group><article-title>Natural Diversity in Phenolic Components and Antioxidant Properties of Oregano (<italic toggle="yes">Origanum vulgare</italic> L.) Accessions, Grown under the Same Conditions</article-title><source>Sci. Rep.</source><year>2022</year><volume>12</volume><fpage>5813</fpage><pub-id pub-id-type="doi">10.1038/s41598-022-09742-4</pub-id><pub-id pub-id-type="pmid">35388099</pub-id><pub-id pub-id-type="pmcid">PMC8987097</pub-id></element-citation></ref><ref id="B393-pharmaceutics-16-00454"><label>393.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>P.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>X.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>L.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name></person-group><article-title>Hypoglycemic Activity of <italic toggle="yes">Origanum vulgare</italic> L. and Its Main Chemical Constituents Identified with HPLC-ESI-QTOF-MS</article-title><source>Food Funct.</source><year>2021</year><volume>12</volume><fpage>2580</fpage><lpage>2590</lpage><pub-id pub-id-type="doi">10.1039/D0FO03166F</pub-id><pub-id pub-id-type="pmid">33629672</pub-id></element-citation></ref><ref id="B394-pharmaceutics-16-00454"><label>394.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vujicic</surname><given-names>M.</given-names></name><name name-style="western"><surname>Nikolic</surname><given-names>I.</given-names></name><name name-style="western"><surname>Kontogianni</surname><given-names>V.G.</given-names></name><name name-style="western"><surname>Saksida</surname><given-names>T.</given-names></name><name name-style="western"><surname>Charisiadis</surname><given-names>P.</given-names></name><name name-style="western"><surname>Orescanin-Dusic</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Blagojevic</surname><given-names>D.</given-names></name><name name-style="western"><surname>Stosic-Grujicic</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tzakos</surname><given-names>A.G.</given-names></name><name name-style="western"><surname>Stojanovic</surname><given-names>I.</given-names></name></person-group><article-title>Methanolic Extract of <italic toggle="yes">Origanum vulgare</italic> Ameliorates Type 1 Diabetes through Antioxidant, Anti-Inflammatory and Anti-Apoptotic Activity</article-title><source>Br. J. Nutr.</source><year>2015</year><volume>113</volume><fpage>770</fpage><lpage>782</lpage><pub-id pub-id-type="doi">10.1017/S0007114514004048</pub-id><pub-id pub-id-type="pmid">25671817</pub-id></element-citation></ref><ref id="B395-pharmaceutics-16-00454"><label>395.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parra</surname><given-names>C.</given-names></name><name name-style="western"><surname>Mu&#241;oz</surname><given-names>P.</given-names></name><name name-style="western"><surname>Bustos</surname><given-names>L.</given-names></name><name name-style="western"><surname>Parra</surname><given-names>F.</given-names></name><name name-style="western"><surname>Simirgiotis</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Escobar</surname><given-names>H.</given-names></name></person-group><article-title>UHPLC-DAD Characterization of <italic toggle="yes">Origanum vulgare</italic> L. from Atacama Desert Andean Region and Antioxidant, Antibacterial and Enzyme Inhibition Activities</article-title><source>Molecules</source><year>2021</year><volume>26</volume><elocation-id>2100</elocation-id><pub-id pub-id-type="doi">10.3390/molecules26072100</pub-id><pub-id pub-id-type="pmid">33917599</pub-id><pub-id pub-id-type="pmcid">PMC8038783</pub-id></element-citation></ref><ref id="B396-pharmaceutics-16-00454"><label>396.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sharifi-Rad</surname><given-names>M.</given-names></name><name name-style="western"><surname>Berkay Y&#305;lmaz</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Antika</surname><given-names>G.</given-names></name><name name-style="western"><surname>Salehi</surname><given-names>B.</given-names></name><name name-style="western"><surname>Tumer</surname><given-names>T.B.</given-names></name><name name-style="western"><surname>Kulandaisamy Venil</surname><given-names>C.</given-names></name><name name-style="western"><surname>Das</surname><given-names>G.</given-names></name><name name-style="western"><surname>Patra</surname><given-names>J.K.</given-names></name><name name-style="western"><surname>Karazhan</surname><given-names>N.</given-names></name><name name-style="western"><surname>Akram</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Phytochemical Constituents, Biological Activities, and Health-Promoting Effects of the Genus Origanum</article-title><source>Phytother. Res.</source><year>2021</year><volume>35</volume><fpage>95</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1002/ptr.6785</pub-id><pub-id pub-id-type="pmid">32789910</pub-id></element-citation></ref><ref id="B397-pharmaceutics-16-00454"><label>397.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>S.-J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.-H.</given-names></name><name name-style="western"><surname>Dai</surname><given-names>Y.-Y.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>M.-H.</given-names></name><name name-style="western"><surname>Rahman</surname><given-names>K.</given-names></name><name name-style="western"><surname>Nian</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name></person-group><article-title><italic toggle="yes">Prunella vulgaris</italic>: A Comprehensive Review of Chemical Constituents, Pharmacological Effects and Clinical Applications</article-title><source>Curr. Pharm. Des.</source><year>2019</year><volume>25</volume><fpage>359</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.2174/1381612825666190313121608</pub-id><pub-id pub-id-type="pmid">30864498</pub-id></element-citation></ref><ref id="B398-pharmaceutics-16-00454"><label>398.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mrabti</surname><given-names>H.N.</given-names></name><name name-style="western"><surname>El Menyiy</surname><given-names>N.</given-names></name><name name-style="western"><surname>Charfi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Saber</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bakrim</surname><given-names>S.</given-names></name><name name-style="western"><surname>Alyamani</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Rauf</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ali</surname><given-names>A.M.H.</given-names></name><name name-style="western"><surname>Abdallah</surname><given-names>E.M.</given-names></name><name name-style="western"><surname>El Omari</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Phytochemistry and Biological Properties of <italic toggle="yes">Salvia verbenaca</italic> L.: A Comprehensive Review</article-title><source>Biomed. Res. Int.</source><year>2022</year><volume>2022</volume><elocation-id>3787818</elocation-id><pub-id pub-id-type="doi">10.1155/2022/3787818</pub-id><pub-id pub-id-type="pmid">35655480</pub-id><pub-id pub-id-type="pmcid">PMC9155978</pub-id></element-citation></ref><ref id="B399-pharmaceutics-16-00454"><label>399.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mamache</surname><given-names>W.</given-names></name><name name-style="western"><surname>Amira</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ben Souici</surname><given-names>C.</given-names></name><name name-style="western"><surname>Laouer</surname><given-names>H.</given-names></name><name name-style="western"><surname>Benchikh</surname><given-names>F.</given-names></name></person-group><article-title>In Vitro Antioxidant, Anticholinesterases, Anti-&#945;-Amylase, and Anti-&#945;-Glucosidase Effects of Algerian <italic toggle="yes">Salvia aegyptiaca</italic> and <italic toggle="yes">Salvia verbenaca</italic></article-title><source>J. Food Biochem.</source><year>2020</year><volume>44</volume><elocation-id>e13472</elocation-id><pub-id pub-id-type="doi">10.1111/jfbc.13472</pub-id><pub-id pub-id-type="pmid">33000487</pub-id></element-citation></ref><ref id="B400-pharmaceutics-16-00454"><label>400.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nassar</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zadri</surname><given-names>F.</given-names></name><name name-style="western"><surname>Slimani</surname><given-names>S.</given-names></name></person-group><article-title>Assessment of Protective Effects of Methanolic Extract of <italic toggle="yes">Salvia verbenaca</italic> Roots Against Oxidative Damage Induced by Hydrogen Peroxide</article-title><source>Turk. J. Pharm. Sci.</source><year>2021</year><volume>18</volume><fpage>360</fpage><pub-id pub-id-type="doi">10.4274/tjps.galenos.2020.74555</pub-id><pub-id pub-id-type="pmid">34157827</pub-id><pub-id pub-id-type="pmcid">PMC8231329</pub-id></element-citation></ref><ref id="B401-pharmaceutics-16-00454"><label>401.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rodrigues</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lopes</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Vaz</surname><given-names>F.</given-names></name><name name-style="western"><surname>Filipe</surname><given-names>M.</given-names></name><name name-style="western"><surname>Alves</surname><given-names>G.</given-names></name><name name-style="western"><surname>Ribeiro</surname><given-names>M.P.</given-names></name><name name-style="western"><surname>Coutinho</surname><given-names>P.</given-names></name><name name-style="western"><surname>Araujo</surname><given-names>A.R.T.S.</given-names></name></person-group><article-title><italic toggle="yes">Thymus mastichina</italic>: Composition and Biological Properties with a Focus on Antimicrobial Activity</article-title><source>Pharmaceuticals</source><year>2020</year><volume>13</volume><elocation-id>479</elocation-id><pub-id pub-id-type="doi">10.3390/ph13120479</pub-id><pub-id pub-id-type="pmid">33352776</pub-id><pub-id pub-id-type="pmcid">PMC7766293</pub-id></element-citation></ref><ref id="B402-pharmaceutics-16-00454"><label>402.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rezaei</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ashkar</surname><given-names>F.</given-names></name><name name-style="western"><surname>Koohpeyma</surname><given-names>F.</given-names></name><name name-style="western"><surname>Mahmoodi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gholamalizadeh</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mazloom</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Doaei</surname><given-names>S.</given-names></name></person-group><article-title>Hydroalcoholic Extract of <italic toggle="yes">Achillea millefolium</italic> Improved Blood Glucose, Liver Enzymes and Lipid Profile Compared to Metformin in Streptozotocin-Induced Diabetic Rats</article-title><source>Lipids Health Dis.</source><year>2020</year><volume>19</volume><fpage>81</fpage><pub-id pub-id-type="doi">10.1186/s12944-020-01228-4</pub-id><pub-id pub-id-type="pmid">32340610</pub-id><pub-id pub-id-type="pmcid">PMC7184710</pub-id></element-citation></ref><ref id="B403-pharmaceutics-16-00454"><label>403.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coskun</surname><given-names>O.</given-names></name><name name-style="western"><surname>Kanter</surname><given-names>M.</given-names></name><name name-style="western"><surname>Korkmaz</surname><given-names>A.</given-names></name><name name-style="western"><surname>Oter</surname><given-names>S.</given-names></name></person-group><article-title>Quercetin, a Flavonoid Antioxidant, Prevents and Protects Streptozotocin-Induced Oxidative Stress and &#946;-Cell Damage in Rat Pancreas</article-title><source>Pharmacol. Res.</source><year>2005</year><volume>51</volume><fpage>117</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1016/j.phrs.2004.06.002</pub-id><pub-id pub-id-type="pmid">15629256</pub-id></element-citation></ref><ref id="B404-pharmaceutics-16-00454"><label>404.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mustafa</surname><given-names>K.G.</given-names></name><name name-style="western"><surname>Ganai</surname><given-names>B.A.</given-names></name><name name-style="western"><surname>Akbar</surname><given-names>S.</given-names></name><name name-style="western"><surname>Dar</surname><given-names>M.Y.</given-names></name><name name-style="western"><surname>Masood</surname><given-names>A.</given-names></name></person-group><article-title>&#946;-Cell Protective Efficacy, Hypoglycemic and Hypolipidemic Effects of Extracts of <italic toggle="yes">Achillea millifolium</italic> in Diabetic Rats</article-title><source>Chin. J. Nat. Med.</source><year>2012</year><volume>10</volume><fpage>185</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.3724/SP.J.1009.2012.00185</pub-id></element-citation></ref><ref id="B405-pharmaceutics-16-00454"><label>405.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Asakawa</surname><given-names>A.</given-names></name><name name-style="western"><surname>Inui</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kaga</surname><given-names>T.</given-names></name><name name-style="western"><surname>Yuzuriha</surname><given-names>H.</given-names></name><name name-style="western"><surname>Nagata</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ueno</surname><given-names>N.</given-names></name><name name-style="western"><surname>Makino</surname><given-names>S.</given-names></name><name name-style="western"><surname>Fujimiya</surname><given-names>M.</given-names></name><name name-style="western"><surname>Niijima</surname><given-names>A.</given-names></name><name name-style="western"><surname>Fujino</surname><given-names>M.A.</given-names></name><etal/></person-group><article-title>Ghrelin Is an Appetite-Stimulatory Signal from Stomach with Structural Resemblance to Motilin</article-title><source>Gastroenterology</source><year>2001</year><volume>120</volume><fpage>337</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1053/gast.2001.22158</pub-id><pub-id pub-id-type="pmid">11159873</pub-id></element-citation></ref><ref id="B406-pharmaceutics-16-00454"><label>406.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karimi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Niazkar</surname><given-names>H.R.</given-names></name><name name-style="western"><surname>Sefidmooye Azar</surname><given-names>P.</given-names></name><name name-style="western"><surname>Tutunchi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Karimi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Asghariazar</surname><given-names>V.</given-names></name><name name-style="western"><surname>Kooshki</surname><given-names>F.</given-names></name></person-group><article-title>Protective Effect of Hydro-Alcoholic Extract of <italic toggle="yes">Achillea millefolium</italic> on Renal Injury and Biochemical Factors in Streptozotocin-Induced Diabetic Rats</article-title><source>Nutr. Food Sci.</source><year>2021</year><volume>51</volume><fpage>1068</fpage><lpage>1083</lpage><pub-id pub-id-type="doi">10.1108/NFS-11-2020-0437</pub-id></element-citation></ref><ref id="B407-pharmaceutics-16-00454"><label>407.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ch&#225;vez-Silva</surname><given-names>F.</given-names></name><name name-style="western"><surname>Cer&#243;n-Romero</surname><given-names>L.</given-names></name><name name-style="western"><surname>Arias-Dur&#225;n</surname><given-names>L.</given-names></name><name name-style="western"><surname>Navarrete-V&#225;zquez</surname><given-names>G.</given-names></name><name name-style="western"><surname>Almanza-P&#233;rez</surname><given-names>J.</given-names></name><name name-style="western"><surname>Rom&#225;n-Ramos</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ram&#237;rez-&#193;vila</surname><given-names>G.</given-names></name><name name-style="western"><surname>Perea-Arango</surname><given-names>I.</given-names></name><name name-style="western"><surname>Villalobos-Molina</surname><given-names>R.</given-names></name><name name-style="western"><surname>Estrada-Soto</surname><given-names>S.</given-names></name></person-group><article-title>Antidiabetic Effect of <italic toggle="yes">Achillea millefollium</italic> through Multitarget Interactions: &#945;-Glucosidases Inhibition, Insulin Sensitization and Insulin Secretagogue Activities</article-title><source>J. Ethnopharmacol.</source><year>2018</year><volume>212</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2017.10.005</pub-id><pub-id pub-id-type="pmid">29031783</pub-id></element-citation></ref><ref id="B408-pharmaceutics-16-00454"><label>408.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zolghadri</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Fazeli</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kooshki</surname><given-names>M.</given-names></name><name name-style="western"><surname>Shomali</surname><given-names>T.</given-names></name><name name-style="western"><surname>Karimaghayee</surname><given-names>N.</given-names></name><name name-style="western"><surname>Dehghani</surname><given-names>M.</given-names></name></person-group><article-title><italic toggle="yes">Achillea millefolium</italic> L. Hydro- Alcoholic Extract Protects Pancreatic Cells by Down Regulating IL- 1&#946; and INOS Gene Expression in Diabetic Rats</article-title><source>Int. J. Mol. Cell Med.</source><year>2014</year><volume>3</volume><fpage>255</fpage><pub-id pub-id-type="pmid">25635252</pub-id><pub-id pub-id-type="pmcid">PMC4293613</pub-id></element-citation></ref><ref id="B409-pharmaceutics-16-00454"><label>409.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Noda</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kato</surname><given-names>E.</given-names></name><name name-style="western"><surname>Kawabata</surname><given-names>J.</given-names></name></person-group><article-title>Intestinal &#945;-Glucosidase Inhibitors in <italic toggle="yes">Achillea millefolium</italic></article-title><source>Nat. Prod. Commun.</source><year>2017</year><volume>12</volume><fpage>1259</fpage><lpage>1261</lpage><pub-id pub-id-type="doi">10.1177/1934578X1701200828</pub-id></element-citation></ref><ref id="B410-pharmaceutics-16-00454"><label>410.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nieto-Trujillo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Cruz-Sosa</surname><given-names>F.</given-names></name><name name-style="western"><surname>Luria-P&#233;rez</surname><given-names>R.</given-names></name><name name-style="western"><surname>Guti&#233;rrez-Rebolledo</surname><given-names>G.A.</given-names></name><name name-style="western"><surname>Rom&#225;n-Guerrero</surname><given-names>A.</given-names></name><name name-style="western"><surname>Burrola-Aguilar</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zepeda-G&#243;mez</surname><given-names>C.</given-names></name><name name-style="western"><surname>Estrada-Z&#250;&#241;iga</surname><given-names>M.E.</given-names></name></person-group><article-title><italic toggle="yes">Arnica montana</italic> Cell Culture Establishment, and Assessment of Its Cytotoxic, Antibacterial, &#945;-Amylase Inhibitor, and Antioxidant In Vitro Bioactivities</article-title><source>Plants</source><year>2021</year><volume>10</volume><elocation-id>2300</elocation-id><pub-id pub-id-type="doi">10.3390/plants10112300</pub-id><pub-id pub-id-type="pmid">34834662</pub-id><pub-id pub-id-type="pmcid">PMC8624820</pub-id></element-citation></ref><ref id="B411-pharmaceutics-16-00454"><label>411.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haselgr&#252;bler</surname><given-names>R.</given-names></name><name name-style="western"><surname>Stadlbauer</surname><given-names>V.</given-names></name><name name-style="western"><surname>St&#252;bl</surname><given-names>F.</given-names></name><name name-style="western"><surname>Schwarzinger</surname><given-names>B.</given-names></name><name name-style="western"><surname>Rudzionyte</surname><given-names>I.</given-names></name><name name-style="western"><surname>Himmelsbach</surname><given-names>M.</given-names></name><name name-style="western"><surname>Iken</surname><given-names>M.</given-names></name><name name-style="western"><surname>Weghuber</surname><given-names>J.</given-names></name></person-group><article-title>Insulin Mimetic Properties of Extracts Prepared from <italic toggle="yes">Bellis perennis</italic></article-title><source>Molecules</source><year>2018</year><volume>23</volume><elocation-id>2605</elocation-id><pub-id pub-id-type="doi">10.3390/molecules23102605</pub-id><pub-id pub-id-type="pmid">30314325</pub-id><pub-id pub-id-type="pmcid">PMC6222741</pub-id></element-citation></ref><ref id="B412-pharmaceutics-16-00454"><label>412.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nowicka</surname><given-names>P.</given-names></name><name name-style="western"><surname>Wojdy&#322;o</surname><given-names>A.</given-names></name></person-group><article-title>Anti-Hyperglycemic and Anticholinergic Effects of Natural Antioxidant Contents in Edible Flowers</article-title><source>Antioxidants</source><year>2019</year><volume>8</volume><elocation-id>308</elocation-id><pub-id pub-id-type="doi">10.3390/antiox8080308</pub-id><pub-id pub-id-type="pmid">31443202</pub-id><pub-id pub-id-type="pmcid">PMC6719929</pub-id></element-citation></ref><ref id="B413-pharmaceutics-16-00454"><label>413.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Icoz</surname><given-names>U.G.</given-names></name><name name-style="western"><surname>Orhan</surname><given-names>N.</given-names></name><name name-style="western"><surname>Altun</surname><given-names>L.</given-names></name><name name-style="western"><surname>Aslan</surname><given-names>M.</given-names></name></person-group><article-title>In Vitro and in Vivo Antioxidant and Antidiabetic Activity Studies on Standardized Extracts of Two Bidens Species</article-title><source>J. Food Biochem.</source><year>2017</year><volume>41</volume><elocation-id>e12429</elocation-id><pub-id pub-id-type="doi">10.1111/jfbc.12429</pub-id></element-citation></ref><ref id="B414-pharmaceutics-16-00454"><label>414.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Azay-Milhau</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ferrare</surname><given-names>K.</given-names></name><name name-style="western"><surname>Leroy</surname><given-names>J.</given-names></name><name name-style="western"><surname>Aubaterre</surname><given-names>J.</given-names></name><name name-style="western"><surname>Tournier</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lajoix</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Tousch</surname><given-names>D.</given-names></name></person-group><article-title>Antihyperglycemic Effect of a Natural Chicoric Acid Extract of Chicory (<italic toggle="yes">Cichorium intybus</italic> L.): A Comparative in Vitro Study with the Effects of Caffeic and Ferulic Acids</article-title><source>J. Ethnopharmacol.</source><year>2013</year><volume>150</volume><fpage>755</fpage><lpage>760</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2013.09.046</pub-id><pub-id pub-id-type="pmid">24126061</pub-id></element-citation></ref><ref id="B415-pharmaceutics-16-00454"><label>415.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tousch</surname><given-names>D.</given-names></name><name name-style="western"><surname>Lajoix</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Hosy</surname><given-names>E.</given-names></name><name name-style="western"><surname>Azay-Milhau</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ferrare</surname><given-names>K.</given-names></name><name name-style="western"><surname>Jahannault</surname><given-names>C.</given-names></name><name name-style="western"><surname>Cros</surname><given-names>G.</given-names></name><name name-style="western"><surname>Petit</surname><given-names>P.</given-names></name></person-group><article-title>Chicoric Acid, a New Compound Able to Enhance Insulin Release and Glucose Uptake</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2008</year><volume>377</volume><fpage>131</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2008.09.088</pub-id><pub-id pub-id-type="pmid">18834859</pub-id></element-citation></ref><ref id="B416-pharmaceutics-16-00454"><label>416.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jackson</surname><given-names>K.M.P.</given-names></name><name name-style="western"><surname>Rathinasabapathy</surname><given-names>T.</given-names></name><name name-style="western"><surname>Esposito</surname><given-names>D.</given-names></name><name name-style="western"><surname>Komarnytsky</surname><given-names>S.</given-names></name></person-group><article-title>Structural Constraints and Importance of Caffeic Acid Moiety for Anti-Hyperglycemic Effects of Caffeoylquinic Acids from Chicory</article-title><source>Mol. Nutr. Food Res.</source><year>2017</year><volume>61</volume><fpage>1601118</fpage><pub-id pub-id-type="doi">10.1002/mnfr.201601118</pub-id><pub-id pub-id-type="pmid">28371117</pub-id></element-citation></ref><ref id="B417-pharmaceutics-16-00454"><label>417.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ebrahiminia</surname><given-names>M.</given-names></name><name name-style="western"><surname>Esmaeili</surname><given-names>F.</given-names></name><name name-style="western"><surname>Shabani</surname><given-names>L.</given-names></name></person-group><article-title>In Vitro Differentiation Induction of Embryonal Carcinoma Stem Cells into Insulin-Producing Cells by <italic toggle="yes">Cichorium intybus</italic> L. Leaf Extract</article-title><source>J. Ethnopharmacol.</source><year>2020</year><volume>246</volume><fpage>112214</fpage><pub-id pub-id-type="doi">10.1016/j.jep.2019.112214</pub-id><pub-id pub-id-type="pmid">31491437</pub-id></element-citation></ref><ref id="B418-pharmaceutics-16-00454"><label>418.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dalar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Konczak</surname><given-names>I.</given-names></name></person-group><article-title><italic toggle="yes">Cichorium intybus</italic> from Eastern Anatolia: Phenolic Composition, Antioxidant and Enzyme Inhibitory Activities</article-title><source>Ind. Crops Prod.</source><year>2014</year><volume>60</volume><fpage>79</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1016/j.indcrop.2014.05.043</pub-id></element-citation></ref><ref id="B419-pharmaceutics-16-00454"><label>419.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferrare</surname><given-names>K.</given-names></name><name name-style="western"><surname>Bidel</surname><given-names>L.P.R.</given-names></name><name name-style="western"><surname>Awwad</surname><given-names>A.</given-names></name><name name-style="western"><surname>Poucheret</surname><given-names>P.</given-names></name><name name-style="western"><surname>Cazals</surname><given-names>G.</given-names></name><name name-style="western"><surname>Lazennec</surname><given-names>F.</given-names></name><name name-style="western"><surname>Azay-Milhau</surname><given-names>J.</given-names></name><name name-style="western"><surname>Tournier</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lajoix</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Tousch</surname><given-names>D.</given-names></name></person-group><article-title>Increase in Insulin Sensitivity by the Association of Chicoric Acid and Chlorogenic Acid Contained in a Natural Chicoric Acid Extract (NCRAE) of Chicory (<italic toggle="yes">Cichorium intybus</italic> L.) for an Antidiabetic Effect</article-title><source>J. Ethnopharmacol.</source><year>2018</year><volume>215</volume><fpage>241</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2017.12.035</pub-id><pub-id pub-id-type="pmid">29325917</pub-id></element-citation></ref><ref id="B420-pharmaceutics-16-00454"><label>420.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muthusamy</surname><given-names>V.S.</given-names></name><name name-style="western"><surname>Anand</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sangeetha</surname><given-names>K.N.</given-names></name><name name-style="western"><surname>Sujatha</surname><given-names>S.</given-names></name><name name-style="western"><surname>Arun</surname><given-names>B.</given-names></name><name name-style="western"><surname>Lakshmi</surname><given-names>B.S.</given-names></name></person-group><article-title>Tannins Present in <italic toggle="yes">Cichorium intybus</italic> Enhance Glucose Uptake and Inhibit Adipogenesis in 3T3-L1 Adipocytes through PTP1B Inhibition</article-title><source>Chem. Biol. Interact.</source><year>2008</year><volume>174</volume><fpage>69</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1016/j.cbi.2008.04.016</pub-id><pub-id pub-id-type="pmid">18534569</pub-id></element-citation></ref><ref id="B421-pharmaceutics-16-00454"><label>421.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aydin</surname><given-names>T.</given-names></name><name name-style="western"><surname>Saglamtas</surname><given-names>R.</given-names></name><name name-style="western"><surname>Dogan</surname><given-names>B.</given-names></name><name name-style="western"><surname>Kostekci</surname><given-names>E.</given-names></name><name name-style="western"><surname>Durmus</surname><given-names>R.</given-names></name><name name-style="western"><surname>Cakir</surname><given-names>A.</given-names></name></person-group><article-title>A New Specific Method for Isolation of Tomentosin with a High Yield from <italic toggle="yes">Inula viscosa</italic> (L.) and Determination of Its Bioactivities</article-title><source>Phytochem. Anal.</source><year>2022</year><volume>33</volume><fpage>612</fpage><lpage>618</lpage><pub-id pub-id-type="doi">10.1002/pca.3114</pub-id><pub-id pub-id-type="pmid">35243708</pub-id></element-citation></ref><ref id="B422-pharmaceutics-16-00454"><label>422.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>W.Y.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J.-J.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>I.-S.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Park</surname><given-names>J.-S.</given-names></name><name name-style="western"><surname>Myung</surname><given-names>C.-S.</given-names></name></person-group><article-title>7-O-Methylaromadendrin Stimulates Glucose Uptake and Improves Insulin Resistance In Vitro</article-title><source>Article Biol. Pharm. Bull.</source><year>2010</year><volume>33</volume><fpage>1494</fpage><lpage>1499</lpage><pub-id pub-id-type="doi">10.1248/bpb.33.1494</pub-id><pub-id pub-id-type="pmid">20823563</pub-id></element-citation></ref><ref id="B423-pharmaceutics-16-00454"><label>423.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ranilla</surname><given-names>L.G.</given-names></name><name name-style="western"><surname>Kwon</surname><given-names>Y.I.</given-names></name><name name-style="western"><surname>Apostolidis</surname><given-names>E.</given-names></name><name name-style="western"><surname>Shetty</surname><given-names>K.</given-names></name></person-group><article-title>Phenolic Compounds, Antioxidant Activity and in Vitro Inhibitory Potential against Key Enzymes Relevant for Hyperglycemia and Hypertension of Commonly Used Medicinal Plants, Herbs and Spices in Latin America</article-title><source>Bioresour. Technol.</source><year>2010</year><volume>101</volume><fpage>4676</fpage><lpage>4689</lpage><pub-id pub-id-type="doi">10.1016/j.biortech.2010.01.093</pub-id><pub-id pub-id-type="pmid">20185303</pub-id></element-citation></ref><ref id="B424-pharmaceutics-16-00454"><label>424.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferheen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ur-Rehman</surname><given-names>A.</given-names></name><name name-style="western"><surname>Afza</surname><given-names>N.</given-names></name><name name-style="western"><surname>Malik</surname><given-names>A.</given-names></name><name name-style="western"><surname>Iqbal</surname><given-names>L.</given-names></name><name name-style="western"><surname>Azam Rasool</surname><given-names>M.</given-names></name><name name-style="western"><surname>Irfan Ali</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bakhsh Tareen</surname><given-names>R.</given-names></name></person-group><article-title>Galinsosides A and B, Bioactive Flavanone Glucosides from <italic toggle="yes">Galinsoga parviflora</italic></article-title><source>J. Enzyme Inhib. Med. Chem.</source><year>2009</year><volume>24</volume><fpage>1128</fpage><lpage>1132</lpage><pub-id pub-id-type="doi">10.1080/14756360802667688</pub-id><pub-id pub-id-type="pmid">19772485</pub-id></element-citation></ref><ref id="B425-pharmaceutics-16-00454"><label>425.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>H.-M.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J.-M.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ku</surname><given-names>J.-J.</given-names></name><name name-style="western"><surname>Park</surname><given-names>K.-W.</given-names></name></person-group><article-title>Inhibition of Aldose Reductase from Rat Lenses by Methanol Extracts from Korean Folk Plants</article-title><source>Nat. Prod. Sci.</source><year>2010</year><volume>16</volume><fpage>285</fpage><lpage>290</lpage></element-citation></ref><ref id="B426-pharmaceutics-16-00454"><label>426.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paun</surname><given-names>G.</given-names></name><name name-style="western"><surname>Neagu</surname><given-names>E.</given-names></name><name name-style="western"><surname>Alecu</surname><given-names>A.</given-names></name><name name-style="western"><surname>Albu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Seciu-Grama</surname><given-names>A.-M.</given-names></name><name name-style="western"><surname>Radu</surname><given-names>G.L.</given-names></name></person-group><article-title>Evaluation of the Antioxidant, and Antidiabetic Properties of Flavonoids and Isoflavonoids-Rich Extracts of <italic toggle="yes">Medicago sativa</italic> and <italic toggle="yes">Solidago virgaurea</italic></article-title><source>Complement. Altern. Med. Prepr.</source><year>2023</year><volume>2023</volume><fpage>101307</fpage><pub-id pub-id-type="doi">10.20944/preprints202310.1307.v1</pub-id></element-citation></ref><ref id="B427-pharmaceutics-16-00454"><label>427.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>L.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>X.</given-names></name><name name-style="western"><surname>Fan</surname><given-names>X.</given-names></name><name name-style="western"><surname>Qian</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lv</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Teng</surname><given-names>H.</given-names></name></person-group><article-title><italic toggle="yes">Sonchus oleraceus</italic> Linn Extract Enhanced Glucose Homeostasis through the AMPK/Akt/ GSK-3&#946; Signaling Pathway in Diabetic Liver and HepG2 Cell Culture</article-title><source>Food Chem. Toxicol.</source><year>2020</year><volume>136</volume><fpage>111072</fpage><pub-id pub-id-type="doi">10.1016/j.fct.2019.111072</pub-id><pub-id pub-id-type="pmid">31877369</pub-id></element-citation></ref><ref id="B428-pharmaceutics-16-00454"><label>428.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hwang</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>H.Y.</given-names></name><name name-style="western"><surname>Quispe</surname><given-names>Y.N.G.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zuo</surname><given-names>G.</given-names></name><name name-style="western"><surname>Lim</surname><given-names>S.S.</given-names></name></person-group><article-title>Aldose Reductase, Protein Glycation Inhibitory and Antioxidant of Peruvian Medicinal Plants: The Case of <italic toggle="yes">Tanacetum parthenium</italic> L. and Its Constituents</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>2010</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24102010</pub-id><pub-id pub-id-type="pmid">31130646</pub-id><pub-id pub-id-type="pmcid">PMC6571560</pub-id></element-citation></ref><ref id="B429-pharmaceutics-16-00454"><label>429.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zengin</surname><given-names>G.</given-names></name><name name-style="western"><surname>Cvetanovi&#263;</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ga&#353;i&#263;</surname><given-names>U.</given-names></name><name name-style="western"><surname>Stupar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bulut</surname><given-names>G.</given-names></name><name name-style="western"><surname>&#350;enkardes</surname><given-names>I.</given-names></name><name name-style="western"><surname>Dogan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ibrahime Sinan</surname><given-names>K.</given-names></name><name name-style="western"><surname>Uysal</surname><given-names>S.</given-names></name><name name-style="western"><surname>Aumeeruddy-Elalfi</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>Modern and Traditional Extraction Techniques Affect Chemical Composition and Bioactivity of <italic toggle="yes">Tanacetum parthenium</italic> (L.) Sch.Bip</article-title><source>Ind. Crops Prod.</source><year>2020</year><volume>146</volume><fpage>112202</fpage><pub-id pub-id-type="doi">10.1016/j.indcrop.2020.112202</pub-id></element-citation></ref><ref id="B430-pharmaceutics-16-00454"><label>430.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boutahiri</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bouhrim</surname><given-names>M.</given-names></name><name name-style="western"><surname>Abidi</surname><given-names>C.</given-names></name><name name-style="western"><surname>Mechchate</surname><given-names>H.</given-names></name><name name-style="western"><surname>Alqahtani</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Noman</surname><given-names>O.M.</given-names></name><name name-style="western"><surname>Elombo</surname><given-names>F.K.</given-names></name><name name-style="western"><surname>Gressier</surname><given-names>B.</given-names></name><name name-style="western"><surname>Sahpaz</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bnouham</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Antihyperglycemic Effect of Lavandula Pedunculata: In Vivo, In Vitro and Ex Vivo Approaches</article-title><source>Pharmaceutics</source><year>2021</year><volume>13</volume><elocation-id>2019</elocation-id><pub-id pub-id-type="doi">10.3390/pharmaceutics13122019</pub-id><pub-id pub-id-type="pmid">34959301</pub-id><pub-id pub-id-type="pmcid">PMC8703280</pub-id></element-citation></ref><ref id="B431-pharmaceutics-16-00454"><label>431.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elrherabi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bouhrim</surname><given-names>M.</given-names></name><name name-style="western"><surname>Abdnim</surname><given-names>R.</given-names></name><name name-style="western"><surname>Berraaouan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ziyyat</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mekhfi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Legssyer</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bnouham</surname><given-names>M.</given-names></name></person-group><article-title>Antihyperglycemic Potential of the <italic toggle="yes">Lavandula stoechas</italic> Aqueous Extract via Inhibition of Digestive Enzymes and Reduction of Intestinal Glucose Absorption</article-title><source>J. Ayurveda Integr. Med.</source><year>2023</year><volume>14</volume><fpage>100795</fpage><pub-id pub-id-type="doi">10.1016/j.jaim.2023.100795</pub-id><pub-id pub-id-type="pmid">37683576</pub-id><pub-id pub-id-type="pmcid">PMC10492212</pub-id></element-citation></ref><ref id="B432-pharmaceutics-16-00454"><label>432.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kulabas</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Ipek</surname><given-names>H.</given-names></name><name name-style="western"><surname>Tufekci</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>Arslan</surname><given-names>S.</given-names></name><name name-style="western"><surname>Demirtas</surname><given-names>I.</given-names></name><name name-style="western"><surname>Ekren</surname><given-names>R.</given-names></name><name name-style="western"><surname>Sezerman</surname><given-names>U.</given-names></name><name name-style="western"><surname>Tumer</surname><given-names>T.B.</given-names></name></person-group><article-title>Ameliorative Potential of <italic toggle="yes">Lavandula stoechas</italic> in Metabolic Syndrome via Multitarget Interactions</article-title><source>J. Ethnopharmacol.</source><year>2018</year><volume>223</volume><fpage>88</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2018.04.043</pub-id><pub-id pub-id-type="pmid">29729383</pub-id></element-citation></ref><ref id="B433-pharmaceutics-16-00454"><label>433.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yui</surname><given-names>S.</given-names></name><name name-style="western"><surname>Fujiwara</surname><given-names>S.</given-names></name><name name-style="western"><surname>Harada</surname><given-names>K.</given-names></name><name name-style="western"><surname>Motoike-Hamura</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sakai</surname><given-names>M.</given-names></name><name name-style="western"><surname>Matsubara</surname><given-names>S.</given-names></name><name name-style="western"><surname>Miyazaki</surname><given-names>K.</given-names></name></person-group><article-title>Beneficial Effects of Lemon Balm Leaf Extract on In Vitro Glycation of Proteins, Arterial Stiffness, and Skin Elasticity in Healthy Adults</article-title><source>J. Nutr. Sci. Vitaminol.</source><year>2017</year><volume>63</volume><fpage>59</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.3177/jnsv.63.59</pub-id><pub-id pub-id-type="pmid">28367927</pub-id></element-citation></ref><ref id="B434-pharmaceutics-16-00454"><label>434.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kwon</surname><given-names>Y.-I.I.</given-names></name><name name-style="western"><surname>Vattem</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Shetty</surname><given-names>K.</given-names></name></person-group><article-title>Evaluation of Clonal Herbs of <italic toggle="yes">Lamiaceae</italic> Species for Management of Diabetes and Hypertension</article-title><source>Asia Pac. J. Clin. Nutr.</source><year>2006</year><volume>15</volume><fpage>107</fpage><lpage>118</lpage><pub-id pub-id-type="pmid">16500886</pub-id></element-citation></ref><ref id="B435-pharmaceutics-16-00454"><label>435.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mccue</surname><given-names>P.P.</given-names></name><name name-style="western"><surname>Shetty</surname><given-names>K.</given-names></name></person-group><article-title>Inhibitory Effects of Rosmarinic Acid Extracts on Porcine Pancreatic Amylase in Vitro</article-title><source>Asia Pacific J. Clin. Nutr.</source><year>2004</year><volume>13</volume><fpage>101</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">15003922</pub-id></element-citation></ref><ref id="B436-pharmaceutics-16-00454"><label>436.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schreck</surname><given-names>K.</given-names></name><name name-style="western"><surname>Melzig</surname><given-names>M.F.</given-names></name></person-group><article-title>Traditionally Used Plants in the Treatment of Diabetes Mellitus: Screening for Uptake Inhibition of Glucose and Fructose in the Caco2-Cell Model</article-title><source>Front. Pharmacol.</source><year>2021</year><volume>12</volume><fpage>692566</fpage><pub-id pub-id-type="doi">10.3389/fphar.2021.692566</pub-id><pub-id pub-id-type="pmid">34489694</pub-id><pub-id pub-id-type="pmcid">PMC8417609</pub-id></element-citation></ref><ref id="B437-pharmaceutics-16-00454"><label>437.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yen</surname><given-names>H.F.</given-names></name><name name-style="western"><surname>Hsieh</surname><given-names>C.T.</given-names></name><name name-style="western"><surname>Hsieh</surname><given-names>T.J.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>F.R.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C.K.</given-names></name></person-group><article-title>In Vitro Anti-Diabetic Effect and Chemical Component Analysis of 29 Essential Oils Products</article-title><source>J. Food Drug Anal.</source><year>2015</year><volume>23</volume><fpage>124</fpage><pub-id pub-id-type="doi">10.1016/j.jfda.2014.02.004</pub-id><pub-id pub-id-type="pmid">28911435</pub-id><pub-id pub-id-type="pmcid">PMC9351752</pub-id></element-citation></ref><ref id="B438-pharmaceutics-16-00454"><label>438.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marrelli</surname><given-names>M.</given-names></name><name name-style="western"><surname>Loizzo</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Nicoletti</surname><given-names>M.</given-names></name><name name-style="western"><surname>Menichini</surname><given-names>F.</given-names></name><name name-style="western"><surname>Conforti</surname><given-names>F.</given-names></name></person-group><article-title>In Vitro Investigation of the Potential Health Benefits of Wild Mediterranean Dietary Plants as Anti-Obesity Agents with &#945;-Amylase and Pancreatic Lipase Inhibitory Activities</article-title><source>J. Sci. Food Agric.</source><year>2014</year><volume>94</volume><fpage>2217</fpage><lpage>2224</lpage><pub-id pub-id-type="doi">10.1002/jsfa.6544</pub-id><pub-id pub-id-type="pmid">24535986</pub-id></element-citation></ref><ref id="B439-pharmaceutics-16-00454"><label>439.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Buchholz</surname><given-names>T.</given-names></name><name name-style="western"><surname>Melzig</surname><given-names>M.F.</given-names></name></person-group><article-title>Medicinal Plants Traditionally Used for Treatment of Obesity and Diabetes Mellitus&#8212;Screening for Pancreatic Lipase and &#945;-Amylase Inhibition</article-title><source>Phytother. Res.</source><year>2016</year><volume>30</volume><fpage>260</fpage><lpage>266</lpage><pub-id pub-id-type="doi">10.1002/ptr.5525</pub-id><pub-id pub-id-type="pmid">26632284</pub-id></element-citation></ref><ref id="B440-pharmaceutics-16-00454"><label>440.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abbou</surname><given-names>F.</given-names></name><name name-style="western"><surname>Azzi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ouffai</surname><given-names>K.</given-names></name><name name-style="western"><surname>El Haci</surname><given-names>I.A.</given-names></name><name name-style="western"><surname>Belyagoubi-Benhammou</surname><given-names>N.</given-names></name><name name-style="western"><surname>Bensouici</surname><given-names>C.</given-names></name><name name-style="western"><surname>Benamar</surname><given-names>H.</given-names></name></person-group><article-title>Phenolic Profile, Antioxidant and Enzyme Inhibitory Properties of Phenolic-Rich Fractions from the Aerial Parts of <italic toggle="yes">Mentha pulegium</italic> L.</article-title><source>South Afr. J. Bot.</source><year>2022</year><volume>146</volume><fpage>196</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1016/j.sajb.2021.10.024</pub-id></element-citation></ref><ref id="B441-pharmaceutics-16-00454"><label>441.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mccue</surname><given-names>P.</given-names></name><name name-style="western"><surname>Vattem</surname><given-names>D.</given-names></name><name name-style="western"><surname>Shetty</surname><given-names>K.</given-names></name></person-group><article-title>Inhibitory Effect of Clonal Oregano Extracts against Porcine Pancreatic Amylase in Vitro</article-title><source>Asia Pac. J. Clin. Nutr.</source><year>2004</year><volume>13</volume><fpage>401</fpage><lpage>408</lpage><pub-id pub-id-type="pmid">15563448</pub-id></element-citation></ref><ref id="B442-pharmaceutics-16-00454"><label>442.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koukoulitsa</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zika</surname><given-names>C.</given-names></name><name name-style="western"><surname>Geromichalos</surname><given-names>G.D.</given-names></name><name name-style="western"><surname>Demopoulos</surname><given-names>V.J.</given-names></name><name name-style="western"><surname>Skaltsa</surname><given-names>H.</given-names></name></person-group><article-title>Evaluation of Aldose Reductase Inhibition and Docking Studies of Some Secondary Metabolites, Isolated from <italic toggle="yes">Origanum vulgare</italic> L. Ssp. Hirtum</article-title><source>Bioorg. Med. Chem.</source><year>2006</year><volume>14</volume><fpage>1653</fpage><lpage>1659</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2005.10.013</pub-id><pub-id pub-id-type="pmid">16249088</pub-id></element-citation></ref><ref id="B443-pharmaceutics-16-00454"><label>443.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Christensen</surname><given-names>K.B.</given-names></name><name name-style="western"><surname>Minet</surname><given-names>A.</given-names></name><name name-style="western"><surname>Svenstrup</surname><given-names>H.</given-names></name><name name-style="western"><surname>Grevsen</surname><given-names>K.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Schrader</surname><given-names>E.</given-names></name><name name-style="western"><surname>Rimbach</surname><given-names>G.</given-names></name><name name-style="western"><surname>Wein</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wolffram</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kristiansen</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Identification of Plant Extracts with Potential Antidiabetic Properties: Effect on Human Peroxisome Proliferator-Activated Receptor (PPAR), Adipocyte Differentiation and Insulin-Stimulated Glucose Uptake</article-title><source>Phytother. Res.</source><year>2009</year><volume>23</volume><fpage>1316</fpage><lpage>1325</lpage><pub-id pub-id-type="doi">10.1002/ptr.2782</pub-id><pub-id pub-id-type="pmid">19172665</pub-id></element-citation></ref><ref id="B444-pharmaceutics-16-00454"><label>444.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bower</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Real Hernandez</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Berhow</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>De Mejia</surname><given-names>E.G.</given-names></name></person-group><article-title>Bioactive Compounds from Culinary Herbs Inhibit a Molecular Target for Type 2 Diabetes Management, Dipeptidyl Peptidase IV</article-title><source>J. Agric. Food Chem.</source><year>2014</year><volume>62</volume><fpage>6147</fpage><lpage>6158</lpage><pub-id pub-id-type="doi">10.1021/jf500639f</pub-id><pub-id pub-id-type="pmid">24881464</pub-id></element-citation></ref><ref id="B445-pharmaceutics-16-00454"><label>445.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Valentov&#225;</surname><given-names>K.</given-names></name><name name-style="western"><surname>Nhu</surname><given-names>T.T.</given-names></name><name name-style="western"><surname>Moncion</surname><given-names>A.</given-names></name><name name-style="western"><surname>De Waziers</surname><given-names>I.</given-names></name><name name-style="western"><surname>Ulrichov&#225;</surname><given-names>J.</given-names></name></person-group><article-title>Induction of Glucokinase MRNA by Dietary Phenolic Compounds in Rat Liver Cells in Vitro</article-title><source>J. Agric. Food Chem.</source><year>2007</year><volume>55</volume><fpage>7726</fpage><lpage>7731</lpage><pub-id pub-id-type="doi">10.1021/jf0712447</pub-id><pub-id pub-id-type="pmid">17715892</pub-id></element-citation></ref><ref id="B446-pharmaceutics-16-00454"><label>446.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>H.M.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J.K.</given-names></name><name name-style="western"><surname>Jang</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Kwon</surname><given-names>S.O.</given-names></name><name name-style="western"><surname>Cui</surname><given-names>C.B.</given-names></name><name name-style="western"><surname>Lim</surname><given-names>S.S.</given-names></name></person-group><article-title>The Inhibitory Effect of <italic toggle="yes">Prunella vulgaris</italic> L. on Aldose Reductase and Protein Glycation</article-title><source>J. Biomed. Biotechnol.</source><year>2012</year><volume>2012</volume><elocation-id>928159</elocation-id><pub-id pub-id-type="doi">10.1155/2012/928159</pub-id><pub-id pub-id-type="pmid">23091363</pub-id><pub-id pub-id-type="pmcid">PMC3471066</pub-id></element-citation></ref><ref id="B447-pharmaceutics-16-00454"><label>447.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ha</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kelley</surname><given-names>J.</given-names></name><name name-style="western"><surname>Young</surname><given-names>A.</given-names></name><name name-style="western"><surname>Breuel</surname><given-names>K.</given-names></name></person-group><article-title><italic toggle="yes">Prunella vulgaris</italic> Aqueous Extract Attenuates IL-1&#946;-Induced Apoptosis and NF-&#954;B Activation in INS-1 Cells</article-title><source>Exp. Ther. Med.</source><year>2012</year><volume>3</volume><fpage>919</fpage><lpage>924</lpage><pub-id pub-id-type="doi">10.3892/etm.2012.524</pub-id><pub-id pub-id-type="pmid">22969993</pub-id><pub-id pub-id-type="pmcid">PMC3438608</pub-id></element-citation></ref><ref id="B448-pharmaceutics-16-00454"><label>448.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raafat</surname><given-names>K.</given-names></name><name name-style="western"><surname>Wurglics</surname><given-names>M.</given-names></name><name name-style="western"><surname>Schubert-Zsilavecz</surname><given-names>M.</given-names></name></person-group><article-title><italic toggle="yes">Prunella vulgaris</italic> L. Active Components and Their Hypoglycemic and Antinociceptive Effects in Alloxan-Induced Diabetic Mice</article-title><source>Biomed. Pharmacother.</source><year>2016</year><volume>84</volume><fpage>1008</fpage><lpage>1018</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2016.09.095</pub-id><pub-id pub-id-type="pmid">27768926</pub-id></element-citation></ref><ref id="B449-pharmaceutics-16-00454"><label>449.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Cai</surname><given-names>G.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>Y.</given-names></name></person-group><article-title>Screening of Potent &#945;-Glucosidase Inhibitory and Antioxidant Polyphenols in <italic toggle="yes">Prunella vulgaris</italic> L. by Bioreaction&#8211;HPLC&#8211;Quadrupole-Time-of-Flight-MS/MS and in Silico Analysis</article-title><source>J. Sep. Sci.</source><year>2022</year><volume>45</volume><fpage>3393</fpage><lpage>3403</lpage><pub-id pub-id-type="doi">10.1002/jssc.202200374</pub-id><pub-id pub-id-type="pmid">35819998</pub-id></element-citation></ref><ref id="B450-pharmaceutics-16-00454"><label>450.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aazza</surname><given-names>S.</given-names></name><name name-style="western"><surname>El-Guendouz</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gra&#231;a Miguel</surname><given-names>M.</given-names></name><name name-style="western"><surname>Antunes</surname><given-names>M.D.</given-names></name><name name-style="western"><surname>Faleiro</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Correia</surname><given-names>A.I.</given-names></name><name name-style="western"><surname>Figueiredo</surname><given-names>A.C.</given-names></name></person-group><article-title>Antioxidant, Anti-Inflammatory and Anti-Hyperglycaemic Activities of Essential Oils from <italic toggle="yes">Thymbra capitata</italic>, <italic toggle="yes">Thymus albicans</italic>, <italic toggle="yes">Thymus caespititius</italic>, <italic toggle="yes">Thymus carnosus</italic>, <italic toggle="yes">Thymus lotocephalus</italic> and <italic toggle="yes">Thymus mastichina</italic> from Portugal</article-title><source>Nat. Prod. Commun.</source><year>2016</year><volume>11</volume><fpage>1029</fpage><lpage>1038</lpage><pub-id pub-id-type="doi">10.1177/1934578X1601100739</pub-id><pub-id pub-id-type="pmid">30452188</pub-id></element-citation></ref><ref id="B451-pharmaceutics-16-00454"><label>451.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eddouks</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lemhadri</surname><given-names>A.</given-names></name><name name-style="western"><surname>Zeggwagh</surname><given-names>N.A.</given-names></name><name name-style="western"><surname>Michel</surname><given-names>J.B.</given-names></name></person-group><article-title>Potent Hypoglycaemic Activity of the Aqueous Extract of Chamaemelum Nobile in Normal and Streptozotocin-Induced Diabetic Rats</article-title><source>Diabetes Res. Clin. Pract.</source><year>2005</year><volume>67</volume><fpage>189</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1016/j.diabres.2004.07.015</pub-id><pub-id pub-id-type="pmid">15713350</pub-id></element-citation></ref><ref id="B452-pharmaceutics-16-00454"><label>452.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>K&#246;nig</surname><given-names>G.M.</given-names></name><name name-style="western"><surname>Wright</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Keller</surname><given-names>W.J.</given-names></name><name name-style="western"><surname>Judd</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>Bates</surname><given-names>S.</given-names></name><name name-style="western"><surname>Day</surname><given-names>C.</given-names></name></person-group><article-title>Hypoglycaemic Activity of an HMG-Containing Flavonoid Glucoside, Chamaemeloside, from Chamaemelum Nobile</article-title><source>Planta Med.</source><year>1998</year><volume>64</volume><fpage>612</fpage><lpage>614</lpage><pub-id pub-id-type="doi">10.1055/s-2006-957532</pub-id><pub-id pub-id-type="pmid">9810266</pub-id></element-citation></ref><ref id="B453-pharmaceutics-16-00454"><label>453.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Witherup</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>McLaughlin</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Judd</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>Ziegler</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Medon</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Keller</surname><given-names>W.J.</given-names></name></person-group><article-title>Identification of 3-Hydroxy-3-Methylglutaric Acid (HMG) as a Hypoglycemic Principle of Spanish Moss (<italic toggle="yes">Tillandsia usneoides</italic>)</article-title><source>J. Nat. Prod.</source><year>1995</year><volume>58</volume><fpage>1285</fpage><lpage>1290</lpage><pub-id pub-id-type="doi">10.1021/np50122a023</pub-id><pub-id pub-id-type="pmid">7595594</pub-id></element-citation></ref><ref id="B454-pharmaceutics-16-00454"><label>454.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yonei</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Miyazaki</surname><given-names>R.</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Nomoto</surname><given-names>K.</given-names></name><name name-style="western"><surname>Yagi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kawai</surname><given-names>H.</given-names></name><name name-style="western"><surname>Kubo</surname><given-names>M.</given-names></name><name name-style="western"><surname>Matsuura</surname><given-names>N.</given-names></name></person-group><article-title>Anti-Glycation Effect of Mixed Herbal Extract in Individuals with Pre-Diabetes Mellitus A Double-Blind, Placebo-Controlled, Parallel Group Study</article-title><source>Anti-Aging Med.</source><year>2010</year><volume>7</volume><fpage>26</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.3793/jaam.7.26</pub-id></element-citation></ref><ref id="B455-pharmaceutics-16-00454"><label>455.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pushparaj</surname><given-names>P.N.</given-names></name><name name-style="western"><surname>Low</surname><given-names>H.K.</given-names></name><name name-style="western"><surname>Manikandan</surname><given-names>J.</given-names></name><name name-style="western"><surname>Tan</surname><given-names>B.K.H.</given-names></name><name name-style="western"><surname>Tan</surname><given-names>C.H.</given-names></name></person-group><article-title>Anti-Diabetic Effects of <italic toggle="yes">Cichorium intybus</italic> in Streptozotocin-Induced Diabetic Rats</article-title><source>J. Ethnopharmacol.</source><year>2007</year><volume>111</volume><fpage>430</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2006.11.028</pub-id><pub-id pub-id-type="pmid">17197141</pub-id></element-citation></ref><ref id="B456-pharmaceutics-16-00454"><label>456.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghamarian</surname><given-names>A.</given-names></name><name name-style="western"><surname>Abdollahi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Su</surname><given-names>X.</given-names></name><name name-style="western"><surname>Amiri</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ahadi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Nowrouzi</surname><given-names>A.</given-names></name></person-group><article-title>Effect of Chicory Seed Extract on Glucose Tolerance Test (GTT) and Metabolic Profile in Early and Late Stage Diabetic Rats</article-title><source>DARU J. Pharm. Sci.</source><year>2012</year><volume>20</volume><fpage>56</fpage><pub-id pub-id-type="doi">10.1186/2008-2231-20-56</pub-id><pub-id pub-id-type="pmcid">PMC3556018</pub-id><pub-id pub-id-type="pmid">23352214</pub-id></element-citation></ref><ref id="B457-pharmaceutics-16-00454"><label>457.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jurgo&#324;ski</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ju&#347;kiewicz</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zdu&#324;czyk</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Kr&#243;l</surname><given-names>B.</given-names></name></person-group><article-title>Caffeoylquinic Acid-Rich Extract from Chicory Seeds Improves Glycemia, Atherogenic Index, and Antioxidant Status in Rats</article-title><source>Nutrition</source><year>2012</year><volume>28</volume><fpage>300</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1016/j.nut.2011.06.010</pub-id><pub-id pub-id-type="pmid">22014632</pub-id></element-citation></ref><ref id="B458-pharmaceutics-16-00454"><label>458.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Petrovi&#263;</surname><given-names>A.</given-names></name><name name-style="western"><surname>Madi&#263;</surname><given-names>V.</given-names></name><name name-style="western"><surname>Stojanovi&#263;</surname><given-names>G.</given-names></name><name name-style="western"><surname>Zlatanovi&#263;</surname><given-names>I.</given-names></name><name name-style="western"><surname>Zlatkovi&#263;</surname><given-names>B.</given-names></name><name name-style="western"><surname>Vasiljevi&#263;</surname><given-names>P.</given-names></name><name name-style="western"><surname>&#272;or&#273;evi&#263;</surname><given-names>L.</given-names></name></person-group><article-title>Antidiabetic Effects of Polyherbal Mixture Made of <italic toggle="yes">Centaurium erythraea</italic>, <italic toggle="yes">Cichorium intybus</italic> and <italic toggle="yes">Potentilla erecta</italic></article-title><source>J. Ethnopharmacol.</source><year>2024</year><volume>319</volume><fpage>117032</fpage><pub-id pub-id-type="doi">10.1016/j.jep.2023.117032</pub-id><pub-id pub-id-type="pmid">37582477</pub-id></element-citation></ref><ref id="B459-pharmaceutics-16-00454"><label>459.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Q.W.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>L.G.</given-names></name><name name-style="western"><surname>Ye</surname><given-names>W.C.</given-names></name></person-group><article-title>Techniques for Extraction and Isolation of Natural Products: A Comprehensive Review</article-title><source>Chin. Med.</source><year>2018</year><volume>13</volume><fpage>20</fpage><pub-id pub-id-type="doi">10.1186/s13020-018-0177-x</pub-id><pub-id pub-id-type="pmid">29692864</pub-id><pub-id pub-id-type="pmcid">PMC5905184</pub-id></element-citation></ref><ref id="B460-pharmaceutics-16-00454"><label>460.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Or&#353;oli&#263;</surname><given-names>N.</given-names></name><name name-style="western"><surname>Sirovina</surname><given-names>D.</given-names></name><name name-style="western"><surname>Odeh</surname><given-names>D.</given-names></name><name name-style="western"><surname>Gajski</surname><given-names>G.</given-names></name><name name-style="western"><surname>Balta</surname><given-names>V.</given-names></name><name name-style="western"><surname>&#352;ver</surname><given-names>L.</given-names></name><name name-style="western"><surname>Jembrek</surname><given-names>M.J.</given-names></name></person-group><article-title>Efficacy of Caffeic Acid on Diabetes and Its Complications in the Mouse</article-title><source>Molecules</source><year>2021</year><volume>26</volume><elocation-id>3262</elocation-id><pub-id pub-id-type="doi">10.3390/molecules26113262</pub-id><pub-id pub-id-type="pmid">34071554</pub-id><pub-id pub-id-type="pmcid">PMC8199327</pub-id></element-citation></ref><ref id="B461-pharmaceutics-16-00454"><label>461.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schaalan</surname><given-names>M.</given-names></name><name name-style="western"><surname>El-Abhar</surname><given-names>H.S.</given-names></name><name name-style="western"><surname>Barakat</surname><given-names>M.</given-names></name><name name-style="western"><surname>El-Denshary</surname><given-names>E.S.</given-names></name></person-group><article-title>Westernized-like-Diet-Fed Rats: Effect on Glucose Homeostasis, Lipid Profile, and Adipocyte Hormones and Their Modulation by Rosiglitazone and Glimepiride</article-title><source>J. Diabetes Complicat.</source><year>2009</year><volume>23</volume><fpage>199</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1016/j.jdiacomp.2008.02.003</pub-id><pub-id pub-id-type="pmid">18407527</pub-id></element-citation></ref><ref id="B462-pharmaceutics-16-00454"><label>462.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saleh Aldayel</surname><given-names>T.</given-names></name><name name-style="western"><surname>Alshammari</surname><given-names>G.M.</given-names></name><name name-style="western"><surname>Mohammed Omar</surname><given-names>U.</given-names></name><name name-style="western"><surname>Grace</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Ann Lila</surname><given-names>M.</given-names></name><name name-style="western"><surname>Yahya</surname><given-names>M.A.</given-names></name></person-group><article-title>Hypoglycaemic, Insulin Releasing, and Hepatoprotective Effect of the Aqueous Extract of <italic toggle="yes">Aloe perryi</italic> Baker Resin (Socotran Aloe) in Streptozotocin-Induced Diabetic Rats</article-title><source>J. Taibah Univ. Sci.</source><year>2020</year><volume>14</volume><fpage>1671</fpage><lpage>1685</lpage><pub-id pub-id-type="doi">10.1080/16583655.2020.1855859</pub-id></element-citation></ref><ref id="B463-pharmaceutics-16-00454"><label>463.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peungvicha</surname><given-names>P.</given-names></name><name name-style="western"><surname>Temsiririrkkul</surname><given-names>R.</given-names></name><name name-style="western"><surname>Prasain</surname><given-names>J.K.</given-names></name><name name-style="western"><surname>Tezuka</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Kadota</surname><given-names>S.</given-names></name><name name-style="western"><surname>Thirawarapan</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Watanabe</surname><given-names>H.</given-names></name></person-group><article-title>4-Hydroxybenzoic Acid: A Hypoglycemic Constituent of Aqueous Extract of <italic toggle="yes">Pandanus odorus</italic> Root</article-title><source>J. Ethnopharmacol.</source><year>1998</year><volume>62</volume><fpage>79</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(98)00061-0</pub-id><pub-id pub-id-type="pmid">9720616</pub-id></element-citation></ref><ref id="B464-pharmaceutics-16-00454"><label>464.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tan</surname><given-names>H.Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>N.</given-names></name><name name-style="western"><surname>Cheung</surname><given-names>F.</given-names></name><name name-style="western"><surname>Hong</surname><given-names>M.</given-names></name><name name-style="western"><surname>Feng</surname><given-names>Y.</given-names></name></person-group><article-title>The Potential and Action Mechanism of Polyphenols in the Treatment of Liver Diseases</article-title><source>Oxidative Med. Cell. Longev.</source><year>2018</year><volume>2018</volume><fpage>8394818</fpage><pub-id pub-id-type="doi">10.1155/2018/8394818</pub-id><pub-id pub-id-type="pmcid">PMC5817364</pub-id><pub-id pub-id-type="pmid">29507653</pub-id></element-citation></ref><ref id="B465-pharmaceutics-16-00454"><label>465.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ganesan</surname><given-names>D.</given-names></name><name name-style="western"><surname>Albert</surname><given-names>A.</given-names></name><name name-style="western"><surname>Paul</surname><given-names>E.</given-names></name><name name-style="western"><surname>Ananthapadmanabhan</surname><given-names>K.</given-names></name><name name-style="western"><surname>Andiappan</surname><given-names>R.</given-names></name><name name-style="western"><surname>Sadasivam</surname><given-names>S.G.</given-names></name></person-group><article-title>Rutin Ameliorates Metabolic Acidosis and Fibrosis in Alloxan Induced Diabetic Nephropathy and Cardiomyopathy in Experimental Rats</article-title><source>Mol. Cell. Biochem.</source><year>2020</year><volume>471</volume><fpage>41</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1007/s11010-020-03758-y</pub-id><pub-id pub-id-type="pmid">32529498</pub-id></element-citation></ref><ref id="B466-pharmaceutics-16-00454"><label>466.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quine</surname><given-names>S.</given-names></name><name name-style="western"><surname>Raghu</surname><given-names>P.S.</given-names></name></person-group><article-title>Effects of (-)-Epicatechin, a Flavonoid on Lipid Peroxidation and Antioxidants in Streptozotocin-Induced Diabetic Liver, Kidney and Heart</article-title><source>Pharmacol. Rep.</source><year>2005</year><volume>57</volume><fpage>610</fpage><lpage>615</lpage><pub-id pub-id-type="pmid">16227644</pub-id></element-citation></ref><ref id="B467-pharmaceutics-16-00454"><label>467.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name><name name-style="western"><surname>He</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>W.</given-names></name><name name-style="western"><surname>Dai</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>D.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>K.</given-names></name></person-group><article-title>Hyperoside Ameliorates Glomerulosclerosis in Diabetic Nephropathy by Downregulating MiR-21</article-title><source>Can. J. Physiol. Pharmacol.</source><year>2016</year><volume>94</volume><fpage>1249</fpage><lpage>1256</lpage><pub-id pub-id-type="doi">10.1139/cjpp-2016-0066</pub-id><pub-id pub-id-type="pmid">27704873</pub-id></element-citation></ref><ref id="B468-pharmaceutics-16-00454"><label>468.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>X.</given-names></name><name name-style="western"><surname>Lou</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Bao</surname><given-names>J.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>J.</given-names></name></person-group><article-title>Hyperoside Ameliorates Diabetic Nephropathy Induced by STZ via Targeting the MiR-499&#8211;5p/APC Axis</article-title><source>J. Pharmacol. Sci.</source><year>2021</year><volume>146</volume><fpage>10</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.jphs.2021.02.005</pub-id><pub-id pub-id-type="pmid">33858650</pub-id></element-citation></ref><ref id="B469-pharmaceutics-16-00454"><label>469.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>R.</given-names></name><name name-style="western"><surname>Yao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ren</surname><given-names>G.</given-names></name></person-group><article-title>Antidiabetic Activity of Isoquercetin in Diabetic KK -A y Mice</article-title><source>Nutr. Metab.</source><year>2011</year><volume>8</volume><fpage>85</fpage><pub-id pub-id-type="doi">10.1186/1743-7075-8-85</pub-id><pub-id pub-id-type="pmcid">PMC3245443</pub-id><pub-id pub-id-type="pmid">22133267</pub-id></element-citation></ref><ref id="B470-pharmaceutics-16-00454"><label>470.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jayachandran</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ganesan</surname><given-names>K.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>B.</given-names></name><name name-style="western"><surname>Chung</surname><given-names>S.S.M.</given-names></name></person-group><article-title>Isoquercetin Ameliorates Hyperglycemia and Regulates Key Enzymes of Glucose Metabolism via Insulin Signaling Pathway in Streptozotocin-Induced Diabetic Rats</article-title><source>Eur. J. Pharmacol.</source><year>2018</year><volume>829</volume><fpage>112</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2018.04.015</pub-id><pub-id pub-id-type="pmid">29665363</pub-id></element-citation></ref><ref id="B471-pharmaceutics-16-00454"><label>471.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ajiboye</surname><given-names>T.O.</given-names></name><name name-style="western"><surname>Ajala-Lawal</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Adeyiga</surname><given-names>A.B.</given-names></name></person-group><article-title>Caffeic Acid Abrogates 1,3-Dichloro-2-Propanol-Induced Hepatotoxicity by Upregulating Nuclear Erythroid-Related Factor 2 and Downregulating Nuclear Factor-Kappa B</article-title><source>Hum. Exp. Toxicol.</source><year>2019</year><volume>38</volume><fpage>1092</fpage><lpage>1101</lpage><pub-id pub-id-type="doi">10.1177/0960327119851257</pub-id><pub-id pub-id-type="pmid">31142131</pub-id></element-citation></ref><ref id="B472-pharmaceutics-16-00454"><label>472.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ayyoub</surname><given-names>S.</given-names></name><name name-style="western"><surname>Al-Trad</surname><given-names>B.</given-names></name><name name-style="western"><surname>Aljabali</surname><given-names>A.A.A.</given-names></name><name name-style="western"><surname>Alshaer</surname><given-names>W.</given-names></name><name name-style="western"><surname>Al Zoubi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Omari</surname><given-names>S.</given-names></name><name name-style="western"><surname>Fayyad</surname><given-names>D.</given-names></name><name name-style="western"><surname>Tambuwala</surname><given-names>M.M.</given-names></name></person-group><article-title>Biosynthesis of Gold Nanoparticles Using Leaf Extract of <italic toggle="yes">Dittrichia viscosa</italic> and In Vivo Assessment of Its Anti-Diabetic Efficacy</article-title><source>Drug Deliv. Transl. Res.</source><year>2022</year><volume>12</volume><fpage>2993</fpage><pub-id pub-id-type="doi">10.1007/s13346-022-01163-0</pub-id><pub-id pub-id-type="pmid">35499716</pub-id><pub-id pub-id-type="pmcid">PMC9636081</pub-id></element-citation></ref><ref id="B473-pharmaceutics-16-00454"><label>473.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zeggwagh</surname><given-names>N.A.</given-names></name><name name-style="western"><surname>Ouahidi</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Lemhadri</surname><given-names>A.</given-names></name><name name-style="western"><surname>Eddouks</surname><given-names>M.</given-names></name></person-group><article-title>Study of Hypoglycaemic and Hypolipidemic Effects of <italic toggle="yes">Inula viscosa</italic> L. Aqueous Extract in Normal and Diabetic Rats</article-title><source>J. Ethnopharmacol.</source><year>2006</year><volume>108</volume><fpage>223</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2006.05.005</pub-id><pub-id pub-id-type="pmid">16787724</pub-id></element-citation></ref><ref id="B474-pharmaceutics-16-00454"><label>474.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mostafa</surname><given-names>I.</given-names></name><name name-style="western"><surname>El-Aziz</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Hafez</surname><given-names>S.</given-names></name><name name-style="western"><surname>El-Shazly</surname><given-names>A.</given-names></name></person-group><article-title>Chemical Constituents and Biological Activities of <italic toggle="yes">Galinsoga parviflora</italic> Cav. (<italic toggle="yes">Asteraceae</italic>) from Egypt</article-title><source>Z. Fur Naturforschung C</source><year>2013</year><volume>68</volume><fpage>285</fpage><lpage>292</lpage><pub-id pub-id-type="doi">10.5560/ZNC.2013.68c0285</pub-id><pub-id pub-id-type="pmid">24066513</pub-id></element-citation></ref><ref id="B475-pharmaceutics-16-00454"><label>475.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salih</surname><given-names>B.A.</given-names></name></person-group><article-title>Effect of <italic toggle="yes">Lactuca serriola</italic> on &#946;-Cell Dysfunction and Glucose Tolerance Induced by High Sucrose Fed in Albino Rats</article-title><source>J. Phys. Conf. Ser.</source><year>2019</year><volume>1294</volume><fpage>062092</fpage><pub-id pub-id-type="doi">10.1088/1742-6596/1294/6/062092</pub-id></element-citation></ref><ref id="B476-pharmaceutics-16-00454"><label>476.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sharef</surname><given-names>A.Y.</given-names></name><name name-style="western"><surname>Hamdi</surname><given-names>B.A.</given-names></name><name name-style="western"><surname>Alrawi</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>H.O.</given-names></name></person-group><article-title><italic toggle="yes">Onopordum acanthium</italic> L. Extract Attenuates Pancreatic &#946;-Cells and Cardiac Inflammation in Streptozocin-Induced Diabetic Rats</article-title><source>PLoS ONE</source><year>2023</year><volume>18</volume><elocation-id>e0280464</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0280464</pub-id><pub-id pub-id-type="pmid">36696433</pub-id><pub-id pub-id-type="pmcid">PMC9876371</pub-id></element-citation></ref><ref id="B477-pharmaceutics-16-00454"><label>477.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sanad</surname><given-names>F.A.A.</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>S.F.</given-names></name><name name-style="western"><surname>El-Tantawy</surname><given-names>W.H.</given-names></name></person-group><article-title>Antidiabetic and Hypolipidemic Potentials of <italic toggle="yes">Solidago virgaurea</italic> Extract in Alloxan-Induced Diabetes Type 1</article-title><source>Arch. Physiol. Biochem.</source><year>2022</year><volume>128</volume><fpage>716</fpage><lpage>723</lpage><pub-id pub-id-type="doi">10.1080/13813455.2020.1722705</pub-id><pub-id pub-id-type="pmid">32026741</pub-id></element-citation></ref><ref id="B478-pharmaceutics-16-00454"><label>478.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khan</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Shah</surname><given-names>N.A.</given-names></name><name name-style="western"><surname>Sahreen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Siddiq</surname><given-names>P.</given-names></name></person-group><article-title>Modulation of Carbon Tetrachloride-Induced Nephrotoxicity in Rats by n-Hexane Extract of <italic toggle="yes">Sonchus asper</italic></article-title><source>Toxicol. Ind. Health</source><year>2015</year><volume>31</volume><fpage>955</fpage><lpage>959</lpage><pub-id pub-id-type="doi">10.1177/0748233713485885</pub-id><pub-id pub-id-type="pmid">23589407</pub-id></element-citation></ref><ref id="B479-pharmaceutics-16-00454"><label>479.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Teugwa</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Mejiato</surname><given-names>P.C.</given-names></name><name name-style="western"><surname>Zofou</surname><given-names>D.</given-names></name><name name-style="western"><surname>Tchinda</surname><given-names>B.T.</given-names></name><name name-style="western"><surname>Boyom</surname><given-names>F.F.</given-names></name></person-group><article-title>Antioxidant and Antidiabetic Profiles of Two African Medicinal Plants: Picralima Nitida (Apocynaceae) and <italic toggle="yes">Sonchus oleraceus</italic> (<italic toggle="yes">Asteraceae</italic>)</article-title><source>BMC Complement. Altern. Med.</source><year>2013</year><volume>13</volume><elocation-id>175</elocation-id><pub-id pub-id-type="doi">10.1186/1472-6882-13-175</pub-id><pub-id pub-id-type="pmid">23855679</pub-id><pub-id pub-id-type="pmcid">PMC3718716</pub-id></element-citation></ref><ref id="B480-pharmaceutics-16-00454"><label>480.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>L.</given-names></name><name name-style="western"><surname>Fan</surname><given-names>X.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>X.</given-names></name><name name-style="western"><surname>Qian</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zengin</surname><given-names>G.</given-names></name><name name-style="western"><surname>Delmas</surname><given-names>D.</given-names></name><name name-style="western"><surname>Paoli</surname><given-names>P.</given-names></name><name name-style="western"><surname>Teng</surname><given-names>H.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>J.</given-names></name></person-group><article-title>Phenolic Extract from <italic toggle="yes">Sonchus oleraceus</italic> L. Protects Diabetes-Related Liver Injury in Rats through TLR4/NF-&#954;B Signaling Pathway</article-title><source>eFood</source><year>2020</year><volume>1</volume><fpage>77</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.2991/efood.k.191018.002</pub-id></element-citation></ref><ref id="B481-pharmaceutics-16-00454"><label>481.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salim</surname><given-names>N.S.</given-names></name><name name-style="western"><surname>Abdel-Alim</surname><given-names>M.</given-names></name><name name-style="western"><surname>Said</surname><given-names>H.E.M.</given-names></name><name name-style="western"><surname>Foda</surname><given-names>M.F.</given-names></name></person-group><article-title>Phenolic Profiles, Antihyperglycemic, Anti-Diabetic, and Antioxidant Properties of Egyptian <italic toggle="yes">Sonchus oleraceus</italic> Leaves Extract: An In Vivo Study</article-title><source>Molecules</source><year>2023</year><volume>28</volume><elocation-id>6389</elocation-id><pub-id pub-id-type="doi">10.3390/molecules28176389</pub-id><pub-id pub-id-type="pmid">37687218</pub-id><pub-id pub-id-type="pmcid">PMC10489745</pub-id></element-citation></ref><ref id="B482-pharmaceutics-16-00454"><label>482.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sebai</surname><given-names>H.</given-names></name><name name-style="western"><surname>Selmi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rtibi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Souli</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gharbi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Sakly</surname><given-names>M.</given-names></name></person-group><article-title>Lavender (<italic toggle="yes">Lavandula stoechas</italic> L.) Essential Oils Attenuate Hyperglycemia and Protect against Oxidative Stress in Alloxan-Induced Diabetic Rats</article-title><source>Lipids Health Dis.</source><year>2013</year><volume>12</volume><fpage>189</fpage><pub-id pub-id-type="doi">10.1186/1476-511X-12-189</pub-id><pub-id pub-id-type="pmid">24373672</pub-id><pub-id pub-id-type="pmcid">PMC3880178</pub-id></element-citation></ref><ref id="B483-pharmaceutics-16-00454"><label>483.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sebai</surname><given-names>H.</given-names></name><name name-style="western"><surname>Selmi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rtibi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Gharbi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Sakly</surname><given-names>M.</given-names></name></person-group><article-title>Protective Effect of <italic toggle="yes">Lavandula stoechas</italic> and <italic toggle="yes">Rosmarinus officinalis</italic> Essential Oils Against Reproductive Damage and Oxidative Stress in Alloxan-Induced Diabetic Rats</article-title><source>J. Med. Food</source><year>2015</year><volume>18</volume><fpage>241</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1089/jmf.2014.0040</pub-id><pub-id pub-id-type="pmid">25105335</pub-id></element-citation></ref><ref id="B484-pharmaceutics-16-00454"><label>484.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mustafa</surname><given-names>S.B.</given-names></name><name name-style="western"><surname>Akram</surname><given-names>M.</given-names></name><name name-style="western"><surname>Muhammad Asif</surname><given-names>H.</given-names></name><name name-style="western"><surname>Qayyum</surname><given-names>I.</given-names></name><name name-style="western"><surname>Hashmi</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Munir</surname><given-names>N.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>F.S.</given-names></name><name name-style="western"><surname>Riaz</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>S.</given-names></name></person-group><article-title>Antihyperglycemic Activity of Hydroalcoholic Extracts of Selective Medicinal Plants <italic toggle="yes">Curcuma longa</italic>, <italic toggle="yes">Lavandula stoechas</italic>, <italic toggle="yes">Aegle marmelos</italic>, and <italic toggle="yes">Glycyrrhiza glabra</italic> and Their Polyherbal Preparation in Alloxan-Induced Diabetic Mice</article-title><source>Dose-Response</source><year>2019</year><volume>17</volume><fpage>1559325819852503</fpage><pub-id pub-id-type="doi">10.1177/1559325819852503</pub-id><pub-id pub-id-type="pmid">31191187</pub-id><pub-id pub-id-type="pmcid">PMC6539569</pub-id></element-citation></ref><ref id="B485-pharmaceutics-16-00454"><label>485.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Demir</surname><given-names>D.</given-names></name><name name-style="western"><surname>Toygar</surname><given-names>I.</given-names></name><name name-style="western"><surname>Soylu</surname><given-names>E.</given-names></name><name name-style="western"><surname>Aksu</surname><given-names>A.T.</given-names></name><name name-style="western"><surname>T&#252;reyen</surname><given-names>A.</given-names></name><name name-style="western"><surname>Y&#305;ld&#305;r&#305;m</surname><given-names>I.</given-names></name><name name-style="western"><surname>&#199;etinkalp</surname><given-names>&#350;.</given-names></name></person-group><article-title>The Effect of <italic toggle="yes">Lavandula stoechas</italic> on Wound Healing in an Experimental Diabetes Model</article-title><source>Cureus</source><year>2023</year><volume>15</volume><fpage>e45001</fpage><pub-id pub-id-type="doi">10.7759/cureus.45001</pub-id><pub-id pub-id-type="pmid">37829966</pub-id><pub-id pub-id-type="pmcid">PMC10565121</pub-id></element-citation></ref><ref id="B486-pharmaceutics-16-00454"><label>486.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chung</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Cho</surname><given-names>S.Y.</given-names></name><name name-style="western"><surname>Bhuiyan</surname><given-names>M.J.H.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>K.H.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.J.</given-names></name></person-group><article-title>Anti-Diabetic Effects of Lemon Balm (<italic toggle="yes">Melissa officinalis</italic>) Essential Oil on Glucose- and Lipid-Regulating Enzymes in Type 2 Diabetic Mice</article-title><source>Br. J. Nutr.</source><year>2010</year><volume>104</volume><fpage>180</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1017/S0007114510001765</pub-id><pub-id pub-id-type="pmid">20487577</pub-id></element-citation></ref><ref id="B487-pharmaceutics-16-00454"><label>487.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weidner</surname><given-names>C.</given-names></name><name name-style="western"><surname>Wowro</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Freiwald</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kodelja</surname><given-names>V.</given-names></name><name name-style="western"><surname>Abdel-Aziz</surname><given-names>H.</given-names></name><name name-style="western"><surname>Kelber</surname><given-names>O.</given-names></name><name name-style="western"><surname>Sauer</surname><given-names>S.</given-names></name></person-group><article-title>Lemon Balm Extract Causes Potent Antihyperglycemic and Antihyperlipidemic Effects in Insulin-Resistant Obese Mice</article-title><source>Mol. Nutr. Food Res.</source><year>2014</year><volume>58</volume><fpage>903</fpage><lpage>907</lpage><pub-id pub-id-type="doi">10.1002/mnfr.201300477</pub-id><pub-id pub-id-type="pmid">24272914</pub-id></element-citation></ref><ref id="B488-pharmaceutics-16-00454"><label>488.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hasanein</surname><given-names>P.</given-names></name><name name-style="western"><surname>Riahi</surname><given-names>H.</given-names></name></person-group><article-title>Antinociceptive and Antihyperglycemic Effects of <italic toggle="yes">Melissa officinalis</italic> Essential Oil in an Experimental Model of Diabetes</article-title><source>Med. Princ. Pract.</source><year>2015</year><volume>24</volume><fpage>47</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1159/000368755</pub-id><pub-id pub-id-type="pmid">25402675</pub-id><pub-id pub-id-type="pmcid">PMC5588194</pub-id></element-citation></ref><ref id="B489-pharmaceutics-16-00454"><label>489.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moshtaghian</surname><given-names>J.</given-names></name><name name-style="western"><surname>Khodsooz</surname><given-names>S.</given-names></name><name name-style="western"><surname>Moshtaghian</surname><given-names>J.</given-names></name><name name-style="western"><surname>Eivani</surname><given-names>M.</given-names></name></person-group><article-title>Antihyperglycemic and Antihyperlipidemic Effects of Hydroalcoholic Extract of <italic toggle="yes">Melissa officinalis</italic> (Lemon Balm) in Alloxan-Induced Diabetic Rats</article-title><source>Physiol. Pharmacol.</source><year>2016</year><volume>20</volume><fpage>24</fpage><lpage>30</lpage></element-citation></ref><ref id="B490-pharmaceutics-16-00454"><label>490.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>D.</given-names></name><name name-style="western"><surname>Shin</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Roh</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Ahn</surname><given-names>J.</given-names></name><name name-style="western"><surname>Jeoong</surname><given-names>S.</given-names></name><name name-style="western"><surname>Shin</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>M.</given-names></name></person-group><article-title>Lemon Balm Extract ALS-L1023 Regulates Obesity and Improves Insulin Sensitivity via Activation of Hepatic PPAR&#945; in High-Fat Diet-Fed Obese C57BL/6J Mice</article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><elocation-id>4256</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21124256</pub-id><pub-id pub-id-type="pmid">32549364</pub-id><pub-id pub-id-type="pmcid">PMC7352304</pub-id><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="retraction-forward" ext-link-type="pmc" xlink:href="PMC11831240"/></element-citation></ref><ref id="B491-pharmaceutics-16-00454"><label>491.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shin</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ahn</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>M.</given-names></name><name name-style="western"><surname>Shin</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>M.</given-names></name></person-group><article-title>The Herbal Extract ALS-L1023 from <italic toggle="yes">Melissa officinalis</italic> Reduces Weight Gain, Elevated Glucose Levels and &#946;-Cell Loss in Otsuka Long-Evans Tokushima Fatty Rats</article-title><source>J. Ethnopharmacol.</source><year>2021</year><volume>264</volume><fpage>113360</fpage><pub-id pub-id-type="doi">10.1016/j.jep.2020.113360</pub-id><pub-id pub-id-type="pmid">32918993</pub-id></element-citation></ref><ref id="B492-pharmaceutics-16-00454"><label>492.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yellanur Konda</surname><given-names>P.</given-names></name><name name-style="western"><surname>Egi</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Dasari</surname><given-names>S.</given-names></name><name name-style="western"><surname>Katepogu</surname><given-names>R.</given-names></name><name name-style="western"><surname>Jaiswal</surname><given-names>K.K.</given-names></name><name name-style="western"><surname>Nagarajan</surname><given-names>P.</given-names></name></person-group><article-title>Ameliorative Effects of <italic toggle="yes">Mentha aquatica</italic> on Diabetic and Nephroprotective Potential Activities in STZ-Induced Renal Injury</article-title><source>Comp. Clin. Pathol.</source><year>2020</year><volume>29</volume><fpage>189</fpage><lpage>199</lpage><pub-id pub-id-type="doi">10.1007/s00580-019-03042-6</pub-id></element-citation></ref><ref id="B493-pharmaceutics-16-00454"><label>493.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Farid</surname><given-names>O.</given-names></name><name name-style="western"><surname>Zeggwagh</surname><given-names>N.A.</given-names></name><name name-style="western"><surname>Ouadi</surname><given-names>F.E.L.</given-names></name><name name-style="western"><surname>Eddouks</surname><given-names>M.</given-names></name></person-group><article-title><italic toggle="yes">Mentha pulegium</italic> Aqueous Extract Exhibits Antidiabetic and Hepatoprotective Effects in Streptozotocin-Induced Diabetic Rats</article-title><source>Endocr. Metab. Immune Disord. Drug Targets</source><year>2018</year><volume>19</volume><fpage>292</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.2174/1871530318666181005102247</pub-id><pub-id pub-id-type="pmid">30289084</pub-id></element-citation></ref><ref id="B494-pharmaceutics-16-00454"><label>494.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Farid</surname><given-names>O.</given-names></name><name name-style="western"><surname>Eddouks</surname><given-names>M.</given-names></name></person-group><article-title>Evaluation of the Anti-Hypercholesterolemic and Antioxidant Activity of <italic toggle="yes">Mentha pulegium</italic> (L.) Aqueous Extract in Normal and Streptozotocin-Induced Diabetic Rats</article-title><source>Nat. Prod. J.</source><year>2019</year><volume>10</volume><fpage>236</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.2174/1574893614666190103101527</pub-id></element-citation></ref><ref id="B495-pharmaceutics-16-00454"><label>495.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ajebli</surname><given-names>M.</given-names></name><name name-style="western"><surname>Eddouks</surname><given-names>M.</given-names></name></person-group><article-title>Pharmacological and Phytochemical Study of <italic toggle="yes">Mentha suaveolens</italic> Ehrh in Normal and Streptozotocin-Induced Diabetic Rats</article-title><source>Nat. Prod. J.</source><year>2018</year><volume>8</volume><fpage>213</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.2174/2210315508666180327120434</pub-id></element-citation></ref><ref id="B496-pharmaceutics-16-00454"><label>496.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lemhadri</surname><given-names>A.</given-names></name><name name-style="western"><surname>Zeggwagh</surname><given-names>N.A.</given-names></name><name name-style="western"><surname>Maghrani</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jouad</surname><given-names>H.</given-names></name><name name-style="western"><surname>Eddouks</surname><given-names>M.</given-names></name></person-group><article-title>Anti-Hyperglycaemic Activity of the Aqueous Extract of <italic toggle="yes">Origanum vulgare</italic> Growing Wild in Tafilalet Region</article-title><source>J. Ethnopharmacol.</source><year>2004</year><volume>92</volume><fpage>251</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2004.02.026</pub-id><pub-id pub-id-type="pmid">15138008</pub-id></element-citation></ref><ref id="B497-pharmaceutics-16-00454"><label>497.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohamed</surname><given-names>N.A.</given-names></name><name name-style="western"><surname>Nassier</surname><given-names>O.A.</given-names></name></person-group><article-title>The Antihyperglycaemic Effect of the Aqueous Extract of <italic toggle="yes">Origanium vulgare</italic> Leaves in Streptozotocin-Induced Diabetic Rats</article-title><source>Jordan J. Biol. Sci.</source><year>2013</year><volume>6</volume><fpage>31</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.12816/0000256</pub-id></element-citation></ref><ref id="B498-pharmaceutics-16-00454"><label>498.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vujicic</surname><given-names>M.</given-names></name><name name-style="western"><surname>Nikolic</surname><given-names>I.</given-names></name><name name-style="western"><surname>Kontogianni</surname><given-names>V.G.</given-names></name><name name-style="western"><surname>Saksida</surname><given-names>T.</given-names></name><name name-style="western"><surname>Charisiadis</surname><given-names>P.</given-names></name><name name-style="western"><surname>Vasic</surname><given-names>B.</given-names></name><name name-style="western"><surname>Stosic-Grujicic</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gerothanassis</surname><given-names>I.P.</given-names></name><name name-style="western"><surname>Tzakos</surname><given-names>A.G.</given-names></name><name name-style="western"><surname>Stojanovic</surname><given-names>I.</given-names></name></person-group><article-title>Ethyl Acetate Extract of <italic toggle="yes">Origanum vulgare</italic> L. Ssp. Hirtum Prevents Streptozotocin-Induced Diabetes in C57BL/6 Mice</article-title><source>J. Food Sci.</source><year>2016</year><volume>81</volume><fpage>H1846</fpage><lpage>H1853</lpage><pub-id pub-id-type="doi">10.1111/1750-3841.13333</pub-id><pub-id pub-id-type="pmid">27219840</pub-id></element-citation></ref><ref id="B499-pharmaceutics-16-00454"><label>499.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prasanna</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ashraf</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Essam</surname><given-names>M.A.</given-names></name></person-group><article-title>Chamomile and Oregano Extracts Synergistically Exhibit Antihyperglycemic, Antihyperlipidemic, and Renal Protective Effects in Alloxan-Induced Diabetic Rats</article-title><source>Can. J. Physiol. Pharmacol.</source><year>2017</year><volume>95</volume><fpage>84</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1139/cjpp-2016-0189</pub-id><pub-id pub-id-type="pmid">27875075</pub-id></element-citation></ref><ref id="B500-pharmaceutics-16-00454"><label>500.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martha erez Guti errez</surname><given-names>R.P.</given-names></name><name name-style="western"><surname>Fernando Mart&#237;nez Jer onimo</surname><given-names>F.</given-names></name><name name-style="western"><surname>Guadalupe Contreras Soto</surname><given-names>J.</given-names></name><name name-style="western"><surname>Mu</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ram&#237;rez</surname><given-names>N.</given-names></name><name name-style="western"><surname>Fernanda Estrella Mendoza</surname><given-names>M.</given-names></name></person-group><article-title>Optimization of Ultrasonic-Assisted Extraction of Polyphenols from the Polyherbal Formulation of <italic toggle="yes">Cinnamomum verum</italic>, <italic toggle="yes">Origanum majorana</italic>, and <italic toggle="yes">Origanum vulgare</italic> and Their Anti-Diabetic Capacity in Zebrafish (<italic toggle="yes">Danio rerio</italic>)</article-title><source>Heliyon</source><year>2017</year><volume>8</volume><fpage>e08682</fpage><pub-id pub-id-type="doi">10.1016/j.heliyon.2021.e08682</pub-id><pub-id pub-id-type="pmcid">PMC8749454</pub-id><pub-id pub-id-type="pmid">35036595</pub-id></element-citation></ref><ref id="B501-pharmaceutics-16-00454"><label>501.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silva</surname><given-names>M.L.A.E.</given-names></name><name name-style="western"><surname>Lucarini</surname><given-names>R.</given-names></name><name name-style="western"><surname>dos Santos</surname><given-names>F.F.</given-names></name><name name-style="western"><surname>Martins</surname><given-names>C.H.G.</given-names></name><name name-style="western"><surname>Pauletti</surname><given-names>P.M.</given-names></name><name name-style="western"><surname>Januario</surname><given-names>A.H.</given-names></name><name name-style="western"><surname>Santos</surname><given-names>M.F.C.</given-names></name><name name-style="western"><surname>Cunha</surname><given-names>W.R.</given-names></name></person-group><article-title>Hypoglycemic Effect of Rosmarinic Acid-Rich Infusion (RosCE) from <italic toggle="yes">Origanum vulgare</italic> in Alloxan-Induced Diabetic Rats</article-title><source>Nat. Prod. Res.</source><year>2022</year><volume>36</volume><fpage>4525</fpage><lpage>4531</lpage><pub-id pub-id-type="doi">10.1080/14786419.2021.1990282</pub-id><pub-id pub-id-type="pmid">34647501</pub-id></element-citation></ref><ref id="B502-pharmaceutics-16-00454"><label>502.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hwang</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>Y.J.</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Kang</surname><given-names>D.G.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>H.S.</given-names></name></person-group><article-title>Anti-Diabetic Atherosclerosis Effect of <italic toggle="yes">Prunella vulgaris</italic> in Db/Db Mice with Type 2 Diabetes</article-title><source>Am. J. Chin. Med.</source><year>2012</year><volume>40</volume><fpage>937</fpage><lpage>951</lpage><pub-id pub-id-type="doi">10.1142/S0192415X12500693</pub-id><pub-id pub-id-type="pmid">22928826</pub-id></element-citation></ref><ref id="B503-pharmaceutics-16-00454"><label>503.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>Q.X.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>F.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>J.G.</given-names></name><name name-style="western"><surname>Gu</surname><given-names>Z.L.</given-names></name><name name-style="western"><surname>Gu</surname><given-names>G.X.</given-names></name></person-group><article-title>Effects of Triterpenic Acid from <italic toggle="yes">Prunella vulgaris</italic> L. On Glycemia and Pancreas in Rat Model of Streptozotozin Diabetes</article-title><source>Chin. Med. J.</source><year>2013</year><volume>126</volume><fpage>1647</fpage><lpage>1653</lpage><pub-id pub-id-type="doi">10.3760/cma.j.issn.0366-6999.20121860</pub-id><pub-id pub-id-type="pmid">23652045</pub-id></element-citation></ref><ref id="B504-pharmaceutics-16-00454"><label>504.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>O.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Cai</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>R.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>F.</given-names></name><name name-style="western"><surname>Ji</surname><given-names>B.</given-names></name></person-group><article-title>Anti-Diabetic Effects of the Ethanol Extract of a Functional Formula Diet in Mice Fed with a Fructose/Fat-Rich Combination Diet</article-title><source>J. Sci. Food Agric.</source><year>2015</year><volume>95</volume><fpage>401</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1002/jsfa.6737</pub-id><pub-id pub-id-type="pmid">24817112</pub-id></element-citation></ref><ref id="B505-pharmaceutics-16-00454"><label>505.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Namgung</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>Han</surname><given-names>B.H.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>E.S.</given-names></name><name name-style="western"><surname>Oh</surname><given-names>H.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>Y.C.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>Y.J.</given-names></name><name name-style="western"><surname>Kang</surname><given-names>D.G.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>H.S.</given-names></name></person-group><article-title><italic toggle="yes">Prunella vulgaris</italic> Attenuates Diabetic Renal Injury by Suppressing Glomerular Fibrosis and Inflammation</article-title><source>Am. J. Chin. Med.</source><year>2017</year><volume>45</volume><fpage>475</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1142/S0192415X1750029X</pub-id><pub-id pub-id-type="pmid">28359196</pub-id></element-citation></ref><ref id="B506-pharmaceutics-16-00454"><label>506.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Upson</surname><given-names>T.</given-names></name><name name-style="western"><surname>Andrews</surname><given-names>S.</given-names></name><name name-style="western"><surname>Royal Botanic Gardens</surname><given-names>K.</given-names></name></person-group><source>The Genus Lavandula</source><publisher-name>Timber Pr</publisher-name><publisher-loc>Springfield, OR, USA</publisher-loc><year>2004</year><fpage>442</fpage></element-citation></ref><ref id="B507-pharmaceutics-16-00454"><label>507.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sahranavard</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ghafari</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mosaddegh</surname><given-names>M.</given-names></name></person-group><article-title>Medicinal Plants Used in Iranian Traditional Medicine to Treat Epilepsy</article-title><source>Seizure</source><year>2014</year><volume>23</volume><fpage>328</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1016/j.seizure.2014.01.013</pub-id><pub-id pub-id-type="pmid">24525263</pub-id></element-citation></ref><ref id="B508-pharmaceutics-16-00454"><label>508.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cocco</surname><given-names>E.</given-names></name><name name-style="western"><surname>Maccioni</surname><given-names>D.</given-names></name><name name-style="western"><surname>Sanjust</surname><given-names>E.</given-names></name><name name-style="western"><surname>Falconieri</surname><given-names>D.</given-names></name><name name-style="western"><surname>Farris</surname><given-names>E.</given-names></name><name name-style="western"><surname>Maxia</surname><given-names>A.</given-names></name></person-group><article-title>Ethnopharmacobotany and Diversity of Mediterranean Endemic Plants in Marmilla Subregion, Sardinia, Italy</article-title><source>Plants</source><year>2022</year><volume>11</volume><elocation-id>3165</elocation-id><pub-id pub-id-type="doi">10.3390/plants11223165</pub-id><pub-id pub-id-type="pmid">36432894</pub-id><pub-id pub-id-type="pmcid">PMC9695302</pub-id></element-citation></ref><ref id="B509-pharmaceutics-16-00454"><label>509.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nayebi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Esteghamati</surname><given-names>A.</given-names></name><name name-style="western"><surname>Meysamie</surname><given-names>A.</given-names></name><name name-style="western"><surname>Khalili</surname><given-names>N.</given-names></name><name name-style="western"><surname>Kamalinejad</surname><given-names>M.</given-names></name><name name-style="western"><surname>Emtiazy</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hashempur</surname><given-names>M.H.</given-names></name></person-group><article-title>The Effects of a <italic toggle="yes">Melissa officinalis</italic> L. Based Product on Metabolic Parameters in Patients with Type 2 Diabetes Mellitus: A Randomized Double-Blinded Controlled Clinical Trial</article-title><source>J. Complement. Integr. Med.</source><year>2019</year><volume>16</volume><fpage>20180088</fpage><pub-id pub-id-type="doi">10.1515/jcim-2018-0088</pub-id><pub-id pub-id-type="pmid">30681971</pub-id></element-citation></ref><ref id="B510-pharmaceutics-16-00454"><label>510.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Asadi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Shidfar</surname><given-names>F.</given-names></name><name name-style="western"><surname>Safari</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hosseini</surname><given-names>A.F.</given-names></name><name name-style="western"><surname>Fallah Huseini</surname><given-names>H.</given-names></name><name name-style="western"><surname>Heidari</surname><given-names>I.</given-names></name><name name-style="western"><surname>Rajab</surname><given-names>A.</given-names></name></person-group><article-title>Efficacy of <italic toggle="yes">Melissa officinalis</italic> L. (Lemon Balm) Extract on Glycemic Control and Cardiovascular Risk Factors in Individuals with Type 2 Diabetes: A Randomized, Double-Blind, Clinical Trial</article-title><source>Phytother. Res.</source><year>2019</year><volume>33</volume><fpage>651</fpage><lpage>659</lpage><pub-id pub-id-type="doi">10.1002/ptr.6254</pub-id><pub-id pub-id-type="pmid">30548118</pub-id></element-citation></ref><ref id="B511-pharmaceutics-16-00454"><label>511.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoon</surname><given-names>M.</given-names></name></person-group><article-title>The Role of PPAR&#945; in Lipid Metabolism and Obesity: Focusing on the Effects of Estrogen on PPAR&#945; Actions</article-title><source>Pharmacol. Res.</source><year>2009</year><volume>60</volume><fpage>151</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1016/j.phrs.2009.02.004</pub-id><pub-id pub-id-type="pmid">19646654</pub-id></element-citation></ref><ref id="B512-pharmaceutics-16-00454"><label>512.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoon</surname><given-names>M.</given-names></name></person-group><article-title>PPAR in Obesity: Sex Difference and Estrogen Involvement</article-title><source>PPAR Res.</source><year>2010</year><volume>2010</volume><fpage>584296</fpage><pub-id pub-id-type="doi">10.1155/2010/584296</pub-id><pub-id pub-id-type="pmid">20871824</pub-id><pub-id pub-id-type="pmcid">PMC2943125</pub-id></element-citation></ref><ref id="B513-pharmaceutics-16-00454"><label>513.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>P.</given-names></name><name name-style="western"><surname>Mishra</surname><given-names>S.</given-names></name><name name-style="western"><surname>Malik</surname><given-names>A.</given-names></name><name name-style="western"><surname>Satya</surname><given-names>S.</given-names></name></person-group><article-title>Insecticidal Properties of Mentha Species: A Review</article-title><source>Ind. Crops Prod.</source><year>2011</year><volume>34</volume><fpage>802</fpage><lpage>817</lpage><pub-id pub-id-type="doi">10.1016/j.indcrop.2011.02.019</pub-id></element-citation></ref><ref id="B514-pharmaceutics-16-00454"><label>514.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Peter</surname><given-names>K.</given-names></name></person-group><source>Handbook of Herbs and Spices</source><publisher-name>Woodhead Publishing</publisher-name><publisher-loc>Sawston, UK</publisher-loc><year>2006</year><volume>Volume 3</volume></element-citation></ref><ref id="B515-pharmaceutics-16-00454"><label>515.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rahman</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Dhar</surname><given-names>P.S.</given-names></name><collab>Sumaia</collab><name name-style="western"><surname>Anika</surname><given-names>F.</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>L.</given-names></name><name name-style="western"><surname>Islam</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Sultana</surname><given-names>N.A.</given-names></name><name name-style="western"><surname>Cavalu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Pop</surname><given-names>O.</given-names></name><name name-style="western"><surname>Rauf</surname><given-names>A.</given-names></name></person-group><article-title>Exploring the Plant-Derived Bioactive Substances as Antidiabetic Agent: An Extensive Review</article-title><source>Biomed. Pharmacother.</source><year>2022</year><volume>152</volume><elocation-id>113217</elocation-id><pub-id pub-id-type="doi">10.1016/j.biopha.2022.113217</pub-id><pub-id pub-id-type="pmid">35679719</pub-id></element-citation></ref><ref id="B516-pharmaceutics-16-00454"><label>516.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pereira</surname><given-names>A.S.P.</given-names></name><name name-style="western"><surname>Banegas-Luna</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Pe&#241;a-Garc&#237;a</surname><given-names>J.</given-names></name><name name-style="western"><surname>P&#233;rez-S&#225;nchez</surname><given-names>H.</given-names></name><name name-style="western"><surname>Apostolides</surname><given-names>Z.</given-names></name></person-group><article-title>Evaluation of the Anti-Diabetic Activity of Some Common Herbs and Spices: Providing New Insights with Inverse Virtual Screening</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>4030</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24224030</pub-id><pub-id pub-id-type="pmid">31703341</pub-id><pub-id pub-id-type="pmcid">PMC6891552</pub-id></element-citation></ref><ref id="B517-pharmaceutics-16-00454"><label>517.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>A.-K.</given-names></name><name name-style="western"><surname>Yadav</surname><given-names>D.</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>N.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>J.-O.</given-names></name><name name-style="western"><surname>Dipeptidyl</surname><given-names>J.</given-names></name></person-group><article-title>Dipeptidyl Peptidase (DPP)-IV Inhibitors with Antioxidant Potential Isolated from Natural Sources: A Novel Approach for the Management of Diabetes</article-title><source>Pharmaceuticals</source><year>2021</year><volume>14</volume><elocation-id>586</elocation-id><pub-id pub-id-type="doi">10.3390/ph14060586</pub-id><pub-id pub-id-type="pmid">34207217</pub-id><pub-id pub-id-type="pmcid">PMC8234173</pub-id></element-citation></ref><ref id="B518-pharmaceutics-16-00454"><label>518.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liao</surname><given-names>H.J.</given-names></name><name name-style="western"><surname>Tzen</surname><given-names>J.T.C.</given-names></name></person-group><article-title>The Potential Role of Cyclopeptides from <italic toggle="yes">Pseudostellaria heterophylla</italic>, <italic toggle="yes">Linum usitatissimum</italic> and <italic toggle="yes">Drymaria diandra</italic>, and Peptides Derived from Heterophyllin B as Dipeptidyl Peptidase IV Inhibitors for the Treatment of Type 2 Diabetes: An In Silico Study</article-title><source>Metabolites</source><year>2022</year><volume>12</volume><elocation-id>387</elocation-id><pub-id pub-id-type="doi">10.3390/metabo12050387</pub-id><pub-id pub-id-type="pmid">35629891</pub-id><pub-id pub-id-type="pmcid">PMC9146144</pub-id></element-citation></ref><ref id="B519-pharmaceutics-16-00454"><label>519.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scott</surname><given-names>L.J.</given-names></name></person-group><article-title>Sitagliptin: A Review in Type 2 Diabetes</article-title><source>Drugs</source><year>2017</year><volume>77</volume><fpage>209</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.1007/s40265-016-0686-9</pub-id><pub-id pub-id-type="pmid">28078647</pub-id></element-citation></ref><ref id="B520-pharmaceutics-16-00454"><label>520.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Godinho</surname><given-names>R.</given-names></name><name name-style="western"><surname>Mega</surname><given-names>C.</given-names></name><name name-style="western"><surname>Teixeira-De-Lemos</surname><given-names>E.</given-names></name><name name-style="western"><surname>Carvalho</surname><given-names>E.</given-names></name><name name-style="western"><surname>Teixeira</surname><given-names>F.</given-names></name><name name-style="western"><surname>Fernandes</surname><given-names>R.</given-names></name><name name-style="western"><surname>Reis</surname><given-names>F.</given-names></name></person-group><article-title>The Place of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Therapeutics: A &#8220;Me Too&#8221; or &#8220;the Special One&#8221; Antidiabetic Class?</article-title><source>J. Diabetes Res.</source><year>2015</year><volume>2015</volume><fpage>806979</fpage><pub-id pub-id-type="doi">10.1155/2015/806979</pub-id><pub-id pub-id-type="pmid">26075286</pub-id><pub-id pub-id-type="pmcid">PMC4449938</pub-id></element-citation></ref><ref id="B521-pharmaceutics-16-00454"><label>521.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klemann</surname><given-names>C.</given-names></name><name name-style="western"><surname>Wagner</surname><given-names>L.</given-names></name><name name-style="western"><surname>Stephan</surname><given-names>M.</given-names></name><name name-style="western"><surname>von H&#246;rsten</surname><given-names>S.</given-names></name></person-group><article-title>Cut to the Chase: A Review of CD26/Dipeptidyl Peptidase-4&#8242;s (DPP4) Entanglement in the Immune System</article-title><source>Clin. Exp. Immunol.</source><year>2016</year><volume>185</volume><fpage>1</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1111/cei.12781</pub-id><pub-id pub-id-type="pmid">26919392</pub-id><pub-id pub-id-type="pmcid">PMC4908298</pub-id></element-citation></ref><ref id="B522-pharmaceutics-16-00454"><label>522.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olennikov</surname><given-names>D.N.</given-names></name><name name-style="western"><surname>Shamilov</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Kashchenko</surname><given-names>N.I.</given-names></name></person-group><article-title>New Glycoside of Quercetin from the Genus <italic toggle="yes">Prunella</italic></article-title><source>Chem. Nat. Compd.</source><year>2023</year><volume>59</volume><fpage>647</fpage><lpage>650</lpage><pub-id pub-id-type="doi">10.1007/s10600-023-04078-5</pub-id></element-citation></ref><ref id="B523-pharmaceutics-16-00454"><label>523.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bai</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>B.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>W.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>H.</given-names></name><name name-style="western"><surname>Liao</surname><given-names>D.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>L.</given-names></name><name name-style="western"><surname>Li</surname><given-names>C.</given-names></name></person-group><article-title>Phytochemistry and Pharmacological Activities of the Genus <italic toggle="yes">Prunella</italic></article-title><source>Food Chem.</source><year>2016</year><volume>204</volume><fpage>483</fpage><lpage>496</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2016.02.047</pub-id><pub-id pub-id-type="pmid">26988527</pub-id></element-citation></ref><ref id="B524-pharmaceutics-16-00454"><label>524.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pan</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name></person-group><article-title><italic toggle="yes">Prunella vulgaris</italic> L.&#8212;A Review of Its Ethnopharmacology, Phytochemistry, Quality Control and Pharmacological Effects</article-title><source>Front. Pharmacol.</source><year>2022</year><volume>13</volume><fpage>23</fpage><pub-id pub-id-type="doi">10.3389/fphar.2022.903171</pub-id><pub-id pub-id-type="pmcid">PMC9261270</pub-id><pub-id pub-id-type="pmid">35814234</pub-id></element-citation></ref><ref id="B525-pharmaceutics-16-00454"><label>525.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>National Health Commission</collab></person-group><source>List of New Food Materials and Common Foods</source><publisher-name>National Health Commission</publisher-name><publisher-loc>Beijing, China</publisher-loc><year>2016</year></element-citation></ref><ref id="B526-pharmaceutics-16-00454"><label>526.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Chinese Pharmacopoeia Commission</collab></person-group><source>The 2020 Edition of Pharmacopoeia of the People&#8217;s Republic of China</source><publisher-name>Chinese Pharmacopoeia Commission</publisher-name><publisher-loc>Beijing, China</publisher-loc><year>2020</year></element-citation></ref><ref id="B527-pharmaceutics-16-00454"><label>527.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>K.</given-names></name><name name-style="western"><surname>Hui-Xia</surname><given-names>Y.</given-names></name></person-group><article-title>Value of Fructosamine Measurement in Pregnant Women with Abnormal Glucose Tolerance</article-title><source>Chin. Med. J.</source><year>2006</year><volume>119</volume><fpage>1861</fpage><lpage>1865</lpage><pub-id pub-id-type="doi">10.1097/00029330-200611020-00003</pub-id><pub-id pub-id-type="pmid">17134583</pub-id></element-citation></ref><ref id="B528-pharmaceutics-16-00454"><label>528.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Katakami</surname><given-names>N.</given-names></name></person-group><article-title>Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus</article-title><source>J. Atheroscler. Thromb.</source><year>2018</year><volume>25</volume><fpage>27</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.5551/jat.RV17014</pub-id><pub-id pub-id-type="pmid">28966336</pub-id><pub-id pub-id-type="pmcid">PMC5770221</pub-id></element-citation></ref><ref id="B529-pharmaceutics-16-00454"><label>529.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>La Sala</surname><given-names>L.</given-names></name><name name-style="western"><surname>Prattichizz</surname><given-names>F.</given-names></name><name name-style="western"><surname>Ceriello</surname><given-names>A.</given-names></name></person-group><article-title>The Link between Diabetes and Atherosclerosis</article-title><source>Eur. J. Prev. Cardiol.</source><year>2019</year><volume>26</volume><fpage>15</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1177/2047487319878373</pub-id><pub-id pub-id-type="pmid">31722564</pub-id></element-citation></ref><ref id="B530-pharmaceutics-16-00454"><label>530.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Poznyak</surname><given-names>A.</given-names></name><name name-style="western"><surname>Grechko</surname><given-names>A.V.</given-names></name><name name-style="western"><surname>Poggio</surname><given-names>P.</given-names></name><name name-style="western"><surname>Myasoedova</surname><given-names>V.A.</given-names></name><name name-style="western"><surname>Alfieri</surname><given-names>V.</given-names></name><name name-style="western"><surname>Orekhov</surname><given-names>A.N.</given-names></name></person-group><article-title>The Diabetes Mellitus&#8211;Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation</article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><elocation-id>1835</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21051835</pub-id><pub-id pub-id-type="pmid">32155866</pub-id><pub-id pub-id-type="pmcid">PMC7084712</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="pharmaceutics-16-00454-f002" orientation="portrait"><label>Figure 2</label><caption><p>Diagram of the systematic literature review.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pharmaceutics-16-00454-g002.jpg"/></fig><fig position="float" id="pharmaceutics-16-00454-f003" orientation="portrait"><label>Figure 3</label><caption><p>Families containing the highest number of species with antidiabetic potential (out of 888) in NPSE.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pharmaceutics-16-00454-g003.jpg"/></fig></floats-group></article></pmc-articleset>